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Particle size reduction or comminution by milling is often required to enhance the 
bioavailability of pharmaceutical solid dosage formulations through increased 
dissolution rate or solubility inherent in small particulate powders
1-4
. However, these 
unit operations have the highest risk of inadvertently generating process induced 
disorder (PID) due to their intense mechanical nature and associated high processing 
input energies
5-10
. It is therefore important to develop strategies to control, characterise 
and optimise the particle properties to ensure the safety and quality of the final product.  
The work presented in this thesis describes a novel analytical approach using a 
combination of techniques and analytical responses to give a single normalised value 
that can be used to represent the relative level of disorder present in material due to a 
given process without the need for standard mixtures or calibration curves. 
A model set of 10 materials: salbutamol sulphate, loperamide HCl, γ-indomethacin, 
caffeine, sulfamerazine, sulfadiazine, acetylsalicylic acid, phenacetin, acetaminophen 
and methyl paraben were selected that encompassed the whole of the amorphous-
crystalline continuum when subjected to mechanical comminution. These materials 
were then characterised by a core set of techniques: X-ray powder diffraction (XRPD), 
gravimetric vapor sorption (GVS), differential scanning calorimetry (DSC), thermal 
gravimetric analysis, scanning electron microscopy, polarised light microscopy, particle 
size analysis, high performance liquid chromatography, and Fourier transform infrared 
spectroscopy both before and after comminution by ball- and jet-milling under different 
conditions.  
The presence of PID was identified and semi-quantified for each comminuted material 
based upon the relative changes in a combination of XRPD, DSC and GVS responses 
give a score (DPro) out of 10. The larger the DPro value the more likely disorder is 
present. This successfully allowed the materials to be ranked based on their relative PID 
contents and the effect of the different comminution processes to be assessed, 
confirming the validity of the new analytical approach. The high frequency ball-milled 
materials of salbutamol sulphate, loperamide HCl, and γ-indomethacin exhibited the 
highest levels of disorder (DPro 6 to 10), while phenacetin, acetaminophen and methyl 
paraben exhibited the least (DPro 0 to 3). The remaining materials exhibited some degree 
of disorder depending on the comminution process employed. High frequency ball-
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1 Introduction 
Drug products are typically solid dosage forms (inhaled powders or oral solid dose 
tablets or capsules) manufactured using powdered crystalline active pharmaceutical 
ingredients (APIs) due to their good physiochemical stability and ease of handling
11
. 
However, during the manufacturing of these pharmaceutical products, the crystalline 
API and associated excipients can be subjected to a number of thermal and mechanical 
unit operations (processes) that can cause process-induced phase transformations 
resulting in the formation of new solid-state forms or phases
11,12
. As a consequence, the 
physicochemical properties of the original starting material can be altered and this may 
ultimately change the pharmaceutical product’s physiochemical stability and therapeutic 
performance
13-17
. When the manufacturing process results in the inadvertent generation 
of disorder or the formation of amorphous domains, process induced disorder (PID) or 
mechanical activation is said to have occurred
17-28
. The amount of induced disorder will 
not only depend on the type and conditions of the pharmaceutical process employed but 
also on the intrinsic properties of the material itself. However, quantifying the amount 
of disorder is typically only achieved by the use of calibration curves constructed using 




In recent years our knowledge of the crystalline (ordered) and amorphous (disordered) 
solid-state has vastly improved
11,12,14,15,17,31
. However, little is known of the propensity 
of crystalline materials to undergo process induced disorder. The work presented in this 
thesis will concentrate on developing an analytical approach using a combination of 
techniques to investigate the propensity for PID without the need of 
amorphous/crystalline standards and calibration curves of the material being 
investigated. The selectivity and sensitivity of this approach will be investigated using a 
model set of pharmaceutical relevant materials that will be mechanically processed 
under different conditions and changes in the material’s molecular, particulate and bulk 
properties assessed with respect to the presence of PID. However, in this introductory 
chapter it is important that the different solid-states or phases of organic matter are 
firstly defined (Section 1.1), secondly their associated properties examined (Section 
1.2), and finally the relevant pharmaceutical mechanical processes reviewed in the 
context of their potential to generate PID (Section 1.4). 
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 Solid-states of organic matter 1.1
In terms of solid-state structure, organic solids can be ordered (crystalline), disordered 
(amorphous) or be comprised of varying degrees of both (mesophases) (Figure 1-1). 
This diversity can be influenced by the relative molecular structure, composition
15,32-35
 
and by the strength of the intermolecular linkages of the constituent molecules with 




Figure 1-1 Top level classification for the solid-states of matter based on molecular equilibrium  
 Crystalline solids  1.1.1
Molecules within crystalline solids are packed into a repeated three-dimensional highly 
ordered rigid structure exhibiting long-range order (LRO)
30
. Crystalline solids exhibit 
limited amounts of molecular mobility and can be considered rigid with respect to the 
other states of matter. However, structural differences in molecular conformation and/or 
packing for a given crystalline solid with the same chemical composition can give rise 
to what is termed “polymorphism”17,37-39.  
 Amorphous solids  1.1.2
Amorphous or disordered solids can be differentiated from the crystalline state by the 
absence of LRO whereby molecules appear in a random orientation but may still exhibit 
some form of short-range order (SRO), i.e. molecular interactions between the first- or 
second-nearest neighbours of an atom
40
 which  may be similar or identical to that in the 
crystalline state allowing interactions such as hydrogen bonding patterns to also be 
similar
34,41,42
. Slight changes in the interaction between molecules or the molecular 
network motifs, i.e. changes in their SRO can alter pharmaceutical functions and 
thermodynamic stability and potentially lead to amorphous instability and 
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recrystallisation to a new polymorphic form
41,43
. For example, at different temperatures 
changes in the hydrogen-bond (H-bond) patterns for amorphous indomethacin resulted 
in molecular recognition events that can lead to the self-assembly (crystallisation) of 
either the - or -indomethacin polymorphic forms44,45. 
Amorphous solids are more molecularly mobile allowing them to behave more like a 
liquid
40
. This enhanced molecular mobility can imply conformational diversity for 
amorphous solids. The number of conformations will depend on the flexibility of the 
molecule and the preparation route along with any processing history, i.e. how the 
material has been processed and/or stored. This conformational diversity has often been 
regarded as a type of polymorphism of the disordered state and as such has been 
referred to as “polyamorphism”32,33,35,46-48. 
Two different classes of polyamorphism are said to occur: “true” and “apparent” 
polyamorphs
32. “True” polyamorphism occurs when a material has two distinct meta-
stable amorphous states which are separated by a clear phase transition between them
32
. 
However, evidence for this type of polyamorphism has only been reported for inorganic 
and polymer substances and not for small organic pharmaceuticals
34,49-55
. 
“Apparent” polyamorphs which are also referred to as relaxation polyamorphs or 
pseudo-polyamorphs arise when there is an energy release or structural relaxation 
process that occurs when the mobility of the amorphous material is sufficient to allow 
movement of the system towards the meta-stable pseudo-equilibrium state of the liquid 
or glassy phase under certain processing or experimental conditions
18,32,34,35,56,57
.  
A number of examples of this type of polyamorphism for pharmaceutical materials have 
been observed and reported over the last few decades as a result of differences in their 
kinetic and mobility properties imparted by their previous processing history e.g. modes 
of preparation, storage conditions and thermal and mechanical treatments
34,46,49-55,58-62
. 
For example, Yamaguchi et al. reported different isolated amorphous forms of an 
antibiotic compound (MAT) prepared by spray drying that exhibited different thermal 
properties and dissolution behaviours depending on the preparation conditions 
employed
62
. While, Yonemochi et al., concluded that different molecular states of 
amorphous ursodeoxycholic acid can exist that exhibit different crystallisation 
behaviours as a result of the preparation method (quench cooled or grinding)
56,63
.  
For the two classes of polyamorphism, new terms and definitions are proposed here in 
this thesis according to the processes used to generate them (Table 1-1). True 
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polyamorphs, are defined as being metamorphs as they represent meta-stable 
amorphous states separated by a phase transition. In contrast, relaxation or “apparent” 
polyamorphs which are generated as a result of differences in their kinetic properties but 
are related by structural relaxations are defined as kinetamorphs. 
Table 1-1 Proposed classification and definitions for different types of polyamorphs  
Historical Classification New Classification New Definition 
True polyamorph Metamorph 
The existence of distinct amorphous states of the same 
material separated by a phase transition. 
Relaxation, pseudo or 
apparent polyamorph 
Kinetamorph 
The existence of distinct amorphous states of the same 
material as a result of differences in their kinetic and 
mobility properties imparted by their previous 
processing history. 
Amorphous solids are by definition not at thermodynamic equilibrium with their 
surroundings as they contain an excess of Gibbs free energy (G) relative to the 
crystalline phase at a stated storage temperature and humidity (Equation [1-1]).  
        -    
 
 [1-1] 
where the enthalpy difference between the phases (H) reflects the lattice or structural 
energy (enthalpy) differences, while, the entropy difference (S) is related to the 
disorder and lattice vibrations at absolute temperature (T). 
As amorphous solids are unstable they may lie in a number of positions in the energy 
landscape relative to the crystalline phase as illustrated in (Figure 1-2). Therefore, the 
Gibbs free energy value for amorphous solids should be considered to represent an 
average position or value.  
Figure 1-2 can also be used to illustrate the existence of metamorphs. An amorphous 
material (metamorph 1) may exist as a collection of states separated by an activation 
energy barrier Ea1 from another polyamorph (metamorph 2) which is at a lower energy 
state. Ea1 represents the energy required to transform metamorph 1 to metamorph 2 and 
is smaller than the energy required to overcome the activation energy barrier (Ea2) for a 
phase transformation from the amorphous to crystalline phase. The stored or excess 
energy of amorphous solids can be released completely via recrystallisation if G is 
negative, or partially by means of an irreversible structural relaxation process
64
. The 
rate at which the recrystallisation process takes place is determined by the molecular 





Figure 1-2 Schematic showing the energy landscape and relationship between metastable 
amorphous (metamorphs) and the crystalline material   
 Ea1 is the activation energy barrier to overcome for the transition of metamorph 1 to metamorph 2. 
Ea2 is the activation energy barrier to overcome going from amorphous material to a crystalline 
material.  
Figure 1-3 represents a plot of the enthalpy (H) or specific volume (V) of a solid 
substance as a function of its temperature
65
. For a crystalline material it can be seen, that 
as the temperature increases there is a small increase in enthalpy and volume at low 
temperatures, where the slope is equivalent to the heat capacity (Cp) of the material. 
Once the temperature reaches the melting point (Tm) of the crystalline phase, a first 
order transition occurs to the liquid state
65
. 
When the liquid is rapidly cooled below Tm, a super-cooled liquid is obtained where the 
thermal molecular motions are significantly reduced down to a time scale larger than 
that of any structural relaxation. This is often referred to as the “rubbery state”40,65. In 
theory, if the super-cooled liquid was cooled and remained in equilibrium as shown by 
the blue dashed line in Figure 1-3 then at some point the volume and enthalpy of the 
system would be equal to that of the crystalline material. This hypothetical point is 
referred to as the Kauzmann temperature (TK) or the Kauzmann paradox
66-68
. Kauzmann 
in 1948 postulated that upon cooling, the entropy of the super cooled liquid would 
became less than that of the crystalline solid
68
. However, this point can never be reached 
without violating the Third Law of Thermodynamics
66,67
. Instead, as the temperature 
decreases the molecular volume of the super-cooled liquid correspondingly decreases 
and the material becomes increasingly viscous or less mobile, and in such a milieu the 
molecules can adopt a number of different conformations. The point at which the 
material deviates from that of a super-cooled liquid resulting in a “frozen” non-
equilibrium state (amorphous or glassy material) is called the glass transition 
temperature (Tg)
65,67
. The Tg is associated with a reduction in the heat capacity and 




Pa.s) and over time the glass may age and relax to a lower energy state. This slow 
relaxation in glasses towards the equilibrium state is known as structural relaxation, 
physical aging or annealing
65,69
.   
In theory, an infinite number of different glasses or kinetamorphs may be generated 
with different glass transition temperatures and potentially distinct physical and 
chemical properties
32,70
 by adjusting the cooling rate of a material below its melting 
temperature (Figure 1-3). In general, the faster the cooling rate the higher the Tg and 
therefore the greater the molecular volume and molecular mobility.  
 




The red line denotes the pathway of an amorphous material while the green line denotes the 
behaviour of a crystalline material. Varying the cooling rate (R1 and R2) can result in the formation 
of different amorphous solids i.e. kinetamorphs (1 and 2).  These kinetamorphs can exhibit different 
glass transition temperatures, Tg1 and Tg2 respectively. The melting point temperature (Tm) is a 
thermodynamic first order transition from the crystalline to the liquid state. TK:Kauzmann 
temperature. 
 
The physical property changes that occur during glass transition can be detected and 
quantified by several techniques
65,71
 but most commonly the Tg and heat capacity (Cp) 
changes are measured using techniques such as differential scanning calorimetry (DSC). 
The determination of Tg for amorphous and PID materials can provide information 
around the material’s chemical reactivity and physical stability. As the storage 
temperature approaches the Tg, physical stability is reduced while chemical reactivity 
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increases. For pharmaceutical processes operating near or above the Tg uncontrolled 
phase transformations may occur which could result in new solid state forms that may 
lead to detrimental effects on downstream processing and affect the pharmaceutical 
performance of the final product
9,72-78
. 
It has been observed that the Tg region occurs over a temperature range that is 
approximately two-thirds of the melting point (Tm) (in kelvin)
40
. This observation can be 
used to estimate the location of Tg based on Tm. If both values are known then the 
temperature dependency of molecular mobility in the regions just above Tg can be 
estimated by determining the amount of deviation from the “two-thirds rule”. If Tg/Tm is 
significantly greater than 2/3 then molecular mobility for material is likely to be 
strongly temperature dependent around the Tg region and can be classed as “fragile”. 
However, there is no simple method to estimate the temperature dependence of 
molecular mobility in the temperature region below Tg where a large proportion of 
pharmaceutical materials are processed and stored
79-81
. 
 The amorphous-crystalline continuum: mesophases 1.1.3
The amorphous-crystalline continuum
12,64,82
 can be considered to be composed of 
material (mesophases) of differing proportions of both pure disordered (amorphous) and 
pure ordered (crystalline) phases
83
. These heterogeneous systems are composed of 
various distinct domains, each of which is in itself homogeneous in composition, but 
separated from the other by distinct boundary surfaces
38
. The amorphous-crystalline 
continuum can be visualised by a number of models based on their phase composition 
and location.  
The first model often referred to as the “one-state” model18,47,65,84,85 arises where there 
exists a completely crystalline solid with a high degree of order. As the amount of 
crystal defects and/or distortions increases, so does the level of disorder until a highly 
disordered (amorphous) material is generated (Figure 1-4). Lattice defects of this type 
predominately occur on the surfaces of crystals as a consequence of mechanical 
processes by processes such as ball-milling and micronisation and are quite often 
difficult to detect
82,86
. Crystal defects are discussed further in Section 1.3. 
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Figure 1-4 Depiction of the “One-State” Model for the conversion of 100% crystalline material to 
100% amorphous via progressive incorporation of lattice defect 
A progressive increase in lattice defects within a crystalline solid causes a subsequent decrease in 
crystallinity until a highly disordered solid is generated 
 
A second model often referred to as the “two-state”34,42,47,65,84,85 model arises due to the 
presence of pure amorphous or pure crystalline phases co-existing either within a single 
crystal as domains (Figure 1-5A) or within a molecular mixture (Figure 1-5B).  
 
Figure 1-5  Depiction of the “Two-State” model for describing pure amorphous/crystalline domains 
within a solid (A) or a mixture (B) 
Often in literature, mixtures of pure amorphous and crystalline material are used to 
construct calibration curves to quantify the levels of disorder that maybe present
23,87
. 
However, these “pure” amorphous standards are typically prepared by processes such as 
spray drying or melt-quenching resulting in complete disorder of the bulk of the 
material which may not necessarily best represent the material or the analytical 
responses for materials where disorder is generally surface located as a consequence of 
mechanical pharmaceutical unit processes such as ball-milling or micronisation
47,84,88
.  
If standard curves are to be employed it is important that the standards used reflect not 
only the type and location of the disorder, i.e. surface or bulk as described by the one- 
and two-state models, but also the associated analytical response for the desired 
physical property being investigated. 
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 Properties of the crystalline solid-state 1.2
Properties of solids can be broadly classified into two levels; primary (intrinsic) and 
secondary (derived) properties. The former defines the fundamental properties such as 
structure and solid-state form, while the latter defines the solid’s behavioural and 
manufacturability properties
17,39,89,90,91
 (Table 1-2). Only the primary properties or 
molecular characteristics will be discussed in this chapter. Further information 
regarding the other properties listed can be found in the numerous well documented 
reviews in the literature
91-93
. 
Table 1-2 Some typical primary and secondary properties of solids [Adapted
91
]  
Primary (Inherent) properties 
[Molecular characteristics] 
Secondary (derived) properties 




Absolute or true density 
Lattice energies and entropies 
Molecular mobility 
Chemical and physical stability   
Thermal behaviour (melting etc) 
Bulk and tapped density 
Electrostatic properties 
Dissolution rate and solubility 







 Molecular structure and packing 1.2.1
Knowledge of the molecular packing and conformation of solids as well as their 
thermodynamic properties provides important information on how a solid may act under 
certain conditions such as pressure, temperature and relative humidity. This information 
can be used to highlight the propensity for potential phase transformations and hence 
the solids’ respective relative stabilities94. 
The geometry of crystal packing can be described by a number of molecular descriptors 
(see Section 1.2.1.1). However, it is important to understand the nature of the molecular 
interactions or bonds that hold the crystal together, or in the case of disordered or 
amorphous materials the reduction of molecular interaction.  
Chemical bonds can be classified in decreasing strength as ionic, covalent, metallic, van 
der Waals and hydrogen bonds
95-97
. Materials possessing strong bonds such as ionic, 
covalent and metallic bonds typically have much stronger or larger mechanical 
properties such as hardness as well as higher melting points than small organic 
crystalline materials such as pharmaceuticals which are held together by the weaker van 
der Waals and hydrogen bonds
95-97
. For materials such as pharmaceuticals, these weak 
interactions must be maximised to ensure optimal molecular packing
95-97
. This 
optimisation of the non-covalent interactions is based on three fundamental principles. 
These are, (i) to maximise density and minimise free volume
98




 and (iii), minimise electrostatic energy
98
. Using these 
principles the atoms or molecules of the crystal are arranged into a three dimensional 
motif called a crystal lattice which represents an array of points with a definite volume 
(V) and defined by the lattice parameters, axial lengths (a, b and c) and angles (,  and 
) that forms the unit cell85,91,101 (Figure 1-6[A]). Arranging the unit cells into an 
ordered molecular array, results in a high density packed lattice exhibiting LRO (Figure 
1-6[B]).  
  




 Molecular descriptors for the geometry of crystal packing 1.2.1.1
There are only fourteen possible crystal lattice types referred to as Bravais 
lattices
85,102,103
 which can be categorized into seven crystal systems (Table 1-3). Each 
Bravais lattice is given a space lattice code in brackets next to its respective name as 
shown in Table 1-3. P represents the primitive or simple unit cell with lattice points at 
the cube corners. I refers to a body centered unit cell with lattice points at the corners 
and in the middle of the cell.  F refers to a face centered unit cell with lattice points at 
the corners and in the center of each face. While C, represents an end-centered unit cell 
with lattice points at the corners and in the center of one set of parallel face. Any crystal 
structure can be described with a unit cell from one of the seven crystal systems. 
The unit cell typically contains more than one molecule, and these molecules can also 
be described on the basis of symmetry. There are five symmetry elements (Table 1-4) 















  [A] [B] 
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 =  = 90º    
a   b  c 
Orthorhombic 
 
 =  =  = 90º 
a   b  c 
Triclinic 
 
      90º 
a  b  c 
Tetragonal 
 
 =  =  = 90º 




 =  =   90º 
a = b = c 
Hexagonal 
 
 =  = 90º, 
 = 120° 
a = b  c 
Cubic 
 
 =  =  = 90º 
a = b = c 
 
A space group starts with a capital letter to indicate the Bravais lattice type, followed by 
a symbol for the principal axis. If there is a plane of symmetry or a glide plane 
perpendicular to the principal axis the symbols are combined. This is followed by 
symbols for the symmetries of the secondary and tertiary axes and the planes of 
symmetry or glide planes parallel to these axes. For example, in the space group Pmm2, 
P refers to a primitive lattice and mm2 means that the cell contains mirror (m) planes 
perpendicular to both the a and b axes and a two-fold rotation axis along the c axis
103
. In 
the case of small organic molecules which are typically classed as irregular shaped 
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molecules there is little or no symmetry and molecules adopt a strategy to optimise 
intermolecular interactions by packing into arrangements with inversion centers, glide 
planes and/or two-fold screw axes as is the case for the most abundant group 
monoclinic space group P21/c which contains all three symmetry elements. 
Approximately 75% of all known organic compounds crystallise in only five space 
groups
107
: P21/c, P212121, P1, P21 and C2/c which correspond to space group numbers 
14, 19, 1, 4 and 15 respectively
108,109
.  
Table 1-4 The symmetry elements of crystal packing [Adapted
15,103
] 
Symmetry Element Description 
Rotation axis 
(n = 2,3,4,6) 
Rotation of 360°/n results in the same structure, then the crystal contains a n-fold 
rotation axis.  
Screw axis (n1) 
Rotation of 360°/n followed by a translation parallel to the axis of rotation brings the 
structure into coincidence. 
Rotatory-inversion axis  
  (n = 2, 3 , 4, 6) 
Rotation of 360°/n followed by inversion results in the same structure. 
Mirror plane (m) Reflection through the plane results in the same structure. 
Glide plane (c) 
Reflection through a mirror plane followed by translation brings the structure into 
coincidence. 
 
Molecules with symmetries that allow close packing generally form more ordered 
crystals and crystallise more easily than irregular molecules
103
. The efficiency of 
packing defined by the packing coefficient, (C) can be calculated as the amount of filled 
space in the unit cell divided by the total unit cell volume as shown in Equation 
[1-2]
110,111.  
    
  .   m
 cell  
 [1-2] 
where Z is the number of molecules in the unit cell, Vm is the molecular volume and 
Vcell is the unit cell volume. Typically most stable crystals have a packing coefﬁcient 
between 0.65 and 0.8098,110,111. However, H-bonded systems tend to have packing 
coefficients in the lower range (< 0.7) due to their open configuration (positioning) to 
maximise the H-bond network99. 
 Hydrogen bonding and molecular aggregates 1.2.2
H-bonds play a key role in the molecular packing and stability of small organic 
crystals
100
. The formation of a network of H-bonds within a solid is a means of 
molecular stabilisation by the creation of a molecular aggregate
97,112
. For example, H-
bonding is a primary feature in the crystal structure of acetaminophen Form I a 
monoclinic crystal
113
. There are two H-bond donors (HD): NH, OH and two H-Bond 
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acceptors (HA): CO, OH with a total of eight atoms involved in the H-bond pattern. 
Within the crystal, molecules are linked by hydrogen bonds to form pleated sheets
114
. 
Each molecule in the sheet is surrounded by six others which are connected to the 
central molecule by four hydrogen bonds. The sheets are stacked along the b plane by 
relatively strong van der Waals interactions between the benzene rings. These 
interactions contribute to nearly 60% of the entire lattice energy and define the 
anisotropy of the crystal properties, such as differences in dissolution for the different 
faces
113-115
. For disorder to be generated as a consequence of a mechanical processing, 
destabilisation of the crystal lattice requires that the H-bonding pattern and molecular 
interactions must be first overcome. 
H-bonding patterns have also been shown to influence cleavage along slip planes
116-122
. 
For example, cleavage was shown to occur between networks of hydrogen bonds for 
adipic acid and salicylamide while for sucrose and -lactose monohydrate it involves 
breaking the weakest hydrogen bonds
119,120
. A structure-property relationship can 
potentially be derived from H-bonding patterns which may lead to a correlation with the 
propensity of a material to become disordered upon mechanical processing, i.e. solids 
with weaker or limited hydrogen bonding patterns may fracture more as the strength of 
the bonds stabilising the molecular aggregate are less. Therefore, the amount of energy 
required to disrupt the crystal lattice is lower, if too much energy is applied to the solid 
there is the potential for lattice destabilisation and the formation of process induced 
disorder.  
 Crystal morphology (habits) 1.2.3
Crystal morphology is a term often used to describe the external geometry or shape of a 
crystal
2,123-125
. However, when a material of the same chemical composition and the 
same solid state form, i.e. the same unit cell exhibits different shapes, this is often 
referred to as exhibiting different crystal habits
125
. Crystal morphology defines the 
particle shape, size, and other mechanical properties which can affect manufacturing 
processes and product efficacy
125,126
.  
The final crystal morphology of a crystal is decided by the ease and speed of attachment 
of new molecules at each crystal face. The energy released on the attachment of a 
growth slice to a growing crystal surface or face is called the attachment energy 
(EATT)
126
. The growth rate of the face is proportional to its EATT. Faces with the lowest 
EATT are the slowest growing and, therefore, have the most morphological importance, 
i.e. faces with the lowest EATT will be the major habit face and will coincide with the 
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major cleavage face as this face provides the weakest plane and can give rise to slip 
planes
119,120,127
.  Slip planes can also be characterised by stacked layers of molecules 
strengthened by a 2D H-bonding network
118
. 
The relationship between structure and properties can be considered anisotropic. A 
crystal will contain a lattice of unit cells with potentially different symmetry elements 
along their axes
126
. As a consequence of this, the properties or functional groups of a 
crystal may differ in different directions or faces exhibiting different physicochemical 
and processing properties
126,128
. For example, different habits/faces may have different 
dissolution rates or they may also exhibit different fracturing behaviour during 




 Crystal defects 1.3
In theory crystals are generally considered to be a highly ordered molecular array of 
atoms. However, in reality they are never “100% perfect”. A large number of crystal 
imperfections exist in the form of point, lattice and plane defects
119,120,126,132-134
 (Figure 
1-7, Figure 1-8 and Figure 1-10 respectively). These defects can develop during 
crystallisation and act as nuclei for crystal growth or as fracture points during 






Figure 1-7  Schematics of the three types of point defects: vacancy (A), interstitial (B) & 
substitutional (C) depicted in 2- and 3-dimensions 
Atoms coloured red depict the position of the lattice defect, while the neighbouring atoms are 
coloured green. For vacancy defects the red depicts the missing atom. 
Point defects are imperfections that occur only at or around a single lattice point on a 
crystal face and are defined as vacancy, interstitial or substitutional defects
133,134,138
 
(Figure 1-7). A vacancy defect is caused by the absence of an atom at a specific 
point
134,138
 (Figure 1-7[A]). Interstitial defects are atoms that occupy a site in the crystal 
Vacancy defects [A] 
 
Interstitial defects [B] 
 
Substitutional defects [C] 
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structure at which there is usually not an atom
134,138
 (Figure 1-7 [B]). 
Substitutional defects arise due to impurities being incorporated at a regular atomic site 
in the crystal structure
134,138
 (Figure 1-7 [C]). Both interstitial and substitutional defects 
will cause a displacement of neighbouring atoms and a strain in the crystal
134
. 
Impurities or additives can lead to lattice defects such as line (edge) and screw 
dislocations (Figure 1-8)
133,134,138
. A line dislocation is an extra half-plane of atoms that 
is inserted midway into the crystal lattice, distorting nearby planes of atoms (Figure 
1-8[A]). When enough force is applied from one side of the crystal structure as occurs 
in a shear stress, this extra plane passes through the planes of other atoms breaking and 
remaking bonds until it reaches the grain boundary (Figure 1-9). Grain boundaries are 
interfaces where crystals of different orientations meet, and contain atoms that have 
been perturbed and migrated from their original lattice sites by dislocations and 
impurities. Dislocation migration can provide a mechanism for strain release or 
structural relaxation as a consequence of mechanical processing. The stresses and 




Figure 1-8  Schematics of the two types of lattice defects: line or edge dislocations (A) and screw 
dislocations (B) depicted in 2- and 3-dimensions [Adapted
119,132,134
] 
Atoms coloured red depict the position of the lattice defect, while the neighbouring atoms are 
coloured green. 
Line or edge dislocation [A] 
 




Figure 1-9 Movement of an edge dislocation  during the application of a shear stress [Adapted
119
]. 
The solid red line and atoms represent the position of the line dislocation. The dashed red line 
identifies the bond which is broken as the line dislocation traverses the planes of atoms (numbered) in 
the crystal lattice. Dashed and solid green lines show the next and newly formed bonds respectively. 
Green atoms show the progress of the line dislocation along the planes of atoms towards the grain 
boundary.  The amount of internal strain is released as the dislocation travels towards the grain 
boundary  
Screw dislocations provide a number of additional exposed crystal faces that normally 
are not exposed thereby potentially changing the behaviour of the material (Figure 
1-8[B]). For example, screw dislocations can expose a number of hydrophobic groups 
which could alter the solubility and dissolution characteristics of the material. Or the 
presence of exposed surfaces can act as nuclei for further crystal growth thereby 
changing the crystal habit. 
A crystal solid (particle) can be thought to consist of a number of small crystals called 
crystallites which are held together by grain boundaries
133,134,138
 (Figure 1-10). These 
grain boundaries can be considered to be an array of dislocations and defects resulting 
in plane defects and areas in which the crystalline lattice can fracture when exposed to 
an external force
12,132,137
. The mechanical process of crystal fracture will be discussed in 
Section 1.4.2. 
 
Figure 1-10 Schematic of a crystalline particle containing different orientated crystallites separated 
by grain boundaries. 
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 Pharmaceutical processes and process induced disorder 1.4
In the manufacture of inhaled and non-inhaled pharmaceutical solid dosage 
formulations the primary focus is on converting a molecule to a crystal, a crystal to 
particles and then particles to a dosage form. During these processes, the API and 
excipients can be subjected to a number of thermal and mechanical processes as shown 
in Figure 1-11. Pharmaceutical unit operations that are associated with the API only 
such as crystallisation and particle size reduction (comminution) processes are referred 
to as primary processes. While, pharmaceutical unit operations which are employed to 
formulate the API and excipients into a product  such as mixing, blending and 
compaction are referred to as secondary processes. During each step of the primary and 
secondary manufacturing process there is a need to develop strategies to control, 
characterise and optimise the particle properties.  
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Risk of process induced disorder 
Figure 1-11 General pharmaceutical manufacturing process map showing the associated mechanical 
and thermal processes for the manufacturing of inhaled and non-inhaled solid dosage 
formulations  
Each manufacturing process is colour coded to reflect the risk of inducing disorder from low risk 
(green) to red (high risk). [Product images courtesy of GSK] 
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Mechanical processes are pharmaceutical unit operations such as agitated drying, high 
energy milling, compaction and high shear granulation, which employ or involve 
physical processes or media without a chemical reaction to modify or obtain a desired 
behaviour or physical property. While thermal processes are pharmaceutical unit 
operations that are associated with changes in temperature such as cooling 
(crystallisation) or heating (drying). For a number of mechanical unit operations, 
changes in temperature can also occur. For example, during the compaction of a powder 
into a tablet an increase in temperature from 5 – 30 °C above ambient is typically 
observed which can influence not only compaction behaviour but also tensile strength 
of the material
139-141
. Both thermal and mechanical processes can inadvertently cause 
process-induced phase transformations such as the generation of lattice disorder or PID 
which is a significant concern to the pharmaceutical industry
17-28,65
. Typically PID can 
result in a number of significant changes to the material which can affect the 
performance and quality of the intended product. These changes are exemplified by; (i) 
the formation of agglomerates during or post processing
19-21
, (ii) physical and chemical 
instabilities
4,83,142-144
, (iii) solid state form or phase transformations
6,17-28,145-150
, (iv) 
electrostatic and surface energy changes
151-159
 and (v) increased hygroscopicity
19,20
.  
In Figure 1-11 each pharmaceutical unit operation has been colour coded to reflect its 
potential to induce disorder, i.e. the PID risk. Units coloured red signify a high PID risk, 
those coloured orange a medium risk, while unit operations with the lowest PID risk are 
green. The unit operations with the highest PID risk are the particle size reduction or 
comminution processes due to their intense mechanical nature and associated high 
processing input energies
5-10
. It is for this reason that two commonly used mechanical 
comminution processes, vibrating ball-milling and air jet-milling (fluid energy mill) 
were selected as the units of operation to potentially generate PID to investigate the 
presence or absence of disorder in a selection of model pharmaceutical materials.  
 Mechanical process stresses and material responses (strains) 1.4.1
Pharmaceutical mechanical processes can subject the API and associated excipients to a 
number of external forces or stresses as illustrated in Figure 1-12. When exposed to a 
stress, the solid will attempt to resist the force and prevent permanent deformations, 
distortions and fractures. How much the material resists the applied force depends on 





Figure 1-12 Four types of mechanical stresses that can be applied to materials during pharmaceutical 
unit operations 
Direction of applied stress is shown by the red arrows. Black arrows show the direction of the 
resulting deformation, i.e. the direction of the materials response. The square box shows the shape of 
the unstressed material 
 
When a change occurs in the materials dimensions as a result of an applied stress then 
the material is said to be strained. When the external stress is removed the material 
attempts to recover to its original state. If there is no permanent deformation the 
material is said to have behaved elastically. However, if the elastic limit has been 
reached and the material does not return to its original state after removal of the external 
stress, the material is said to have behaved plastically and this results in a permanent 
deformation. Materials which can undergo significant permanent or irreversible 
deformation prior to fracture are termed ductile (Figure 1-13[A]), while materials that 
fracture immediately are defined as brittle
161-165
 (Figure 1-13[B]). As shown in Figure 
1-13, when a stress is applied to a solid the material behaves elastically whereby the 
amount of strain is proportional to the applied stress until an elastic limit is reached. 
Plastic deformation will occur beyond the elastic limit until the yield point is reached 
and fracture or lattice collapse occurs releasing the strain in the lattice. For brittle 
materials the amount of deformation and subsequent fracturing is a function of not only 
the stress but also the rate at which it is applied.  
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Figure 1-13 Depiction of material deformation profiles for ductile [A] and brittle [B] materials as a 
consequence of and applied mechanical stress 
 
The amount of plastic deformation in crystals is influenced by: (i) lattice structure, (ii) 
the types of bonding present and (iii) the type and number of crystal defects present
166
. 
For example, crystallographic features, such as the existence of slip planes, can greatly 
facilitate the ability of crystals to deform plastically
121
. Slip planes are molecular planes 
in the crystal structure that have relatively stronger intra-planar interactions and weaker 
inter-planar interactions
122
. This can be demonstrated by acetaminophen, which forms 
H-bonded molecular pleated sheets which are stacked together by van der Waals forces 
allowing slip planes to exist in which fracture can occur allowing a strain release and 
plastic deformation
166,167
. Conversely, the absence of slip planes in methyl paraben 
crystal structure results in significantly poorer tableting performance due to poor 
plasticity
121
.  It was also demonstrated by Shekunov and York (2000)
168
 that relatively 
large molecules and those with a certain degree of rotational flexibility tend to form a 
disordered state as a result of plastic deformation by mechanical processes. 
 The mechanical comminution process 1.4.2
Particle size reduction or comminution is often required to enhance the bioavailability 
of inhaled and non-inhaled pharmaceutical solid dosage formulations through increased 
dissolution rate or solubility
1-4
.  
During comminution processes, material is mechanically broken down (ground) into 
smaller fragments with a consequential increase in surface area to produce particles 
within a specified particle size range. This process typically involves high energies and 
stresses such as shearing (attrition and abrasion) and compression depending on the type 
of comminution process employed. Two types of mechanically comminuted processes 
Ductile material [A] 
 
Brittle material [B] 
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will be utilized in this thesis, vibrational ball-milling (VBM) and jet micronisation or 
milling (JM) (Table 1-5). VBM involves attrition, abrasion and compression 
mechanisms using solid grinding balls, while JM involves impact, attrition and some 
abrasion processes using gas as the comminution media
169
. Both VBM and JM 
processes are routinely used to reduce particle sizes of materials but the selection of 
which technique to use is dependent on the final particle size that is required
170
. For 
example, JM is frequently used in the pharmaceutical industry to obtain particles of 
respirable size (<10 µm)
21
.  
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The two types of shear stresses typically encountered in VBM and JM comminution 
processes are attrition and abrasion. Attrition refers to a force applied to only part of the 
particle surface resulting in a small amount of breakage at the edges of the particle and 
the generation of fine particles and larger rounded particles
171
. This can be analogous to 
using a chisel on the edge of a stone block. While abrasion is analogous to using 
sandpaper, as a shear force is applied tangentially to the particle resulting in very fine 
particles. The original particle is smoother with little change in size or shape
171
. 
Compressive stresses commonly used in comminution processes do not cause fracturing 
directly but rather generate distortions by tensile or shear stresses to form a crack tip 
away from initial point of primary stress application. 
During a mechanical comminution process, a mechanical load or force is applied to a 
particle creating a state of stress, i.e. a stress field. Once subjected to the stress the 
particle will initiate a response relative to the intrinsic properties of the material, the 
type of comminution process and the strength of the stress field employed. This initially 
involves absorbing the applied mechanical energy and storing this as a strain energy 
within the lattice enabling mechanical activation (higher free energy state), defects and 
dislocations typically on the surface of the crystal lattice
150,9-13,158,162
 (Figure 1-14[i]). 
The lattice will then fracture by plastic deformation thereby relieving the stress (Figure 
1-14[ii]). The presence of slip planes, defects and dislocations enable the stress to be 
concentrated in this vicinity so failure (fracture) can occur at much lower applied 
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strength. Hence the more defects present, the less stress needed to cause fracturing. This 
can explain why material becomes progressively difficult to grind as particle size 
decreases as the probability of the particle containing an effective defect also decreases. 
Larger particles fracture better as there is more chance that defects exist.  
 
Figure 1-14 Comminution process for the milling of a crystalline particle 
Initial milling results in a particle which can fracture into smaller fragments due to the presence of 
concentrated defects [i &ii]. Extensive milling can result in the formation of surface disorder [iii] 
which can be transmitted into the crystalline core [iv] and cause complete lattice collapse to an 
amorphous form [v]. Energy from milling process can also allow for increased molecular mobility 
and realignment resulting in the transformation into a new solid-state form [vi]. 
 
Comminution will continue as long as the stress field is applied. Extensive and 
prolonged comminution results in the reduction in crystal particle size through 
fragmentation mechanisms until a minimum particle size limit is reached. However, the 
majority of applied energy is lost to other processes other than particle breakage such as 
the production of sound, heat and plastic deformation. Disorder induced by mechanical 
stress during milling is expected to occur preferentially on the surface regions of 
particles and decreases moving towards the lattice core
17,23,25-28,150
(Figure 1-14[iii]). If 
the number of defects increases beyond a limit the lattice can collapse completely and 
an amorphous material can be formed
17,25-28,150,172
 (Figure 1-14[iv & v]).  
For some materials during the comminution process a transformation to another solid-
state form may occur
6,17-28,145-150
 (Figure 1-14[vi]). This transformation may be a result 
of the applied and absorbed milling energy causing increased molecular mobility of the 
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molecules or surface PID realigning into a more favourable energetic orientation 
resulting in a new solid-state form. 
Comminution is in general a simple operation but the outcomes or product can be 
complex. This complexity can be material specific and driven by the fundamental 
molecular or particulate properties of the molecule being milled.  
Initial particle size can have an influence on the material properties of the comminuted 
material. Particle strength increases as particle size decreases therefore the energy to 
break smaller particles must be larger. Smaller particles will also contain less defects 
hence will require more energy to cause comminution. 
Crystal morphology or habit can also influence the breakage behavior. Non-spherical 
particles become more spherical as a result of attrition. Corners are knocked off during 
collisions and particles are exposed to unequal distribution of stress compared to more 
spherical particles. For example, Chikhalia (2006)
2
 investigated the influence of crystal 
shape on ball-milling and jet milling using different crystal habits of β-succinic acid. It 
was observed that crystallinity was reduced more when plate morphologies were used 
as the input material compared to milling needle-like (acicular) crystals. It was also 
observed that ball-milling caused the greatest decrease in crystallinity. 
 Vibrational ball-milling 1.4.3
Ball-milling is a high-energy mechanical grinding process that breaks down particles by 
physical interactions between the particles and the grinding ball and container (Figure 
1-15 [A]). The grinding jars perform oscillations at a frequency (f) in a horizontal 
position up to 1800 impacts per minute. The inertia of the grinding balls causes them to 
impact with high energy on the sample material at the rounded ends of the grinding jars 
resulting in attrition, abrasion and compression stresses (Figure 1-15 [B]).  
Ball-milling can be described as a closed comminution system as the coarse input 
material and the resulting fines are retained within the grinding jar until the milling 
process is completed and this can result in over grinding, caking to the side of the 
grinding jar and ball as well as the potential generation of PID. The caking of 
comminuted material to the grinding ball is illustrated in (Figure 1-15) and provides a 
new type of stress particle-particle impact or abrasion and could in fact reduce the 
efficiency of milling by dampening the effect of the grinding ball.  
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Figure 1-15 Cross-section of a vibrational ball-milling grinding jar [A] and the associated 
comminution stresses that can occur within it [B] 
Purple arrows show the direction of the applied stress 
 
Milling energy is determined by the mass and material density of the grinding balls, 
whilst milling efficiency depends on the intensity of the applied stress and the number 
of contacts between the grinding ball, material and jar. In theory, the greater the density 
and mass of the balls the higher the milling energy (shear stress), while increasing the 
number of balls increases the number of contact points and therefore increases the shear 
rate.  
It has been noted that ball-milling is more likely to generate surface PID than jet milling 
but it depends on the processing parameters as well as the properties of the material 
itself
2
. In the literature there are a number of theories relating to the mechanisms that 
might be involved in the process of amorphous generation by ball-milling
5,173,174
. One 
such theory is that localised melting of the material and its subsequent quenching can 
result in amorphous material
7,175
. However it has been shown that amorphous material 
can be generated when ball-milling under controlled temperatures using liquid nitrogen 
(cryomilling), at a temperature far below the glass transition temperature (Tg)
22,26,175-177
 
and the analytical responses of material obtained by melt-quenching differs to that 
 
 





































. Therefore it is more likely that the primary 
mechanism for amorphous generation by ball-milling is by the accumulation of defects 
and associated loss in lattice structure and LRO
7,179
. It is also likely that the use of 
cryomilling can increase fracturing as the extreme cold temperature can make the 
particles more brittle and therefore more susceptible to breaking thus increasing the 
probability of defect formation and reducing both the energy and time required for 
effective milling. 
 Jet-milling (micronisation) 1.4.4
Jet-milling (JM) or micronisation is a high energy mechanical process used to produce a 
fine powder with a narrow particle size distribution, typically less than 10 µm
4
. A major 
characteristic of JM is the absence of mechanical parts for particle breakage and the use 
of a gas as the grinding media which can help to cool or dissipate any generated heat 
thereby avoiding excessive heat and contamination during its operation
180
. 
During the operation of a JM, the coarse input particles are fed into the feed funnel at a 
defined rate (Figure 1-16). These coarse particles are then sucked into the grinding zone 
due to a pressure gradient or differential between the venturi/feed (P1) and grinding 
pressure (P2) using pressurised air or nitrogen. P1 must be much higher than P2 to 
ensure material is not blown back out of the JM. Within the grinding chamber, the 
grinding gas enters the grinding zone through nozzles in the grinding ring wall and 
entrains and accelerates the feed particles to sub-sonic velocities in a spiral pattern
180
. 
Particle breakage occurs when the slower incoming particles and the faster particles in 
the spiral path collide (inter-particle collisions) and by particle impacts on the grinding 
ring walls
181
. Particle-particle impaction induces particle fracture via the weakest 
binding face and also by particle attrition. The fracture mode is the predominating mode 
when micronisation energy is low. But when micronisation energy is high the attrition 
mode predominates. It is possible based on the crystal packing that these two modes 
produce surfaces exhibiting different physical properties such as hydrophobicity and 
surface energies which could affect the stability and performance of the formulated 
product. 
JM can be defined as an open comminution system as material is removed once it is 
comminuted to a suitable size. Centrifugal force retains the larger, heavier particles for 
further grinding while the smaller and lighter comminuted particles exit with the 
exhaust gas through the central outlet to the collection chamber. Very fine material is 
collected in a mill bag at the top of the grinding chamber. 
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Figure 1-16 Schematic of a jet- mill (microniser) 
 
Figure 1-17 Schematic of the inside of a jet-mill grinding chamber (top view) 
































     















The most important operating parameters that control the extent of micronisation are the 
amount of material to be micronised (feed material) and feed rate, the grinding media 
(gas) pressure and the differential between the feed and grinding gas pressure
182-184
. 
Feed pressure controls the acceleration of particles into the grinding chamber but does 
not promote collisions
182
, while feed rate influences the concentration of the material 
supplied to the grinding zone. The greater the feed rate, the less efficient the 
micronisation and the larger the comminuted materials as there is less energy per 
particle meaning particle velocities are slower which leads to less collisions
181-184
. 
Grinding pressure can influence the amount of amorphisation generated. For example it 
has been observed that the optimal grind pressure for the micronisation of salbutamol 
sulphate was 6 bar, below this pressure JM was unable to produce the desired particle 
size, but above 6 bar amorphous content increased but with no further reduction in 
particle size
21
. However, the differential between the feed and grinding gas pressure is 
the main parameter that controls the extent of micronisation. The greater the differential 
the greater the velocity imparted upon the particles
180
.   
It is important to note that even though JM is less likely to lead to potential 
unintentional and unwanted changes to the surfaces of particles such as PID and surface 
energies compared to other high energy comminution processes such as VBM theses 
can still occur, so care must be taken to reduce these affects as well as identifying any 
PID that may be generated as a consequence of the unit operation
2,160,184-189
. 
 Research objectives  1.5
Comminution of pharmaceutical materials can be a challenging process with many 
potential critical parameters. Knowledge of the molecular structure and mechanical 
properties of the input material and the potential pre-existing structural flaws could 
enable the development of more robust pharmaceutical comminution processes and lead 
to a better understanding of the propensity of materials to undergo process induced 
disorder. However, once PID has been generated it is of equal importance to be able to 
identify and potentially quantify the amount of PID that is generated.  
Typically the qualitative detection of PID or amorphous domains is performed using 
individual techniques such as XRPD, DSC and GVS
21,28,88,175,190-193
. However, 
quantitating the amount of disorder is typically only achieved with the use of calibration 
curves using mixtures of “pure” amorphous and crystalline standards which can be both 




The primary aim of this thesis was to develop a combined analytical approach to define 
the level of PID present in pharmaceutically relevant materials as well as their 
propensities to generate PID as a consequence of mechanical comminution processes 
such as ball- and jet-milling without the need of “pure” amorphous and crystalline 
calibration standards and curves.  
To achieve this aim, several research objectives needed to be accomplished, these where 
to; 
 Define a small set of pharmaceutical relevant materials using literature and online 
databases that encompasses the amorphous-crystalline continuum when subjected to 
mechanical comminution processes, this test set should also possess crystallographic 
and molecular property diversity (Chapter 2). 
 Define a core set of analytical techniques and associated analytical response that can 
be used to characterise the physical and chemical properties of the model test set 
before and after comminution (Chapter 3). 
 Characterise the comminution input materials using the core analytical techniques 
and associated responses (Chapter 4). 
 Perform mechanical comminution (micronisation and ball-milling) under different 
operating conditions on the selected materials to potentially generate different levels 
of PID (Chapter 5). 
 Characterise the comminuted materials using the core analytical techniques and 
associated responses and compare these responses with those of the input materials 
by a novel Comparative Response Analysis (CRA) approach (Chapter 6). 
 Investigate the potential generation and presence of PID in the study materials under 
different comminution conditions by defining a novel scoring system called 
Response Disorder Analysis (RDA) that links changes in analytical technique 
responses with the presence of disorder (Chapter 7). 
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2 Material selection 
 Introduction 2.1
Historically, studies that were carried out to investigate the properties of amorphous 
materials were typically performed using only one or two 
materials
1,22,44,149,155,175,176,179,199-220
. However, there are some investigations which 
encompass a much larger model set but often these do not include an explanation as to 
the rationale for the selection of a particular material and can appear to over process the 
materials in an attempt to generate “pure” amorphous phases using different processes 
and/or conditions
160,221
. For example Lin et al. (2009)
221
 investigated the physical state 
of 23 compounds after cryogenic milling for up to 5 h and attempted to correlate the 
presence of disorder with known material properties in order to predict the disordering 
potential or propensity. Milling times varied between 1-5 h and it was reported that 
disorder occurred in 15 or 65% of the compounds (Table 2-1).  




Observed disorder after milling for X h   Overall observed 
disorder 
Lin et al. 221 
Observed  disorder 
(scaled - mill time) 1 hr 2 hr 3 hr 4 hr 5 hr 
Sucrose No No Yes   Yes 3 
Salicylamide No No No No No No 0 
Aspirin No No No No No No 0 
Acetaminophen No No No No No No 0 
γ-Indomethacin No No Yes   Yes 3 
Sulfadiazine No No No No Yes Yes 1 
β-D-mannitol No No No*   No 3 
α-D-lactose-monohydrate No No Yes   Yes 3 
D(+)-trehalose dihydrate No No No Yes  Yes 2 
β-D-lactose No Yes    Yes 4 
D-trehalose Yes     Yes 5 
Theophylline No No No No Yes Yes 1 
Tolbutamide I No No No No No No 0 
Ibuprofen No No No No No No 0 
Cimetidine A No No Yes   Yes 3 
Ketoprofen No No Yes   Yes 3 
Naproxen No No No No No No 0 
β-Piroxicam Yes     Yes 5 
Carbamazepine III No No No No Yes Yes 1 
β-Sulfanilamide No No No No No No 0 
Sulfathiazole III No No Yes   Yes 3 
PFZ1 No No Yes   Yes 3 
PFZ2 No No Yes   Yes 3 
* Polymorphic phase transformation observed, this may have indicated the material was disordered. Green cell – 




It is important to note that the investigators only used the overall observation of disorder 
in their correlation models and did not take into account the different milling times. This 
may skew the data in favour of amorphous materials and lead to misinterpretations with 
respect to the property-phase relationships. It would have been more appropriate to mill 
all the materials for the same period of time or maybe include a weighting/scale factor 
as suggested in the last column of Table 2-1 that takes into account the time required to 
generate disorder. 
Based on the example given and to ensure the accuracy and sensitivity of the generated 
data, it was decided that the material selection process for this thesis would be based on 
a defined acceptance criterion that would take into account the materials molecular and 
crystallographic properties as well as their behaviour upon mechanical comminution. 
The selected materials would also be subjected to the same mechanical processes and 
operating conditions (See Chapter 5). This would allow comparisons to be made 
between the behaviour of materials and correlations to be established between the 
observed phase(s) and material properties.  
To this end a number of objectives were set to: (i) search the literature for 
pharmaceutical relevant materials i.e. small organic molecules typically used as APIs or 
excipients in pharmaceutical products (See Section 2.2.1), (ii) list the relevant materials 
in a database and collate the associated crystallographic and molecular properties (See 
Section 2.2.2), (iii) extract from the literature qualitative assessments for the presence or 
absence of PID in the materials as a consequence of mechanical comminution (See 
Section 2.2.2.4), (iv) define the material selection criteria (MSC) (See Section 2.2.3), (v) 
apply the MSC and use these to define a model set of pharmaceutical relevant materials 
that might be expected to encompass different levels of PID across the whole of the 




 Methods and processes 2.2
 Literature search for pharmaceutically relevant materials 2.2.1
An extensive literature search was performed using the online search engine, 
EMBASE
222
 and the search terms defined in Table 2-2. The results from this search 
were then exported to the electronic reference manager EndNoteX7 (Thomson Reuters) 
where the citations were manually reviewed to identify appropriate pharmaceutically 
relevant materials. These materials were then entered into an Excel
©
 based database 
called the Research Material Database (RMD) specifically developed for the work 
reported in this thesis. It is important to note that a material may have multiple entries in 
the RMD as different solid-state forms can exist and these will possess different 
crystallographic and other physical properties.  
Table 2-2 Search terms employed to identify suitable materials using online search engines. 
Search 
No. 
Reason for search Search terms used in EMBASE 
1 To identify only pharmaceutically relevant 
papers 
(pharmaceuticals, excipients, solid dosage 
forms etc) 
pharmaceut*.ab. or pharmaceut*.kw. or API.af. or active 
pharmaceutical ingredient*.af. or excipient.af. or 
inactive.af. or dosage*.af. or inhalation.af. or inhaled.af. or 
tablet.af. or solid*.af. 
2 Search based on phase and solid- state 
classes 
(Amorphous to crystalline, polymorphs and 
polyamorphs) 
((Amorphous or disorder* or crystal* or mesophase or 
polymorph* or polyamorph*) not inorganic not metal not 
zinc not copper not Cu not iron not virus not barium not 
Nickel not silicon not titanium not calcium not selenium 
not magnesium not carbon not silver not Ag).af. 
3 Search based on pharmaceutical unit 
operations 
(Crystallisation, comminution , granulation 
and compression etc) 
(micronisation or micronization).af. or mill*.ab. or 
mill*.kw. or comminut*.af.  or mechanical*.af. or 
granulat*.af. or compression.af. or crystal*.af. or spray.af. 
or freeze.af. 
4 Search based on physical property techniques  
(X-ray crystallography, differential scanning 
calorimetry and gravimetric vapour sorption 
etc) 
(crystallography or pxrd or xrpd or diffraction or 
thermogravimetric or TGA or differential scanning or DSC 
or microscopy or gravimetric or GVS or sorption or DVS 
or calorimetry).af. 
5 Combining the searches to identify 
pharmaceutically relevant  papers based on 
phase, pharmaceutical unit operations and 
analytical techniques 
Combine  searches 1 to 4 with “and” 
Ab – abstract, af – all fields, kw – key words 
 Material properties from on-line sources 2.2.2
For each material listed in the RMD, molecular and crystallographic properties were 
obtained and collated along with safety, sourcing and PID information (Table 2-4). This 




















 and from the 
relevant literature citations. 
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Compound name Systematic and trivial name GEN CSD223 or 
PubChem224 




A moiety formula with stoichiometry (and charges) is given 
e.g. C8 H9 N1 O2 
GEN PubChem224 
Solid State form Hydrate or anhydrate and polymorphic form GEN PubChem224 
CSD ID Unique Cambridge Structural Database reference code of six 
letters and potentially 2 numbers that identifies the material 
crystallographic entry in the CSD. 
Refer to Section 2.2.2.1  
CRYS CSD223 
Crystal system Any crystal must belong to one of seven crystal systems, the 
symmetry of which introduces constraints on the possible 
values of the Unit Cell Parameters   
Refer to Section 1.2.1.1 
CRYS CSD223 or 
citation 
Space group & 
Space group 
number 
230 possible arrangements of symmetry elements in the solid 
state.  
Refer to Section 1.2.1.1 
CRYS CSD223 or 
citation 
Unit cell length 
(a, b & c) 
Unit cell vectors that form the edges of a parallelepiped. 
Refer to Section 1.2.1 
CRYS CSD223 or 
citation 
Unit cell angle  
(α, β & γ) 
The angles between the vectors (α, the angle between b and 
c; β, the angle between a and c; γ the angle between a and b)  
Refer to Section 1.2.1 
CRYS 
molecules per unit 
cell (Z) 
Number of structural (molecular) units per cell CRYS CSD223 or 
citation 
R factor A measure of data quality and provides a measure of how 
well the refined structure agrees with the experimental 
model. R-factors over 10% may indicate errors with 
determination of crystal structure.  









Unit cell volume calculated using cell vectors a, b and c, 
expressed as cm3.  
Refer to Section 1.2.1 
MOLEC CSD223 or 
citation 
Cell Density (ρcell) Density of the unit cell. 
See Equation [2-1] 




Volume occupied by the molecule. 
See Equation [2-2] 




A volume physically occupied by one mole of substance 
under normal conditions, expressed as cm3 




Efficiency of molecular packing  




Predictor of molar refractivity measuring the total 
polarizability of a mole of compound, expressed as cm3 
MOLEC ACD230,231 
Parachor* A constant representing the molecular volume of the 
substance at such temp when its surface tension is equal to 




Ratio of speed of light in vacuum to speed of light in 
substance. This is an average value for the whole of the 
molecule and relates to the density of the material  
MOLEC ACD230,231 






external forces, expressed as dyne/cm 
Polarizability* Indicates electron cloud redistribution under the influence of 




The surface sum over all polar atoms, primarily oxygen and 




Number of rotatable bonds (non-cyclic single bonds between 
any two atoms having at least two neighbours each 




Number of hydrogen bond acceptors in structure, e.g. the 
number of O and N atoms 
Refer to Section 1.2.2 




H-bond donors* Number of hydrogen bond donors in structure, e.g. H atoms 
directly connected to O and N atoms  
Refer to Section 1.2.2 




LogP* Octanol-water partition co-efficient 
Refer to Section 2.2.2.2 
PART ACD230,231 
Solubility* Prediction of solubility in pure water, expressed as mg/ml 




The temperature at which the material melts. Note: this is  
NOT necessarily taken from DSC analysis 




Safety risk statement code describing the risks involved in 
using and handling the material. 
Refer to Section 2.2.2.3 
LGST MSDSxchange2
26, Suppliers or  
SIRI MSDS 
Index235 
Sourcing and cost 
per gram (cpg ) 
(£/g) 
Information with respect to how easy the material is to 
procure and the cost per gram. 




Literature PID Qualitative observation of presence or absence of PID as a 
result of a mechanical comminution process 
Refer to Section 2.2.2.4 
PID Citations 
* Predicted values calculated using appropriate online software  
GEN – general property or information, CRYS – crystallographic/unit cell properties, MOLEC – molecular 
properties, PART – particle properties, LGST – logistic or safety information, PID –designation of presence of PID 
from literature citations 
 
 Material crystallographic properties from the CSD 2.2.2.1
Crystallographic properties for each material was in general sourced through the CSD 
database
223
. However, for some materials this information is either not available or not 
publicly accessible for commercial reasons. In these cases the crystallographic 
properties were left blank in the RMD. 
For those materials that are listed in the CSD, each entry corresponds to an individual 
determination of a specific crystal structure identified by a unique CSD reference code 
(refcode), comprising of six alphabetic characters
236
 (e.g. HXACAN). Where multiple 
entries for the same material exists an additional two-digit number is attached to 
identify a specific experimental determination of the crystal structure or different 
authors etc (e.g. HXACAN06, HXACAN09, etc.)
237
. These entries represent 
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polymorphs, redeterminations or republications
236
.  A redetermination is an entry for a 
known crystal structure from a different set of experimental data and usually submitted 
by different authors. A republication is an entry for a compound with the same 
determination (parameters) without any additional crystallographic experimental data. 
These typically have lower R-factor values
236
. The R-factor value is a measure of the 
crystallographic data quality and provides a measure of how well the refined structure 
agrees with the experimental mode, i.e. the R-factor is an indicator of accuracy, the 
lower the R-factor, the more accurate the determined structure
237,238
. R-factors below 
5% indicate a high quality structure determination, while those over 10% may indicate 




One of the major obstacles in using the CSD database was the difficulty in choosing the 
most appropriate CSD entry for a particular material. If the material exists in more than 
one crystal system then a representative from each crystal system was included in the 
RMD. If there was more than one entry for a given system, then the entry with the 
lowest reported R-factor value which also had an available X-ray diffraction pattern was 
included
236,239
. For example, there are over ten entries for acetaminophen in the CSD 
but there are only two polymorphic forms. On reviewing the entries only two entries 
were selected one for each crystal system (or polymorph) based on the smallest R-factor 
value and the availability of the X-ray diffraction patterns
236,239
. Accordingly, 
HXACAN11 was selected to represent monoclinic Form I, and HXACAN08 was 
selected to represent orthorhombic Form II acetaminophen. 
Cell density (ρcell) is given by: 
ρ      
1.   x Mw x  
CC  
 [2-1] 
Where Mw is Molar or molecular weight, Z is the number of structural (molecular) units 
per cell and CCV is Calculated (unit) cell volume. 
Molecular volume (Mv) is given by: 





Where Z is the number of structural (molecular) units per cell and CCV is Calculated 




Molar volume (Mrv) is given by: 
Mrv    
  
ρ     
 [2-3] 
 Determination of predicted properties 2.2.2.2
A number of predicted properties were obtained from online databases and software 
programs as indicated with an asterix (*) in Table 2-3. These predicted properties 
represent molecular descriptors that can be used as qualitative indicators of the 




However, a number of different databases and software programs list or predict the 
same properties and these values may vary depending on the way they are calculated or 
predicted. For example, the potential number of H-bond acceptors and donors (HBDA) 
can be predicted using four different software programs: (i) from  SpresiWeb
232
 which 
uses the Chemical Computing Group Inc.’s Molecular Operating Environment (MOE) 
(version 2004.3) program, (ii) from PubChem
224
 which uses Xemistry GmbH's Cactvs 
program
241
, (iii) from ChemSpider
226
 which uses the built-in ACD/Labs property 
predictor software230,231 and (iv) ChemAxon’s Marvin (version 5.4.0.1)  program233. The 
HBDA values can vary between the programs for the same material; hence it is 
important that when listing these types of properties that the source is clearly identified 
and the prediction algorithm is known.  
In this thesis the HBDA values used during the selection process were calculated using 
the Marvin software whereby sulphur atoms where excluded from acceptors but 
halogens were included. A more detailed discussion regarding the differences in HBDA 
values from different software programs can be found in the results and discussion 
(section 2.3.2). 
Other predicted properties such as LogP and solubility were calculated using the 
ACD/Labs property predictor software230,231. The LogP value is a measure of the 
lipophilicity of a material.  The higher the LogP value, then the more hydrophobic a 
material is and the greater the likelihood that these materials will have low water 
solubilities (especially when values are 4 or greater). Solubility is defined as the 
concentration of dissolved solid (solute) in a solvent medium which becomes a 
saturated solution and is in equilibrium with the solid at a defined temperature and 
pressure. 
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 Determination of material safety, processing hazards and sources 2.2.2.3
For each material, safety (risk statement code
234
, See Appendix 1) and handling 
information were obtained from online sources such as MSDSxchange
226
, SIRI MSDS 
Index
235





Fisher-scientific). The cost per gram (cpg) in British Sterling was also reported for each 
material to assist with the logistics of the investigation.   
 Determination of the presence of mechanical PID from literature 2.2.2.4
A qualitative assessment of the presence or absence of PID in the materials as a 
consequence of mechanical size reduction processes such as milling and micronisation 
was determined using information from the literature. The presence of disorder in the 
literature was predominately based on an observed “amorphous halo” and/or a glass 
transition event by X-ray powder diffraction (XRPD) and differential scanning 
calorimetry (DSC) analyses respectively
6,7,23,160,221,242-247
. More information regarding 
these techniques and associated responses can be found in Chapter 3 (See 3.2 and 3.4 
respectively). 
When reviewing the literature information, it is important to note that the materials can 
be mechanically processed differently, therefore they are exposed to differing levels of 
mechanical loading or stresses (See Section 1.4.2) and this in turn may or may not result 
in the generation of PID. For some materials, milling may only have been carried out 
for 2 min, whereas for others this might have occurred over 30 h depending on the 
objective of the study
5-7,160,195,221,242,248
. This makes it challenging when attempting to 
qualitatively define the presence or absence of disorder for different materials from 
different studies as each investigator may interpret the degree of disorder that maybe 
present differently. However, for the purposes of this screening exercise the observed 
literature PID data serve as a reasonable assessment that disorder might exist in the 
compound and therefore can aid material selection so that a more in-depth investigation 
can be performed under different processing conditions (Chapter 5). To this end, 
materials were qualitatively classified as being either disordered (DIS), remaining 
unchanged (CRYS), or exhibiting some degree of disorder after processing (SOME). 
Materials which exhibited some degree of disorder were those where it was not a 100% 
certain that disorder was present or the literature was ambiguous, i.e. in some cases 
disorder was reported being present and in other studies it was not. For materials where 
no comminution information was available, these were classified as unknown (UKWN). 
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 Material selection process  2.2.3
Initial material selection was made using the material selection criteria (MSC) as 
defined in Table 2-4. Justifications for the criteria values are given below : 
Table 2-4  Material selection criteria (MSC) 
ID Property Acceptance Criteria 
A1 Anhydrous Only anhydrous material and where possible the parent molecule 
A2 Crystallographic properties Only materials with known and measured crystallographic properties 
A3 Safety & handling Only materials with a low safety risk 
A4 Source & cost Only materials that can be easily sourced commercially and cpg <£15 
A5 Melting onset  temperature (Tm)  > 80 °C 
A6 Storage conditions Room Temperature (ambient) in light or away from light 
A7 Solubility* Less than 50 mg/mL 
A8 LogP* Greater than 0 
A9 No. of rotatable bonds* Less than 10 
A10 Literature PID Only observed PID (complete or some) or no PID observed will be 
selected if PID by mechanical processes unknown for the material then 
they are excluded 
* Predicted property 
 
Only anhydrous materials were selected to reduce the complexity that hydrates may 
introduce when milled or micronised, i.e. the presence of hydrated water may act as a 
plasticizer lowering the Tg allowing recrystallisation to occur more easily, thereby 
effectively removing any induced disorder before it could analytically be 
observed
65,85,249-252
 (A1 Table 2-4). Where appropriate only the parent molecule of the 
material was chosen to minimise any complications due to the presence of the counter 
ion. A counter ion is often used to overcome the crystallisation problems which maybe 
encountered during crystallisation and to improve overall solubility
253
. However, in this 
research the presence of counter ions could increase the stability of the crystal lattice 
and restrict the susceptibility for PID during mechanical processing, so where possible 
only the parent molecule was selected. For example, the salt forms of γ-indomethacin 




It was also important that crystallographic properties of the materials were included to 
investigate any relationship with PID. Hence materials which had no crystallographic 
properties reported were excluded (A2 Table 2-4).  
Due to the quantity (grams) of the material required to be mechanically comminuted in 
this research, it was deemed appropriate to mitigate the operational risk by excluding 
those materials with very high toxicity, high inhalation danger, and those with risk 
statement codes
234
 as shown in red in Appendix 1 (A3 Table 2-4). Due to logistical and 
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time constraints materials which could not be sourced commercially or with a cpg 
greater than £15 were excluded (A4 Table 2-4). For example only the acetaminophen 
form 1 is commercially available and form 2 would need to be prepared in-house which 
would require additional resource (time) to develop and validate an appropriate method, 
as well as characterise the generated solid. 
Materials with a melting temperature (Tm) less than 80 °C were excluded from selection 
due to the fact that a lower Tm will likely mean a lower Tg and the presence of any 
absorbed water will potentially lower the Tg further allowing recrystallisation to 
occur
65,85,249-252
(A5 Table 2-7). It has been suggested that for every 1% w/w water 
present the Tg can be lowered by approximately 10 °C as was shown for amorphous 
indomethacin
254
. It has also been noted that mechanically processes such as ball-milling 
can result in localised heating which can cause material melting
137,160,192,221
. Since it was 
planned to employ ball-milling at low and high frequencies in this research to 
potentially produce PID, only materials with a melting temperature greater than 80 °C 
were retained (A5 Table 2-4). The 80 °C limit was selected as experimental 
temperatures within ball-milling grinding jars have been shown to be in excess of +45 
°C when used under non-cryogenic conditions
255
. Though these temperatures represent 




To reduce the influence of external environmental parameters and ensure all the 
materials were handled identically only materials which were stable under ambient 
conditions were included for selection (A6 Table 2-4).  
Typically a large number of compounds selected for product development have poor 
solubilities, poor permeabilities, or both and therefore require particle size reduction to 
enhance their bioavailability through increased dissolution rates or solubilities
234;235
. 
Hence, materials which are unlikely to need size reducing because of good oral 
bioavailability were excluded from selection. Solubility (A7 Table 2-4), LogP (A8 
Table 2-4), and the number of rotatable bonds (A9 Table 2-4) have been shown to be 
very good descriptors of oral bioavailability
256
. LogP values are a measure of the 
lipophilicity of a compound and the higher the value) the more hydrophobic-like the 
material and the greater the likelihood that the material exhibits poor water solubility. 
While the number of rotatable bonds is a measure of molecular flexibility and have also 




To ensure that the final materials selected covered the full range of the amorphous-
crystalline continuum as a consequence of mechanical processing materials were 
classified based on literature observations for PID post mechanical processing (See 
Section 2.2.2.4). Materials where no milling PID information was reported were 
excluded (A10 Table 2-4). 
Using the MSC, a pool of potentially acceptable materials was obtained. The final 
selection of materials was made from this pool with the aid of a principle component 
analysis model (PCA) to ensure that the final materials selected exhibited molecular and 
crystallographic diversity (See Section 2.2.3.1). The number of materials in this final 
test set was limited to ten, based on observed PID behaviour and for logistical reasons. 
These comprised of four materials which will represent materials that maybe resistant to 
PID, three materials that may exhibit some PID and three materials where PID may 
likely to be observed as a consequence of mechanical comminution.  
 Principle Component Analysis (PCA) for final material selection 2.2.3.1
Multivariate techniques such as PCA can handle a large number of variables 
simultaneously and can provide a powerful means to elucidate complex multivariate 
relationships between properties and process parameters
258
.  
In a PCA model, the original dimensions of the data set consisting of a matrix of X 
variables are transformed into another coordinate system through projection. The new 
coordinate axes are called principal components. The first principal component covers 
as much of the variation in the data set as possible. The second principal component is 
orthogonal to the first and covers as much of the remaining variation as possible and so 
on
259
. Further information about the principles of PCA and its applications can be found 








For the materials that passed the MSC, the molecular and crystallographic properties as 
defined in Table 2-5 were used as the x variables to generate a PCA model using the 
SIMCA-P+ software, version 11.0.0.0 (Umetrics AB, Umea, Sweden). The SIMCA-P+ 
software automatically scales the data using centering and unit variance (UV) to ensure 
correct and equal weighting of the x variables. The PCA model is displayed graphically 
as a Bi-plot which displays loadings scaled as correlation and the scores scaled inside 
the correlation circle. 
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Table 2-5 X variables used to generate a PCA model to aid in material selection  
Property Xvar ID Source 
Compound name/ID CMPD PubChem224 
Molar  weight (Mw) Mw PubChem
224 
Calculated (unit) cell volume (CCV)  CCV CSD223  
Z Z CSD223  
Cell Density CD CSD223 
Molecular  volume Mv CSD223 
Molar Volume Mrv calculated 
Molar refractivity* MrR ACD230,231 
Parachor* Par ACD230,231 
Index of refraction* RI ACD230,231 
Surface tension*  ST ACD230,231 
Polarizability* Pz ACD230,231 
Topological Polar Surface Area* TPSA ACD230,231 
No. rotatable bonds* RB ACD230,231 
LogP* LogP ACD230,231 
Solubility* Sol ACD230,231 
H-bond acceptors* HA MarvinView233 
H-bond donors* HD MarvinView233 
Melting temperature Tm CSD223, NIST224 or citation 
* Predicted property 
 Results and discussions 2.3
 Literature search for pharmaceutically relevant materials 2.3.1
During the literature search a large number of papers (4000+) were identified using the 
search terms as defined in Table 2-2. The citations from this search were then exported 
to create a reference library and 356 pharmaceutically relevant materials (including 
polymorphs) were identified and entered into the novel Research Material Database 
(RMD). These materials were used to create a pool from which the investigational 
materials could be drawn from. This database was not intended to be exhaustive but 
rather provide a more analytical and logical approach to the selection process. In general 
the materials listed in the RMD have been well investigated over the last two decades 
and therefore, any property data and information should be fairly accessible. 
 Material properties 2.3.2
The molecular and crystallographic properties as defined in Table 2-3 were collated for 
the RMD materials using information from a variety of online databases. During the 
search for these properties it was noted that no single database contained all the property 
data for a particular material and it appeared that for some properties different values 
can be observed depending on the database and prediction algorithm/program used. As 
a result there is the potential for ambiguity to occur and highlights an issue over using 
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calculated properties from different databases. This can be illustrated using HBDA 
values predicted using different software programs (Table 2-6). 
Table 2-6 Software used to predict HBDA values 
Database/supplier Prediction software  
PubChem224 Xemistry GmbH's Cactvs program 
SpresiWeb 232 MOE v2004.3 
ChemSpider226 ACD/Labs property predictor 230,231 
ChemAxon233 Marvin v5.4.0.1 
 
HBDA values provide an estimate of the degree of H-bonding that may occur within a 
molecule based upon the availability of H-bond acceptors and donors within the 
chemical structure. For each material in the RMD, the potential number of H-bond 






226)  and calculated using ChemAxon’s Marvin view software233. Each 




 the number of H-bond donors and acceptors were calculated using the 
Xemistry GmbH's Cactvs implementation and classification by Wang et al. (1997)262, 
i.e. the hydrogen donor can be a heteroatom attached to one or two hydrogens. While 
the hydrogen acceptor, can be any sp
2
-hybridized oxygen, fluorine, or hydrogen donor 
atom. 
The H-bond donors reported for materials using the SpresiWeb interface
232
 (MOE 
software) appeared to be incorrect on a number of occasions. For example adipic acid 
was reported to have four H-bond donors, but the chemical structure only shows two 
potential donors (Figure 2-1).   
The ACD/Labs property predictor software on the ChemSpider
226
 website counts the 
number of N, F and O atoms in the structure and uses these values for the H-bond 
acceptor count. For example loperamide HCl, indomethacin, caffeine and adipic acid 
appear to have 4, 5, 6 and 4 H-bond acceptors respectively (Figure 2-1).  In contrast 
both the Marvin and CACTVS programs apply a more detailed set of rules in assigning 
the H-bond acceptor count, based on the structural motifs of the N and O atoms and 
their connectivity to other atoms. Only the –N= and =O atoms are counted as H-bond 
acceptors for caffeine (Figure 2-1).   
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Figure 2-1 HBDA analysis for loperamide HCl, indomethacin, caffeine and adipic acid 
HD: Hydrogen bond donors, HA: Hydrogen bond acceptors 
MOE:  Molecular Operating Environment (version 2004.3) used in  SpresiWeb232 
CACTVS: from Xemistry GmbH241 used in PubChem224, ACD/Labs: property predictor software used 
in ChemSpider 226, Marvin: From ChemAxon (version 5.4.0.1)   
 
Of all the programs investigated only the Marvin software included the halogen atoms, 
and took into account the counter ions such as the chloride ion for loperamide HCl 
(Figure 2-1). It is important to include any counter ions in the HBDA values as the 
presence of ions strongly influences the molecular stabilities and physicochemical 
properties of the crystals such as the solubilities, dissolution rates and hygroscopicity of 
the materials. 
The Marvin software appeared to be the most consistent when assigning both H-bond 
donors and acceptors, hence it was selected as the program of choice for predicting 
HBDA values for the individual materials listed in the RMD. 
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 Material selection 2.3.3
Using the material selection criterion (MSC) as defined in Table 2-4 as an initial screen, 
the number of materials from the RMD pool of 356 was significantly reduced to only 14 
(Table 2-7). The MSC includes not only information regarding safety, handling and 
potential processing considerations but also limits for some of the predicted properties 











Number  of RMD 
excluded 
% retained from 
RMD 
A1 Anhydrate 303 53 85 
A2 Crystallographic properties 170 133 48 
A3 Safety & handling 126 44 35 
A4 Source & cost 47 79 13 
A5 Melting onset temperature  38 9 11 
A6 Storage conditions 33 5 9 
A7 Solubility* 24 9 7 
A8 LogP* 22 2 6 
A9 No. Rotatable bonds* 21 1 6 
A10 Observed PID from literature 14 7 4 
* Predicted properties. MSC ID – material selection criterion property ID from Table 2-4 
 
The molecular and crystallographic property data for these 14 materials were then used 
to construct a principle component analysis (PCA) model to discriminate the materials 
further and aid in the final material selection. The PCA model data can be found in 
APPENDIX 2. 
The PCA model generated could explain 81.5% of the variation in the x variables 
(loadings) in the first three principal components. Using PCA, the values for each of the 
x variables (loadings) for a material are reduced to a single value (score) and 
relationships (correlations) between loadings and scores can be visualised using a 
loadings bi-plot where loadings are expressed as correlation coefficients and the scores 
(observations) (Figure 2-2).  Observations (materials) situated near variables are high in 
these variables and are low in variables situated opposite. For example, in Figure 2-2 
caffeine (C88) is in close proximity to the loading Z, the number of structural 
(molecular) units per cell, hence caffeine is said to be highly correlated to Z and will 
have a higher Z value (20) than say indomethacin (C11) which is located further away 
with a Z value of 2. 
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The bi-plot also allows the easier identifications of groupings between materials. The 
literature observations for PID were not included in the PCA model but it can be seen 
that the materials can be easily identified and grouped based on these observations: (i) 
no PID, (ii) some PID and (iii) observed PID (Figure 2-2).   
 
Figure 2-2 Loadings bi-plot for the PCA model for the molecular and crystallographic properties of 
the screened RMD materials 
Colours correlate with the literature PID observations; green (no PID), orange (some PID) and red 
(observed PID).   
 
From Figure 2-2, it can be seen that in general materials which have higher LogP, Mw, 
molar and molecular volume, molar refractivity, parachor, polarizability and number of 
rotatable bonds are more likely to be completely disordered as a consequence of a 
milling process. This is in line with other observations by other investigators
160,221,264
. 
Conversely, materials with lower Mw, LogP and number of rotatable bonds etc. will be 
less likely to have PID as a consequence of milling. It must be noted that these 
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inferences were made based on the data from only 14 materials and should not be used 
as a general conclusions for all materials. However, the PCA model reported here was 
suitable for its intended purpose to discriminate the materials based on observed 
literature PID so that a final selection of materials for further investigation could be 
made. 
The final selection of 10 materials within the groups was arbitrarily chosen but 
materials were selected to ensure a good representation of PID behaviour across the 
amorphous-crystalline continuum. Four out of five materials that did not exhibit any 
PID were selected: acetaminophen, methyl paraben, acetylsalicylic acid and phenacetin. 
Three out of five materials possessing some degree of PID were selected: caffeine, 
sulfadiazine and sulfamerazine, and finally three out of four materials that were mainly 
disordered were chosen: salbutamol sulphate, γ-Indomethacin and loperamide 
hydrochloride (Table 2-8).   
Table 2-8 Final material selection based on observed PID and PCA model 
ID Material PCA group Literature observed PID Final selection 
C1 Acetaminophen 1 (No PID) No160,221 Included 
C140 Methyl paraben 1 (No PID) No255 Included 
C69 Phenacetin 1 (No PID) No265 Included 
C33 Acetylsalicylic acid 1 (No PID) No160,221,266,267 Included 
C39 Naproxen 1 (No PID) No268 Excluded 
C88 Caffeine 2 (Some PID) Some217,269 Included 
C87 Sulfadiazine 2 (Some PID) Some221,270 Included 
C54 Sulfamerazine 2 (Some PID) Some270,271 Included 
C86 Sulfathiazole 2 (Some PID) Some221 Excluded 
C118 Sulfamethoxazole 2 (Some PID) Some 272-274 Excluded 
C24 Salbutamol sulphate 3 (Yes PID) Yes1,20,21,246,247,275-277 Included 
C11 γ-Indomethacin 3 (Yes PID) Yes 148,160,178,212,221,268,271 Included 
C14 Loperamide hydrochloride 3 (Yes PID) Yes278 Included 
C34 Ursodeoxycholic acid 3 (Yes PID) Yes279 Excluded 
 
Following material selection, the materials were purchased and stored under controlled 
conditions according to the supplier’s recommendations, i.e. at room temperature and 
protected from light in a desiccator containing phosphorus pentoxide (P2O5). All 
materials were of pharmaceutical quality and high purity (> 98%) (See APPENDIX 3 





The reasons for a particular material exhibiting or not exhibiting PID are poorly 
understood and moreover quite often even the nature of the disorder can been 
misinterpreted
137
. When searching for information regarding a material’s PID 
classification, it was observed that often these materials are over processed and milled 
under different conditions. This makes it difficult to compare the propensities for PID 
between materials and further correlate PID with material properties. A PCA approach 
proved to be very valuable in extracting some correlations between PID and material 
properties, but it did not take into account the impact of different processing methods 
such as ball- or jet-milling, control of temperature and length of milling. Hence a more 
detailed laboratory investigation is warranted where these operating variables can be 
controlled and applied to all the materials allowing a better comparative investigation, 
which has not been explored adequately in the literature before.  
The systematic selection process as described in this chapter was employed to select ten 
materials that exhibited sufficient diversity in their structural and molecular properties 
as well as in their literature PID observations (Table 2-9) to serve as an appropriate 
cohort of compounds for further in-depth study involving mechanical comminution by 
ball- and jet-milling under different conditions. 
Table 2-9 Structural, molecular and PID diversity within the final 10 selected materials 
Property Range  Property Range 
Literature PID 3 levels  
Number of rotatable bonds* 
(RB) 0 - 7 
Space groups (SPG) 7 groups  H-bond acceptors* (HA) 2 - 6 
Number of structural (molecular) 
units per cell (Z) 2 - 20  H-bond donors* (HD) 0 - 5 
Calculated (unit) cell volume 
(CCV)  cm3 604 - 4352  Melting temperature (Tm) °C 127 - 251 
Cell Density (CD) 1.2 - 1.6  Molar refractivity * (MrR) cm3 40 - 138 
Molecular  volume (Mv) cm3 163 - 657  Parachor * (Par) cm3 326 - 1067 
Molar Volume (Mrv) cm
3 98 - 396  Index of refraction* (RI) 1.5 - 1.7 
Molar  or molecular weight (Mw) 
g/mol 
151 - 513  Surface tension* (ST) dyne/cm 39 - 83 
LogP 0 - 5.6  Polarizability * (Pz) cm3 1.6 - 5.5 (x10-23) 
Solubility * (Sol) mg/mL 0 - 33  Topological Polar Surface 
Area* (TPSA) Å2 38 - 122 
* predicted property 
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3 General physical characterisation methods: Core 
test set   
 Introduction 3.1
There is no single test which is capable of assessing all the physical properties of a 
material. It is for this reason that a number of different techniques are required to 
measure, monitor and characterise the different properties of the material being 
examined. The techniques described in this chapter represent a core test set (Table 3-1) 
which will be utilised in this research for the characterisation of a number of important 
molecular, particulate and bulk properties of the selected study materials before and 
after mechanical comminution. 
For each technique a brief description is provided of the relevance of the technique in 
characterising a specific property or properties of the material, along with the associated 
acquisition method (AM). A description of the relevant analytical responses and how 
these responses are analysed (response analysis method or RA) is then provided. 
Table 3-1 Techniques used for the general characterisation of the study materials (core test set) 
Material Property Technique Refer to section 
Phase detection & identification 
X-ray powder diffraction (XRPD) 3.2 
Polarised light microscopy (PLM) 3.5 
Gravimetric vapour sorption (GVS) 3.7 
Differential scanning calorimetry (DSC) 3.4 
Chemical structure & H-Bonding Fourier transform infra-red spectroscopy (FTIR) 3.9 
Moisture sorption 
Thermogravimetric analysis (TGA) 3.3 
Gravimetric vapour sorption (GVS) 3.7 
Fourier transform infra-red spectroscopy (FTIR) 3.9 
Thermal 
Differential scanning calorimetry (DSC) 3.4 
Thermogravimetric analysis (TGA) 3.3 
Particle shape 
Polarised light microscopy (PLM) 3.5 
Scanning electron microscopy (SEM) 3.5 
Particle size 
Laser light particle size (PSA) 3.6 
Polarised light microscopy (PLM) 3.5 
Scanning electron microscopy (SEM) 3.5 
Purity 
(solid state form & chemical) 
Differential scanning calorimetry (DSC) 3.4 
X-ray powder diffraction (XRPD) 3.2 
High pressure liquid chromatography (HPLC) 3.8 
Fourier transform infra-red spectroscopy (FTIR) 3.9 
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 X-ray powder diffraction (XRPD) 3.2
XRPD is a key analytical technique used primarily in the solid state characterisation of 
crystalline materials
29,93,280,281
. For a given X-ray wavelength, the positions of the 
diffraction peaks (reflection) are characteristic of the crystal lattice (d-spacing) and 
intensities are dependent on the crystallographic unit cell content (nature and position of 
atoms). In this way the XRPD pattern provides a “fingerprint” of the solid state 
crystalline form present in the solid state bulk of the material and is a representative of 
the average structure
29,93,280,282,283
. Disordered and amorphous materials however, scatter 
the incident x-rays in all directions giving rise to a featureless “halo”. However, the 
detection and quantification of partially amorphous materials can be limited by the 
presence of the much stronger crystalline diffracting peaks which may obscure this 
characteristic “halo”29,93,280.  
It is important to be aware of the manner in which the physical characteristics of organic 
pharmaceuticals can influence XRPD responses such as the peak intensity (height), 
broadening and the overall interpretation of the diffractogram. Typically organic 
samples have a low X-ray absorption allowing deeper X-ray penetration resulting in 
greater peak broadening compared to inorganic compounds and metals. The common 
crystal habits of columnar, acicular particles and plates can also create a texture, which 
is a non-random or preferred orientation of the particles that alters the XRPD patterns 




The particle size of materials can also contribute to misinterpretation of the resultant 
diffractogram. Materials with particle sizes below 1 µm may exhibit peak broadening 
and a reduction in peak intensity which could be misinterpreted as disorder
150,284
. Larger 
particle sizes can influence the crystallographic responses by introducing a preferred 
orientation effect and could give rise to some sharper and higher intensity diffraction 
peaks, while other peaks appear much smaller and could be difficult to identify unless 
they are magnified
29,280
. In general a crystallite size of 1 to 50 µm is sufficient to 
provide good resolution of diffraction peaks
29,284
. To minimise preferred orientation 
affects, samples are often ground in a mortar and pestle
29,280
. However, it is the author’s 
opinion that this approach does not fully represent the actual sample as it changes not 
only the particle size of the material but could also add an element of disorder via the 
mechanical grinding process. For the purposes of this research, materials were not 
ground during sample preparation and the presence or absence of preferred orientation 
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noted so that any observed changes could then be dually assigned to an external process 
and not to the sample preparation.   
 XRPD acquisition method 3.2.1
Sample X-ray powder diffraction patterns were obtained using a PANalytical CubiX 
PRO Fast diffractometer (details in APPENDIX 4). A representative sample of the 
experimental material was spread thinly on to a lightly silicone greased zero background 
holder (silicon wafer, PANalytical part number: PW1817/32) and placed on a spinner 
stage with a spinner revolution time of 1 s. Bragg-Brentano geometry was applied using 
monochromatic Cu K radiation (λ   1.540  Å) and soller slits (0.02 rad) for both the 
incident and diffracted beam paths. The instrument was operated at a voltage of 45 kV 
and a current of 40 mA over a scan range 2-70 °2θ with a step size of 0.0201 °2θ and a 
time per step of 71.75 s. System suitability was performed daily for diffraction line 
position and peak and tube intensity using -Alumina standard SRM 1976. Samples for 
XRPD analysis were prepared under ambient conditions with both the laboratory 
temperature and ambient percentage relative humidity (%RH) monitored. The average 
sample preparation time was approximately 2 min.  
Routine XRPD acquisitions usually stop at 40 to 50 °2θ which may not capture the 
entire diffraction signal and thus scans to higher °2θ values such as 70 °2θ may allow 
other potential unique peaks to be identified
285,286
. This extended range may also 
provide valuable information to investigate the amorphous character by advanced 
analysis methods such as those using pairwise distribution function (PDF) 
algorithms
285,286
. PDF could be used to provide information on the local molecular 
structure and short range order for materials across the crystalline-amorphous 
continuum and this is a subject of further investigation by other researchers
285,286
. 
 XRPD data treatment method 3.2.1.1
To obtain numerical response data for analysis, the acquired XRPD diffraction patterns 
were pre-processed using the PANalytical X’Pert HighScore Plus (version 3.0) software 
to separate the crystalline peak data from the background (baseline) and to identify the 
associated diffraction peaks.  
Replicate XRPD patterns were averaged by combining the merge scans with simple 
sum and taking the mean value. A background search was performed on the average 
scan using the following parameters: automatic with granularity = 25 and bending factor 
(See APPENDIX 5 for more information about granularity and bending factor settings). 
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A peak search was carried out to automatically locate peak positions and peak 
intensities using the minimum of second derivative and the following search parameters 
(Table 3-2). The minimum of second derivative peak search method provides optimal 
results for scans with overlapping peaks
287
. The treated XRPD peak data (*.HPF) and 
background profile (*.RD) were then saved for further analysis. 
Table 3-2 XRPD peak search parameters 
Parameter Value Details and Comments 
Minimum significance 15 or 5 for patterns with 
high noise values, i.e. 
milled materials 
The significance of a peak is a measure of the probability that 
a peak found is not noise-induced. Only peaks with 
significance above the minimum significance are accepted by 
the peak search procedure. 
Minimum tip width 0.05 The minimum and the maximum tip width are a measure of the 
width of the peaks to be found. The tip width is the width, 
where the 2nd derivative is < zero. 
Maximum tip width 1.0 
Peak Base Width 2.0 The width of the peak base. It must be greater than the 
maximum peak tip width. 
 
 XRPD response analysis 3.2.2
Using the treated data a number of individual peak and general diffractogram responses 
were reported and tabulated for further data analysis and interpretation (Figure 3-1 and 
Table 3-3). 
 
Figure 3-1 Reported and calculated responses for individual XRPD peak data  
























Table 3-3  XRPD responses: Definitions and calculations for individual peaks and whole 
diffractogram. 

















Peak position (PP)  Peak position of diffraction reflection [°2θ.] e.g. PP1 and PP2 refer to peak 
positions of peaks 1 and 2 respectively in Figure 3-1. 
Relative peak intensity (RPI)  % Intensity relative to the strongest peak. In X'Pert HighScore relative 
intensities are calculated on the basis of the net peak height.  
e.g. In Figure 3-1 the strongest intensity peak is peak 1 therefore the RPI for 
peak 2 = (PH2/PH1)*100. 
Peak height (PH)  Intensity of the peak maximum in [counts or cts]. 
The peak height is determined by the composition and structure of the lattice, 
as well as instrumental factors (slit width, tube settings, tube age) e.g. PH1 and 
PH2 refer to peak height of peaks 1 and 2 respectively in Figure 3-1 
Background height (BH)   Height of the background [counts or cts] influenced by sample preparation, 
instrument, air and crystallite properties (size, shape and lattice disorder). 
e.g. BH1 and BH2 refer to background height of peaks 1 and 2 respectively in 
Figure 3-1. 
Peak area (PA) Peak area in [cts
×scan axis]. 
e.g. PA1 and PA2 refer to peak areas of peaks 1 and 2 respectively in Figure 
3-1. Peak area is influenced by the lattice structure, instrumental factors and 
particle size. 
FWHM Full Width at Half Maximum of a peak [°2θ.]   The half-height width depends 
on the particle size, crystallite size and internal strains and instrument effects. 
FWHM in this research will be used as a measure of peak width. 
















Most intense  peak (MIP) The peak position of the peak with the highest intensity. This value is used in 
the determination of the relative peak intensities for all the other peaks. 
e.g. PH1 is the most intense peak in Figure 3-1. 
Significant peaks (SP) List between 15-30 significant peaks based on relative peak intensities (RPI) 
to discriminate the material. Typically peaks above 5.0 % RPI were selected. 
However, for some materials the MIP is so intense it results in very low RPI’s 
for the other peaks. In these cases a cut-off % RPI value of 0.5-2 % may have 
been used. 
The % RPI value used for peak selection was reported.  
Sum of net intensity signals for 
crystalline (XI), background (BI) 
and observed (TI) [cts] 
Net signal information for crystalline (XI), background (BI) and observed (TI) 
obtained during the background search. These values are reported in the 
signal statistics section of the object inspector panel. 
Sum of Net peak (XA), 
background (BA) and gross areas 
(TA)  [cts*°2θ] 
The net areas for peaks (XA), background (BA) and total areas (TA) are 
calculated after performing the peak search. These values are reported in the 
peak statistics section of the object inspector panel. 
 Thermogravimetric analysis (TGA) 3.3
Thermogravimetric analysis is typically used to determine sample mass changes as a 
function of temperature
29,288,289
. These mass change events primarily represent the loss 
of volatiles or material decomposition. TGA of the bulk crystalline material was 
performed to demonstrate that the material was not a solvate or hydrate and to provide 
the upper temperature limit to be applied during DSC acquisition based on the observed 
degradation temperature.  
It is important to note that TGA does not provide a direct indicator for the presence of 
disorder in materials but indirectly some valuable information can be ascertained. For 
example changes to surface disorder, particle size and levels of impurities maybe be 
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implied through changes to the mass loss profile and, or degradation temperatures
46,55,58
. 
Understanding the causes of these changes, especially the weight loss due to the 
presence of water that may have been sorbed as a consequence of processing or storage, 
can be used to highlight any potential solid state stability issues. The sorption of water 
either during processing or storage can be used to accelerate the crystallisation of any 
disordered surfaces and could lead to agglomeration and in worst cases new solid state 
forms
288,290
. It has been noted that a greater than 0.5 % w/w absorption of water could 
be indicative of the presence of a small level of amorphous content
250
. 
 TGA acquisition method 3.3.1
TGA analyses were performed using a TA Instruments Q500 TGA (details in 
APPENDIX 4). The instrument was calibrated using a two point temperature calibration 
with alumel (CRM3-5291) and nickel (CRM2-8058) at a heating rate of 10 °C/min.  All 
measurements were performed in a dry nitrogen environment with a constant purge gas 
flow of 60 mL/min. 5-15 mg of each material was placed on a tarred platinum sample 
rig with an aluminum pan insert and analysed at a heating rate of 10 °C/min from 20-
350 °C (the typical temperature range for studying pharmaceutical organics
288,289
).  Data 
points were collected every 0.5 s. 
 TGA response analysis 3.3.2
The acquired TGA thermograms were analysed using TA instruments Universal 
Analysis (version 4.5) software and the responses tabulated as described in Table 3-4 
and illustrated in Figure 3-2. 
Two weight loss measurements were selected to aid in the reporting of volatiles such as 
solvents or adsorbed water in the materials and to provide a measure of consistency in 
the reporting of percentage weight loss over a set temperature range (Table 3-4). 
Percentage weight loss below 50° C (WL50) may be indicative of loosely bound volatiles 
present in the material
288
. While, percentage weight loss below 150 °C (WL150) generally 
represents the total amount of both loose and strongly bound volatiles such as moisture 
or solvent as it also includes WL50
288
. However, it must be noted that in some instances 
solvent loss may not occur until degradation occurs, i.e. for occluded solvents.  
  
73 
Table 3-4 Description of TGA responses to be reported 
Response Details and Comments 
Number of weight loss events (#WE) Report the number of weight loss events occurring before degradation 
(Td).  
Weight loss event(s) (WE) Report in order: % weight loss (WL#), onset temperature of weight loss 
event (O#) and temperature range (start (S) to end (E)) in the format; WL, 
(O, range). Where the onset temperature cannot be calculated only the 
range is reported, i.e. WL, (range). 
If an unresolved weight loss event occurs at degradation this is denoted 
as “LoD”. 
% weight loss below 50° C (WL50) % mass change (w/w) between start and 50 °C. This temperature range is 
fixed to allow comparison across materials.  
Weight loss below 50 °C generally represents loosely bound volatiles 
such as moisture or solvent. 
% weight loss below 150 °C (WL150) % mass change (w/w) between start and 150°C. This temperature range 
is fixed to allow comparison across materials.  
Weight loss below 150 °C generally represents the amount of volatiles 
such as moisture or solvent present (both loose and strongly bound). 
For materials which started to thermally degrade below 150 °C, WL150 
could not be calculated so were be denoted as “D”.  
Degradation onset temperature, (Td ) Extrapolated onset temperature for sample degradation (°C). 
 
 
Figure 3-2   A hypothetical TGA thermogram describing the reported responses  
See Table 3-4 for definitions of terms. 
S = Start point of event, E= End point of event, green circle is onset point (O2) for the weight loss 
event (WL2), black circle is the onset point of degradation (Td). 
 Differential scanning calorimetry (DSC) 3.4
DSC provides information regarding the thermal properties of both crystalline and 
disordered material as a function of temperature
288,289,291
. DSC is a destructive technique 
and the responses obtained can be dependent on the parameters of acquisition such as 
heating rate, pan type and sample weight
288,289,291-296
. Solid-state form changes can also 
occur during acquisition, which may result in phases being identified that are not 
initially present in sample material
289,291-297
. Therefore, it is important that the correct 
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acquisition parameters are selected and reported alongside the resulting responses to 
ensure consistency in the interpretation. Information from the DSC thermogram is 
typically used to verify the solid state form identified by XRPD and vice versa, which 




 DSC acquisition method 3.4.1
The thermal properties of the materials were measured using a TA Instruments Q2000 
DSC (details in APPENDIX 4) with an attached integrated refrigerated cooling system 
(RCS). The instrument was calibrated using a two point temperature and enthalpy 
calibration with indium (LGC2601) and lead (LGC2608) at a heating rate of 10 °C/min. 
All measurements were performed in a dry nitrogen environment with a constant purge 
gas flow of 50 mL/min. 1-2 mg of each material was accurately weighed into a standard 
aluminum pan and a lid placed on top before lightly crimping using a proprietary 
sealing press. The samples were heated at a rate of 10 °C/min from -10 °C to the 
respective end temperature based on the observed TGA degradation temperatures. 
These endpoints were selected to reduce the occurrence of degradation in the DSC cell 
which could interfere with the analysis of subsequent samples. Data points were 
collected every 0.2 s. Samples for DSC analysis were prepared under ambient 
conditions with both the laboratory temperature and RH monitored. The average sample 
preparation time was approximately 2 min. 
A heating rate of 10 °C/min was chosen as this provides a good balance between 




 DSC response analysis 3.4.2
A DSC thermogram may contain a number of different thermal events as shown in 
Figure 3-3. These thermal events can be endothermic (heat absorbed), exothermic (heat 
released) or involve a change in heat capacity (change in baseline). In some cases the 
observed event may have an associated weight gain or losses, which can be verified by 
TGA analysis (Table 3-5). 
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Figure 3-3 A hypothetical DSC thermogram depicting a number of thermal events that may be 
observed 
 
Table 3-5  Classification of thermal events as endothermic or exothermic 
Event Weight gain Weight loss Endothermic Exothermic 
Absorption Yes - - Yes 
Desorption - Yes Yes - 
Dehydration/desolvation - Yes Yes - 
Vaporisation - Yes Yes - 
Sublimation - Yes Yes - 
Decomposition/degradation - Yes Yes Yes 
Oxidative degradation - Yes - Yes 
Dissolution - - Yes - 
Melting - - Yes - 
Solid state transition - - Yes* Yes** 
Enthalpic recovery - - Yes - 
* Enantiotropic reversible, ** Monotropic irreversible 
 
For each thermal event there are a number of responses which can be used to both 
define and quantify the thermal event as illustrated in Figure 3-4, Figure 3-5 and Table 
3-6. For each acquired DSC thermogram the thermal events were reported and the 
relative responses tabulated using the Universal Analysis software (version 4.5). 
Occluded solvents (solvents trapped in crystal lattice) and gas generated as a result of 
thermal degradation can be released during melting (M) and degradation (D), but as 
these observations coincide with those events they are likely to be unresolved. In this 
research, volatile (V) events in the DSC refers only to desolvation of liquids that occur 




Figure 3-4 Depictions of glass transition (G) and recrystallisation events (C) with associated 
responses. 
(See Table 3-6 for definitions of terms). Exothermic is up. 
 
 
Figure 3-5 Depictions of desolvation (V), solid-solid transition (T) and melting (M) and degradation 
(D) event with their associated responses  
(See Table 3-6 for definitions of terms). Exothermic is up. 
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Table 3-6 Description of reported DSC responses for different thermal events 
Property/event Response Details and Comments 
# events G#V#C#T#M#D# The number of occurrences for each type of thermal event 
Glass transition (G) Tg-s  & Tg-e Start and end temperatures of glass transition respectively (°C) 
Tg-0 Extrapolated onset  temperature of glass transition (°C) 
Tg (i) Glass transition temperature (°C) inflexion point 
Tg-r Temperature at which curve returns to baseline (°C) 
Ter Peak temperature of enthalpic recovery (°C) 
Tg size Size of glass transition or heat capacity (J/(g°C)) 
Tg range Temperature range of glass transition  (°C) (equation [3-1]) 
Δ er Enthalpic recovery (J/g) 
Desolvation (V) before 
melting or degradation 
Tv-s, Tv, Tv-p & Tv-e  Start, onset, peak and end temperatures of desolvation respectively 
(°C)  
Δ v Heat of desolvation (J/g) 
Recrystallisation (C) Tc-s, Tc, Tc-p &Tc-e Start, onset, peak and end temperatures of crystallisation respectively 
(°C) 
Δ c Heat of crystallisation (J/g) 
Solid-solid transition (T) Tt-s,Tt, Tt-p &Tt-e Start, onset, peak and end temperatures of transition respectively (°C) 
Δ t Transition enthalpy (J/g) 
Melting (M) Tm Extrapolated onset  temperature of melting (°C) 
Tm-s & Tm-e Start and end temperatures of melting respectively (°C) 
Tm-p Peak temperature of melting (°C) 
WHH Width at half peak height (°C) 
Tmtrans Temperature range of melting (°C) (equation [3-2]) 
Δ f Heat of fusion (J/g) 
Melt-L Total temperature range for melting to occur  (°C) (equation [3-3]) 
Melt-R Total temperature range for material to recover after melting (°C) 
(equation [3-4]) 
SYM Measure of peak shape (equation [3-5]) 
Degradation (D) Td Onset temperature of degradation (°C) 
 Calculations 3.4.2.1
Temperature range of glass transition, Tg range (°C) is given by: 
Tg range = Tg-e  - Tg-0    [3-1] 
where Tg-e and Tg-0 are the end and extrapolated onset temperatures of glass transition 
respectively. 
Temperature range of melting, Tmtrans (°C) is given by: 
Tmtrans = Tm-p  - Tm [3-2]  
where Tm-p and Tm are the peak and extrapolated onset temperatures of melting 
respectively. 
Total temperature range for melting to occur, Melt-L (°C) is given by: 
Melt-L = Tm-p  - Tm-s    [3-3] 
where Tm-p and Tm-s are the peak and start temperatures of melting respectively. 
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Total temperature range for material to recover after melting, Melt-R (°C) is given by:
 
Melt-R = Tm-e  - Tm-p [3-4]  
where Tm-e and Tm-p are the end and peak temperatures of melting respectively. 
Measure or symmetry of peak shape (SYM) is given by: 
SYM = Melt-L / Melt-R [3-5] 
 Microscopy methods 3.5
Microscopy methods in the context of this research refer to both polarised light 
microscopy (PLM) and scanning electron microscopy (SEM) used to obtain preliminary 
estimations of particle size and shape. The choice of which microscopic method to use 
is dependent on the size of particles and the particle property information that is 
required.  
Light microscopy is typically used to acquire optical crystallographic information such 
as crystal size, shape (habit) and agglomeration for particles greater than 1 µm in 
size
29,103,298,299
. However, when the sample is viewed under crossed-polarised light on a 
rotating stage (PLM) a qualitative check for crystallinity can be employed
29,30,103,298,299
. 
This is because most crystals are optically anisotropic and are birefringent, exhibiting 
different indices of refraction that is dependent upon the direction of vibration and 
transmission of the light passing through them
103,298
. Anisotropic crystals appear white 
to highly colored under cross polarised light and as the microscope stage is rotated the 
intensity of light will decrease to zero (crystal appears dark)
103,299
. These dark positions 
are called “extinction” positions and occur when a refractive index of the crystal 
coincides with the polarised light from the polariser
30,103,299
. Optical isotropic materials 
such as non-crystalline materials and cubic crystals exhibit identical optical properties 
in all directions and are described as non-birefringent. When these materials are viewed 




SEM can also be used to provide particulate information about the material such as 
crystal shape (habit), agglomeration and particle size but can also provide additional 
information on crystal morphology, surface topography and extent of agglomeration due 
to its higher magnification and resolution, and greater depth of field and surface 
sensitivity (contrast) than that of optical microscopy 
91,93,281
. 
When a material is subjected to a mechanical process such as ball-milling or 
micronisation, changes to the crystal habit and particle size can be monitored quickly 
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using microscopic methods. It is important to note that chemical and solid-state phase 
changes cannot be inferred directly or unambiguously by microscopy alone
300
. It is 
often up to the interpreters’ experience to discern the information and then reach 
qualitative conclusions. Therefore it is important that any inferences with respect to the 
presence of disorder is made in conjunction with information provided by more direct 
measures of disorder using techniques such as XRPD and DSC. 
 PLM acquisition method 3.5.1
Any measurement must be representative of the bulk powder being analysed therefore 
the sample container was inverted end-over-end 20 times before a small sample of the 
material (approximately 20 mg) was removed using a spatula and placed in a 1 mL glass 
vial containing 1 mL of silicone oil (200/200 CS fluid, Dow Corning, Batch 
000005E888, Lot L8-105). The suspension was then mixed using a vortex mixer 
(details in APPENDIX 4) for 15 s at medium speed. Two drops of suspension were then 
placed onto a glass slide. A metal wire was used to lightly disperse the particles in a few 
drops of silicon oil before a cover slip was applied. At least 3 images of each slide were 
acquired using a Zeiss Axioplan2 microscope (details in APPENDIX 4) with attached 
5x, 10x and 20x objective lenses and transmitted light. Each slide was also viewed 
under polarised light and the stage rotated around at 90 degree angles to observe for the 
presence/absence of birefringence. Images were acquired under ambient conditions, 
with both the laboratory temperature and RH being monitored. The average sample 
preparation and acquisition time was approximately 5 min. 
 SEM acquisition method 3.5.2
The sample container was inverted end-over-end 20 times. Using a small plastic 
paintbrush a few milligrams of sample powder was sprinkled onto a carbon coated 
sample stub from a height of about 1-2 cm. Excess sample was tapped off the stub. The 
stub was then coated with a gold/palladium metal film using an argon-plasma sputter 
coater (details in APPENDIX 4) set at 20 mA for 3 min.  
SEM images of the sample material were obtained using a high resolution FEI Quanta 
200 SEM instrument (details in APPENDIX 4) operating under high vacuum, 0.45Torr 
pressure a voltage of 3.2-5 kV, an electron column spot size of 5.0 and a working 
distance of approximately 10 mm. Images were obtained at magnifications of 1000x (50 
µm), 500x (100 µm), 100x (500 µm). 
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 Microscopy response analysis 3.5.3
The microscopic images obtained using the PLM or SEM methods were qualitatively 
analysed using the Image Pro plus software (version 4.0). No image analysis was 
performed but rather a visual inspection was carried out to establish the primary particle 
habit and size, birefringence (PLM only), the extent of particle association (if any), 
along with surface characteristics (Table 3-7). 
Table 3-7  Description of the microscopy responses to be reported 
Response Details and Comments 
Primary particle shape or habit As described and illustrated in Figure 3-6. 
Particle surface characteristics and 
condition 
As described and illustrated in Figure 3-7. 
Birefringence (PLM Only) For crystalline material extinction (darkening) observed upon rotation under 
polarised light. Disordered and cubic (isotropic) materials remain dark upon 
rotation. 
Typical primary linear particle size 
(µm) & range 
The longest linear dimension from edge to edge of a particle oriented parallel to 
the ocular scale as shown in Figure 3-8. This is an estimated value representing 
the average  which is determined by manual calculation using the Image Pro plus 
(version 4.0) software. 
Particle association 
(secondary crystal habits) 
Primary particles can be associated into a collection of particles as described and 
illustrated in Figure 3-9. 
Typical agglomerated particle size 
(µm) & range 
The longest linear dimension from edge to edge for a mass of associated particles 
as shown in Figure 3-8. This is an estimated value representing the average  which 













Figure 3-8  Longest linear dimensions (LLD) for primary and agglomerated particles 
 
 






 Laser particle size analysis (PSA) 3.6
Laser diffraction is a commonly used particle sizing technique within the 
pharmaceutical industry on account of its speed of analysis, ability to handle a range of 
sample presentations and sizes, and ease of data presentation
301-303
  
Unlike two dimensional microscopy methods which are number based and uses the 
longest linear dimension (length) as the defining particle size measure, particle size 
analysis by laser diffraction is a volume based three dimensional measurement 
technique which is sensitive to small changes in the amount of large material in the 
sample
301
. In the case of microscopic numerical distributions the fines may be over 
emphasised, and conversely for laser particle size volume distributions the coarse 
particles may be over emphasised
301
. 
It is also important to note that particle size analysis by laser diffraction does not 
measure particle size directly, but rather the property measured is the angular 
distribution of scattered light which is then converted into an approximation of 
homogenous spheres to give a particle size distribution based on either the Mie or 
Fraunhöfer theory
301
. However, the majority of pharmaceutical substances are non-
spherical, and will therefore be measured over all orientations, resulting in a broadening 
in the measured size distribution. In addition, if particles are textured, they will tend to 
give enhanced weighting to the fine end of the distribution
301
. 
The two theories of light scattering - the Fraunhöfer theory and the Mie theory each 
make assumptions relating to physical attributes of the particles and the interaction of 
light with matter
301,302
. The Mie theory assumes that all the particles are spherical and 
translucent whereas the Fraunhöfer theory assumes that particles are spherical and 
opaque.  In this research only the Fraunhöfer theory has been applied since it does not 
require knowledge of the refractive index of the materials being investigated
301,302
. As 
the particle sizes (>1 μm) being investigated are significantly greater than the 
wavelength of the laser light the Fraunhöfer approximation can be suitably applied to 
derive the particle size distribution
304,305
.  
As laser particle size analysis cannot distinguish between single particles and 
agglomerated particles care must be taken when preparing samples for analysis and 
when interpreting the results
303
. It is for this reason that results from laser particle size 
analysis should be viewed in conjunction with microscopy study information to evaluate 
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the accuracy of the values, or at the very least provide an understanding whether it is the 
primary or secondary particles that have been measured
301-303
. 
 PSA acquisition method 3.6.1
Under ambient conditions, the sample container was inverted end-over-end 20 times 
before six aliquots of approximately 50 mg of sample were placed in clear ASPIROS 
sample tubes and capped. The samples were then analysed in the dry state using a 
Sympatec HELOS laser light diffraction particle size analyser with an attached RODOS 
dry disperser and an ASPIROS dry dispersion unit (details in APPENDIX 4).  The 
samples were dispersed with compressed air at 1 bar with a feed velocity of 40.00 
mm/s.  
The choice of lens used depended on the qualitative assessment of the linear particle 
size range defined using an appropriate microscopic technique (sections 3.5.1 or 3.5.2). 
Table 3-8 defines the acceptable particle range for each lens type R1 to R8. 
Table 3-8 Sympatec HELOS Lens Table 
Lens No. Lens focal length (mm) Particle size range (µm) 
R1 20 0.18 – 35 
R2 50 0.45 – 87.5 
R3 100 0.9 – 175 
R4 200 1.8 – 350 
R5 500 4.5 – 875 
R6 1000 9.0 – 1750 
R7 2000 18 – 3500 
R8 5000 45 – 8750 
 
In between aliquot runs, silicon carbide was used to clean the dispersing line. Different 
size ranges of silicon carbide standards were also used to check instrument performance 
and the accuracy of each lens. 
 PSA response analysis 3.6.2
Particle size analysis was performed using the WINDOX 5.0 software (Sympatec 
GmbH). The particle size distributions can be plotted as a log-normal distribution curve 
cumulative distribution by volume vs. logarithm particle size, or density distribution, 
(q3*) versus logarithm particle size, whereby particle size responses could be calculated 
and tabulated
302,306
 (Table 3-9).   
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Table 3-9 Description of the particle size analysis responses to be reported 
Response Description 
D10 (µm) Lower decile i.e.10% of the particles by volume are below this size & 90% above. 
D50 (µm) Median i.e. 50% of the particles by volume are below this size & 50% above.  
D90 (µm) Upper decile i.e. 90% of the particles by volume are below this size & 10% above 
Span Is a numerical indication of the width of the distribution (see equation [3-6]) 
Mode(s) 
Represents the most common value of  the frequency distribution, i.e. the highest point or peaks 
in the curves 
SMD (µm) Surface mean diameter or Sauter mean diameter 
VMD (µm) Volume mean diameter, the larger the particles the greater the value 
Sm (cm2/g) Surface area, the more fines there are the greater the value 
 
 
Figure 3-10  Example of a bimodal particle size distribution, illustrating some key responses D10, D50, 
D90 and modal positions) as described in Table 3-9 
 Calculations 3.6.2.1
Numerical width of the particle size distribution. Span is given by: 
Span   
D 0 – D10
D50
 [3-6] 
Where D10, D50 and D90 are the lower, median and upper decile particle size values. 
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 Gravimetric vapour sorption (GVS) 3.7
It is important to understand the moisture sorption properties of materials, as water can 
alter the solid state form, affect bulk and mechanical properties and can cause chemical 
interactions
18,24,190,191,252,290,307,308
.   
Water can interact at the surface of materials (adsorption) or it can penetrate into the 
internal bulk structure (absorption) resulting in the formation of crystal hydrates
290
.  
Typically water is adsorbed at the surface of crystalline materials due to the close 
packing and high degree of order within the crystal lattice forming only 2-3 mono-
layers of water molecules and resulting in moisture sorption of typically less than 2% 
(w/w). However, for materials that have been size-reduced but are still crystalline the 





For amorphous or disordered materials, water adsorption can be significant as it 
involves dissolution of water molecules into the solid mass. It has been noted that a 0.5 
% w/w absorption of water could be indicative of the presence of a small level of 
amorphous content
250
. For materials subjected to mechanical process such as ball-
milling or micronisation the introduction of defects allows the ingress (adsorption) of 
moisture initially at the surface which is then absorbed into the internal structure of the 
solid
290
. In these cases water acts as a plasticiser, reducing the value of the Tg allowing 
either surface re-ordering or bulk recrystallisation depending on the location, the 
amount of water adsorbed, the temperature and the relative humidity
19,65,85,249-252,290,311
.  
This recrystallisation event can be observed in the GVS run as a mass loss as %RH is 
maintained at an elevated level
312,313
. It has been suggested that for every 1% w/w water 




Moisture vapour sorption techniques are typically utilised to better understand both the 
amount and the kinetics of moisture adsorption/desorption of materials and in the 
detection of amorphous phases
18,24,190,191,252,290,307,308
. The detection of the presence of 
amorphous and disordered phases is achieved by measuring the release of adsorbed 
vapor from the amorphous phase when it crystallises rather than directly measuring 
properties of the amorphous phase, such as the Tg
18,24,190,191,252,307,308
. However, to 
quantify the amount of disorder or amorphous phase present the use of calibration 
standards are typically used
18,24,190,191,252,307,308
.  This can be problematic as it cannot be 
guaranteed that the standard is 100% amorphous or that the moisture sorption process of 
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the standard reflects that of the sample, i.e. absorption from a spray dried standard 
versus adsorption from a ball-milled sample maybe different. This could result in an 
over estimation of the actual amount of amorphous material present
309
. It is therefore 
better to rely on correlating instrument responses with product performance rather than 
use inappropriate standards.  
 GVS acquisition method 3.7.1
Moisture sorption/desorption properties of the materials were investigated using a 
Surface Measurement Systems DVS-1 instrument (details in APPENDIX 4). 
Approximately 10-20 mg of sample was weighed into a quartz sample holder and held 
for 15 min at 30 %RH and 25 °C to equilibrate before a two cycle adsorption/desorption 
run was initiated using a dm/dt of 0.02 %min-1 with a time interval range of 15 to 120 
min and a nitrogen gas flow of 200 mLmin
-1
.  The % RH was then adjusted at 10 %RH 
intervals within the adsorption/desorption ranges as shown in Table 3-10.  
The DVS instrument is sensitive to electrostatic charge so where possible electrostatic 
charge was dissipated before analysis using a Zerostat 3 electrostatic discharge gun. 
The instrument was calibrated using saturated NaCl reference salt and a weight check 
performed before use. Due to the length of acquisition (+10 h), replicate analysis was 
not performed. 
Table 3-10 %RH ranges for sorption/desorption 
Adsorption/ Desorption cycles 
% RH range 
(increase at 10 %RH intervals) 
Adsorption 1 (ADS1) 30 to 90 
Desorption 1 (DES1) 90 to 0 
Adsorption 2 (ADS2) 0 to 90 
Desorption 2 (DES2) 90 to 0 
Adsorption 3 (ADS3) 0 to 30 
 
From the literature “drying” the sample is often the first step in the G S analysis290,314. 
However, “drying” can potentially alter the solid state properties of the sample if for 
example water is present, then the removal of water could destabilise the crystal lattice 
resulting in the generation of amorphous material
290,310,314
. Therefore, in this research 
30 %RH was selected as the starting RH as this represents a close approximation to the 
typical environmental RH of the laboratory and is unlikely to alter the initial solid state 
form of the material being analysed. 
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 GVS response analysis 3.7.2
The acquired data was exported from the SMS DVS 1 software version 3.01 to Excel
©
 
where the data was plotted as % RH as a function of time, with an overlay plot of the 
percentage change in sample mass (dry) this is referred to as a kinetics plot (Figure 
3-11[A]). The value for % change in sample mass (dry) at a given %RH is calculated 
relative to the value at 0 %RH, i.e. point C in Figure 3-11[A].  
 
Figure 3-11 GVS kinetics [A] and isotherm [B] plots showing the moisture adsorption/desorption 
profile for ball-milled  caffeine 
Points A to F represent the start to end points of the adsorption/desorption cycles.  
Please refer to Table 3-11 for definitions of other responses. 
 
An isotherm plot is also obtained which represents the change in sample mass % (dry) 
as a function of target %RH (Figure 3-11[B]) and can be used to visualise changes in 
moisture adsorption/desorption profiles at different %RH values. Table 3-11 describes 
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the associated GVS responses that are tabulated and reported to aid in characterising the 
moisture sorption properties of the study materials. 
Table 3-11 Description of GVS responses to be reported 
Response Details 
M#, (%) Equilibrium % change in mass (dry) at different %RH values  #  = A, B, C, D, E, F (see Figure 
3-11) 
A represents the initial point at 30 %RH and reflects the amount of moisture initially present. 
However, an elevated value could also be due to an electrostatic charge so need to compare 
with TGA results 
B represents point at 90 % RH (end of first adsorption) 
C represents point at 0 % RH (end of first desorption and dry) 
D represents point at 90 % RH (end of second adsorption) 
E represents point at 0 % RH (end of second desorption and dry) 
F represents final point at 30 %RH (end of third adsorption) 
MEND, (%) Represents the difference in % change in mass (dry) from the starting point (A) to the end 
point (F) during the run.  
If this value is large i.e. greater than ±1 then this may indicate that  moisture has been 
retained or absorbed and that the solid state form of the material being analysed may have 
changed. 
MADS , (%) Represents the difference in equilibrium % change in mass between points B and D, i.e. At 
90 %RH for adsorption cycles 1 and 2. 
ADS#, DES# Represents the adsorption and desorption cycle number # respectively. 
ADS1 30-90 %RH or points A to B 
DES1 90-0 %RH or points B to C 
ADS2 0-90 %RH or points C to D 
DES2 90-0 %RH or points D to E 
ADS3 0-30 %RH or points E to F 
MMAX1, MMAX2 (%) Maximum equilibrium % change in mass (dry) during adsorption cycles 1 (ADS1) and 2 
(ADS2) respectively. 
ADS (%) Represents the difference in the maximum equilibrium % change in mass (dry) during 
adsorption cycles 1 (ADS1) and 2 (ADS2) respectively. A large positive value infers 
irreversible moisture sorption or that a crystallisation event may have occurred in ADS1 
(equation [3-7]) 
Moles of water at x 
%RH (Mwater)  
Moles of water at a specified %RH value calculated using equation [3-8] 
HYS at x %RH, (%) Hysteresis is the difference in change in mass at a defined target %RH value (x) between the 
desorption and adsorption cycle. Calculated using equation [3-9] 
%RHxtal  (%RH) %RH value where a mass loss is observed as %RH value is maintained representing %RH 
for recrystallisation. ND (not detected) reported if not observed 
Mxtal (%) Value for % mass loss observed during recrystallisation at %RHxtal, ND (not detected) 
reported if not observed 
 Calculations 3.7.2.1
The difference in the maximum equilibrium % change in mass (dry) (ADS) during 
adsorption cycles 1 (ADS1) and 2 (ADS2) respectively is given by: 
    (%)   (              ) [3-7] 
where MMAX1 and MMAX2 represent the mmaximum equilibrium % change in mass (dry) 




Moles of water at a specified %RH value (M#) is given by: 
Moles of water (      )   
  
(
       
          
) x 100
 [3-8] 
where M#   represents the % mass change at a specified %RH point or the maximum, 
Mwwater is the molecular weight of water (18.016) and Mw is the molecular weight or 
mass of the study material. 
Hysteresis at a specified %RH value  (HYS at X %RH) is given by: 
              (                            ) [3-9] 
where M# represents the percentage change in mass at a defined target %RH value (X) 
for the respective desorption and adsorption cycle. 
 High pressure liquid chromatography (HPLC) 3.8
A fast gradient HPLC method developed within GSK
315
 was used to provide an estimate 
of the degree of chemical purity of the input study materials and to qualitatively identify 
the presence of any degradants as a result of mechanical processing. It is not intended 
that this method be quantitative nor was it validated.  
 HPLC acquisition method 3.8.1
A sample solution was prepared by weighing approximately 5 mg of study material into 
a 2ml amber HPLC autosampler vial containing 1.5 mL 50% (v/v) acetonitrile:water. A 
blank solution containing 1.5 mL 50% (v/v) acetonitrile: water solution was also 
prepared. The samples were then mixed well and analysed by UV using an Agilent 1100 
series HPLC fitted with a diode array (details in APPENDIX 4).  A gradient system was 
used with initial conditions 1 mLmin
-1 
flow rate and Mobile phase A consisting of 0.05 
% v/v trifluoroacetic acid (TFA) in water. At 8 min the mobile phase was switched to 
95 % Mobile phase B (0.0 5% v/v TFA in acetonitrile) and 5 % mobile phase A. A 
Phenomenex Luna C18 (2), 50 x 2.0 mm, 3 µm column was used with a column 
temperature of 40 °C and an injection volume of 1 µL. 
The wavelength selected for each material was determined initially by identifying the 
maximum absorbance peak (λmax) using A diode array detector. All solvents and 
reagents used were of HPLC grade, filtered and degassed before use. 
 HPLC response analysis 3.8.2
Integration of the area beneath any peaks in the acquired chromatograms was 
determined automatically using the peak integration settings as defined in Table 3-12. 
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For each integrated peak the retention time (RT), peak width, peak area, peak height and 
area % were reported. However, only RT and relative area % were utilised for 
characterising the material in this research. The peak with highest %area was designated 
the primary peak; any other peaks were referred to as secondary peaks. 
Table 3-12 HPLC integration parameters 
Time Event Value 
Initial Slope Sensitivity 35.0 
Initial Peak Width 0.02 
Initial Area Reject 1.00 
Initial Peak Height Reject 0.40 
Initial Shoulders OFF 
Initial Integration OFF 
0.50 Integration ON 
8.50 Integration OFF 
 Fourier transform infra-red spectroscopy (FTIR) 3.9
Fourier transform infrared spectroscopy is a well-established technique that is typically 
used to qualitatively identify and deduce the physical structure, conformation and 
chemical nature of the materials
30,316,317
.  FTIR can also be used to identify differences 
in the solid state forms of materials as a result of processing and shows great sensitivity 
to polar bonds such as O-H, C=O and N-H. Hence, FTIR is a good tool to investigate 
the presence of water and changes in H-bonding
317,318
. 
Solid powder samples can be prepared using Nujol
®
 mulls or KBR disks but this type of 
preparation can influence the solid state form of the materials
317
. By using an 
Attenuated Total Reflectance (ATR) accessory no sample preparation is required, as the 
sample can be analysed directly and has the added advantage that the influence of 
particle size is reduced compared to other techniques such as XRPD
317
.  
 FTIR acquisition method 3.9.1
Under ambient conditions, the sample container was inverted end-over-end 20 times 
before 1-10mg of study material was placed on the ATR accessory of a PE Spectrum 
One FT-IR Spectrometer (details in APPENDIX 4). An applied pressure reading of 20 
was applied and an interferogram representing 32 scans obtained over the 4000 – 650 
cm
-1
 range, with a resolution 2.00 cm
-1
. All samples were measured in triplicate and the 
spectra averaged. Both the laboratory temperature and %RH were monitored during 
sample preparation. 
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 FTIR response analysis  3.9.2
The acquired IR spectra, representing transmittance as a function of wavenumber were 
analysed using the Omnic E.S.P. v5.1 software. The transmittance data was normalised 
by setting the maximum value of the spectrum to 1, allowing the spectra to be overlaid 
and easily compared. A peak search was performed and the results tabulated. 
Interpretation of the spectrum and assignment of the peaks to the group frequencies of 





A set of core test techniques is described in this chapter which will be employed to 
characterise a number of important molecular, particulate and bulk properties of the 
selected study materials before and after mechanical comminution. 
The utilisation of this core test set of analytical methods should provide a reasonably 
comprehensive means of assessing any disorder that might occur to the crystal structure 





4 Characterisation of input materials: Response 
analysis 
 Introduction 4.1
Ten selected materials were identified using the strategy outlined previously (Chapter 2), 
as being a suitable set of model materials to investigate the effects of mechanical 
processing on potential disorder. It was anticipated on the basis of the current literature 
that these materials might span a range that might encompass those with a higher 
propensity for PID through to those with a lower propensity. However before subjecting 
these compounds to mechanical comminution the initial solid state properties of these 
materials would require characterisation so as to provide a baseline to which changes in 
the analytical responses could be compared, and the relevance of the amount of change 
defined. Therefore, the main objectives of the work described here were to: (i) classify 
the study materials into different particle size fractions and (ii) characterise the selected 
size fractions using the core test methods described earlier (Chapter 3).  
Classification would be effected by sieving so that similar size fractions could be 
selected with a view to reducing the potential influence of particle size on the generation 
of PID during the later planned comminution phase of the project. This fractionation 
process would also act to deaggregate the materials and promote sample homogeneity. . 
For each input material, the analytical property responses (APRs) from the core test 
methods will act as references that can be used to compare with the responses measured 
using the corresponding mechanically comminuted materials.  
It was also planned to estimate and quantify where possible the amount of experimental 
and technique variation in the observed APRs.  
 Methods 4.2
 Size fractionation by mechanical sieving 4.2.1
A nest of sieves (Table 4-1) (Endecott Ltd, London UK) was used to separate the 
material into a series of particle fractions using a Retsch mechanical agitation sieve 
assembly (details in APPENDIX 4)
319
. Approximately 25 g of bulk material received 
‘as-is’ from the suppliers was added to the top sieve (425 micron). The sieving 
assembly was then securely fastened and shaken for 10 min with an amplitude setting of 
1.50 mm and an interval time of 10 s
319
. The laboratory temperature and relative 
humidity (%RH) were also recorded at the time of sieving. Material from each sieve 
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was then transferred to an amber glass container and weighed. The amount of retained 
material in each sieve was expressed as a percentage of the initial input weight (% w/w). 
Any electrostatic charge generated via sieving was then dissipated by placing the sealed 
container under a stream of ionized air for 15 min using a SIMCO Sentry ionizing air 
blower. The material was then stored at 20-25 °C, 0 %RH away from light.  




Sieve Size (µm) US Sieve No. Frame/Mesh Size range (µm) Size class ID 
425 40 Brass/Brass >425 A4 
212 70 Brass/Stainless steel 212 – 425 A1 
125 120 Brass/ Stainless steel 125 – 212 A2 
Receiver N/A Brass <125 A3 
 Laser particle size analysis (PSA) 4.2.2
The particle size distributions for the sieved fractions for each of the study materials 
were obtained and analysed using the methods described in Section 3.6.1 and 3.6.2 
respectively. For the selected sieved fraction, six replicates were analysed. For the other 
sieved fractions only three replicates were measured and analysed. The amount of 
variation in the responses was estimated based on the relative standard deviation (RSD) 
values. The particle size distributions were plotted as normalised density distribution 
(q3*) versus logarithm particle size obtained by dividing each q3* value by the highest 
q3* value observed.  
 Microscopy methods 4.2.3
PLM and SEM images for the selected sieved fractions of the study materials were 
obtained and analysed using the methods described in Section 3.5. 
 X-ray powder diffraction (XRPD) 4.2.4
 Acquisition and response analysis 4.2.4.1
X-ray powder diffraction patterns for the selected sieved fractions of the study materials 
were obtained and analysed using the methods described in Section 3.2.1 and 3.2.2 
respectively. Three replicates were obtained and an estimate of the amount of apparent 
variation observed in the responses quantified using the relative standard deviation 
(RSD) and range values. APPENDIX 6 illustrates the process used to investigate this 
variation using a worked example. For each material a single representative reference 
XRPD pattern was obtained by averaging the three replicates (method 3.2.1.1). The 
solid-state form of this XRPD pattern was confirmed by comparing it to the simulated 
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XRPD pattern of the respective CSD reference for each material as described in section 
4.2.4.2.  
 Confirmation of the solid state form by XRPD  4.2.4.2
A simulated reference XRPD pattern for the CSD reference for each material was  
obtained using the CSD CrystalWeb software
320
. This file was first saved in *.Cif 
format and then converted to Bruker format (*.Raw) using the CSD Mercury (v2.3) 
software. The Bruker format file was then finally converted to a PHILIPS binary scan 
(*.RD) using PANalytical X’Pert HighScore Plus (v 3.0) and used to confirm the solid-
state identity of the study materials. This was achieved by qualitatively matching 
(overlaying) the data treated XRPD diffractogram of the study material with that of the 
simulated XRPD reference pattern (Table 4-2).  
Table 4-2 CSD references
320








γ-Indomethacin   INDMET03  Sulfadiazine SULDAZ02 
Salbutamol sulphate SALBUT  Sulfamerazine  SLFNMA02 
Loperamide HCl WAWVOH  Acetaminophen  HXACAN11 
Caffeine   NIWFEE03  Phenacetin PYRAZB21 
Methyl paraben CEBGOF01  Acetylsalicylic acid ACSALA01 
 Fourier transform infra-red spectroscopy (FTIR) 4.2.5
FTIR spectra for the selected sieved fractions of the study materials were obtained and 
analysed using the methods described in Section 3.9.1 and 3.9.2 respectively. 
 Thermogravimetric analysis (TGA) 4.2.6
TGA thermograms for the selected sieved fractions of the study materials were obtained 
and analysed using the methods described in Section 3.3.1 and 3.3.2 respectively. Each 
study material was analysed in triplicate and the responses averaged. The amount of 
variation in the responses was estimated using the relative standard deviation (RSD) 
values for % weight loss events or range values (°C) for temperature responses. 
 Differential scanning calorimetry (DSC) 4.2.7
DSC thermograms for the selected sieved fractions of the study materials were obtained 
and analysed using the methods described in Section 3.4.1 and 3.4.2 respectively. To 
reduce the potential for DSC contamination between sequential measurements the final 
analysis temperature for each material was selected based on the degradation 
temperature observed during the TGA analysis (Table 4-3). Six replicate sample 
preparations for each study material were prepared, acquired, analysed and the DSC 
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responses averaged. The amount of variation in the responses was estimated using either 
the range values (°C) for temperature responses or the relative standard deviations 
(RSD) observed for other types of DSC responses such as enthalpies. 
Table 4-3 End point temperatures used during DSC acquisition for the study materials based on 
TGA data to reduce DSC cell contamination 
Material End-point temp (° C)  Material End-point  temp (° C) 
γ-Indomethacin   200  Sulfadiazine 250 
Salbutamol sulphate 250  Sulfamerazine  260 
Loperamide HCl 240  Acetaminophen  200 
Caffeine   240  Phenacetin 150 
Methyl paraben 135  Acetylsalicylic acid 150 
 High pressure liquid chromatography (HPLC) 4.2.8
The wavelength of maximum absorbance (λmax) was obtained for each study material 
using the method described in Section 3.8.1. This wavelength was then used to 
determine the HPLC responses of the selected study materials using the method 
described in Section 3.8.2. Samples after DSC analysis were also examined using the 
HPLC method for some materials to demonstrate the suitability of the method to detect 
the presence of thermal and/or induced degradants. 
 Gravimetric vapour sorption (GVS) 4.2.9
Moisture sorption profiles for the selected sieved fractions of the study materials were 
obtained and analysed using the methods described in Section 3.7.1 and 3.7.2 
respectively. Due to the length of time that was required to acquire these moisture 
sorption profiles, replicate analysis was not performed. 
 Results and discussion 4.3
 Sieve fractionation 4.3.1
Historically, many investigators use materials as they are received from the suppliers, 
without carrying out any pre-processing procedures to ensure homogeneity in some of 
the physical properties, such as particle size or morphology (crystal habit). The potential 
problem in following this approach is that the material may exhibit a wide range of 
particle properties such as size or morphology (habit) and these may give rise to a wide 
range of analytical responses when characterised. Sieving the material can reduce the 
inherent variation in the bulk but quite often, the efficiency of sieving is not 
investigated
247,248
. These assumptions could lead to misinterpretations during 
characterisation and the possibility of the misidentification of correlations between the 
properties. 
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Therefore, the initial bulk  materials as received from the suppliers in this reseach were 
first sieved and then separated into the different particle size fractions as shown in Table 
4-4. The decision on which particle size class to use as the input for comminution 
processing was made based on the amounts retained in each sieve fraction and where 
possible, the same particle size class (PSC) for all the study materials was chosen. The 
minimum amount per size fraction to allow for characterisation and processing was 5 g 
(20 % of the 25 g input). Sieve fractions with less than 5 g were rejected and no further 
characterisation or processing was carried out on these.  
Table 4-4 Sieving results for the 10 study materials (25 g bulk input), showing the amount of 
material collected per sieve fraction. 
 
Amount per sieve fraction  (g)  
Material 
<125 µm  Size 
class A3 
125-212 µm 
Size class A2 
212-425 µm 
Size class A1 
>425 µm  Size 
class A4 
Comments 
Acetaminophen 1 (4%) 12 (48%) 3 (12%) 8 (30%) electrostatic 
γ-Indomethacin 1 (4%) 15 (60%) 8 (30%) 
 
electrostatic 
Loperamide HCl 6 (24%) 12 (48%) 5 (20%) 
 
electrostatic 
Salbutamol sulphate 6 (24%) 10 (40%) 5 (20%) 3 (12%) sieves well 
Methyl paraben 1 (4%) 14 (56%) 6 (24%) 
 
electrostatic 
Phenacetin 1 (4%) 20 (80%) 1 (4%) 
 
electrostatic 
Caffeine 1 (4%) 18 (72%) 4 (16%) 
 
electrostatic 
Acetylsalicylic acid 1 (4%) 18 (72%) 4 (16%) 
 
sieves well 
Sulfamerazine 3 (12%) 19 (76%) 1 (4%) 
 
electrostatic 
Sulfadiazine 1 (4%) 2 (8%) 19 (76%) 
 
electrostatic 
Value in brackets represents the percentage of the sieved fraction relative to the 25 g input bulk. Red indicates 
insufficient material to be used as the input for mechanical processing. Green shaded cell indicates the size class 
selected for further testing. 
It can be seen from Table 4-4 that the most common sieved size fractions were between 
125-212 µm (size class A2). This size class was selected to be used as the input material 
for the majority of the study materials. However, for sulfadiazine there was insufficient 
material in the A2 class, hence the 212-425 µm (A1 size class) fraction was selected. 
For a number of materials there were difficulties in sieving due to generated 
electrostatic charges. This charge was effectively dissipated using an ionized air flow 
after sieving (refer to section 4.2.1). It is has also been reported in the literature that 
relative humidity and temperature can affect the sieving process through the absorption 
of moisture to the material, which can result in larger or agglomerated particles
319
. 
However, in this study the sieving process was performed with relative humidities and 
temperatures recorded between 20-35 %RH and 21-26 °C respectively, so it is unlikely 
that the environmental conditions would have affected the sieving process. 
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 Laser particle size analysis (PSA) and microscopy 4.3.2
To verify the particle sizes of the sieved fractions, the fractions containing material 
greater than 5 g were analysed by PSA and microscopy (Table 4-5 and Table 4-6 
respectively). 
Table 4-5 Particle size analysis summary for the sieved study materials  





















10.3 47.5 5854 3 
γ-Indomethacin 








20.2 106 2982 2 








10.6 38.8 5690 2 
Loperamide HCl 








17.0 182 3541 2 








5.5 43.3 11021 3 








4.60 20.6 13039 2 
Salbutamol sulphate 








59.5 227 1012 1 








50.4 153 1194 1 








18.1 77.5 3323 1 
Methyl paraben 








95.0 215 632 2 








36.4 76.7 1650 2 









15.3 44.8 3941 1 









8.0 51.0 7613 3 









121 217 495 2 









19.7 37.5 3044 1 









6.1 17.0 10151 2 
n – Number of replicates, RSD values for the respective particle size and span values are shown in brackets. Red 
values indicate where the particle size did not match the expected sieve class. PSC: Particle sieve class, SMD: 
Surface mean diameter, VMD: Volume mean diameter, Sm: Surface area, No. Mode: Number of modes. For further 
definitions of the terms please refer to Table 3-9. 
All the sieved fractions for the study materials exhibited birefringence by polarised light 
microscopy, indicating that the materials appeared crystalline (Table 4-6). However, 
particle size analysis by laser diffraction revealed that for a number of materials the 
particle size did not match that of the expected sieve class (shown as red in Table 4-5). 
These differences can most likely be attributed to the presence or breaking of 
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agglomerates, or due to other material properties such as crystal morphology and, or 
electrostatic charges generated during the sieving process. A brief description of the 
microscopy and particle size analyses for the materials follows. 
For acetaminophen, phenacetin, sulfamerazine and caffeine only the A2 sieved fractions 
were obtained in sufficient quantities to be used as the input materials for mechanical 
comminution (Table 4-4). However, the particle sizes for these fractions were lower 
than expected considering the size of the sieve employed, i.e. 125-212 µm (Table 4-5). 
A potential reason for this lower than expected particle size maybe due to the observed 
electrostatic charge generated during sieving. This electrostatic charge may have caused 
smaller particles to “clump” together forming agglomerates, which prevented the 
smaller particles passing through the sieve. However, when analysed by laser particle 
size and in some cases microscopy these agglomerates start to breakup into the primary 
particles, hence the smaller primary particles are measured.  
The particle size distributions for the A2 sieved fractions of acetaminophen and caffeine 
were multimodal with large span values, indicating broad distributions (Figure 4-1). The 
particle size distribution for caffeine also indicated the presence of agglomerates which 
suggests that these agglomerates are fairly robust and are not fully dispersed during 
particle size analysis. Both phenacetin and sulfamerazine exhibited mono-modal particle 
size distributions (Figure 4-1). 
 
Figure 4-1 Particle size distributions for the A2 sieved fractions of acetaminophen (red), caffeine 
(blue), sulfamerazine (green) and phenacetin (black)   
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Table 4-6 Microscopy analysis for the sieved fractions of the study materials 
Material PSC Tech 
Crystal 
habit 





























Yes 200 10-425 Drusy 300 100-425 
A2 







N/A 50 10-250 Drusy ND ND 
Loperamide 
HCl 
A1 PLM Irregular Fractured 
Rough & 
cracked 
Yes 20 10-75 Agg 300 50-425 
A2 
PLM Irregular Fractured 
Rough & 
cracked 
Yes 20 10-150 Agg 150 50-200 
SEM Irregular Fractured 
Rough & 
pitted 
N/A 25 5-100 Drusy ND ND 
A3 
PLM Irregular Fractured 
Rough & 
cracked 
Yes 5 5-50 Agg 50 20-50 
SEM Irregular Fractured 
Rough & 
pitted 











































Angular Smooth N/A 75 5-150 Drusy ND ND 
Methyl paraben 
A1 PLM Irregular Fractured Rough Yes 10 5-25 Agg 200 100-450 
A2 
PLM Irregular Fractured Rough Yes 50 25-150 Agg 75 50-225 









Fractured Smooth N/A 75 10-200 Drusy ND ND 
Caffeine A2 
PLM Acicular Fractured Rough Yes 25 10-100 Agg 75 50-150 









Cracked N/A 200 150-500 ND ND ND 
Sulfamerazine A2 
















PLM Acicular Sharp Smooth Yes 25 10-75 ND ND ND 
SEM Acicular Sharp Smooth N/A 50 10-200 Agg ND ND 
PSC: sieve particle size class or sieve fraction, Tech: technique, BiFr: birefringence, 1°LLD: primary particle 
longest linear dimension, 1° range: primary particle size range, Agg: agglomeration, Agg size: agglomeration 
particle size, Agg range: agglomerate particle size range. ND: not determined. For further definitions of the terms 
please refer to Table 3-7 and Figure 3-6 to Figure 3-9. 
 
Microscopy analysis for all four materials supported the observations made by laser 
particle size (Figure 4-2). For example, there are two different crystal habits observed in 
samples of acetaminophen which vary in particle size along with the presence of 
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agglomeration which accounts for the large span value. Microscopy images for caffeine 
also show the presence of agglomerates. 











































Figure 4-2  Microscopic images for the A2 sieved fractions of acetaminophen [A], phenactin [B], 
sulfamerazine [C] and caffeine [D]   
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Three sieved fractions of loperamide HCl were analysed by microscopy and laser 
particle size. The particle sizes for the sieve fractions A1, and A3 were consistent with 
the size of sieve employed (Table 4-5). However, for the A2 sieve fraction, particle 
sizes were smaller than expected (Table 4-5). PLM images for all of the fractions show 
that the primary particles were small but that they formed agglomerates in the A1 and 
A2 fractions (Figure 4-3), and these agglomerates were not dispersed during particle 
size analysis (Figure 4-3 [A] and [B]).  The particle size distributions for all three sieved 
fractions A1, A2 and A3 were bimodal with large span values for the sieved fractions 
A2 and A3 (Figure 4-4). 














































Figure 4-3  Microscopic images for loperamide HCl sieved fractions A1, A2 and A3 
PLM images for sieved fractions A1 [A], and A2 [B] illustrate the presence of agglomerates and the 
smaller irregular primary particles.  
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Figure 4-4  Particle size distributions for loperamide HCl sieved fractions A1 (blue), A2 (red) and 
A3 (green) 
The two sieve fractions for methyl paraben were analysed and shown to be 
predominately agglomerated (Table 4-5 and Table 4-6), while the A2 sieved fraction for 
acetylsalicylic acid exhibits a mono-modal particle size distribution where the particle 
size was consistent with the type of sieve used (Table 4-5 and Figure 4-5 [A]). 
Only the A1 sieved fraction was obtained in sufficient quantity for sulfadiazine (Table 
4-4). Analysis by laser diffraction and microscopy showed that the particles retained in 
the A1 sieved fraction were smaller than expected (Table 4-5 and Figure 4-5 [B]). 
Sieving of sulfadiazine resulted in an electrostatic charge which caused the material to 
“clump” and be retained in the upper sieve. During PSA analysis these agglomerates 
were dispersed and only the primary particles were measured. 
The two sieved fractions, A1 and A2 for indomethacin were analysed by microscopy 
and laser particle size (Table 4-5 and Table 4-6 respectively). The A1 fraction consisted 
predominately of large plates with attached (drusy) smaller particles (Figure 4-6 [A]), 
while the A2 sieved fraction consisted predominately of irregular particles with some 
weak agglomeration through electricstatic charging. The degree of agglomeration 































Figure 4-5  Microscopic images for sieved fractions A2 for acetylsalicylic acid [A] & sieved fraction 
A1 for sulfadiazine [B]  































Figure 4-6  Microscopic images for indomethacin sieved fractions A1[A] & A2 [B].  
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Three sieved fractions for salbutamol sulphate were obtained and analysed by laser 
particle size and microscopy (Table 4-5 and Table 4-6 respectively). The particle sizes 
for all three fractions were consistent with size of the sieves used and were shown to 
have monomodal particle size distributions (Figure 4-7 and Figure 4-8). Within sieve 
fraction A1 the particles were predominately agglomerated (Figure 4-8 [A]), while sieve 
fractions A2 and A3 consisted mainly of primary particles with some smaller particles 
attached, i.e. appear drusy (Figure 4-8 [B] & [C]).  
 
Figure 4-7  Particle size distributions for salbutamol sulphate sieved fractions A1 (blue), A2 (red) 
and A3 (green) 
 
Based on the particle size and microscopy results, the selected sieved fractions which 
were to be used as the input material during mechanical comminution were reclassified 
to reflect the actual particle size and agglomeration present, as it has been shown based 
on the data presented, that in practice the actual particle size of a material does not 
necessarily match the sieve fraction employed. The presence of agglomeration and 
generated electrostatic charges can influence particle retention during sieving and can 
result in a less predictable sieving process, i.e. results in a different particle size range 
from that expected. 
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Figure 4-8  Microscopic images for salbutamol sulphate sieved fractions A1, A2 and A3 
PLM images for PSC-A1 [A] illustrate the presence of agglomerates. PLM images for PSC-A2 [B] 
and PSC-A3 [C] illustrates the presence of primary particles with smaller attached particles (drusy). 
 
The new size classifications for the materials were defined using the designator codes 
outlined in Table 4-7. These are based on the material’s D50, D90 and span values. For 
example the A2 sieved fraction for acetaminophen, which has D50, D90 and span values 
of 23.5 µm, 132 µm and 5.5 respectively would have a size classification code  (SCC) 
of S1B3 (Table 4-8). In some cases the sieved fractions for the study materials 
contained a significant amount of agglomerated material which was not easily dispersed 




Table 4-7 Size classification designation codes 










< 50 1 < 100 A < 2 1 
50 - 100 2 100 - 200 B 2 - 5 2 
> 100 3 > 200 C > 5 3 
 
Table 4-8 Size reclassification for the selected sieved fractions for the study materials  
Material 
Size class based on 
Sieve used 
D50 D90 Span 
Size class based on PSA & 
microscopy  (SCC) 
Acetaminophen A2 23.5 132 5.5 S1B3 
Indomethacin A2 24.4 94.7 3.7 S1A2 
Loperamide HCl A2 17.1 139 8.0 S1B3* 
Salbutamol sulphate A2 144 267 1.5 S3C1 
Acetylsalicylic acid A2 203 346 1.1 S3C1 
Sulfamerazine A2 33.8 67.0 1.6 S1A1 
Phenacetin A2 34.3 96.2 2.6 S1A2 
Caffeine A2 23.7 147 6.1 S1B3* 
Methyl paraben A2 63.7 157 2.2 S2B2* 
Sulfadiazine A1 10.6 42.8 5.5 S1A3 
* indicates the presence of a significant amount of agglomerated particles 
 X-ray powder diffraction (XRPD) 4.3.3
For each material a single representative XRPD pattern was obtained by averaging three 
replicates and the XRPD responses investigated. Table 4-9 provides details for the peak 
position and height of the most intense peak (MIP) and the %RPI significance value 
which was used to select the number of significant peaks for each material. This value 
was selected for each material based on the respective MIP height intensities as defined 
in APPENDIX 6 (worked example step 3). It was observed that for some materials 
(salbutamol sulphate, acetylsalicylic acid, phenacetin, caffeine, and methyl paraben) the 
MIP peak intensities were significantly larger than that observed for others. Large MIP 
peak height values reflect the particle size present in the material and the influence that 
particle size has on the XRPD responses
29,280
. However, based on this observation, 
loperamide HCl would have been expected to have had higher peak intensities, similar 
to caffeine which has the same size classification and observed particle sizes but this 
proved not to be the case. A likely reason for this could have been due to the dispersion 
of the loperamide HCl agglomerates during the XRPD sample preparation, while for 
caffeine the agglomerates remained intact.  
  
107 






% RPI Significance 
value 
No. Significant peaks 
Acetaminophen S1B3 18.23 31181 5.0 17 
γ-Indomethacin S1A2 19.68 24805 5.0 32 
Loperamide HCl S1B3* 16.29 43235 5.0 23 
Salbutamol sulphate S3C1 10.60 297687 1.0 24 
Acetylsalicylic acid S3C1 15.65 714853 0.5 25 
Sulfamerazine S1A1 14.67 34175 5.0 21 
Phenacetin S1A2 13.72 298635 1.0 17 
Sulfadiazine S1A3 23.07 64213 5.0 15 
Caffeine S1B3* 12.01 138861 1.0 23 
Methyl paraben S2B2* 26.25 101681 2.0 24 
SCC: size classification code, MIP: Most intense peak. Size class as defined in Table 4-7. cts: Counts. %RPI: % 
relative peak intensity 
 
For each study material the average XRPD diffraction pattern was qualitatively 
compared to the simulated powder diffractograms constructed using the respective CSD 
reference data (see section 4.2.4.2 (Table 4-10)).  
All of the study materials appeared crystalline, as assessed by XRPD. However, in a 
few cases the acquired XRPD pattern did not match that of the simulated powder 
diffractogram of the initial CSD reference (coloured red in Table 4-10).  




Acquired XRPD concordant  with 
crystallographic (CSD) reference 
Solid-state form 
of study material 
γ-Indomethacin INDMET03 INDMET Crystalline 
Acetaminophen HXACAN11 HXACAN19 Crystalline 
Methyl paraben CEBGOF01 CEBGOF Crystalline 
Salbutamol sulphate SALBUT SALBUT Crystalline 
Loperamide HCl WAWVOH WAWVOH Crystalline 
Caffeine NIWFEE03 NIWFEE03 Crystalline 
Sulfadiazine SULDAZ02 SULDAZ02 Crystalline 
Sulfamerazine SLFNMA02 SLFNMA02 Crystalline 
Phenacetin PYRAZB21 PYRAZB21 Crystalline 
Acetylsalicylic acid ACSALA01 ACSALA01 Crystalline 
Red entries indicate materials where the acquired XRPD diffractogram did not match the initial CSD reference   
 
The crystallographic CSD references (from Chapter 2) for each material were initially 
selected based on their respective R-factor values, with the lowest R-factor value being 
selected
238. However, in practice this entry may not be “truly” representative of the 
crystal lattice of the material purchased. Differences in preferred orientation and the 
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temperature at which single crystal data were collected could account for these 
discrepancies. 
For those materials which did not match the initial crystallographic CSD reference the 
acquired XRPD diffractograms were compared to other simulated XRPD patterns for 
CSD entries of the same structural family. For example the XRPD diffractogram for 
bulk γ-Indomethacin was concordant with that of the simulated powder pattern for 
INDMET (R= 5.9 %) but not INDMET03 (R= 4.4 %) even though the latter had the 
slightly lower R-factor value (Figure 4-9). In this example, differences in peak 
intensities could account for some of the discrepancies as there was an indication of 
some degree of preferred orientation being present, i.e. differences in the most intense 
peak (MIP) and in the intensities of other peaks.  
 
Figure 4-9 XRPD diffractograms for sieved γ-indomethacin (blue) and the reference simulated 
XRPD diffractograms INDMET (red) and INDMET03 (green).  
Differences in the patterns can be seen between 20 and 30 ° 2Theta (insert) 
 
The amount of variation in the XRPD responses was also investigated. An overlay of 
the replicate XRPD patterns revealed only small differences in the peak, but other 
differences such as shifts in peak position, variations in background height, peak widths 
(FWHM) and peak areas were not so apparent. For example, in Figure 4-10, the 
replicate XRPD patterns for acetylsalicylic acid are overlaid. It can be seen that the only 
discernible difference between the replicates is in the peak heights and then only for a 
few peaks. However, numerical analysis of the variation in the replicate XRPD peak 
responses allows the amount of variation between replicates to be more readily 
identified and quantified. Variation (expressed as RSDs) in peak and background 
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height, peak width and area were calculated (similar to worked example in Appendix 6) 
to be 20, 12, 15 and 19 % respectively (inserted table in Figure 4-10). These RSDs and 
peak position ranges can be used to define acceptable tolerance levels for further 
investigations. 
 
Figure 4-10 Overlaid XRPD diffraction patterns for three replicates (red, blue & green) of 
acetylsalicylic acid 
Table 4-11, illustrates the observed variation in the average XRPD peak responses for 
the selected study materials calculated using the process defined in APPENDIX 6.  
Table 4-11 Calculated variation in the average XRPD peak responses for the study materials 













Acetaminophen S1B3 3 0.02 15 4 15 19 
γ-Indomethacin S1A2 3 0.01 16 7 14 19 
Loperamide HCl S1B3* 3 0.02 12 5 10 17 
Salbutamol sulphate S3C1 3 0.03 16 7 16 18 
Acetylsalicylic acid S3C1 3 0.02 20 12 15 19 
Sulfamerazine S1A1 3 0.01 6 8 10 14 
Phenacetin S1A2 3 0.04 16 16 9 20 
Sulfadiazine S1A3 3 0.02 13 4 9 17 
Caffeine S1B3* 3 0.03 11 20 19 18 
Methyl paraben S2B2* 3 0.03 14 11 15 19 
SCC: size classification code, Range and RSD values calculated using the process defined in APPENDIX 6.  
n: number of replicates. RSD: relative standard deviation 
 
The magnitude of the variation in the XRPD responses between replicates can be 
attributed to the physical properties of the materials. For example large particle sizes 
and particle morphologies such as plates, columnar and acicular can cause differences in 




. Other factors such as the amount of sample and silicone grease used 
during sample preparation could also influence the observed levels of variation in the 
XRPD peak responses, so care must be taken to minimise these influences
29,280
. Based 
on the RSD values (Table 4-11) for the average XRPD peak responses peak height, 
background height, peak width (FWHM) and peak area values, a limit of not greater 
than 20 % to the amount of variation (RSD value) that can typically be expected 
between replicates can be applied. While variation in the peak positions was found to be 
less than 0.05 °2θ for both the calculated average and individual peak positions. 
The XRPD analysis applied in this research separates the background from the peak 
data, enabling a background profile to be visualised (Figure 4-11 and APPENDIX 5). It 
is important to note that this background profile represents not only the amount of 
disorder and microcrystalline material present but also background scattering due to the 
instrument and sample preparation (APPENDIX 5).  
 
Figure 4-11 Average XRPD background profiles for the study materials (n=3 replicates) 
* Particle size refers to the overall size including agglomeration.  
 
As illustrated in Figure 4-11, particle size and peak intensities appear to influence the 
height of the background profiles for crystalline materials: the larger the particle size 
and intensities of the MIPs the larger the background profiles. For example, 
acetylsalicylic acid and methyl paraben which have large particle sizes (size class S3C1) 
exhibit high intensity crystalline peaks (MIP >100 k cts) by XRPD compared to that of 
acetaminophen, which is comprised of smaller particles and has less intense XRPD 
peaks. However, caffeine has a larger background profile than other materials of similar 
particle size class due to the presence and the strength of agglomeration.  
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It is postulated that for materials exhibiting disorder, changes in the XRPD responses 
will occur over the whole of the XRPD pattern and not just in a few individual peaks. 
Changes in XRPD responses for only a few individual peaks are most likely due to 
orientation effects as a result of processing, such as a reduction in particle size rather 
than the presence of disorder. It is for this reason that it was proposed to investigate the 
changes in the average XRPD responses across the whole XRPD pattern in comminuted 
materials compared to those of the input material.   
 Fourier transform infra-red spectroscopy (FTIR) 4.3.4
FTIR spectra for the sieved study materials were obtained and shown to be concordant 
with those reported in the literature and from online databases (Table 4-12), confirming 
the solid state form purity observed by XRPD (Table 4-10). There appeared to be only 
small differences, but these generally arose as a consequence of differences in the 
sample preparations between the reference and acquired IR spectra, i.e. Nujol mull or 
KBr disc versus ATR used in this research respectively. 
Table 4-12 Frequency assignment of IR peaks for the study materials 












(N–H in-plane bending), 1328 cm-1 (O–H bending), 1259 cm-1 (C–O 
stretch), 1225 cm
-1 




(O-H stretch), 1714 cm
-1 









Loperamide HCl 2959 cm
-1 
(C-H aromatic stretch),1623 cm
-1 
(C=O stretch tertiary amide),1484 cm
-1 
(C-C 








(O-H stretch), 3409 cm
-1 
(N-H stretch), 1616 cm
-1 
(C-N stretch), 1507 cm
-1 
(C-
N stretch), 1496 cm
-1 
(O-H bend), 1205 cm
-1 











(C=O acetyl stretch ester), 1680 cm
-1 
(C=O stretch carboxylic acid),1605 cm
-1 






(NH2 stretch), 3482 cm
-1 
(NH2 stretch), 1641 cm
-1 
(NH2 scissoring), 1628 cm
-1 
(NH2 scissoring), 1326 cm
-1 
(S=O stretch), 1304 cm
-1 




Phenacetin 3283 cm-1 (N-H stretch), 3073 cm-1 (aromatic-H stretch), 2928 cm-1 (C-H stretch amide), 
2885 cm
-1 
(C-H stretch), 1658 cm
-1 
(C=O stretch), 1645 cm
-1 
(C-NH deformation), 1480 
cm
-1 










(NH2 scissoring), 1580 cm
-1 
(NH2 scissoring), 1326 cm
-1 






(C=O stretch), 1599 cm
-1 
(C-N stretch), 1547 cm
-1 
(C-N stretch), 339 
Methyl paraben 3285 cm-1 (O-H stretch) 1678 cm-1 (C=O stretch), 1513 cm-1 (Phenol C-O stretch), 1433 
cm
-1 
(Enol C-O stretch) 
340 
 Thermogravimetric analysis (TGA) and differential scanning 4.3.5
calorimetry (DSC) 
The thermal properties for the selected sieved fractions were determined by TGA (Table 
4-13) and DSC analysis (Table 4-14). Overall the onset temperatures of melting (Tm) for 
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the materials were consistent with those cited in the literature and/from databases232,320,341 
(Table 4-14). All of the materials appeared anhydrous, as determined by TGA and the 
very small WL50 and WL150 values. A number of materials, such as phenacetin, exhibit a 
broad weight loss event associated with thermal degradation below 150 °C. For caffeine 
this broad weight loss event is associated with sublimation
216,342,343
. As a consequence 
of such degradation occurring below 150°C, WL150 values could not be calculated and 
these materials are denoted with a D in Table 4-13. All materials exhibited degradation 
below 290 °C and these degradation temperatures were used to select the appropriate 
end-point temperatures when the DSC studies were undertaken. The small amount of 
weight loss observed, i.e. below 0.5% (w/w) for WL50 and WL150 for the materials is 
likely to be due to experimental noise. As these values are relatively small, any variation 
between the replicates resulted in large RSD values being obtained. Therefore, any 
WL50 and WL150 values less than 0.5% (w/w) are denoted as < 0.5% for later studies. 
Table 4-13  Summary of average TGA responses for the sieved study materials  
Material 
WL50  % w/w 
(RSD) 
WL150  % w/w 
(RSD) 
Td ° C 
(range) 
Comments 
Acetaminophen 0.07 (0) 0.30 (3) 235 (2.1°C) 
No weight loss events observed before 
degradation 
γ-Indomethacin 0.05 (0) 0.20 (25) 266 (0.3°C) 
No weight loss events observed before 
degradation 
Loperamide HCl 0.12 (25) 0.29 (17) 262 (3.2°C) 
No weight loss events observed before 
degradation 
Salbutamol sulphate 0.09 (33) 0.24 (21) 197 (0.2°C) 
Unresolved weight loss event is observed on 
degradation 
Acetylsalicylic acid 0.07 (29) D 126 (3.1°C) 
Unresolved weight loss event is observed on 
degradation, Degradation starts below 150 °C 
Sulfamerazine 0.07 (14) 0.15 (27) 255 (3.1°C) 
No weight loss events observed before 
degradation 
Phenacetin 0.10 (20) D 198 (0.9°C) Degradation starts below 150 °C 
Sulfadiazine 0.20 (10) 0.49 (4) 263 (0.3°C) 
Unresolved weight loss event is observed on 
degradation 
Caffeine 0.17 (6) D 201 (1.6°C) Sublimation starts below 150 °C 
Methyl paraben 0.03 (33) D 115 (1.8°C) 
Unresolved weight loss events observed on 
degradation, Degradation starts below 150 °C 
Number of replicates n = 3, WL50: % Weight loss (w/w) below 50° C. WL150: % Weight (w/w) loss below 150 °C.  
D:  Degrades below 150 °C, Td: Degradation temperature (°C). Please refer to Table 3-4 for further descriptions of 
the terms  
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Transition at 146 °C 
observed, melt-
sublimination  












Number of replicates n = 6, ND: Not detected, NC: Not calculated, Td: Degradation temperature (°C), Tm: Onset of 
melting temperature (°C), Tm     :      g               g  (° ), Δ f: Heat of fusion (J/g), WHH: width at half peak 
height (°C), Tm-p: Peak melting temperature (°C). Please refer to Table 3-6 for further descriptions of the terms 
* Literature Tm
232,320,341 
** Tm-p value used to represent Td as material melts-degrades or melt-sublimes 
 
For some materials the first derivative signal in the TGA can indicate that unresolved 
weight loss events may be occurring upon degradation which may coincide with 
melting, i.e. melt-degradation event. For example the first derivative signals for the 
TGA and DSC analyses of salbutamol sulphate (Figure 4-12) suggested multiple 
unresolved events occurred around the melt at 198 °C and decomposition at 204 °C 
events. Melting occurs initially, involving the dissociation of the sulphate, followed 
immediately by degradation
1,19,297
. Typically, materials that exhibit melt-degradation 
events have larger WHH and T
m
trans values as shown for salbutamol sulphate and 
acetylsalicylic acid (Table 4-14). These materials also typically exhibit more variation 
in their DSC responses as shown by the RSD and range values (Table 4-14).  Based on 
the observed variations in the DSC responses for the materials, temperature values for 
the same material should fall within 4 °C for materials exhibiting unresolved melt-
degradation events and 2 °C for materials that have resolved melting events. However, 
it should be noted that, in cases where the melt-degradation or sublimation events 
cannot be resolved, values for WHH and heats of fusion (Δ f) may not be accurately 
determined. For these materials, Tm-p values can be used to indicate the start of 
degradation and Tmtrans values can be used as an indicator of melting broadness. For 
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example, WHH and Δ f could not be determined for caffeine, which exhibits a melt 
sublimation event around 236 °C, hence, Tm-p of 238 °C was used to indicate the start of 
degradation temperature with a Tmtrans value of 1.6 °C to describe melting broadness 
(Table 4-14). An endothermic event representing a form II to form I solid-state 
transition for caffeine was also observed around 145 °C consistent with literature 
observations
216,217,342,343
 (Figure 4-13).   
 
Figure 4-12 TGA and DSC thermograms for salbutamol sulphate    
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Figure 4-13  DSC thermogram for caffeine 
When interpreting DSC data, it is important to consider the effects of other material 
properties and sample preparation on the observed DSC responses
288,289
. Large sample 
weights may cause thermal lags and event broadening while particle size can affect heat 
transfer properties. The larger the particle size the smaller the surface area, therefore the 
material will be in contact with the sample pan less resulting in less heat transfer. A 
thermal gradient can also occur within the sample, whereby smaller particles can melt 
first resulting in broader, unresolved or split peaks depending on the size of particles 
present
288,289
. It has also been shown that sample weights can influence DSC 
responses
288,289
 and therefore, so as to minimise the influence of sample weight on the 
thermal responses, sample weights were kept at a minimum during the current study. 
Accordingly, only 1-2 mg of each material was employed and particle size was 
measured and taken into consideration during interpretation. 
 High pressure liquid chromatography (HPLC) 4.3.6
A fast gradient HPLC method
315
 was used to first identify the wavelength of maximum 
absorbance (λmax) using a diode array detector for each study material (Table 4-15). 
This wavelength was then used to identify the retention times of the major peak and that 
of any other peaks for each study material (Table 4-15). 
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Primary peak RT, min 
(% area in brackets) 
Other Peaks RT, min 
(% area in brackets) 
Acetaminophen 240 1 1.56 (100) -- 
γ-Indomethacin 240 3 5.33 (99.65) 5.71 (0.05), 6.35 (0.3) 
Loperamide HCl 220 3 4.53 (99.8) 2.57 (0.07), 4.26 (0.13) 
Salbutamol sulphate 225 2 1.88 (99.8) 2.61 (0.2) 
Acetylsalicylic acid 235 2 2.91 (99.4) 3.09 (0.6) 
Sulfamerazine 240 3 2.06 (99.76) 1.77 (0.08), 3.10 (0.16) 
Phenacetin 245 4 3.17 (99.5) 2.06 (0.03), 3.48 (0.27), 3.57 (0.2) 
Sulfadiazine 265 1 1.67 (100) -- 
Caffeine 265 1 2.27 (100) -- 
Methyl paraben 260 1 3.04 (100) -- 
 
To demonstrate the suitability of the HPLC method in detecting thermal degradants, 
post-DSC samples were analysed at the selected wavelengths for indomethacin, 
loperamide HCl, salbutamol sulphate and caffeine (Table 4-16). These results 
demonstrate that the HPLC method was capable of detecting thermal degradants of the 
material understudy. Though the primary peak was reduced by only 3.45% in area for 
the DSC sample of indomethacin seven new peaks were observed, suggesting that some 
thermal degradation had occurred. The material following DSC analysis was also 
discoloured (light brown) which further indicates thermal degradation had occurred.  
For the DSC sample of loperamide HCl, the primary peak was reduced by 8.7% in area 
and another identified peak (RT 2.57 min) increased in area 1.84%. Eleven new peaks 
were observed verifying the TGA and DSC interpretation that the melting of loperamide 
HCl is closely followed by degradation. HPLC analysis of the DSC sample for 
salbutamol sulphate also verified that a melt-degradation event occurs, as the area of the 
primary peak was reduced by 43.1% and another identified peak (RT 2.60 min) 
increased in area by 19.8%. There were also 20 new peaks observed.  However, HPLC 
analysis of post-DSC caffeine did not detect any degradation products as a consequence 
of the melt-sublimation event. 
From the HPLC results, it can be seen that all materials were of high purity, but upon 
melting, degradation may occur for a number of materials which could impact chemical 
purity. For these materials the use of quench-cooling to generate amorphous materials 
or standards could potentially introduce thermal degradants and influence any acquired 
analytical responses. Hence, quench-cooling was not used in this thesis.  
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Primary peak RT, min 
(% area in brackets) 
Reference Peaks RT, min 
(% area in brackets) 
New Peaks RT, min 
(% area in brackets) 
γ-Indomethacin 9 5.34 (96.2) 6.35 (0.3) 3.09 (0.22), 4.58 (0.37), 4.76 (0.12), 
4.96 (0.69), 6.53 (0.25), 6.82 (1.72), 
6.92 (0.08) 
Loperamide HCl 13 4.54 (91.08) 2.57 (1.91) 1.9 (0.18), 3.16 (0.15), 3.61 (0.44), 
4.46 (0.18), 4.76 (1.53), 4.96 (1.41), 
5.13 (0.33), 5.88 (0.94), 6.13 (0.28), 
6.72 (0.41), 6.82 (1.16) 
Salbutamol 
sulphate 
22 1.89 (56.7) 2.60 (20.04) 1.67 (4.19), 2.02 (0.24), 2.19 (1.75), 
2.26 (0.28), 2.30 (0.18), 2.34 (0.33), 
2.41 (0.41), 2.48 (1.40), 2.53 (0.36), 
2.73 (0.79), 2.83 (3.82), 2.91 (1.80), 
3.00 (1.74), 3.09 (0.68), 3.11 (0.77), 
3.19 (0.62), 3.23 (0.22), 3.38 (2.57), 
3.46 (0.55), 3.50 (0.53) 
Caffeine 1 2.27 (100)  -- 
 Gravimetric vapour sorption (GVS) 4.3.7
Moisture sorption profiles for the selected study materials were obtained and the 
responses tabulated (Table 4-17). These results verify the TGA, DSC and FTIR 
observations that initially the materials appear anhydrous and further show that after a 
two moisture sorption/desorption cycles little or no moisture sorption is observed 
indicating that the input materials are moisture stable between 0-90 % RH (Table 4-17). 
A representative moisture sorption profile illustrating the moisture sorption stability of 
the materials is shown in Figure 4-14 for indomethacin which exhibits a reversible 
change in mass of less than 0.1 % over the 0-90 %RH range. 
 Table 4-17  Summary of GVS results for the study material sieved fractions 
Material MA MB MC MD ME Δ F MEND MMAX1 MMAX2 ∆MAX MADS 
Acetaminophen 0.04 0.07 0.00 0.03 0.01 0.01 -0.03 0.07 0.03 0.03 0.03 
γ-Indomethacin 0.02 0.09 0.00 0.09 0.00 0.02 0.00 0.09 0.09 0.00 0.00 
Loperamide HCl 0.05 0.13 0.00 0.12 0.00 0.03 -0.01 0.13 0.12 0.01 0.01 
Salbutamol sulphate -0.01 0.04 0.00 0.04 0.00 0.00 0.01 0.04 0.04 0.00 0.00 
Acetylsalicylic acid 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.01 0.00 0.00 
Sulfamerazine 0.06 0.22 0.00 0.20 -0.07 0.00 -0.06 0.22 0.20 0.03 0.03 
Phenacetin 0.00 0.10 0.00 0.10 0.00 0.00 0.00 0.10 0.10 0.00 0.00 
Sulfadiazine -0.05 0.07 0.00 0.06 -0.01 0.00 0.05 0.07 0.06 0.01 0.01 
Caffeine -0.01 0.13 0.00 0.11 0.00 0.02 0.03 0.13 0.11 0.02 0.02 
Methyl paraben 0.00 0.02 0.00 0.01 0.00 0.00 0.00 0.02 0.01 0.01 0.01 
M#: % mass change at %RH points A (30%RH, B (90%RH), C (0%RH), D (90%RH), E (0%RH), and F (30%RH),  
MEND: difference between final (F) and initial (A) values. MMAX1 and MMAX1 are the maximum % mass change 
observed during first and second adsorption intervals (ADS1 and ADS2). ∆MAX is the difference in MMAX1 and MMAX1 
values. MADS is the difference in % change in mass between points B and D, i.e. at 90 %RH for adsorption cycles 1 




Figure 4-14 Two-cycle GVS moisture sorption profile for γ-indomethacin 
 Conclusions 4.4
In this chapter, the ten selected study materials were classified into different particle 
size fractions by mechanical sieving and the sieving efficiency investigated using a 
combination of laser particle size and optical and electron microscopy. It was shown 
that the sieving process was effective in separating the materials into different particle 
size fractions. However, these particle size fractions were not necessarily consistent 
with the mesh size used (Table 4-5). For each study material one sieved fraction was 
selected and defined with respect to particle size using a novel approach according to 
their microscopy and particle size values (Table 4-8). The selected sieved fractions for 
the materials were then successfully characterised using the core test methods (XRPD, 
IR, TGA, DSC, HPLC and GVS). The analytical property responses (APRs) from these 
core techniques demonstrated that the all the sieved powders were highly crystalline as 
shown by the intense and sharp diffraction peaks in the powder X-ray patterns and the 
observance of birefringence under a polarized-light microscope. Additionally, all 
materials were shown to be anhydrous as indicated by the relatively small mass changes 
in their TGA thermograms and GVS moisture sorption profiles. The APRs from these 
core tests will also act as reference values that will be used to compare with the 
responses of the corresponding mechanically comminuted materials. The amount of 
experimental and instrumental variations in the observed APRs was also estimated and 
these values will be used to define what constitutes a marked change in the analytical 
responses during the comparative response analysis (CRA) of the processed material in 
Chapter 6. 
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5 Mechanical comminution of input materials 
 Introduction 5.1
Ten study materials have been fractionated into different particle size fractions by 
sieving and one of the fractions was then selected and characterised using the core test 
methods (Chapter 4). These selected fractions were then used as the input material to be 
mechanically comminuted by ball-milling and jet-milling (micronisation) under varying 
operating parameters. 
An overview of the mechanical comminution process was given previously (Section 
1.4.2) along with an introduction to the principles of ball- and jet-milling with respect to 
their uses within the pharmaceutical industry (Sections 1.4.3 and 1.4.4). 
The primary aim of this chapter was to obtain mechanically comminuted material which 
can then be used to investigate the respective analytical property responses (APRs) 
using the core test methods as described in Chapter 3. It is envisioned that different 
levels of PID may be obtained by employing both ball- and jet-milling for materials that 
maybe susceptible to PID and this variation can translate into different analytical 
response levels which can be investigated using the core test methods. 
 Input materials 5.2
The materials selected (sieved fractions) to be used as the input materials for both the 
ball-milling and micronisation processes are given in Table 4-8. 
 Mechanical comminution methods 5.3
 Ball-milling methods (Mill-A & Mill-B) 5.3.1
Two ball-milling methods utilising primarily different ball sizes, milling frequencies 
and periods were employed to mechanically comminute the input materials using the 
conditions as outlined in Table 5-1 to potentially generate different levels of PID in 
materials that maybe susceptible to PID. These methods will commonly be referred to 
as the high frequency (Mill-A) and low frequency (Mill-B) milling methods.  
Method Mill-A, is a high energy comminution process that vibrates a larger milling ball 
at a higher frequency, for a longer period then method Mill-B, hence, method mill-A is 
more likely to generate PID of the two methods. 
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Table 5-1 Ball-milling method conditions and operating parameters 
Process Variable Method Mill-A Method Mill-B 
Milling Jar preparation Jar size (cm3) 50 50 
Ball size (mm) 20 15 
Number of balls 1 1 
Charge size (g) 2 2 
Milling parameters Cycle mill time (min) 5 5 
Cycle pause/cool time (min) 2 2 
No. cycles 12 6 
Total mill time (min) 60 30 
Cryogenic cooling with liquid 
nitrogen 
Yes Yes 
Frequency (Hz) 25 15 
 
For each ball-milling method (Table 5-1), 2 g of the input material were weighed 
(charged) into a stainless-steel milling jar with the appropriate sized stainless-steel 
milling ball. The milling jars were then sealed inside a glove box purged with dry 
nitrogen gas to minimise surface adsorption of atmospheric water which has the 
potential to promote recrystallisation during milling. The sealed milling jars were then 
immersed in a Dewar containing liquid nitrogen for 15 min. Following cryo-cooling the 
milling jars were fixed into place on the MM301 Retsch bench-top mixer-mill (details 
in APPENDIX 4) and milled using the operational parameters as outlined in Table 5-1. 
Materials were milled at 5 min intervals with a 2 min pause between milling cycles to 
reduce any localised temperature build-up
22
. After every 15 min of milling time, the 
milling jars were re-immersed in a Dewar containing liquid nitrogen for 5 min. 
At the completion of milling, the milling jars were placed in a glove box purged with 
dry nitrogen gas and the comminuted material transferred to a pre-weighed glass 
container before sealing. The %RH within the glove box was shown to be 3-5 %RH as 
determined using a portable %RH meter (details in APPENDIX 4). To ensure 
homogeneity of the materials for analysis, the containers were mixed using a spiral 
mixer (details in APPENDIX 4) for 5 min prior to the start of analysis using the core 
test methods. In addition, in order to aid in the dissipation of any generated electrostatic 
charge the sealed containers were placed in front of a SIMCO sentry ionizing air blower 
(details in APPENDIX 4) for 10 min.  
Throughout the milling process the environmental relative humidity (%RH) and 
temperature were monitored and recorded. Any material observations were also 
recorded, such as electrostatic behaviour, change in colour and general handling. The 
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ratio of milling ball weight to charge (BCR) and % yield were also reported for each 
material using the equations given below: 
     Milling ball weight (g)
Charge weight (g)  
 [5-1] 
 
% yield   Weight of milled material (g) 
Charge weight (g)
 
 x 100 
[5-2] 
For each study material, the selected sieved fractions were milled using both ball-
milling methods (Mill-A and Mill-B) at least once. However, to demonstrate 
repeatability of the milling process, the milling of acetaminophen, indomethacin and 
salbutamol sulphate were performed in duplicate and on different days. In addition to 
the methods described above, salbutamol sulphate was also ball-milled using method 
Mill-A without cooling in liquid nitrogen to control the milling temperature, with a 
view to investigate whether or not limited or no temperature control can affect PID 
generation; all the other method parameters and timings remained the same for this 
investigation. 
 Jet-milling (micronisation) method (JM-A) 5.3.2
Jet micronisation was performed only once for each study material using the process 
described below. 
In a Class II cabinet with a dry nitrogen gas atmosphere, approximately 1 g of input 
material was manually feed into a JETPHARMA MC One jet-mill microniser (details in 
APPENDIX 4) over a 4 min period. Micronisation was performed using a venturi (feed) 
and ring (grind) pressure of 8 and 6 bar respectively with nitrogen as the carrier gas
344
. 
Micronisation was stopped approximately 1-2 min after the final addition of material. 
At the completion of micronisation the collection vessel was disassembled in a glove 
box purged with dry nitrogen gas and the micronised material transferred to a pre-
weighed glass container before sealing. The %RH within the glove box was shown to be 
3-5 %RH, as determined using a portable %RH meter (APPENDIX 4). To ensure 
homogeneity of the materials for analysis, the contents of the containers were mixed 
using a spiral mixer (details in APPENDIX 4) for 5 min prior to the start of analysis. In 
addition, in order to aid in the dissipation of any electrostatic charge the sealed 
containers were placed in front of a SIMCO sentry ionizing air blower (details in 
APPENDIX 4) for 10 min.  
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Throughout the micronisation process the environmental relative humidity (%RH) and 
temperature were monitored and recorded. Any material observations were also 
recorded, such as electrostatic behaviour, change in colour and general handling. The 
amount of time taken to feed the charge and total micronisation time were reported for 
each material and the feed rate (FR) and % yield calculated using the equations given 
below: 
   (gmin- )   Charge weight (g)
Feed time (min)  
 [5-3] 
 
% yield   Weight of micronised material (g) 
Charge weight (g)
 
 x 100 
[5-4] 
 Results & discussion 5.4
The potential for crystalline pharmaceutical material to undergo mechanically activation 
or disordering has been investigated for a number of materials
137,160,192,221
. However, 
these studies involved variations in milling time and intensity to produce complete 
disordering of the crystalline material so as to generate the amorphous state. In the 
current study, a more systematic and controlled investigation into the milling and 
micronisation behaviour was performed. The same mechanical comminution process 
and operational parameters were employed for all of the study materials to mimic the 
“reality” of generating unintentional induced disorder, rather than over-processing with 
the intent to completely collapse the crystal lattice. To this end, two ball-milling 
methods, involving low and high frequency were employed to comminute mechanically 
the input materials. These methods differed not only in their operational frequency but 
also in the size of the milling balls used and in the time of milling (Table 5-1). It is 
proposed that by ensuring the same processing conditions are employed for each 
material, the relative amounts of any observed disorder can be compared across the 
materials. In addition by designing the study to ensure that different processing 
conditions were applied to the same material, any difference in the levels of PID that 
might be generated for materials with the propensity for PID could be assessed as a 
function of the selected conditions. 
All of the materials were cryogenic ball-milled using liquid nitrogen to ensure that 
milling occurred below room temperature. Milling below room temperature is thought 
to reduce the conversion of any generated transient disordered solid to another more 
stable form during the milling process. The low temperature might also be expected to 
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render the sample more brittle (less elastic) and therefore more amenable to size 
reduction
137,146,160,191,192,221,247,345
. However, for one milling investigation involving 
salbutamol sulphate, cryogenic ball-milling was not performed with a view to 
investigating any differences between this material and the material cryogenic ball-
milled. Salbutamol sulphate was chosen for this investigation as it has been reported 
previously to exhibit PID
1,20,21,246,247,275-277
, has a low Tg (°C) and has been shown to 
exhibit a melt-degradation event (Section 4.3), hence, any increase in internal milling 
temperature could affect PID generation as well as chemical and solid state form 
stability. The importance of local %RH and temperature has been highlighted by the 
investigation by Burnett et al.
311
 in which the recrystallisation of disordered salbutamol 
sulphate was studied using GVS at different temperatures. It was found that as 
temperature was increased the amount %RH required to initiate recrystallisation 
decreased. Therefore, by ensuring the milling temperature is controlled using liquid 
nitrogen and using a dry nitrogen atmosphere to charge the milling jars, precautions 
have been taken to reduce the influence of local %RH and milling temperatures to cause 
recrystallisation of any transient or permanent PID material during ball-milling. 
Table 5-2 summaries the post milling observations along with the reported BCR and % 
yield values for the study materials ball-milled using the two methods. In general, the 
high frequency ball-mill method generated material which was more electrostatic. The 
most notable observation was for γ-indomethacin, which upon milling changes colour 
from white to bright yellow and formed lumps and a hard layer that encased the milling 
ball (Figure 5-1). 
 
Figure 5-1 Post milling images of the milling ball for γ-indomethacin after high frequency ball-















Observations post ball-milling Electrostatic 
Acetaminophen Mill-A1 1-MA1 16 81 White powder, no colour change Yes 
Mill-A2 1-MA2 16 89 White powder, no colour change Yes 
Mill-B1 1-MB1 7 85 White powder, no colour change Yes 
Mill-B2 1-MB2 7 83 White powder, no colour change Yes 
γ-Indomethacin  
Mill-A1 11-MA1 16 65 
Colour change- yellow clumpy 
powder 
Yes 
Mill-A2 11-MA2 15 72 
Colour change from white free-
flowing  to a  yellow clumpy 
powder 
Yes 
Mill-B1 11-MB1 7 87 Colour change- yellow powder Slightly 
Mill-B2 11-MB2 7 81 Colour change- yellow powder Slightly 
Salbutamol 
sulphate 
Mill-A1 24-MA1 16 72 White powder, no colour change Yes 
Mill-A2 24-MA2 15 89 White powder, no colour change Yes 
Mill-A3* 24-MA3 15 89 White powder, no colour change Yes 
Mill-B1 24-MB1 7 88 White powder, no colour change Slightly 
Mill-B2 24-MB2 7 88 White powder, no colour change Slightly 
Loperamide 
HCl 
Mill-A1 14-MA1 16 79 White powder, no colour change Yes 
Mill-B1 14-MB1 7 91 White powder, no colour change Slightly 
Acetylsalicylic 
acid 
Mill-A1 33-MA1 16 75 White powder, no colour change No 
Mill-B1 33-MA2 7 88 White powder, no colour change Slightly 
Sulfamerazine Mill-A1 54-MA1 16 87 White powder, no colour change Yes 
Mill-B1 54-MA2 7 88 White powder, no colour change Slightly 
Phenacetin Mill-A1 69-MA1 16 88 White powder, no colour change Yes 
Mill-B1 69-MA2 7 91 White powder, no colour change Slightly 
Sulfadiazine 
Mill-A1 87-MA1 16 88 
White powder, more free flowing 
after milling 
No 
Mill-B1 87-MA2 7 90 White powder, no colour change No 
Caffeine Mill-A1 88-MA1 16 79 White powder, no colour change No 
Mill-B1 88-MA2 7 84 White powder, no colour change No 
Methyl paraben Mill-A1 140-MA1 16 89 White powder, no colour change No 
Mill-B1 140-MA2 7 92 White powder, no colour change No 
* milled without liquid nitrogen 
 
To demonstrate reproducibility of the milling processes, acetaminophen, indomethacin 
and salbutamol sulphate were milled in duplicate and on different days using both Mill-
A and Mill-B methods. These materials were chosen as they reflect the potential 
extremes when milled, from stable crystalline (acetaminophen160,221) to disordered (γ-
indomethacin
148,160,178,212,221,268,271
 and salbutamol sulphate
1,20,21,246,247,275-277
). The % 
yields for all materials were fairly similar and generally high, which is expected, as the 
ball-milling process is a closed comminution process (Section1.4.3) with all the material 
retained within the milling jars. Any material lost is due to retention of material on the 
sides of the milling jar and around the milling balls as was illustrated for γ-
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indomethacin (Figure 5-1). Any material adhering to either the milling ball or jar was 
scraped off gently and included in the final yield. 
Micronisation of the materials was performed under a dry nitrogen atmosphere, to 
reduce the effects of environmental RH. Though the local environment (laboratory) was 
generally held at a constant temperature, it was noted that during the micronisation 
process, heat was generated by this high energy process. This was detected as an 
increase in temperature within the collection vessels at the end of the micronisation 
process. Initially the temperature at the start of micronisation was around 25 ± 5 °C but 
this rose to 35 ± 2 °C at the end of micronisation. Based on this observation it is likely 
that the temperature within the grinding ring could be markedly higher and as a 
consequence this could have affected the extent of any PID that might have been 
generated. This slightly contradicts previous assumptions that jet-milling with air as the 
grinding media can help to cool or dissipate any generated heat thereby avoiding 
excessive heat and contamination during its operation
180
.  
It has been noted in the literature that low temperature milling is more efficient in 
generating amorphous material than at room temperature
146,345
, hence, at elevated 
temperatures any transient meta-stable phases or solid-state forms may be lost, which 
might not be detected. 
The degree of comminution obtained by micronisation depends on the critical milling 
parameters. The most important parameters are feed rate, feed pressure and grind 
pressure
21,344
. Micronisation feed and grind pressures of 8 and 6 bar respectively were 
selected based on pharmaceutical industry guidance
344
 and on investigations by Brodka-
Pfeiffer et al.
21
, in which salbutamol sulphate was micronised at different pressures. It 
was shown that a grind pressure of 6 bar was effective to achieve a potentially 
respirable particle size distribution, with only a small amount of generated disorder. 
Above 6 bar the effect of the grind pressure decreased as, once a certain pressure has 
been reached, no further increase in the maximum jet speed (sonic velocity) can be 
obtained
21
. Feed pressure is generally set at a higher value than the grinding pressure 
and must be sufficient to prevent any clogging. In this study feed pressure was set at 8 
bar based on manufacturer and industry reccomendations
344
. By applying similar low 
feed rates across the materials, 0.23 to 0.29 gmin
-1
 (Table 5-3), the amounts of material 
introduced within the grinding chamber were similar, thus particles would readily be 
accelerated upon entry. If the material concentration inside the grinding chamber was 
too large then a decrease in inter-particulate acceleration distance would result, giving 
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rise to coarser particles
21
. The amount of micronised material (% yield) collected for all 
the materials were similar but lower than those obtained by ball-milling (Table 5-3). 
Table 5-3 Summary of reported observations and % yields for the micronisation of the study 


















Acetaminophen 1-X1 4.5 0.23 6.0 69 
No colour change, but 
induced agglomeration 
Very 
γ-Indomethacin 11-X1 4.2 0.26 5.2 69 
Colour change from 




24-X1 4.0 0.22 5.0 58 No colour change Yes 
Loperamide 
HCl 
14-X1 4.3 0.25 5.3 69 
Colour change from 




33-X1 4 0.28 5.0 52 No colour change Yes 
Sulfamerazine 54-X1 4 0.26 5.0 68 
Colour change from 
white to slightly off-
white 
Yes 
Phenacetin 69-X1 3.8 0.27 4.8 71 No colour change Yes 
Sulfadiazine 87-X1 5 0.26 6.0 68 
No colour change, more 
free flowing 
Slightly 
Caffeine 88-X1 3.7 0.29 4.7 60 No colour change Yes 
Methyl paraben 140-X1 3.5 0.29 4.5 67 No colour change No 
 
The majority of the micronised materials were electrostatically charged which may have 
been accentuated by the dry nitrogen atmosphere environment employed during the 
process (Table 5-3). The most charged was acetaminophen which resulted in 
agglomeration of the material. However, applying an ionizing airflow to this material 
tended to dissipate this electrostatic charge and reduce agglomeration. Some micronised 
materials also exhibited a limited amount of colour change (Table 5-3), γ-indomethacin, 
became slightly yellow when micronised but the final colour was much less intense than 
that for the ball-milled samples. For loperamide HCl and sulfamerazine there was some 
slight discoloration from the white powdered input material, which could be indicative 
of thermal or chemical changes (Table 5-3). 
 Conclusions 5.5
In this chapter the selected study materials were successfully mechanically comminuted 
by ball-milling using two different conditions and by jet micronisation. Characterisation 
of these processed materials follows in the proceeding chapters (Chapter 6 and 7). 
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6 Characterisation of mechanically comminuted material 
 Introduction 6.1
In the previous chapter the ten model materials were mechanically comminuted to 
produce material with potentially differing amounts of PID depending on the 
comminution process and the material’s inherent propensity for PID.  
The aim of this chapter was to characterise the selected materials that were comminuted 
mechanically previously (Chapter 5) using the described core test methods (Chapter 3). 
The APRs obtained from each core test method would then be compared to those of the 
relative input materials that were analysed under standard conditions (Chapter 4). It was 
planned to do this using a novel approach termed comparative response analysis (CRA). 
Based on the CRA evaluations, the relative amounts of change in each APR obtained 
from the individual analytical techniques could then be defined and quantified and used 
to determine if the comminution processes were successful in generating material that 
encompassed the whole amorphous-crystalline continuum.  
 Materials 6.2
Table 6-1 lists the mechanically comminuted study materials that were characterised 
using the core test methods (Chapter 3). At least three batches of each material, one 
from each comminution method (Mill-A, Mill-B and JM-A) were characterised.  
Table 6-1 Mechanically comminuted material characterised using the core test methods  
 
Particle size class of 
input material 
Number of batches per milling 
method 
 
Material PSC SCC Mill-A Mill-B JM-A 
Total No. 
batches 
Acetaminophen A2 S1B3 2 2 1 5 
γ-Indomethacin A2 S1A2 2 2 1 5 
Salbutamol sulphate A2 S3C1 2 & 1** 2 1 6 
Loperamide HCl A2 S1B3* 1 1 1 3 
Acetylsalicylic acid A2 S3C1 1 1 1 3 
Sulfamerazine A2 S1A1 1 1 1 3 
Phenacetin A2 S1A2 1 1 1 3 
Sulfadiazine A1 S1A3 1 1 1 3 
Caffeine A2 S1B3* 1 1 1 3 
Methyl paraben A2 S2B2* 1 1 1 3 
* indicates the presence of a significant amount of agglomerated particles, ** Milled without liquid nitrogen.  
PSC: particle size class based on sieved fraction, SCC: size classification code Mill-A high frequency ball-mill 
method A, Mill-B: low frequency ball-mill method B. JM-A: jet micronisation method A. Methods are described in 
5.3.1 and 5.3.2 respectively 
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 Methods 6.3
To ensure that the comminuted materials were analysed consistently and efficiently the 
materials were analysed using the same order of techniques immediately after 
completion of the comminution process. Typically the analysis protocol was started 
within 30 min of completing the comminution process (Table 6-2). For the first four 
techniques, samples were prepared quickly (less 3 min each) and acquisition initiated 
before starting sample preparation for the remaining techniques. These four techniques 
were selected first as any disorder present could be either directly observed, or would 
identify the presence of water. The latter, if present could affect the stability of the 
solid-state phase or form present in the comminuted material. 




Acquisition  and 
RA methods  
- see section 
CRA method 
- see section 








































To ensure homogeneity of the comminuted material prior to analysis, each material was 
thoroughly mixed using a spiral mixer and any electrostatic charge was dissipated 
(Section 5.3). Exposure to the environment was also minimised as much as practically 
possible during sample preparation procedures and the temperature and %RH monitored 
and recorded. 
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For each analytical technique, the acquisition and response analysis method along with 
the CRA process are described in each section. The CRA process for each technique 
defines the relevance of the amount of change between the analytical responses of the 
material being investigated (comminuted material) and that of the input/reference 
material. The limits to define the level of relevance for changes in the APRs for the 
individual techniques are based on the observed variations in the responses for the 
input/reference materials as reported earlier (Chapter 4) as well as applicable 
pharmaceutical industry and instrument supplier recommendations.  
 X-ray powder diffraction (XRPD) 6.3.1
 XRPD acquisition and response analysis 6.3.1.1
X-ray powder diffraction patterns for mechanically comminuted materials were 
obtained using the method described in Section 3.2.1. For each comminuted material, 
three replicate sample preparations were prepared and a single representative XRPD 
pattern obtained by averaging the replicates using the PANalytical X’Pert HighScore 
Plus (version 3.0) software (Section 3.2.1.1). The averaged XRPD patterns were then 
analysed using the processes described in Section 3.2.2 and the individual peak 
responses tabulated using five peak descriptors; peak position (PP), peak height or 
intensity (PH), peak width (PW), peak area (PA) and background height (BH). These five 
XRPD peak descriptors or responses, best represent the key indicators to describe 
individual peak characteristics and changes in these values will be investigated as part 
of the comparative response analysis process. 
 Comparative response analysis of XRPD diffractograms  6.3.1.2
CRA between the responses of the comminuted material XRPD diffractogram and those 
of the input/reference material were determined by investigating the changes between 
responses in the individual peak characteristics of the most significant peaks in the input 
and comminuted material averaged across the whole XRPD diffractogram. Any changes 
to the MIP positions and MIP intensities were also determined.   
The XRPD diffractograms of the comminuted and input/reference were overlaid using 
the PANalytical’s X’Pert Data viewer (v1.3) and the peaks inspected visually in 
conjunction with the tabulated peak lists. The presence or absence of the significant 
peaks (peaks with % RPI above the defined % RPI value) in both diffractograms was 
determined by peak matching using a similar method to Patel et al.
346
 and defined using 
novel peak designators, as described below. The labeling of the peaks is illustrated in 
Figure 6-1. If a significant input/reference peak was absent in the XRPD diffractogram 
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for the comminuted material, these were denoted with an A. If a new peak was observed 
in the comminuted material, these were designated with a N. However, if a comminuted 
material peak had broadened or merged such that it overlaid a number of reference 
peaks and could not be resolved, then these were denoted with an M along with the 
peak position value for the maxima of the broadened peak (see Figure 6-1). 
 
Figure 6-1 Example of an overlaid reference (red) and comminuted (green) XRPD diffractogram 
illustrating the labeling of the peaks.  
M refers to merged or broadened peaks and the value represents the peak position of the maxima of 
the broadened/merged peak. N represents a new peak not present in the reference and A represents 
an absent reference peak. 
For each significant peak tabulated, changes in the five key XRPD peak descriptor 
values and the MIP position and MIP intensity (height) were determined using the 
equations defined below and the amount of change in the peak descriptor responses 
were then qualified using the limits defined in Table 6-3. 
Average changes in individual peak position ( PP) and average peak shifting (Av PP) 
across the whole diffractogram are given by: 
 PP (°2θ)    Sample peak position PP   Reference peak position PP [6-1] 
Av PP    θ    
Sum of changes in individual peak shifts  PP 
number of             peaks          
 [6-2] 
Percentage changes in the individual peak responses (% ”RSP”) and average peak 
responses (Av ”RSP”) across the whole diffractogram are given by the general 
equations: 
% “   ” (%)   ( 
Sample peak “   ”   Reference “   ” 
Reference “RSP”
) x 100 [6-3] 
Av “   ” (%)   
Sum of % changes in individual peak “   ”
number of significant peaks in sample
  [6-4] 
where “RSP” can be peak height (PH), peak widths (PW using FWHM), peak areas (PA) 
or background height (BH). 
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Percentage change in MIP intensity (% MIPH) is given by: 
% MIPH (%)   (
Sample MIP  height (cts)    Reference MIP height (cts) 
Reference MIP height (cts)
         [6-5] 
Table 6-3  Qualitative relevance of CRA values for key XRPD peak descriptors over the whole 
XRPD diffractogram 
XRPD Response 
Average amount of 
change (Δ) across all 
peaks 
Qualitative relevance of the amount of change in XRPD 
responses and observations of comminuted material 
Peak position   
PP  
A few new peaks (N) Some new peaks observed suggesting presence of  a new  
solid state form 
All new peaks (N) Suggests presence of a new solid state form 
Merged peaks (M) Some  reference peaks broadened or merged 
A few Absent peaks (A) Some reference peaks missing in sample XRPD 
No peaks present (A) Suggests material is XRPD amorphous 
-0.03 < AvΔPP < 0.03 Peak positions remains relatively unchanged 








Peak height  
PH 
-20% < AvΔPH < 20% Peak heights remains relatively unchanged 
AvΔPH < -20% Reduced peak heights observed  
AvΔPH  > 20% Increased peak heights observed 
Peak widths  
PW 
-20% < AvΔPW < 20% Peak widths remains relatively unchanged 
AvΔPW < -20% Peaks becoming narrower and more sharper 
AvΔPW > 20% Peaks becoming broader 
Peak areas  
PA 
-20% < AvΔPA < 20% Peak areas remains relatively unchanged 
AvΔPA < -20% A decrease in overall peak areas observed 
AvΔPA > 20% An increase in overall peak areas observed  
Background height  
BH 
-20% < AvΔBH < 20% Background height remains relatively unchanged 
AvΔBH < -20% A decrease in background height observed 
AvΔBH > 20% An increase in background height observed  
MIP position  
MIPP 
Different MIP Change in MIP may suggest the presence of preferred 
orientation or a new solid state form 
No Change MIP remains the same 
MIP height 
MIPH 
-20% < % MIPH < 20% MIP height remains relatively unchanged 
% MIPH < -20% Intensity of MIP decreased  
% MIPH > 20% Intensity of MIP increased 
AvΔPP: amount of average peak shifting. AvΔPH: % change in average peak height. AvΔPW: % change in average 
peak width (FWHM).  vΔ A: % change in average peak area. AvΔBH: % change in average background height 
In Table 6-3 the threshold limits for changes in the peak descriptors were based on the 
replicate analysis of the input materials using values selected just above the calculated 
instrumental and sample preparation variance (Table 4-11).   
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 Qualitative classification of solid state phase based on changes in 6.3.1.3
XRPD responses   
Using the observed changes in the XRPD responses (CRA values) and the relative 
threshold limits as defined in Table 6-3, the comminuted materials could be 
qualitatively classified as being crystalline, microcrystalline, disordered or X-ray 
amorphous using novel definitions and decision tree (Table 6-4 and Figure 6-2).   
Table 6-4  Qualitative classification of solid-state phase present based on changes in XRPD 
responses  over the whole XRPD diffratogram 
Solid state phase 






XRPD  diffractogram is identical 
to a reference with same MIP, 
peak positions, similar %RPIs, 





XRPD diffractogram is similar to 
a reference with similar peak 
positions. However, MIP and 
peak heights are different  
 
Crystalline 
(mixed solid state forms) 
XRPD  diffractogram contains 
new peaks  along with peaks 
concordant with the reference 
 
Crystalline 
(New solid state form) 
XRPD diffractogram contains all 
new peaks   
 
Microcrystalline 
(Due to decrease in particle 
size not an increase in 
disorder.) 
XRPD diffractogram has similar 
peak positions as the reference. 
However, MIP is different, peaks 
are broader and the background 
height may be increased. 
 
 
Disordered Peaks have generally shifted and 
broadened with a decrease in 
height. The background height 
has also increased  
 
X-ray amorphous A “halo” or large background is 
observed in the XRPD 
diffractogram with no discernable 
peaks implying complete disorder 
of the crystal lattice 
 






Figure 6-2  Decision tree for the qualitative classification of solid state phases by XRPD 
AvΔPP: amount of average peak shifting. AvΔPH: % change in average peak height.  
AvΔPW: % change in average peak width (FWHM). AvΔBH: % change in average background 




 Thermogravimetric analysis (TGA) 6.3.2
 TGA acquisition and response analysis 6.3.2.1
TGA thermograms for the mechanically comminuted materials were obtained and 
analysed using the methods described in Sections 3.3.1 and 3.3.2 respectively. Each 
study material was analysed in duplicate and the responses averaged. 
Based on the TGA analysis of the input/reference material (Chapter 4) any observed 
weight loss below 0.5% (w/w) for WL50 and WL150 is assumed to be due to 
experimental noise and was therefore reported as “< 0.5% (w/w)”. For materials which 
started to thermally degrade below 150 °C, WL
150
 values could not be calculated and so 
these were denoted as “D”. 
 Comparative response analysis of TGA thermograms 6.3.2.2
CRA was performed by comparing the differences in the weight loss profiles and 
thermal responses of the comminuted material TGA thermogram with those of the 
input/reference obtained under the same acquisition conditions (Section 3.3.1). The 
amount of change in four key TGA responses was determined using the equations 
defined below and the qualitative relevance of these changes defined (Table 6-5). 
Change in % weight loss below 50 °C (ΔWL
50
) is given by: 
ΔWL50 (%)   Sample WL50  – Reference WL50 [6-6] 
if either the sample or reference WL
50
 value is less than 0.5 % w/w, then 0.5 is used in 
the equation for either or both values. 
Change in % weight loss below 150 °C (ΔWL150) is given by: 
ΔWL150 (%)   Sample WL150  – Reference WL150 [6-7] 
if either the sample or reference WL150 value is less than 0.5 % w/w, then 0.5 is used in 
the equation for either or both values. 
For both ΔWL50 and ΔWL150 a negative value indicates a decrease in weight loss, i.e. the 
reference had more volatiles (moisture) present, while a positive value indicates that the 
comminuted material being examined had more volatile (moisture) material present.  
 Shift in degradation temperature (ΔTd) is given by: 
Δ    (° C)   Sample     – Reference    [6-8] 
A negative value indicates a shift to lower temperature and therefore a potential 
decrease in thermal stability which can be indicative of the presence of amorphous or 
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disordered phases. While a positive value indicates a shift to a higher temperature and 
potentially an increase in thermal stability.  
In Table 6-5 the threshold limits for defining the qualitative relevance of the amount of 
change in TGA responses and observations were selected using values just above the 
calculated instrumental and sample preparation variance using data from the replicate 




Table 6-5  Qualitative relevance of CRA values for key TGA responses  
TGA Response Amount of change Δ 
Qualitative relevance of the amount of change in TGA 
responses and observations of comminuted material 
Change in number of 
weight loss events 
#WE 
Δ#WE = 0 No change in number of events 
Δ#WE negative Indicates a decrease in number of events and may suggest 
some volatile/moisture has been removed 
0 < Δ#WE < 3 Suggests a small increase in number of events and may suggest 
moisture may have been absorbed or the sample is less stable 
Δ#WE > 3 or 
continuous weight loss 
May infer large thermal instability 
Change in weight loss 
(% w/v) below 50°C 
WL50  
 
-0.25 < ΔWL50 <  0.25 No change in weight loss below 50 °C  
ΔWL50 <  -0.25 A decrease in weight change may indicate reference contained 
volatiles 
0.25 < ΔWL50 < 1.0 Some loosely bound volatile (moisture) present 
ΔWL50 > 1.0 Marked loosely bound volatile (moisture) present 
Change in weight loss 
(% w/v) below 150°C 
WL150 
-0.25 < ΔWL150 < 0.25 No change in weight loss below 150 °C 
ΔWL150 <  -0.25 A decrease in weight change may indicate reference contained 
volatiles or moisture 
0.25 < ΔWL150 < 1.0 Some bound volatile (moisture) present 
 ΔWL150 > 1.0 Marked bound volatile (moisture) present 
Degrades below 
150°C 
WL150 cannot be determined so denoted as “D” 
Shift in degradation 
temperature 
Td (°C) 
-5 < ΔTd <5 No change in thermal degradation temperature 
ΔTd >  5 Improved thermal stability 
-5 < ΔTd < -10 A decrease in thermal stability 
ΔTd >  -10 Marked decrease in  thermal stability 
Δ#WE: change in number of weight loss events observed, ΔWL50: change in weight loss below 50°C, ΔWL150: 
change in weight loss below 150°C, ΔTd: change in degradation temperature. 
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 Differential scanning calorimetry (DSC) 6.3.3
  DSC acquisition and response analysis 6.3.3.1
DSC thermograms for the mechanically comminuted materials were obtained and 
analysed using the methods described in Sections 3.4.1 and 3.4.2 respectively. Each 
study material was analysed in triplicate and the responses averaged. 
As a number of materials exhibit melt-degradation the typical indicator for peak 
broadness, width at half peak height (WHH) value cannot be determined. Hence, 
T
m
trans which represents the temperature range of melting was used as an indicator of 
the broadness of the melting event.  
 Comparative response analysis of DSC thermograms 6.3.3.2
CRA of the acquired DSC thermograms was performed by comparing the differences in 
the thermal responses associated with five major thermal events; melting (M), 
degradation (D), volatile loss (V), glass transition (G) and recrystallisation (C) of the 
comminuted sample DSC thermogram with that of the input/reference obtained under 
the same acquisition conditions (Section 3.4.1). 
Two general equations (equations [6-9] and [6-10]) can be derived to compare the thermal 
responses, allowing the qualitative relevance of these changes to be defined for each 
type of thermal event, G, V, C, M, and D that maybe present (Table 6-6). 
Shifts in temperature responses (Δ“ ”) are defined by: 
Δ“ ” (° C)   Sample “ ”
  
– Reference “ ” [6-9] 
where “ ” can be melting onset (Tm), temperature range of melting (Tmtrans), 
degradation onset (Td), desolvation onset (Tv), or crystallisation onset (Tc). 
Percentage changes in enthalpic responses (%Δ“H”) are defined by: 
% “ ”           ( 
Sample “ ”    Reference “ ” 
Reference “ ”  
) x 100 [6-10] 
where “H” can be heat of desolvation (ΔHv), heat of crystallisation (ΔHc), or the heat of 
fusion (ΔHf). 
In Table 6-6 the threshold limits for defining the qualitative relevance of the amount of 
change in DSC responses and observations were selected using values just above the 
calculated instrumental and sample preparation variance using data from the replicate 





Table 6-6  Qualitative relevance of CRA values for the DSC thermal responses  
DSC 
event 
DSC Response or 
observation 
Amount of change Δ 
Qualitative relevance of the amount of change in DSC 
responses and observations of comminuted material 
M 
No melt No melt observed Infers presence of disorder*. 
More than one melt 
Additional melting event(s) 
observed 
May suggest presence of a new form*. 
Melting onset, Tm 
ΔTm  < ± 3 °C Effectively no change in melting onset. 
ΔTm  > -3 °C 
A decrease in melting onset as a result of  impurities or thermal 
degradants or it may indicate the presence of a new form*. 
ΔTm  > 3 °C 
An increase in melting onset as a result of  improved solid state 
purity or it may indicate the presence of a new solid state form*. 
Melting transition range, 
Tmtrans 
ΔTmtrans < ± 3 °C** Effectively no change in melting transition range. 
ΔTmtrans > -3 °C** 
Melting transition range narrower as a result of improved solid 
state purity or a change in particle size. 
ΔTmtrans > 3 °C** 
Melting transition range broadened as a result of a decrease in 
solid state purity , crystallinity or a change in particle size. 
Heat of fusion, Hf 
%ΔHf  < ± 25 %** Effectively no change in heat of fusion. 
%ΔHf  > -25 %** 
Heat of fusion reduced as a result of a decrease in solid state purity 
or crystallinity. 
%ΔHf  > 25 %** 
Heat of fusion increased as a result of improved solid state purity 
or crystallinity. 
D 
No degradation No degradation observed 
Material thermally stable over DSC acquisition range. If 
degradation event has been removed this may indicate the material 
has become more thermally stable. 
New degradation 
New degradation event 
observed 
New degradation event observed inferring decreased thermal 
stability. 
Degradation onset, Td 
ΔTd  < ± 3 °C No change in thermal degradation temperature. 
ΔTd  > -3 °C 
A decrease in thermal degradation due to impurities or increased 
disorder. 
ΔTd  > 3 °C 
Higher degradation may infer increased thermal stability due to 
new form if a new Tm observed or improved crystallinity. 
V 
No volatile event No volatile event observed No solvent/moisture present respectively. 
New volatile event New volatile event observed Could infer the presence of absorbed water. 
Volatile loss onset, Tv 
ΔTv < ± 3 °C No change in volatile onset. 
ΔTv > ± 3 °C 
Infers a shift in temperature of volatile loss  This could be related 
to changes in particle size and/or strengths of solvent absorption. 
Heat of desolvation, HV 
%ΔHV < ± 25 %** Effectively no change in the heat of desolvation. 
%ΔHV > -25 %** Amount of solvent/moisture present has decreased. 
%ΔHV > 25 %** Amount of solvent/moisture present has increased. 
G 
No glass transition event No glass transition observed 
No glass transition observed over the analysis temperature range 
selected or ca not be discerned. 
New glass transition event New glass transition observed 
If a glass transition event is observed a recrystallisation event is 
likely to be observed as well. Infers presence of disorder. 
C 
No new crystallisation 
No new recrystallisation event 
observed 
No new recrystallisation  event observed over the analysis 
temperature range. 
New  crystallisation event New recrystallisation observed 
Recrystallisation may result in the same solid state form or a new 
form with a corresponding new Tm. May infer the presence of 
disorder. 
M: melting events. D: degradation events. V: volatile loss events. G: glass transition events. C: recrystallisation event. Δ m: Shift in 
m     g      .  Δ m      :  h  g          g               g .  Δ f: % Change in heat of fusion. Δ d: change in degradation onset. 
Δ v: change in volatile loss onset. Δ v: % Change in heat of desolvation. 
* Check XRPD for confirmation of presence of another solid state form 
** Applicable only if referring to the same reported event  
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The appearance of new glass transition (G) and/or crystallisation (C) events provides 
direct evidence to support the presence of disorder in material following comminution. 
However, it must be noted that the absence of a Tg event does not exclude the presence 
of disorder, as the presence of a recrystallisation event can also possibly suggest some 
degree of disorder
22
. Changes in the melting (M) and degradation (D) events can 
provide information regarding the solid-state form initially present or recrystallised 
during the DSC analysis run. As described in Section 3.4.2, volatile (V) events refer 
only to events associated with the desolvation of liquids that occur before melting or 
degradation. Therefore, changes in volatile responses such as shifts in the onset of 
desolvation (ΔTv) or percentage change in heats of desolvation (%ΔHv) can provide 
information about the presence and potential bound strength of the observed solvent. 
Interpretation of volatile (solvent) components in DSC thermograms should be made in 
conjunction with the TGA data to confirm their presence. For example the presence of a 
new volatile loss (endotherm) after storage or ball-milling may suggest the presence of 
absorbed water. This can be confirmed by observing a weight loss event in the TGA 
thermogram over a similar temperature range as the event in the DSC thermogram. 
 Qualitative classification of solid-state phase based on changes in 6.3.3.3
DSC responses   
Using the observed changes in the DSC responses and the relative threshold limits 
defined in Table 6-6, the comminuted materials could be qualitatively classified as 
being crystalline, microcrystalline, disordered or DSC amorphous using novel 
definitions and decision tree (Table 6-7 and Figure 6-3). 
Table 6-7  Qualitative classification of solid-state phase present based on changes in DSC responses   
Initial solid-state phase DSC characteristics of comminuted material 
Crystalline (Concordant with reference) 
DSC thermogram is identical to a reference with the same  DSC 
responses. 
Crystalline (Improved crystallinity same form) 
DSC thermogram with the same DSC events as reference but with 
increased   Hf. 
Crystalline (Improved crystallinity additional 
form present) 
DSC thermogram with similar DSC events as reference but with 
increased   Hf  for same Tm as the reference and an additional Tm. 
Crystalline (mixed solid-state forms) 
DSC thermogram contains a new Tm along with a Tm concordant with 
the reference or evidence of a solid-state transition. 
Crystalline (New solid-state form) DSC thermogram contains a new Tm. 
Mixed Phase A Same crystalline form with some disorder present. 
Mixed Phase B Potentially a new crystalline form with some disorder present. 
Mixed Phase C Potentially a mixture of crystalline forms with some disorder present. 
Disordered 
Potentially a large amount disorder of the crystal lattice with a Tg 
observed. 
DSC amorphous 
DSC thermogram with no discernable events (multiple  unresolved  
thermal events) implying significant amount of disorder of the crystal 
lattice – confirm by other techniques such as XRPD. 
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Figure 6-3  Decision tree for the qualitative classification of solid state phases by DSC using CRA 
values (comparison between processed and input DSC thermograms & responses) 
Δ m: Shift in m     g      .   Δ f:   h  g     h     f fu    . Δ d: change in degradation onset.  
* confirm by XRPD 
 Laser particle size analysis (PSA) 6.3.4
 PSA acquisition and response analysis 6.3.4.1
Particle size distributions (PSD) and responses for the mechanically comminuted 
materials were obtained and analysed using the methods described in Sections 3.6.1 and 
3.6.2 respectively. Six replicates of each study material were analysed and the responses 
averaged. The particle size distributions were plotted as normalised density distribution 
Multiple unresolved 
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(q3*) versus logarithm particle sizes, obtained by dividing each q3* value by the 
highest q3* value observed. 
 Comparative response analysis of particle size distributions 6.3.4.2
CRA was performed by comparing the differences in the particle size distributions and 
responses of the comminuted material with those of the input/reference obtained under 
the same acquisition conditions (Section 3.6.1). The amount of change in the PSA 
responses was determined by overlaying the relevant particle size distributions and by 
using the equations defined below. The qualitative relevance of these changes could 
then be defined (Table 6-8). 
Changes in particle size response values ( D#) were determined by: 
 D#     Sample D#  – Reference D# [6-11] 
where D# can be D10 (µm), D50 (µm), D90 (µm) values,  
The degree of change in the particle size responses (FRSP) was given by: 
       
    r         
Sample PRSP
 [6-12] 





) values. VMD and Sm values were selected as they give a measure of the 
amount of large particles and sub-micron fines within the material upon comminution 
respectively.  
Table 6-8  Qualitative relevance of CRA values for the PSA responses  
PSA response Amount of change   
Qualitative relevance of the amount of change in PSA responses 
and observations of comminuted material 
Decile% of particles   
D10, D50, D90 
 D# a negative value Particle size reducing for defined percentage of particles 
 D# a positive value Particle size increasing for defined percentage of particles. May 
infer agglomeration has occurred as a result of or during the 
comminution process 
Number of modes Increases Particle size distribution becoming more poly-modal 
Decreases Particle size distribution becoming more uniform 
Span Fspan ~ 1 similar width of particle size distribution 
Fspan < 1 Width of particle size distribution is broader 
Fspan > 1 Width of particle size distribution is narrower 
Volume mean 
diameter, VMD 
FVMD ~ 1 Similar amount of larger particles present 
FVMD > 1 The size of larger particles is decreasing 
FVMD < 1 The size of larger particles is increasing  
Surface area, SM FSm ~ 1 Similar amount (size) of fines (sub-micron) present 
FSm < 1 The number (size) of fines (sub-micron) present is increasing 
FSm > 1 The number (size) of fines (sub-micron) present is decreasing  
 D#: Changes in particle size response values for D10, D50, D90, Fspan: the degree of change in span, FVMD: the degree 
of change in volume mean diameter, FSm: the degree of change in surface area  
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 Scanning electron microscopy (SEM) 6.3.5
 SEM acquisition and response analysis 6.3.5.1
Only SEM images for the mechanically comminuted materials were obtained and 
analysed using the methods described in Sections 3.5.2 and 3.5.3. PLM images were not 
acquired as the comminution processes results in the large reduction in particle size 
(potentially to a particle size of less than 10 µm) and therefore PLM was not deemed an 
appropriate technique to investigate primary particle morphology for these materials.   
Due to the nature of the technique, numerical analysis of the particles with respect to 
particle size is difficult to determine by SEM as there are a limited number of particles 
analysed. Therefore, SEM analysis was restricted to reporting qualitative or descriptor 
responses such as particle, surface and edge morphology. 
 Comparative response analysis of SEM images 6.3.5.2
CRA of the acquired SEM micrographs was performed by qualitatively comparing the 
differences in microscopic responses of the comminuted material against those of the 
input/reference material obtained under the same acquisition conditions (Section 3.5.2). 
This CRA process for SEM was restricted to only the descriptor responses and the 
qualitative relevance for these changes defined (Table 6-9). 
Table 6-9 Qualitative relevance of changes in particulate morphology by SEM analysis 
SEM response 
Qualitative relevance of the amount of change in SEM responses and observations 
of comminuted material 
Primary particle shape or habit A different crystal habit suggests process has caused a morphological change. 
Particle surface characteristics  Changes in surface characteristics as a result of a process may indicate the effect of 
the process on the material, e.g. a transformation from cracked, porous, rough or 
pitted surfaces to smooth may indicate some degree of recrystallisation has 
occurred, whilst a change from a smooth to cracked, porous, rough or pitted 
surface suggests the material has or is fracturing.. 
Particle edge characteristics Changes in edge characteristics as a result of a process may indicate how the 
process affects the material, e.g. a transformation  from fractured to sharp, rounded 
or angular form may suggest some degree of recrystallisation has occurred or 
material has sheared, whilst  a change from a sharp, rounded or angular form to a 
fractured form suggests fracturing has occurred.  
Particle association 
(secondary crystal habits) 
The observance of agglomeration may indicate electrostatic affects, particle 
binding through moisture sorption or the effects of processing resulting in particle 
fusing.  
 Gravimetric vapour sorption (GVS) 6.3.6
 GVS acquisition and response analysis 6.3.6.1
Moisture sorption profiles for the mechanically comminuted materials were obtained 
and analysed using the methods described in Sections 3.7.1 and 3.7.2 respectively. Due 
to the length of time to acquire these moisture sorption profiles, replicate analyses were 
not performed. 
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 Comparative response analysis of moisture sorption profiles 6.3.6.2
Comparative response analysis of the acquired moisture sorption profiles was 
performed by comparing the differences in GVS responses for the comminuted material 
against those of the input/reference material obtained under the same acquisition 
conditions (Section 3.7.1). The amount of change in the GVS responses was determined 
using the equations defined below and the qualitative relevance of these changes 
defined (Table 6-10). 
Table 6-10 Qualitative relevance of changes in moisture sorption properties by GVS analysis 
GVS response Amount of change   
Qualitative relevance of the amount of change in GVS 
responses and observations after comminution 
Initial % mass change, MA  ∆MA ~ 0 % Similar amount of moisture present initially  
∆MA > 0.5 % Amount of moisture initially present increased or may 
be due to an electrostatic charge so need to refer to 
TGA data for confirmation. Increased moisture 
sorption may indicate presence of disorder or could be 
due to increased surface area 
Equilibrium % mass 
changes at defined %RH 
points, 
MB, MC, MD, ME, MF 
-0.5 % < ∆M# < 0.5 % Similar amount of moisture present at defined %RH 
∆M# reduced more than 
 -0.5 % 
Moisture sorption decreased at defined %RH 
∆M# > 0.5 % Moisture sorption increased at defined %RH 
Difference in % mass 
change over run, MEND 
 -0.5 % < MEND < 0.5 % 
for sample 
No irreversible moisture sorption observed during the 
analysis  
MEND > 0.5 % for sample May indicate that moisture has been retained or 
absorbed  (irreversible process) and that the solid state 
form of the material being analysed may have changed 
MEND reduced more than 
 -0.5 % for sample 
May indicate that any initial moisture or electrostatic 
charge has been removed  
Maximum % change in 
mass during adsorption 
cycles, MMAX1 or MMAX2 
-0.5 % < ∆MMAX#  < 0.5 % Similar amount of moisture uptake observed during 
adsorption cycle 
 MMAX# > 0.5 %  Amount of moisture uptake observed during adsorption 
cycle has increased suggesting increased surface area 
or disorder 
 MMAX# reduced more 
than -0.5 % 
Amount of moisture uptake observed during adsorption 
cycle has decreased suggesting material may have a 
smaller surface area 
Difference in % change in 
mass during adsorption 
cycles1 and 2,  ADS 
-0.5 % < ADS < 0.5 % for 
sample 
No difference in moisture uptake between the 
adsorption cycles for a given sample (equation [3-7]) 
ADS reduced more than  
-0.5 % for sample 
Uptake of moisture during adsorption cycle 1 (ADS1) 
is less than that during the second adsorption cycle  
(ADS2) (equation [3-7]) 
ADS > 0.5 % for sample Uptake of moisture during adsorption cycle 1 (ADS1) 
is greater than that during the second adsorption cycle 
(ADS2) suggesting recrystallisation or the irreversible 
formation of a hydrate (equation [3-7]) 
%RH and % mass loss for 
recrystallisation event, 
%RHxtal (%RH) and Mxtal, 
(%) 
 
Recrystallisation observed The observation of a mass loss as %RH is increased or 
maintained at an elevated value (%RHxtal) is indicative 
of recrystallisation and infers that disorder was initially 
present. The size of the mass change (Mxtal) may also 
reflect the degree of disorder present  
∆MA:    h  g     m    (  y)            30   . ∆ #: % change in mass (dry) at different %RH values # = B (90%), 




Comparative difference in % change in mass at a defined %RH value ( M#) is given by; 
∆M# (%)     Sample M#  – Reference M# [6-13] 
where M# is the equilibrium % change in mass (dry) at different %RH values # = A 
(30%), B (90%), C (0%), D (90%), E (0%) and F (30%)  (See Figure 3-11). 
Comparative difference in maximum equilibrium % change in mass (dry) during 
adsorption cycles (∆ MAX#) between the sample and reference is given by; 
 MMAX# (%)     Sample MMAX#  – Reference MMAX# [6-14] 
where # = 1 or 2, i.e. adsorption cycle 1 or 2 respectively 
 
 Qualitative classification of solid state phase based on changes in 6.3.6.3
GVS responses   
Using the observed changes in the GVS responses and the relative threshold limits 
defined in Table 6-10 the comminuted materials could be qualitatively classified as 
being crystalline or disordered using a novel decision tree and definitions (Table 6-11 
and Figure 6-4).  
Table 6-11  Qualitative classification of solid state phase present based on changes in GVS responses   
Initial solid-state phase GVS characteristics of comminuted material 
Crystalline 
(reversible moisture adsorption) 
GVS moisture sorption profile similar to that of the reference, exhibiting reversible 
moisture adsorption/desorption cycles. No effective difference in %mass at end of 
the run compared to the start (-0.5% < MEND < 0.5%) and little difference in the 
adsorption profile.  
Crystalline 
(loss of initial moisture or 
electrostatic charge) 
Small (ΔMMAX1 < 0.5%) irreversible moisture sorption/desorption observed 
(MEND < -0.5%). Infers Loss of initial moisture or electrostatic charge 
Crystalline 
(irreversible moisture adsorption) 
Small (ΔMMAX1 < 0.5%) irreversible moisture sorption/desorption observed  
(MEND > 0.5%). 
Disordered Recrystallisation observed as an expulsion of water from the solid at elevated 
%RH. 
Note that recrystallisation by moisture sorption may not occur for all disordered 
materials. For some materials heat maybe also required or a different solvent.  
Disordered 
(or increased surface area) 
An increase (ΔMMAX1 > 0.5%) in the amount of moisture adsorbed during the first 
adsorption cycle can infer the presence of disorder or it could be as a result of 




Figure 6-4  Decision tree for the qualitative classification of solid-state phase by GVS using CRA values 
 Fourier transform infra-red spectroscopy (FTIR) 6.3.7
 FTIR acquisition and response analysis 6.3.7.1
FTIR spectra for the mechanically comminuted materials were obtained and analysed 
using the methods described in Sections 3.9.1 and 3.9.2 respectively. Each study 
material was prepared and analysed in triplicate and the spectra averaged and 
normalised. 
 Comparative response analysis of FTIR spectra 6.3.7.2
The average normalised FTIR spectra for the comminuted materials were qualitatively 
compared to the spectra of the relevant input material acquired using the same 
conditions (Sections 3.9.1 and 3.9.2). The presence of new peaks and/or missing peaks 
were noted and the vibrational frequencies assigned appropriately using correlation 
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 High pressure liquid chromatography (HPLC) 6.3.8
 HPLC acquisition and response analysis 6.3.8.1
The λmax for each study material (Table 6-12) was used to obtain the HPLC 
chromatograms for the mechanically comminuted materials using the method described 
in Section 3.8.2. 
Table 6-12 λmax values for the study materials 
Material 
Max absorbance 
wavelength  λmax (nm) 
 Material 
Max absorbance 
wavelength  λmax (nm) 
Acetaminophen 240  Sulfamerazine 240 
γ-Indomethacin 240  Phenacetin 245 
Loperamide HCl 220  Sulfadiazine 265 
Salbutamol sulphate 225  Caffeine 265 
Acetylsalicylic acid 235  Methyl paraben 260 
λm x      m                4. .8 
 Comparative response analysis of HPLC chromatograms 6.3.8.2
Comparative response analysis for the HPLC responses of the comminuted material was 
performed by comparing the HPLC responses for the sample material against those of 
the input/reference material obtained under the same acquisition conditions (Section 
3.8.2). The amount of change in the HPLC responses was determined using the 
equations defined below and the qualitative relevance of these changes defined (Table 
6-13). 
Table 6-13 Qualitative relevance CRA values for the HPLC responses  
HPLC response Amount of change   
Qualitative relevance of the amount of change in GVS 
responses and observations after comminution 
Peaks, #peaks   Δ#peaks  > 1 Presence of new peaks infers an increase in impurities or 
degradants as a result of comminution 
Δ#peaks  > -1 Decrease in number of observed peaks may suggest improved 
purity 
Primary peak 
retention time, RT 
∆RT~ 0 % Same primary peak observed  
∆RT > ± 0.2 New primary peak observed which infers new chemical 
identity present 
Primary peak % area  %area  - negative value Suggests chemical purity is reduced  
 %area  - positive value Suggests chemical purity is improved 
Change in retention time,  RT (min) for primary peak is given by: 
ΔRT (min)   Sample RT
 
– Reference RT [6-15] 
Change in percentage area for HPLC peaks,  %area (%) is given by: 
Δ%area (%)   Sample %area
 
– Reference %area [6-16] 
Change in number of peaks (Δ#peaks) is given by: 
Δ#peaks    Total # peaks in sample 
 
– Total # peaks in reference  [6-17] 
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 Results & discussion 6.4
 X-ray powder diffraction (XRPD) 6.4.1
For each comminuted material a single representative XRPD pattern was obtained by 
averaging the acquired XRPD diffractograms from three sample preparations. The 
averaged XRPD patterns were then analysed, and the individual peak responses 
tabulated using five peak descriptors; peak position (PP), peak height or intensity (PH), 
peak width (PW), peak area (PA) and background height (BH). Average differences 
between the individual peak characteristics of the input/reference and comminuted 
material for the most significant peaks over the whole XRPD diffractogram, along with 
any changes to the MIP positions and MIP intensities was assessed using a novel 
comparative response analysis process (Section 6.3.1.2). These values are reported in 
Table 6-14 along with the determined solid-state classification made using the novel 
decision tree (Section 6.3.1.3). 
It can be seen from Table 6-14 that that the XRPD methodology and novel analysis 
processes were able to discern differences between the materials comminuted under the 
same and also under different conditions. Comminution resulted in the generation of 
different solid-state phases. These results confirm that the comminution processes were 
successful in generating materials that encompassed the whole amorphous-crystalline 
continuum. 
Acetaminophen, methyl paraben, caffeine, acetylsalicylic acid, sulfadiazine, and 
phenacetin were all classified as crystalline based on their XRPD responses regardless 
of the type of comminution process employed (Table 6-14). A number of these 
comminuted materials also exhibited preferred orientation effects as illustrated in Figure 
6-5 for micronised phenacetin. A few peaks in the XRPD diffractogram for the input 
material of phenacetin were sharp and of very high intensity, i.e. over 40000 cts, while 
other peaks appear much smaller, suggesting some form of texture or preferred 
orientation exists, i.e. alignment of crystallite particles in the same direction causing 
some peaks to appear much higher in intensity than others).  
Ball-milling indomethacin at low and high frequencies appeared to result in 
microcrystalline and disordered material respectively (Table 6-14). However, 
micronised γ-indomethacin remained crystalline and exhibited preferred orientation, i.e. 
change in MIP and peak intensities. 
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Table 6-14  CRA for XRPD responses of the comminuted materials (comparing responses from averaged XRPD diffractogram to those of the input) 
Material Batch ID 

























Acetaminophen 1-MA1 0.00 59 14 213 40 Yes -8 No No Crystalline – preferred orientation 
1-MA2 -0.01 39 19 195 48 Yes -15 No No Crystalline – preferred orientation 
1-MB1 -0.01 69 27 342 62 Yes 18 No No Crystalline – preferred orientation 
1-MB2 0.00 85 21 395 57 Yes 25 No No Crystalline – preferred orientation 
1-X1 -0.03 -7 -12 9 16 Yes -22 No No Crystalline 
γ-Indomethacin 11-MA1 -0.04 -67 44 -47 68 Yes -79 No Yes Disordered 
11-MA2 -0.03 -57 31 -11 119 Yes -75 No Yes Disordered 
11-MB1 -0.01 -37 27 9 87 Yes -65 No Yes Microcrystalline 
11-MB2 0.01 -49 25 -6 99 Yes -70 No Yes Microcrystalline 
11-X1 -0.01 -36 -27 -31 12 Yes -43 No Yes Crystalline – preferred orientation 
Salbutamol 
sulphate 
24-MA1 NPD NPD NPD NPD NPD NPD NPD NPD NPD X-ray amorphous 
24-MA2 NPD NPD NPD NPD NPD NPD NPD NPD NPD X-ray amorphous 
24-MA3 NPD NPD NPD NPD NPD NPD NPD NPD NPD X-ray amorphous 
24-MB1 0.00 -73 28 -57 73 Yes -96 No Yes Microcrystalline 
24-MB2 0.00 -79 22 -66 76 Yes -97 No Yes Microcrystalline 
24-X1 -0.02 -70 -31 -69 15 Yes -92 No No Crystalline – preferred orientation 
Loperamide 
HCl 
14-MA1 NPD NPD NPD NPD NPD NPD NPD NPD NPD X-ray amorphous 
14-MB1 -0.07 -64 49 44 271 Yes -90 No Yes Disordered 
14-X1 -0.03 -66 1 4 148 No -88 No Yes Crystalline 
Acetylsalicylic 
acid 
33-MA1 -0.09 -63 -26 -59 93 No -96 No No Crystalline 
33-MB1 -0.05 -55 -16 -23 67 No -94 No No Crystalline 
33-X1 -0.07 -62 -43 -54 36 No -95 No No Crystalline 
Sulfamerazine 54-MA1 -0.06 31 21 115 67 Yes -69 Some Yes Crystalline mixture of forms 
54-MB1 0.02 -48 51 -1 124 Yes -74 No Yes Microcrystalline 
54-X1 -0.01 -51 -6 8 147 Yes -77 No Yes Crystalline – preferred orientation 
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Material Batch ID 

























Phenacetin 69-MA1 0.03 60 28 191 48 Yes -81 No No Crystalline – preferred orientation 
69-MB1 0.00 52 13 137 30 No -80 No No Crystalline – concordant with reference 
69-X1 0.01 35 -14 118 59 Yes -89 No No Crystalline – preferred orientation 
Sulfadiazine 87-MA1 0.01 -3 -1 129 109 Yes -88 No Yes Crystalline 
87-MB1 0.01 -4 21 118 88 Yes -87 No Yes Crystalline 
87-X1 -0.03 31 -7 67 -8 Yes -77 No Yes Crystalline – preferred orientation 
Caffeine 88-MA1 0.03 -53 7 4 90 Yes -67 No Yes Crystalline – preferred orientation 
88-MB1 0.03 -48 11 -18 41 No -65 No Yes Crystalline 
88-X1 -0.02 -58 -30 -47 20 No -63 No Yes Crystalline – concordant with reference 
Methyl paraben 140-MA1 0.02 -3 -6 -3 2 No -37 No No Crystalline – concordant with reference 
140-MB1 0.02 -28 -18 -21 17 No -53 No No Crystalline – concordant with reference 
140-X1 -0.01 -53 -31 -50 9 No -60 No No Crystalline – concordant with reference 
NPD: no peaks detected, AvΔPP: amount of average peak shifting. AvΔPH: % change in average peak height. AvΔPW: % change in average peak width (FWHM). AvΔPA: % change in 
average peak area.AvΔBH: % change in average background height. MIP: most intense peak, % MIPH: % change in MIP height. #-MA#: high frequency ball-mill method A, #-MB#: 
low frequency ball-mill method B. #-X#: jet micronisation method A. 
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Figure 6-5 XRPD diffractograms for the input/reference (red) and micronised (JM-A) (black) 
phenacetin illustrating preferred orientation effects 
High frequency ball-milling, of salbutamol sulphate and loperamide HCl resulted in X-
ray amorphous material (Figure 6-6 and Figure 6-7), while low frequency ball-milling 
resulted in microcrystalline material for salbutamol sulphate in accordance with the 
XRPD solid-state phase classification decision tree (Section 6.3.1.3), i.e. no peak 
shifting was observed, however, the MIP was different and overall the peaks were 
broader and reduced in height, whilst the background heights were elevated (Table 6-14 
and Figure 6-7). Low frequency ball-milling of loperamide on the other hand generated 
disordered material, as there was significant peak shifting, a different MIP, broader and 
smaller peaks and an overall increase in the background profile (Table 6-14 and Figure 
6-6). 
Micronisation of either salbutamol sulphate or loperamide HCl did not generate any 
evidence of PID by XRPD, though peak heights were markedly reduced, and the 
background height profiles for both materials appeared to be similar or reduced in 
height with respect to the back ground heights of their input materials as illustrated by 
the black lines in the inserts for Figure 6-6 and Figure 6-7. Based on the XRPD 
responses, both of these comminuted materials were classified as being crystalline using 
the novel XRPD solid-state phase decision tree (Section 6.3.1.3). 
The observed solid-state phases for both salbutamol sulphate and loperamide HCl 
illustrate that both of these materials appear to be susceptible to PID by mechanical 
comminution and that high frequency ball-milling is more likely to generate PID than 
micronisation. This is in agreement with literature observations
2
.  
























Figure 6-6 XRPD diffractograms for the comminuted materials of loperamide HCl by high 
frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(black) compared to the input material (red).  
The insert illustrates the increased background heights of the ball-milled materials relative to the 
input and micronised materials. 
 
Figure 6-7 XRPD diffractograms for the comminuted materials of salbutamol sulphate by high 
frequency ball-milling with liquid nitrogen (blue) at room temperature (purple), low 
frequency ball-milling Mill-B (green) and micronisation (black) compared to the input 
material (red).  
The insert illustrates the increased background heights of the ball-milled materials relative to the 
input and micronised materials 
 
Reproducibility of the ball-milling processes for acetaminophen, indomethacin and 
salbutamol sulphate was demonstrated by the identical XRPD responses for Mill-A1/2 
and Mill-B1/2 samples. High frequency ball-milling with and without liquid nitrogen 
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for salbutamol sulphate illustrated that milling temperature did not have an effect on the 
resulting sold-state form or phase as in both cases an X-ray amorphous material was 
generated (Figure 6-7 blue with liquid nitrogen and purple without liquid nitrogen). 
High frequency ball-milling of sulfamerazine resulted in material containing extra 
XRPD peaks. These extra peaks were consistent with those of sulfamerazine Form 
II
117,348,349
 determined using the simulated XRPD pattern for Form II (CSD reference 
SLFNMA01
348
 ) and the process described in 4.2.4.2 (Figure 6-8).   
The presence of a mixture of two solid-state forms, Form I and Form II  for ball-milled 
sulfamerazine was concordant with earlier studies that demonstrated ball-milling 
sulfamerazine can result in several form solid-state transformations, i.e. transformations 




Figure 6-8 XRPD diffractograms for sulfamerazine. Ball-milled (Mill-A, blue) appears to be a 
mixture of the Form 1 reference (red) and the simulated XRPD pattern for Form II, 
SLFNMA01
348
  (green)  
 Thermogravimetric analysis (TGA) 6.4.2
TGA thermograms for the mechanically comminuted materials were obtained and the 
responses compared to those of the input materials (Figure 6-9 and Table 6-15). 
The majority of the materials remained anhydrous with no apparent change in the TGA 
responses regardless of the type of comminution method employed. However, increased 
weight loss events below 50 °C were observed for ball-milled loperamide HCl and 
salbutamol sulphate suggesting the presence of absorbed moisture and potentially 























increased disorder. It can be suggested that a reduction in particle size or the presence of 
degradants could also account for these observations, as it has been noted that by 
decreasing the particle size, surface areas can increase, thereby increasing the potential 
for greater moisture adsorption at crystal surfaces
290,309,310
. However, of the three 
comminution processes, micronisation would most likely result in smaller particle sizes 
and as there is very little adsorption observed for both micronised loperamide HCl and 
salbutamol sulphate it more likely that the observed weight losses are due to the 
presence of disorder or degradants, rather than as a consequence in particle size 
reduction. The observed weight loss events were more pronounced for the high 
frequency ball-milled materials of loperamide HCl and salbutamol sulphate, which may 
suggest the presence of more disorder present or the presence of degradants ((Figure 6-9 
and Table 6-15). Furthermore, the thermal degradation temperatures (Td) for ball-milled 
salbutamol sulphate were markedly reduced, which also suggests the presence of 
disorder or degradants (Figure 6-9 and Table 6-15), as the greater the degree of disorder 
present, the greater the molecular mobility and therefore the lower the activation energy 
for degradation. Conversely, for acetaminophen the degradation temperature actually 
increased which may suggest a potential improvement in thermal stability and an 
improvement in crystal ordering ((Figure 6-9 and Table 6-15). 
 
Figure 6-9 TGA thermograms for the comminuted materials of salbutamol sulphate by high 
frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(Black) compared to the input material (red).  
Weight loss below 50 °C is increased for the ball-milled samples
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Table 6-15  Average TGA responses and CRA of the comminuted materials  
  Average TGA responses TGA CRA 







Other WL events 








Acetaminophen Input 0 <0.5 <0.5 235 -- -- -- -- -- 
1-MA1 0 <0.5 <0.5 246 -- 0 0 0 11 
1-MA2 0 <0.5 <0.5 247 -- 0 0 0 12 
1-MB1 0 <0.5 <0.5 246 -- 0 0 0 11 
1-MB2 0 <0.5 <0.5 246 -- 0 0 0 11 
1-X1 0 <0.5 <0.5 240 -- 0 0 0 5 
γ-Indomethacin Input 0 <0.5 <0.5 266 -- -- -- -- -- 
11-MA1 0 <0.5 0.52 264 -- 0 0 0 -2 
11-MA2 0 <0.5 0.50 264 -- 0 0 0 -2 
11-MB1 0 <0.5 <0.5 264 -- 0 0 0 -2 
11-MB2 0 <0.5 <0.5 265 -- 0 0 0 -1 
11-X1 0 <0.5 <0.5 265 -- 0 0 0 -1 
Salbutamol 
sulphate 
Input 0 <0.5 <0.5 197 LoD -- -- -- -- 
24-MA1 1 1.79 D 161 3.93 (23-100), LoD 1 1.29 D -36 
24-MA2 1 1.90 D 163 3.93 (23-100), LoD 1 1.40 D -34 
24-MA3 1 1.13 D 163 2.72 (23-100), LoD 1 0.63 D -34 
24-MB1 1 0.69 D 182 0.95 (21-100), LoD 1 0.19 D -15 
24-MB2 1 0.74 D 181 1.15 (24-100), LoD 1 0.24 D -16 
24-X1 1 <0.5 <0.5 191 <0.5 (23-100), LoD 0 0 0 -6 
Loperamide 
HCl 
Input 0 <0.5 <0.5 262 -- -- -- -- -- 
14-MA1 1 1.37 2.39 258 2.22 (27-100) 1 0.87 1.89 -4 
14-MB1 1 0.74 1.21 258 1.14 (27-100) 1 0.24 0.71 -4 
14-X1 0 <0.5 <0.5 258 -- 0 0 0 -4 
Acetylsalicylic 
acid 
Input 0 <0.5 D 126 LoD -- -- -- -- 
33-MA1 0 <0.5 D 125 D 0 0 D -1 
33-MB1 0 <0.5 D 125 D 0 0 D -1 
33-X1 0 <0.5 D 126 D 0 0 D 0 
Sulfamerazine Input 0 <0.5 <0.5 255 -- -- -- -- -- 
54-MA1 0 <0.5 <0.5 256 -- 0 0 0 1 
54-MB1 0 <0.5 <0.5 257 -- 0 0 0 2 
54-X1 0 <0.5 <0.5 255 -- 0 0 0 0 
Phenacetin Input 0 <0.5 D 198 D -- -- -- -- 
69-MA1 0 <0.5 D 198 D 0 0 D 0 
69-MB1 0 <0.5 D 199 D 0 0 D 1 
69-X1 0 <0.5 D 197 D 0 0 D -1 
Sulfadiazine Input 0 <0.5 <0.5 263 LoD -- -- -- -- 
87-MA1 0 <0.5 <0.5 256 LoD 0 0 0 -7 
87-MB1 0 <0.5 <0.5 257 LoD 0 0 0 -6 
87-X1 0 <0.5 <0.5 257 LoD 0 0 0 -6 
Caffeine Input 0 <0.5 D 201 D -- -- -- -- 
88-MA1 1 1.09 D 203 1.28 (27-100), D 1 0.59 0 2 
88-MB1 0 <0.5 D 203 D 0 0 0 2 
88-X1 0 <0.5 D 203 D 0 0 0 2 
Methyl paraben Input 0 <0.5 D 115 LoD -- -- -- -- 
140-MA1 0 <0.5 D 110 D 0 0 0 -5 
140-MB1 0 <0.5 D 111 D 0 0 0 -4 
140-X1 0 <0.5 D 112 D 0 0 0 -3 
Each material analysed in duplicate, #WE: Number of weight loss events observed before degradation, WL50: % Weight loss 
(w/w) below 50° C. WL150: % Weight (w/w) loss below 150 °C. D: Degrades below 150 °C, Td: Degradation temperature (°C). 
WL events: Defined weight loss over a given temperature range i.e. %WL (T range). LoD: unresolved or weight loss observed at 
degradation. #-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation 
method A.  Please refer to Table 3-4 for further descriptions of the term. 
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 Differential scanning calorimetry (DSC) 6.4.3
DSC thermograms for the mechanically comminuted materials were obtained and the 
responses (Table 6-16) compared to those of the input materials (Table 6-17). The 
amount of change in the DSC responses were assessed and used to define the solid-state 
phase present using the novel process outlined in Section 6.3.3.3. 
For a number of materials; acetaminophen, acetylsalicylic acid, phenacetin and methyl 
paraben, applying different comminution processes had little effect on the observed 
DSC thermograms and responses. An example of this can be seen in Figure 6-10 of the 
DSC thermograms for the comminuted materials of acetaminophen, which appeared to 
be similar to that of the input material. 
 
Figure 6-10 DSC thermograms for the comminuted materials of acetaminophen ball-milled at high 
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Table 6-16  Average DSC responses for  the comminuted materials  













































Acetaminophen Input M -- -- -- -- -- -- -- -- 169.0 185 0.90 0.6 169.7 --  
1-MA1 M -- -- -- -- -- -- -- -- 168.7 175 1.34 1.2 169.9 --  
1-MA2 M -- -- -- -- -- -- -- -- 168.6 179 1.27 1.1 169.7 --  
1-MB1 M -- -- -- -- -- -- -- -- 168.4 187 1.10 1.0 169.4 --  
1-MB2 M -- -- -- -- -- -- -- -- 168.4 187 0.90 1.0 169.4 --  
1-X1 M -- -- -- -- -- -- -- -- 168.7 179 1.16 0.9 169.6 --  
γ-Indomethacin Input M -- -- -- -- -- -- -- -- 159.5 107 1.30 1.0 160.5 --  
11-MA1 GCM 45.3 0.345 -- -- 70.3 22.3 -- -- 157.5 106 1.35 1.7 159.2 -- Glass transition & crystallisation 
observed 
11-MA2 GCM 42.9 0.285 -- -- 66.1 18.2 -- -- 156.9 101 1.82 1.9 158.8 -- Glass transition & crystallisation 
observed 
11-MB1 CM -- -- -- -- 53.4 5.4 -- -- 156.6 104 2.17 2.7 159.2 -- crystallisation observed 
11-MB2 CM -- -- -- -- 57.9 1.6 -- -- 156.9 103 2.17 2.5 159.4 -- crystallisation observed 
11-X1 M -- -- -- -- -- -- -- -- 158.8 103 1.13 1.2 159.9 --  
Salbutamol 
sulphate 




-- 30.2 -- 
114.4, 
135.9** 
-- -- -- 151.5 NC NC 26.9 178.4 178.4* 
Volatile loss and two crystallisation 




-- 41.7 -- 
118.1, 
148.6** 
-- -- -- 151.3 NC NC 26.8 178.1 178.1* 
Volatile loss and two crystallisation 




-- 58.5 -- 
116.6, 
149.0** 
-- -- -- 149.0 NC NC 29.3 178.2 178.2* 
Volatile loss and two crystallisation 
events observed, melt-degradation 
24-MB1 VC2MD -- -- 4.9 -- 
116.3, 
138.8** 
-- -- -- 166.7 NC NC 29.9 196.5 196.5* 
Volatile loss and two crystallisation 
events observed, melt-degradation 
24-MB2 VC2MD -- -- 13.6 -- 
115.8, 
138.2** 
-- -- -- 166.8 NC NC 30.5 197.3 197.3* 
Volatile loss and two crystallisation 
events observed, melt-degradation 
24-X1 VCMD -- -- 3.4 -- 98.9** -- -- -- 187.3 NC NC 14.4 201.7 201.7* 
Volatile loss and  crystallisation 
events observed, melt-degradation 
Loperamide HCl Input MD -- -- -- -- -- -- -- -- 227.2 90 2.30 2.2 229.3 235.5 Degradation soon after melt 
14-MA1 GVCMD 120.8 0.265 21.2 71 166.7 68.7 -- -- 223.7 82 2.55 3.3 227.9 235.5 Degradation soon after melt 
14-MB1 VMCD -- -- 11.5 40.9 132.4 11.1 -- -- 221.4 75 3.73 4.4 225.9 235.7 Degradation soon after melt 
14-X1 VMCD -- -- 4.3 14.3 114.9 8 -- -- 224.3 80 2.76 3.4 227.5 235.6 Degradation soon after melt 
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Input MD -- -- -- -- -- -- -- -- 139.3 169 2.60 1.9 141.2 146.4 Degradation soon after melt 
33-MA1 MD -- -- -- -- -- -- -- -- 138.4 173 1.99 2.4 140.8 147.2 Degradation soon after melt 
33-MB1 MD -- -- -- -- -- -- -- -- 139.0 173 1.83 2.2 141.2 149.0 Degradation soon after melt 
33-X1 MD -- -- -- -- -- -- -- -- 138.7 171 1.84 1.9 140.6 146.4 Degradation soon after melt 
Sulfamerazine Input M -- -- -- -- -- -- -- -- 235.9 141 1.30 1.0 236.9 --  
54-MA1 TM -- -- -- -- -- -- 142.3 9.6 234.7 196 1.48 1.9 236.6 -- Form II to Form I transition 
54-MB1 M -- -- -- -- -- -- -- -- 234.4 144 1.58 1.9 236.3 --  
54-X1 M -- -- -- -- -- -- -- -- 234.4 142 1.48 1.9 236.3 --  
Phenacetin Input M -- -- -- -- -- -- -- -- 134.4 170 1.20 1.1 135.5 --  
69-MA1 M -- -- -- -- -- -- -- -- 133.8 174 1.08 1.2 135.0 --  
69-MB1 M -- -- -- -- -- -- -- -- 134.2 180 1.02 0.8 135.1 --  
69-X1 M -- -- -- -- -- -- -- -- 134.2 173 1.19 1.0 135.1 --  
Sulfadiazine Input MD -- -- -- -- -- -- -- -- 261.3 169 0.8 0.2 261.5 266.8 Degradation soon after melt 
87-MA1 MD -- -- -- -- -- -- -- -- 256.9 233 1.51 1.8 258.7 262.0 Degradation soon after melt 
87-MB1 MD -- -- -- -- -- -- -- -- 255.7 240 1.99 2.3 258.0 261.4 Degradation soon after melt 
87-X1 MD -- -- -- -- -- -- -- -- 258.7 176 1.04 1.0 259.7 261.2 Degradation soon after melt 
Caffeine 
Input TMD -- -- -- -- -- -- 146 19.6 236.0 NC NC 0.5 236.4 236.4* 
Form II to Form I transition observed, 
melt-sublimation 
88-MA1 VTMD -- -- 8.2 NC -- -- 116.1 4.1 236.0 NC NC 0.4 236.4 236.4* 
volatile loss first, Form II to Form I 
transition then melt/sublimation 
88-MB1 TMD -- -- -- -- -- -- 120.9 12.6 236.0 NC NC 0.5 236.5 236.5* 
Form II to Form I transition observed, 
melt-sublimation 
88-X1 TMD -- -- -- -- -- -- 137.8 18.8 235.9 NC NC 0.6 236.5 236.5* 
Form II to Form I transition observed, 
melt-sublimation 
Methyl paraben Input M -- -- -- -- -- -- -- -- 125.8 165 1.20 1.2 127 .0 --  
140-MA1 M -- -- -- -- -- -- -- -- 125.2 177 0.82 0.7 125.9 --  
140-MB1 M -- -- -- -- -- -- -- -- 125.5 176 0.84 0.7 126.2 --  
140-X1 M -- -- -- -- -- -- -- -- 125.5 170 0.83 0.8 126.3 --  
All comminuted material were analysed at least in duplicate. Events: M-melt, D-Degradation, T-transition, V-volatile. ND: Not detected, NC: Not calculated, Td: Degradation temperature (°C), Tm: 
Onset of melting temperature (°C), Tmtrans:       g               g  (° ), Δ f: Heat of fusion (J/g), WHH: width at half peak height (°C), Tm-p: Peak melting temperature (°C). Tg: Glass transition 
temperature, Tc:     y                     m     u  , Δ c: Heat of crystallisation, Tv: O      f      h  m   v         v   , Δ v: Heat of desolvation, ND: Not detected, NC: Not calculated. #-MA#: high 
frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation method A. Please refer to Table 3-4 or further descriptions of the terms 
* Tm-p value used to represent Td as material melts-degrades or melt-sublimes.**Tc-p used instead of Tc due to unresolved thermal events  
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Table 6-17  CRA for DSC responses of the comminuted materials  








Melting events (M) Degradation (D) 

















Acetaminophen 1-MA1 ND -- ND -- -0.3 -5.4 0.6 ND -- Crystalline concordant with reference 
1-MA2 ND -- ND -- -0.4 -3.2 0.5 ND -- Crystalline concordant with reference 
1-MB1 ND -- ND -- -0.6 1.1 0.4 ND -- Crystalline concordant with reference 
1-MB2 ND -- ND -- -0.6 1.1 0.4 ND -- Crystalline concordant with reference 
1-X1 ND -- ND -- -0.3 -3.2 0.3 ND -- Crystalline concordant with reference 
γ-Indomethacin 11-MA1 New New ND -- -2.0 -0.9 0.7 ND ND Disordered 
11-MA2 New New ND  -2.6 -5.6 0.9 ND ND Disordered 
11-MB1 ND New ND  -2.9 -2.8 1.7 ND ND Mixed Phase A – same crystalline form with some disorder 
11-MB2 ND New ND  -2.6 -3.7 1.5 ND ND Mixed Phase A – same crystalline form with some disorder 
























-47.7 NC 21.9 New -26.0 
DSC amorphous 
24-MB1 ND New New Large shift or new -30.0 NC 22.5 -- -7.7 Mixed Phase A – same crystalline form with some disorder* 
24-MB2 ND New New Large shift or new -29.9 NC 23.1 -- -6.9 Mixed Phase A – same crystalline form with some disorder* 
24-X1 ND New New Large shift or new -9.4 NC 7.0 -- -2.5 Mixed Phase A – same crystalline form with some disorder* 
Loperamide HCl 14-MA1 New New New shifted or new -3.5 -8.9 1.1 -- 0.0 Disordered 
14-MB1 ND New New shifted or new -5.8 -16.7 2.2 -- 0.2 Mixed Phase A – same crystalline form with some disorder* 
14-X1 ND New New  -2.9 -11.1 1.2 -- 0.1 Mixed Phase A – same crystalline form with some disorder 
Acetylsalicylic 
acid 
33-MA1 ND ND ND -- -0.9 2.4 0.5 -- 0.8 Crystalline concordant with reference 
33-MB1 ND ND ND -- -0.3 2.4 0.3 -- 2.6 Crystalline concordant with reference 
33-X1 ND ND ND -- -0.6 1.2 0.0 -- 0 Crystalline concordant with reference 
Sulfamerazine 
54-MA1 ND ND ND 
New transition 
event 
-1.2 39.0 0.9 ND ND 
Mixed Phase C – maybe mixture of crystalline forms with 
some disorder* 
54-MB1 ND ND ND -- -1.5 2.1 0.9 ND ND Crystalline concordant with reference 
54-X1 ND ND ND -- -1.5 0.7 0.9 ND ND Crystalline concordant with reference 
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Melting events (M) Degradation (D) 

















Phenacetin 69-MA1 ND ND ND -- -0.6 2.4 0.1 ND ND Crystalline concordant with reference 
69-MB1 ND ND ND -- -0.2 5.9 -0.3 ND ND Crystalline concordant with reference 
69-X1 ND ND ND -- -0.2 1.8 -0.1 ND ND Crystalline concordant with reference 
Sulfadiazine 87-MA1 ND ND ND shifted or new -4.4 37.9 1.6 -- -4.8 Mixed Phase A – same crystalline form with some disorder* 
87-MB1 ND ND ND shifted or new -5.6 42.0 2.1 -- -5.4 Mixed Phase A – same crystalline form with some disorder* 
87-X1 ND ND ND  -2.6 4.1 0.8 -- -5.6 Mixed Phase A – same crystalline form with some disorder* 
Caffeine 88-MA1 ND ND New -- 0.0 NC -0.1 -- 0.0 Mixed Phase A – same crystalline form with some disorder 
88-MB1 ND ND ND -- 0.0 NC 0.0 -- 0.1 Mixed Phase A – same crystalline form with some disorder 
88-X1 ND ND ND -- -0.1 NC 0.1 -- 0.1 Mixed Phase A – same crystalline form with some disorder 
Methyl paraben 140-MA1 ND ND ND -- -0.6 7.3 -0.5 ND ND Crystalline concordant with reference 
140-MB1 ND ND ND -- -0.3 6.7 -0.5 ND ND Crystalline concordant with reference 
140-X1 ND ND ND -- -0.3 3.0 -0.4 ND ND Crystalline concordant with reference 
* confirmed by XRPD, ND: Not detected, NC: Not calculated, ∆ d: shift in degradation   m     u   (° ), ∆ m: shift in onset of melting temperature (°C), Tmtrans: change in melting transition range 
(° ),  Δ f: % change in Heat of fusion (%).#-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation method A. Please refer to Table 3-4 for 




For γ-indomethacin, salbutamol sulphate and loperamide HCl comminuted by different 
processes and conditions, the DSC thermograms and responses suggest that a different 
solid-state phase or form maybe present (Table 6-17). However, the XRPD 
diffractograms for these materials (Section 6.4.1) did not indicate the presence of a new 
solid-state form, therefore it can be inferred that the observed changes in the DSC 
responses are likely as a result of solid-state phase changes and that there is  disorder 
present. 
Comminution of γ-indomethacin by different processes and conditions resulted in the 
generation of materials that encompassed the whole amorphous-crystalline continuum 
(Table 6-17). High frequency ball-milling (Mill-A) generated disordered material as 
indicated by the presence of glass transition and recrystallisation events consistent with 
that cited in the literature
254,352-354
. In comparison, no glass transition event was 
observed for material comminuted by low frequency ball-milling (Mill-B) but some 
degree of disorder could be inferred from the observance of a crystallisation event 
(Figure 6-11). However, γ-indomethacin appeared to remain crystalline when 
micronised (JM-A) with respect to the DSC thermogram and associated responses 
(Figure 6-11). 
 
Figure 6-11 DSC thermograms for the comminuted materials of indomethacin ball-milled at high 
frequency (blue), at low frequency (green) and micronised (Black) compared to the input 
material (red) 
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High frequency ball-milling of loperamide HCl resulted in the generation of disordered 
material as shown by the presence of a high temperature glass transition (121 °C), 
recrystallisation events and an observed volatile (moisture) loss (Figure 6-12). It has 
been suggested that the high temperature of the glass transition is due to the stabilisation 
of the amorphous state by the formation of a salt
355
. This type of elevated Tg has also 
been demonstrated for indomethacin using a sodium salt which increased the Tg from 45 
°C to 121 °C
356,357
. Confirmation of the volatile (moisture) loss is shown by the overlaid 
weight loss event in the TGA thermogram and degradation also appears to occur soon 
after melting (Figure 6-12). Both low frequency ball-milling and micronisation of 
loperamide HCl resulted in recrystallisation and volatile loss events, along with an 
observed shift in the melting onsets of their respective DSC thermograms. These 
observations suggest that some degree of disorder was present but more so for the low 
frequency ball-milled material than micronised (Figure 6-13).  
 
Figure 6-12  Overlaid DSC (blue) and TGA (red) thermograms for high frequency ball-milled 
loperamide HCl 
Overlaid TGA thermogram verifies the events associated with weight losses such as volatile (moisture 




Figure 6-13 DSC thermograms for the comminuted materials of loperamide HCl ball-milled at high 
frequency (blue), at low frequency (green) and micronised (black) compared to the input 
material (red) 
DSC analysis of the high frequency ball-milled material of salbutamol sulphate 
exhibited multiple unresolved events (Table 6-16, Figure 6-14). Overlaying the TGA 
and DSC thermograms assisted in defining these events (Figure 6-14). A weight loss 
event observed below 80 °C in the TGA thermogram coincided with the broad 
endotherm in the DSC between 0 and 100 °C, suggesting the loss of absorbed moisture 
over this range. Potentially the Tg for salbutamol sulphate may fall within this region, as 
it has been noted to occur around 60-65 °C when there is moisture the present
19,247,358
. 
However, amorphous salbutamol sulphate prepared by spray or freeze drying has a Tg 
around 120 °C which likely represents the dry Tg
359
 and this may also be present in the 
acquired DSC thermogram (Figure 6-14). Therefore, following the volatile (moisture) 
loss and “wet Tg” there is a potential restructuring of the molecule given rise to the “dry 
Tg” prior to recrystallisation
19,21
. The material then melt-degrades
1,19,297,358
 at a much 
lower temperature than that of the crystalline input material, with an observed shift of 
45 °C. Based on these observations it can be concluded that high frequency ball-milled 
salbutamol sulphate is predominately disordered and can be classed as “DSC 




Figure 6-14  Overlaid DSC (blue) and TGA (red) thermograms for high frequency ball-milled (Mill-
A1) salbutamol sulphate  
The DSC thermogram exhibits multiple unresolved thermal events while the overlaid TGA 
thermogram verifies the events associated with weight losses such as volatile (moisture loss) and 
degradation. 
 
Lower frequency ball-milling and micronisation of salbutamol sulphate also appears to 
generate some level of disorder, though to a much lower degree than higher frequency 
ball-milling, as shown by their respective DSC thermograms and responses (Figure 6-15 
and Table 6-17). For each of these materials, volatile (moisture) loss and 
recrystallisation events were observed alongside a significant decrease in the melt-
degradation onset temperatures.  
It is postulated that the observed large decrease in Tm for the comminuted materials of 
salbutamol sulphate maybe due to the decrease in particle size, the presence of thermal 
degradants or due to increased levels of lattice disordering.  
Information relating to changes in the solid state form or phase present can be discerned 
by changes in melting responses ΔTm, ΔTmtrans and Δ f. For materials which don’t 
melt-degrade then Tm should stay the same for a crystalline materials with the same 
solid state form. However, if impurities such as thermal degradants are generated as a 
result of mechanical processing then Tm could be reduced. If disorder is introduced as a 
form of a phase impurity, the remaining crystalline material will melt at the same Tm but 
163 
the heat of fusion could be reduced proportionally to the amount of disorder present. 
However, if unresolved crystallisation-melting occurs then the change in  Hf for the 
melting peak may not be as pronounced. 
For materials such as salbutamol sulphate which melt-degrade, then the decrease in Tm 
could be due to the introduction of disorder into the material as a consequence of the 
comminution process. The generated disorder decreases the lattice strength thereby 
lowering the amount of energy (and temperature) required to initiate melting. The 
amount of decrease observed therefore is proportional to both the amount of energy 
applied during the comminution process and the degree of induced disorder. For 
salbutamol sulphate, high frequency ball-milling gave the largest shift in Tm followed by 
lower frequency ball-milling and then micronisation. As discussed in Section 1.4.2 ball-
milling is a high impact and high input energy process, where the material is isolated in 
the same chamber for a prolonged period of time and subjected to prolonged impacts. In 
comparison, micronisation exposes the material to only limited high impact processes 
until the particle is reduced in size so that it can be collected. Therefore, it is more likely 
that more disorder will be generated by ball-milling than by micronisation and this can 
be observed by the decrease in Tm as shown by the comminuted materials of salbutamol 
sulphate
2
 (Table 6-17). These observed shifts are more pronounced in materials which 
melt-degrade
360
.   
The fact that micronisation, which in general results in smaller particle sizes had the 
lowest decrease in Tm also supports the suggestion that disorder is responsible for the 
decrease Tm and also suggests that the decrease in particle size is not the cause for this 
observed shift in Tm.   
As the level of disorder increases for a given melt-degradation material, the amount of 
thermal degradants may also increase which can influence the degree of observed Tm 
shifting. When ball-milling at room temperature there is no effective temperature 
control, therefore the likelihood of generating thermal degradants is higher than ball-
milling using liquid nitrogen. For salbutamol sulphate ball-milled at high frequency 
with (Mill-A1/2) and without (Mill-A3) liquid nitrogen there were no significant 
differences in the DSC responses and in both cases “DSC amorphous” material was 
generated (Figure 6-15 and Table 6-17). This implies that the observed decrease in Tm is 
most likely due to the level of disorder generated as a consequence of the comminution 
process rather than due to the presence of thermal degradants, as cryogenic ball-milling 
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should have been sufficient to control the temperature at such a level so as to limit any 
localised melt-degradation and thereby, prevent the generation of thermal degradants. 
 
 
Figure 6-15 DSC thermograms for the comminuted materials of salbutamol sulphate by high 
frequency ball-milling with liquid nitrogen (blue) at room temperature (purple), low 
frequency ball-milling (green) and micronisation (Black) compared to the input material 
(red).  
 
A small degree of disorder was induced in comminuted sulfadiazine, as inferred from 
the observed small shift in Tm, the broadening of the melting event and the decrease in 
degradation temperature (Table 6-17). It should be noted that  Hf values actually 
increase, which may suggest that particle size is influencing the observations. However, 
the DSC responses for the micronised material are less affected than the ball-milled 
materials, so it less likely that particle size is influencing these observations and hence 




Figure 6-16 DSC thermograms for the comminuted materials of sulfadiazine by high frequency ball-
milling (blue), low frequency ball-milling (green) and micronisation (black) compared to 
the input material (red).  
 
The high frequency ball-milling of sulfamerazine resulted in an observed solid-state 
transition at 142 °C from Form II to Form I, consistent with the author’s previous 
observations
350,351
 and those from the literature
336,361,362 
(Figure 6-17). This polymorph 
transition is thought to arise as a consequence of ball-milling, whereby the material is 
transformed through a series of transitions from Form I to amorphous to Form II and 
then back to Form I
349-351
. The solid-state phase present will depend on both the type of 
comminution process and the length of the comminution process employed. In this case 
high frequency ball-milling imparted sufficient energy and was of sufficient duration to 
convert some of the material from Form I to amorphous and then to Form II at the 
completion of the process. When analysed by DSC, disorder is only inferred to have 
occurred in the sulfamerazine subjected to high frequency comminution due to the 
presence of Form II, as there are no other indications of its presence (Figure 6-17). 
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Figure 6-17 DSC thermograms for the comminuted materials of sulfamerazine by high frequency 
ball-milling (blue), low frequency ball-milling (green) and micronisation (black) 
compared to the input material (red). 
 
DSC analysis of the comminuted materials of caffeine show that all the processed 
materials exhibit similar DSC thermograms to that of the input material, i.e. a Form II to 
Form I solid-state transition
216,342,343
 and a melt-sublimation event (Table 6-16). 
However, for the high frequency ball-milled material an endothermic loss of moisture 
also occurs (as verified by the TGA thermogram, Figure 6-18) followed by a shift in the 
solid-state transition temperature (Table 6-16).. These findings suggest that a small 
degree of disorder may have been generated. In fact, all the comminution processes for 
caffeine appear to have caused a shift in the solid-state transition temperature. The more 
aggressive the process, the greater the shift, but in all cases the melt-sublimation 
temperature remained the same (Figure 6-19 and Table 6-16).  
167 
 
Figure 6-18 Overlaid DSC (blue) and TGA (red) thermograms for high frequency ball-milled caffeine 
 
Figure 6-19 DSC thermograms for the comminuted materials of caffeine by high frequency ball-
milling (blue), low frequency ball-milling (green) and micronisation (black) compared to 
the input material (red). 
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 Laser particle size analysis (PSA)  6.4.4
The particle size distributions (PSDs) and responses for the mechanically comminuted 
materials were compared to those of the input materials (Table 6-18). 
During comminution, particle size is generally reduced, which can increase the surface 
area of the material and therefore result in greater moisture adsorption. This sorption of 
water can occur along disordered surfaces forming inter-particle bridges or cause fusion 
of particles resulting in an increase in particle size due to agglomeration or 
recrystallisation19,20,288,290. Agglomeration can also result as a consequence of electrostatic 
charging induced by the milling/micronisation process
363
.  
In general ball-milling produced only moderate effects in reducing the particle size of 
the comminuted materials and often resulted in a broadening of the PSDs (Table 6-18). 
Micronisation on the other hand was effective in reducing the particle size for all the 
materials, and generated the same PSD regardless of the type of material comminuted.  
High frequency ball-milling of acetaminophen did not reduce the particle size of the 
material, but instead resulted in larger or agglomerated particles as illustrated in Figure 
6-20 and Table 6-18. Low frequency milling was more successful in reducing the 
particle size but the PSD was broad and larger particles still remain (Figure 6-20 and 
Table 6-18). When micronised, the particle size of acetaminophen was significantly 
reduced (D90 < 5 µm) giving rise to a narrower (Fspan >1) mono-modal PSD (Figure 
6-20 and Table 6-18). 
 
Figure 6-20 Average particle size distributions for the comminuted materials of acetaminophen by 
high frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(black) compared to the input material (red). 
Note: below 2µm, particle size distribution shape differs between comminuted materials due to the 
size of lens used. 
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Table 6-18  Average particle size responses and CRA of the comminuted materials 
  PSA responses PSA CRA 















 D10  D50  D90 Δmodes Fspan FVMD FSm 
Acetaminophen Input 6 3.58 23.5 132 5.5 47.5 5854 3 -- -- -- -- -- -- -- 
1-MA1 6 2.87 32.5 132 4.0 51.4 7300 3 -0.71 8.94 -0.64 0 1.38 0.92 0.80 
1-MA2 6 2.82 33.8 130 3.8 50.5 7382 3 -0.76 10.2 -2.17 0 1.45 0.94 0.79 
1-MB1 6 1.24 11.0 102 9.1 32.2 15426 4 -2.34 -12.5 -30.9 1 0.60 1.47 0.38 
1-MB2 6 1.22 9.98 102 10.1 31.8 15703 4 -2.36 -13.6 -30.1 1 0.54 1.50 0.37 
1-X1 6 0.79 2.05 5.53 2.3 2.76 37980 1 -2.80 -21.5 -127 -2 2.37 17.2 0.15 
γ-Indomethacin Input 6 4.87 24.4 94.7 3.7 38.8 5690 2 -- -- -- -- -- -- -- 
11-MA1 6 2.19 18.3 115 6.2 39.4 9557 3 -2.68 -6.13 20.6 1 0.60 0.99 0.60 
11-MA2 6 1.90 14.8 76.7 5.1 27.7 11388 4 -2.97 -9.63 -18.0 2 0.73 1.40 0.50 
11-MB1 6 1.51 14.9 115 7.6 41.0 12436 4 -3.36 -9.53 20.3 2 0.48 0.95 0.46 
11-MB2 6 1.40 13.4 97.3 7.2 32.6 13951 4 -3.47 -11.0 2.54 2 0.51 1.19 0.41 
11-X1 6 0.60 1.74 3.77 1.8 2.02 47978 2 -4.27 -22.7 -91.0 0 2.02 19.2 0.12 
Loperamide HCl Input 6 1.71 17.15 139 8.0 43.3 11021 3 -- -- -- -- -- -- -- 
14-MA1 6 1.22 7.06 86.6 12.1 25.8 16649 4 -0.50 -10.1 -52.7 1 0.66 1.68 0.66 
14-MB1 6 1.29 9.34 89.0 9.4 28.1 15233 4 -0.42 -7.81 -50.3 1 0.85 1.54 0.72 
14-X1 6 0.52 1.40 3.19 1.9 1.67 56618 2 -1.20 -15.7 -136 -1 4.20 26.0 0.19 
Salbutamol sulphate Input 6 47.5 144 267 1.5 152.7 1194 1 -- -- -- -- -- -- -- 
24-MA1 6 1.45 11.8 103 8.6 32.6 13424 4 -46.1 -133 -164 3 0.18 4.68 0.09 
24-MA2 6 1.35 10.4 98.4 9.4 30.8 14506 4 -46.2 -134 -169 3 0.16 4.95 0.08 
24-MA3 6 1.24 9.06 94.0 10.2 25.4 16152 4 -46.3 -135 -173 3 0.15 6.01 0.07 
24-MB1 6 1.12 6.97 87.3 12.4 26.4 17780 4 -46.4 -137 -180 3 0.12 5.78 0.07 
24-MB2 6 0.93 6.58 87.0 13.1 20.7 21721 4 -46.6 -138 -180 3 0.12 7.37 0.05 
24-X1 6 0.60 1.58 3.78 2.0 1.96 49925 2 -46.9 -143 -263 1 0.75 78.0 0.02 
Acetylsalicylic acid Input 6 115 203 346 1.1 217 495 2 -- -- -- -- -- -- -- 
33-MA1 6 1.52 13.5 102 7.5 33.8 12624 4 -113 -190 -244 2 0.15 6.41 0.04 
33-MB1 6 1.03 5.96 93.4 15.5 27.8 19518 4 -114 -197 -252 2 0.07 7.80 0.03 
33-X1 6 0.75 1.55 2.92 1.4 1.73 45563 1 -114 -202 -343 -1 0.81 125 0.01 
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  PSA responses PSA CRA 















 D10  D50  D90 Δmodes Fspan FVMD FSm 
Sulfamerazine Input 6 13.0 33.8 67 1.6 37.5 3044 1 -- -- -- -- -- -- -- 
54-MA1 6 1.27 9.21 98.3 10.5 30.0 15380 4 -11.7 -24.6 31.4 3 0.15 1.25 0.20 
54-MB1 6 1.95 27.2 127 4.6 47.8 9612 4 -11.0 -6.61 60.0 3 0.35 0.78 0.32 
54-X1 6 0.54 1.79 4.38 2.1 2.19 49188 1 -12.4 -32.0 -62.6 0 0.74 17.1 0.06 
Phenacetin Input 6 8.3 34.3 96.2 2.6 44.8 3941 1 -- -- -- -- -- -- -- 
69-MA1 6 1.56 11.7 96.5 8.1 30.8 12760 4 -6.70 -22.7 0.31 3 0.31 1.45 0.31 
69-MB1 6 2.04 16.0 53.1 3.2 22.8 10114 2 -6.21 -18.3 -43.1 1 0.80 1.96 0.39 
69-X1 6 0.72 1.95 4.22 1.8 2.27 41917 1 -7.54 -32.4 -92.0 0 1.43 19.7 0.09 
Sulfadiazine Input 6 2.7 10.6 42.8 3.8 17.0 10151 2 -- -- -- -- -- -- -- 
87-MA1 6 1.81 22.0 153 6.9 52.1 10376 4 -0.92 11.4 111 2 0.55 0.33 0.98 
87-MB1 6 1.86 27.4 171 6.2 59.3 9869 4 -0.87 16.8 128 2 0.61 0.29 1.03 
87-X1 6 0.66 2.06 4.61 1.9 2.43 42614 1 -2.07 -8.56 -38.2 -1 1.97 7.00 0.24 
Caffeine Input 6 2.9 23.7 147 6.1 51.0 7613 3 -- -- -- -- -- -- -- 
88-MA1 6 3.29 32.6 141 4.23 54.0 6754 3 0.36 8.82 -5.95 0 1.45 0.94 1.13 
88-MB1 6 1.86 42.2 143 3.37 58.5 9317 3 -1.07 18.5 -3.31 0 1.82 0.87 0.82 
88-X1 6 0.75 1.73 3.46 1.57 2.23 43212 2 -2.18 -22.0 -143 -1 3.90 22.9 0.18 
Methyl paraben Input 6 16.6 63.7 157 2.2 76.7 1650 2 -- -- -- -- -- -- -- 
140-MA1 6 3.33 27.8 115 4.03 44.6 6850 3 -13.3 -35.9 -41.7 1 0.55 1.72 0.24 
140-MB1 6 3.60 29.7 141 4.63 52.4 6436 3 -13.0 -34.0 -16.0 1 0.48 1.46 0.26 
140-X1 6 2.63 8.05 26.1 2.89 11.6 13536 2 -14.0 -55.6 -131.0 0 0.76 6.60 0.12 
n – Number of replicates.  D#: particle size for decile #. VMD: volume mean diameter, Sm: Surface area, No. Mode:  number of modes. Span:  width of particle distribution.  
∆D#:  h  g                 z  f           . ∆m    :  h  g  in the number of modes. Fspan: degree of change in span. FVMD: degree of change in volume mean diameter.  FSm: degree of 
change in surface area. #-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation method A  
For further definitions of the terms please refer to Table 3-9. 
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For indomethacin and phenacetin, ball-milling resulted in material with a broad multi-
modal PSD in which particle size was not significantly reduced. However, when 
micronised the resulting PSD of the product was narrower and mono-modal with the 
majority of the particles (D90) being less than 3-4 µm (Table 6-18). 
The input material for loperamide HCl exhibited agglomeration which upon ball-milling 
was moderately reduced along with the overall particle size. However, some 
agglomeration still remains (Table 6-18 and Figure 6-21).  When micronised a narrow 
mono-modal PSD for loperamide HCl was produced, in which the majority of the 
particles (D90) were less than 3 µm (Table 6-18 and Figure 6-21).  
 
Figure 6-21 Average particle size distributions for the comminuted materials of loperamide HCl by 
high frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(black) compared to the input material (red). 
Note: below 2µm, particle size distribution shape differs between comminuted materials due to the 
size of lens used 
The input material for salbutamol sulphate was large with a mono-modal PSD (Table 
6-18). The particle size was effectively reduced when ball-milled using high or low 
frequency but the PSD was fairly broad and multi-modal (Table 6-18 and Figure 6-22). 
The particle size of micronised salbutamol sulphate on the other hand was significantly 
reduced with the majority of particles (D90) being less than 3 µm (Table 6-18 and Figure 
6-22). 
Ball-milling acetylsalicylic acid was also effective in reducing the particle size but the 
resultant material was found to have a broad and multi-modal PSD. Micronisation, was 
more effective than ball-milling in changing particle sizes and distributions resulting in 




Figure 6-22 Average particle size distributions for the comminuted materials of salbutamol sulphate 
by high frequency ball-milling (blue), low frequency ball-milling (green) and 
micronisation (black) compared to the input material (red). 
Note: below 2µm, particle size distribution shape differs between comminuted materials due to the 
size of lens used 
Like salbutamol sulphate, the input material for sulfamerazine was also mono-modal. 
When ball-milled, the overall particle sizes of the comminuted material were reduced. 
However, some larger particles were observed which may suggest either particle growth 
or agglomeration as a consequence of the comminution process had occurred (Table 
6-18 and Figure 6-23). This is consistent with the XRPD and DSC analysis which 
suggests a solid-state transformation had occurred, therefore large particles maybe as a 
result of recrystallisation that may have occurred during milling. Upon micronisation a 
narrow mono-modal PSD was observed with the majority of the particles (D90) being 
less than 4 µm (Table 6-18 and Figure 6-23). 
 
Figure 6-23 Average particle size distributions for the comminuted materials of sulfamerazine by 
high frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(black) compared to the input material (red). 
Note: below 2µm, particle size distribution shape differs between comminuted materials due to the 
size of lens used 
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Both high and low frequency ball-milling had little effect in reducing the particle size of 
sulfadiazine, and instead introduced agglomerates into the powder (Table 6-18 and 
Figure 6-24). When micronised, a narrow mono-modal PSD was observed with the 
majority of the particles (D90) being less than 4 µm (Table 6-18 and Figure 6-24). 
 
Figure 6-24 Average particle size distributions for the comminuted materials of sulfadiazine by high 
frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(black) compared to the input material (red). 
Note: below 2µm, particle size distribution shape differs between comminuted materials due to the 
size of lens used 
 
Ball-milling methyl paraben had a moderate effect in reducing the particle size, but still 
resulted producing a material with a broad multi-modal PSD. When the input material 
was micronised, the particle size was only reduced to less than 30 µm, the smallest 
reduction of all the micronised materials which typically had particle sizes less than 10 
µm (Table 6-18). 
The input material for comminuted caffeine was initially agglomerated. Ball-milling of 
this material had little effect on either reducing the particle size or altering the PSD 
(Table 6-18 and Figure 6-25). However, when micronised the PSD was narrowed and 
resulted in a majority of particles (D90) being less than 3 µm. 
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Figure 6-25 Average particle size distributions for the comminuted materials of caffeine by high 
frequency ball-milling (blue), low frequency ball-milling (green) and micronisation 
(black) compared to the input material (red). 
Note: below 2µm, particle size distribution shape differs between comminuted materials due to the 
size of lens used 
 
 
 Scanning electron microscopy (SEM) 6.4.5
SEM analysis of the comminuted materials showed that the particles in general 
exhibited irregular particle morphologies with rough surfaces, fractured edges and were 
agglomerated and drusy i.e. coated with finer particles (Table 6-19). An example of this 
agglomeration for the comminuted materials can be seen in Figure 6-26 for sulfadiazine, 
where particle size appears to increase upon ball-milling due to agglomeration of 
smaller particles. This is consistent with the observed PSD for this material (Table 6-18 
and Figure 6-24). Based on this observation it would be expected that Tm may have 
increased as the particle size has increased
288,289
. However, DSC analysis for this 
material (Section 6.4.3) showed that Tm had in fact slightly decreased in temperature, 
which may suggest the presence of some disorder. It is proposed that during the milling 
process the input sulfadiazine particles were reduced in size with some disorder 
introduced onto their surfaces. These smaller particles then fused together via 
recrystallisation of the disordered regions to form agglomerates
19
, as depicted in Figure 
6-26[B] without changing the solid-state form of the final comminuted material, as  the 
XRPD diffractogram was concordant with input (Section 6.4.1).  
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Table 6-19 SEM analysis of the comminuted materials 
  SEM responses 
Material Batch ID Crystal habit Edge Surface Agglomeration 
Acetaminophen Input Acicular & columnar Fractured Rough Drusy 
1-MA1 Irregular Fractured Rough Agg & Drusy 
1-MA2 Irregular Fractured Rough Agg & Drusy 
1-MB1 Irregular Fractured Rough Agg & Drusy 
1-MB2 Irregular Fractured Rough Agg & Drusy 
1-X1 Acicular Rounded Smooth Agg 
Indomethacin Input Irregular & plates Fractured Rough & cracked Drusy 
11-MA1 Irregular Fractured Rough Agg & Drusy 
11-MA2 Irregular Fractured Rough Agg & Drusy 
11-MB1 Irregular Fractured Rough Agg & Drusy 
11-MB2 Irregular Fractured Rough Agg & Drusy 
11-X1 Irregular Fractured Rough Agg & Drusy 
Loperamide HCl Input Irregular Fractured Rough & pitted Agg 
14-MA1 Irregular Fractured Rough Agg & Drusy 
14-MB1 Irregular Fractured Rough Agg & Drusy 
14-X1 Irregular Fractured Rough Agg & Drusy 
Salbutamol 
sulphate 
Input Acicular & columnar Angular 
Smooth & slightly 
cracked 
Drusy & agg 
24-MA1 Irregular Fractured Rough Agg & Drusy 
24-MA2 Irregular Fractured Rough Agg & Drusy 
24-MA3 Irregular Fractured Rough Agg & Drusy 
24-MB1 Irregular Fractured Rough Agg & Drusy 
24-MB2 Irregular Fractured Rough Agg & Drusy 







33-MA1 Irregular Fractured Rough Agg & Drusy 
33-MB1 Irregular Fractured Rough Agg & Drusy 
33-X1 Irregular Fractured Rough Agg & Drusy 
Sulfamerazine 
Input 




Rough with some 
cracks 
Slight drusy 
54-MA1 Irregular Fractured Rough Agg & Drusy 
54-MB1 Irregular Fractured Rough Agg & Drusy 
54-X1 Irregular Fractured Rough Agg & Drusy 
Phenacetin Input Broken plates Fractured Smooth Drusy 
69-MA1 Irregular Fractured Rough Agg & Drusy 
69-MB1 Irregular Fractured Rough Agg & Drusy 
69-X1 Irregular Fractured Rough Agg & Drusy 
Sulfadiazine Input Acicular Sharp Smooth Agg 
87-MA1 Irregular Fractured Rough Agg & Drusy 
87-MB1 Irregular Fractured Rough Agg & Drusy 
87-X1 Irregular Fractured Rough Agg & Drusy 
Caffeine Input Irregular Fractured Rough Agg 
88-MA1 Acicular Sharp Smooth Agg 
88-MB1 Acicular Sharp Smooth Agg 
88-X1 Acicular Rounded Smooth Agg 
Methyl paraben Input Irregular Fractured Rough Agg 
140-MA1 Irregular Fractured Rough Agg & Drusy 
140-MB1 Irregular Fractured Rough Agg & Drusy 
140-X1 Irregular Fractured Rough Agg & Drusy 
Agg: agglomeration, For further definitions of the terms please refer to Table 3-7 and Figure 3-6 to Figure 3-9. #-MA#: 





Figure 6-26 SEM micrographs for sulfadiazine: (A) input/reference, (B) high frequency ball-milled 
  
Unlike the other comminuted materials, ball-milled caffeine appears acicular with sharp 
ends (edges) and smooth surfaces (Figure 6-27[C]), whilst jet-micronised caffeine 
appeared acicular with rounded edges Figure 6-27[D]). These changes in primary 
morphology of caffeine from irregular particles with fractured edges to smaller acicular, 
smooth particles may indicate that the material has undergone a solid-state form 
transition or recrystallisation (from sublimation) during the mechanical comminution 
processes. However, there is no conclusive evidence from XRPD (Section 6.4.1) or 
DSC (Section 6.4.3) to suggest a solid-state transformation was or had occurred as 
analysis is performed after comminution not during the milling process. However, the 
presence of a volatile peak (moisture) in the DSC and a weight loss in the TGA (Table 
6-15) suggests a disruption to the crystal surface whereby, moisture can absorb and 
potentially lead to recrystallisation and the observed changes in crystal morphology
19
 
(Figure 6-27). These observations are also consistent with the particle size data obtained 
for the comminuted materials of caffeine (Table 6-18 and Figure 6-25), i.e. the ball-
milled material appears larger due to recrystallisation and agglomeration while the 
micronised material appears smaller. It is likely that agglomeration for caffeine occurs 








Figure 6-27 SEM micrographs of caffeine - the input (A), high frequency ball-milled (B & C) and jet 
–milled (D)  
 Gravimetric vapour sorption (GVS) 6.4.6
Moisture sorption profiles and associated responses were obtained for the mechanically 
comminuted materials and compared to those of the input materials (Table 6-20).  For 
the comminuted materials of acetylsalicylic acid, phenacetin, methyl paraben and 
acetaminophen very little reversible moisture sorption occurred (less than 0.2% w/w) 
and the materials can be defined as being crystalline and moisture stable. The high 
frequency ball-milled phenacetin illustrates the typical kinetic and isotherm plots for 
this type of material (Figure 6-28).  
Materials exhibiting surface disorder can be identified by observing recrystallisation 
events or large increases in adsorbed water from their moisture sorption profiles. These 
recrystallisation events are recognised by a continuous mass increase at specific %RH 
value as water molecules are adsorbed by the disordered surface. This is followed by an 
expulsion of water from the crystal lattice which is represented as a mass loss
20,276
. An 
example of this can be seen in the kinetics and isotherm plots for ball-milled salbutamol 




Table 6-20  GVS responses and CRA of the comminuted materials 
  GVS responses GVS CRA 











Input 0.04 0.07 0.00 0.03 0.01 0.01 -0.03 0.07 0.03 0.03 ND ND -- -- -- -- 
1-MA1 0.02 0.13 0.00 0.13 0.00 0.03 0.01 0.13 0.13 0.00 ND ND -0.03 0.06 0.10 Crystalline stable reversible moisture  sorption 
1-MA2 0.02 0.14 0.00 0.14 0.00 0.04 0.02 0.14 0.14 0.00 ND ND -0.02 0.07 0.10 Crystalline stable reversible moisture  sorption 
1-MB1 0.03 0.10 0.00 0.09 -0.01 0.02 -0.01 0.10 0.09 0.01 ND ND -0.01 0.03 0.05 Crystalline stable reversible moisture  sorption 
1-MB2 0.03 0.09 0.00 0.09 0.00 0.03 0.00 0.09 0.09 -0.01 ND ND -0.02 0.02 0.06 Crystalline stable reversible moisture  sorption 











Input 0.02 0.09 0.00 0.09 0.00 0.02 0.00 0.09 0.09 0.00 ND ND -- -- -- -- 
11-MA1 0.49 1.42 0.00 1.29 0.00 0.28 -0.22 1.42 1.29 0.13 ND ND 0.48 1.33 1.20 Disordered (or increased surface area) 
11-MA2 0.51 1.40 0.00 1.31 0.00 0.29 -0.23 1.40 1.31 0.09 ND ND 0.50 1.31 1.22 Disordered (or increased surface area) 
11-MB1 0.13 0.37 0.00 0.31 0.00 0.11 -0.02 0.37 0.31 0.06 ND ND 0.12 0.28 0.22 Crystalline stable reversible moisture  sorption 
11-MB2 0.14 0.38 0.00 0.32 0.00 0.12 -0.02 0.38 0.32 0.06 ND ND 0.13 0.29 0.23 Crystalline stable reversible moisture  sorption 










l Input 0.05 0.13 0.00 0.12 0.00 0.03 -0.01 0.13 0.12 0.01 ND ND -- -- -- -- 
14-MA1 
2.28 9.23 0.01 9.18 0.08 2.41 0.13 9.23 9.18 0.05 ND ND 2.23 9.10 9.05 Disordered (or increased surface area) 
14-MB1 
1.33 1.88 0.00 1.41 0.00 0.52 -0.81 3.01 1.41 1.60 90 3.46 1.28 2.88 1.29 Disordered 
14-X1 















-0.01 0.04 0.00 0.04 0.00 0.00 0.01 0.04 0.04 0.00 ND ND -- -- -- -- 
24-MA1 
4.42 1.37 0.00 1.18 -0.02 0.18 -4.24 7.62 1.18 6.45 60 9.76 4.43 7.59 1.14 Disordered 
24-MA2 
4.44 1.21 0.00 1.04 -0.01 0.11 -4.32 7.64 1.04 6.59 60 9.62 4.45 7.60 1.01 Disordered 
24-MA3 
4.81 1.11 0.00 0.96 -0.01 0.11 -4.70 8.48 0.96 7.52 60 9.74 4.83 8.44 0.93 Disordered 
24-MB1 
1.03 0.79 0.00 0.66 -0.02 0.21 -0.82 1.18 0.66 0.52 50 1.33 1.04 1.14 0.62 Disordered 
24-MB2 
1.02 0.79 0.00 0.67 0.00 0.20 -0.82 1.02 0.67 0.35 50 1.25 1.03 0.98 0.63 Disordered 
24-X1 
0.64 0.30 0.00 0.28 -0.01 0.10 -0.55 0.65 0.28 0.36 50 0.68 0.66 0.61 0.25 Disordered or electrostatic 
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  GVS responses GVS CRA 













Input 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.01 0.00 ND ND -- -- -- -- 
33-MA1 0.00 0.13 0.00 0.10 0.00 0.02 0.02 0.13 0.10 0.03 ND ND 0.00 0.12 0.09 Crystalline stable reversible moisture  sorption 
33-MB1 0.01 0.08 0.00 0.07 0.00 0.01 0.00 0.08 0.07 0.01 ND ND 0.01 0.07 0.06 Crystalline stable reversible moisture  sorption 








e Input 0.06 0.22 0.00 0.20 -0.07 0.00 -0.06 0.22 0.20 0.03 ND ND -- -- -- -- 
54-MA1 0.36 0.85 0.00 0.81 0.00 0.24 -0.13 0.85 0.81 0.04 ND ND 0.30 0.63 0.61 Disordered (or increased surface area) 
54-MB1 0.25 0.71 0.00 0.66 0.00 0.19 -0.06 0.71 0.66 0.04 ND ND 0.19 0.48 0.47 Crystalline stable reversible moisture  sorption 








Input 0.00 0.10 0.00 0.10 0.00 0.00 0.00 0.10 0.10 0.00 ND ND -- -- -- -- 
69-MA1 0.04 0.21 0.00 0.20 0.00 0.03 -0.01 0.21 0.20 0.01 ND ND 0.04 0.12 0.10 Crystalline stable reversible moisture  sorption 
69-MB1 0.04 0.09 0.00 0.10 0.00 0.01 -0.03 0.09 0.10 -0.01 ND ND 0.04 -0.01 0.00 Crystalline stable reversible moisture  sorption 









Input -0.05 0.07 0.00 0.06 -0.01 0.00 0.05 0.07 0.06 0.01 ND ND -- -- -- -- 
87-MA1 0.31 1.20 0.00 1.03 0.00 0.24 -0.08 1.20 1.03 0.17 ND ND 0.37 1.13 0.97 Disordered (or increased surface area) 
87-MB1 0.25 0.98 0.00 0.83 0.00 0.19 -0.06 0.98 0.83 0.15 ND ND 0.30 0.91 0.77 Disordered (or increased surface area) 






Input -0.01 0.13 0.00 0.11 0.00 0.02 0.03 0.13 0.11 0.02 ND ND -- -- -- -- 
88-MA1 0.62 7.30 0.00 4.53 -0.07 -0.09 -0.70 7.30 4.53 2.76 ND ND 0.63 7.17 4.42 Disordered (or increased surface area) 
88-MB1 0.11 0.80 0.00 0.72 0.00 0.09 -0.01 0.80 0.72 0.08 ND ND 0.12 0.67 0.61 Disordered (or increased surface area) 










 Input 0.00 0.02 0.00 0.01 0.00 0.00 0.00 0.02 0.01 0.01 ND ND -- -- -- -- 
140-MA1 0.02 0.08 0.00 0.07 0.00 0.01 -0.01 0.08 0.07 0.01 ND ND 0.02 0.06 0.06 Crystalline stable reversible moisture  sorption 
140-MB1 0.04 0.09 0.00 0.06 0.00 0.01 -0.03 0.09 0.06 0.03 ND ND 0.03 0.07 0.04 Crystalline stable reversible moisture  sorption 
140-X1 -0.10 0.04 0.00 0.03 0.00 0.00 0.10 0.04 0.03 0.00 ND ND -0.10 0.02 0.02 Crystalline stable reversible moisture  sorption 
M#: % mass change at %RH points A (30%RH, B (90%RH), C (0%RH), D (90%RH), E (0%RH), and F (30%RH), MEND: difference between final (F) and initial (A) values. MMAX1 and MMAX1 are the maximum % mass change 
observed during first and second adsorption intervals (ADS1 and ADS2). ∆MAX is the difference in MMAX1 and MMAX1 values. MADS is the difference in % change in mass between points B and D, i.e. At 90 %RH for adsorption 
cycles 1 and 2. #-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation method A.  Please refer to Table 3-11 for further descriptions of the terms 
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Kinetics plot Isotherm plot 
 
Figure 6-28 GVS kinetics and isotherm plots showing the reversible moisture adsorption/desorption 
profile for high frequency ball-milled phenacetin. 
Points A to F refer to the equilibrium endpoints at %RH values from the start to end of the 
adsorption/desorption cycles 























































Figure 6-29 GVS kinetics and isotherm plots for the comminuted materials of salbutamol sulphate  
Points A to F refer to the equilibrium endpoints at %RH values from the start to end of the 
adsorption/desorption cycles 
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Both high and low frequency ball-milling of salbutamol sulphate appeared to generate 
surface disorder with recrystallisation occurring at 50-60 %RH, consistent with previous 
literature observations
1,21,246,364
. There is also some suggestion of a small amount of 
disorder for micronised salbutamol sulphate, as a mass loss is observed which could be 
interpreted as a recrystallisation event. However, it is more likely that this observation is 
due to electrostatic charges rather than disorder, as there was no increase in water 
adsorption prior to this event and it can be seen that as  %RH increases the electrostatic 
charge is dissipated
365
 which would account for the observed mass loss (Figure 6-29). 
Surface disorder maybe distinguished from bulk disorder by the amount of moisture 
adsorbed and the observation that a recrystallisation event maybe present. Bulk 
disordered materials typically absorb relatively more moisture and may or may not 
exhibit a recrystallisation event
255
. An example of this distinction can be seen in the 
moisture sorption profiles for ball-milled loperamide HCl (Figure 6-30). High frequency 
ball-milling did not result in an observed recrystallisation in the GVS kinetics plot, but 
instead the material absorbed 9 % (w/w) moisture reversibly during the first and second 
adsorption cycles (points B & D Figure 6-30) and it can be inferred that this is due to 
the presence of bulk disorder. In contrast, low frequency ball-milling results in only 
surface disorder with the observance of a recrystallisation event only at high %RH, i.e. 
90% RH (Figure 6-30). 
It should be noted that loperamide HCl can form a tetrahydrate, but only when 
immersed completely in an aqueous environment
331
. In the latter case the amount of 
moisture sorption was approximately 14.5% (w/w)
331
. For the bulk disordered material 
of loperamide HCl, it is postulated that moisture is readily and reversibly absorbed 
without recrystallisation or formation of the tetrahydrate and that this highly disordered 
material remains amorphous even after multiple adsorption/desorption cycles. This was 
confirmed by investigating the solid-state form/phase post-GVS by XRPD using the 
method described in Section 3.2.1 (Figure 6-31). This XRPD diffractogram post-GVS 
showed that the material remained amorphous, suggesting that moisture sorption by 
itself is not sufficient to facilitate a solid-state transformation of the bulk disordered 
material but rather the addition of heat is required for recrystallisation to occur, as was 



























































Figure 6-30 GVS kinetics and isotherm plots for the comminuted materials of loperamide HCl 
Points A to F refer to the equilibrium endpoints at %RH values from the start to end of the 
adsorption/desorption cycles 
 
Figure 6-31 XRPD diffractograms for the high frequency ball-milled samples of loperamide HCl 
before GVS analysis (red) and post-GVS (blue) 
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Reducing the particle size of loperamide HCl by micronisation did not result in an 
increase in moisture sorption. This further verifies that it is the presence of disorder that 
is responsible for the observed moisture adsorption increase and not the increase in 
particle surface area due to size reduction (Table 6-20). 
For other comminuted materials such as γ-indomethacin disorder may have been 
generated by high frequency ball-milling, as indicated by the increase in moisture 
sorption. In contrast, low frequency ball-milling and micronisation did not appear as 
disruptive with the resulting material remaining crystalline after processing, as little 
moisture sorption was observed (Table 6-20). 
Ball-milling of sulfamerazine and sulfadiazine also resulted in a small amount of 
surface disorder as indicated by the relative small amount of moisture sorption observed. 
However, micronisation of these materials did not cause any change in the moisture 
sorption profiles suggesting that reducing the particle size did not have any significant 
influence (Table 6-20). 
Of all the comminuted materials, only high frequency ball-milling of caffeine appeared 
to result in the formation of a hydrate but this was only produced during GVS analysis 
(Figure 6-32). Significant changes to the moisture sorption profile for this material were 
observed. These changes are likely due to lattice disordering, resulting in irreversible 
moisture adsorption/desorption. The material appears to readily convert to a hydrated 
form above 60 %RH and water is desorbed below 30 %RH. However, the material does 
not readsorb the same amount of moisture during the second adsorption cycle, 
suggesting that another hydrated form may be generated (Figure 6-32). Low frequency 
ball-milling, and to some degree micronisation, resulted in only a small amount of 
moisture sorption, suggesting that these materials remained predominately crystalline. 
Micronised caffeine also appeared to be electrostatically charged but this did not appear 
to affect the overall amount of moisture adsorbed (Figure 6-32).   
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Figure 6-32 GVS kinetics and isotherm plots for the comminuted materials of caffeine 
Points A to F refer to the equilibrium endpoints at %RH values from the start to end of the 
adsorption/desorption cycles  
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 Fourier transform infra-red spectroscopy (FTIR) 6.4.7
Infrared spectra for the mechanically comminuted materials were obtained and 
compared to those of the input/reference materials (Table 6-21). 
Table 6-21 Frequency assignment of FTIR peaks and CRA of the comminuted materials 
  FTIR Response FTIR CRA 












-1 (NH stretch), 3161cm-1 (H-bonded OH stretch), 1650 cm-1 (C=O 
amide stretching), 1562 cm-1 (N–H in-plane bending), 1328 cm-1 (O–H 
bending), 1259 cm-1 (C–O stretch), 1225 cm-1 (C–N amide stretch) 
_ 
1-MA1 3324 cm-1 (NH stretch), 3162cm-1 (H-bonded OH stretch), 1653 cm-1 (C=O 
amide stretching), 1564 cm-1 (N–H in-plane bending), 1328 cm-1 (O–H 
bending), 1260 cm-1 (C–O stretch), 1226 cm-1 (C–N amide stretch) 
No change, concordant with 
input/reference spectra 
1-MA2 3324 cm-1 (NH stretch), 3161cm-1 (H-bonded OH stretch), 1653 cm-1 (C=O 
amide stretching), 1563 cm-1 (N–H in-plane bending), 1328 cm-1 (O–H 
bending), 1260 cm-1 (C–O stretch), 1226 cm-1 (C–N amide stretch) 
No change, concordant with 
input/reference spectra 
1-MB1 3325 cm-1 (NH stretch), 3162cm-1 (H-bonded OH stretch), 1653 cm-1 (C=O 
amide stretching), 1564 cm-1 (N–H in-plane bending), 1328 cm-1 (O–H 
bending), 1260 cm-1 (C–O stretch), 1227 cm-1 (C–N amide stretch) 
No change, concordant with 
input/reference spectra 
1-MB2 3323 cm
-1 (NH stretch), 3162cm-1 (H-bonded OH stretch), 1650 cm-1 (C=O 
amide stretching), 1562 cm-1 (N–H in-plane bending), 1328 cm-1 (O–H 
bending), 1259 cm-1 (C–O stretch), 1226 cm-1 (C–N amide stretch) 
No change, concordant with 
input/reference spectra 
1-X1 3325 cm-1 (NH stretch), 3162cm-1 (H-bonded OH stretch), 1652 cm-1 (C=O 
amide stretching), 1563 cm-1 (N–H in-plane bending), 1328 cm-1 (O–H 
bending), 1259 cm-1 (C–O stretch), 1226 cm-1 (C–N amide stretch) 













-1 (O-H stretch), 1714 cm-1 (C=O stretch of cyclic dimer), 1690 cm-1 
(C=O amide stretch),1613 cm-1 (N-H stretch),1478 cm-1 (C-C stretch) 
_ 
11-MA1 3023 cm-1 (O-H stretch), 1715cm-1 (C=O stretch of cyclic dimer), 1691 cm-1 
(C=O amide stretch),1613 cm-1 (N-H stretch),1479 cm-1 (C-C stretch) 
No change, concordant with 
input/reference spectra 
11-MA2 3023 cm-1 (O-H stretch), 1714 cm-1 (C=O stretch of cyclic dimer), 1691 cm-
1 (C=O amide stretch),1613 cm-1 (N-H stretch),1479 cm-1 (C-C stretch) 
No change, concordant with 
input/reference spectra 
11-MB1 3023 cm-1 (O-H stretch), 1715cm-1 (C=O stretch of cyclic dimer), 1691 cm-1 
(C=O amide stretch),1613 cm-1 (N-H stretch),1479 cm-1 (C-C stretch) 
No change, concordant with 
input/reference spectra 
11-MB2 3023 cm-1 (O-H stretch), 1715 cm-1 (C=O stretch of cyclic dimer), 1691 cm-
1 (C=O amide stretch),1613 cm-1 (N-H stretch),1479 cm-1 (C-C stretch) 
No change, concordant with 
input/reference spectra 
11-X1 3023 cm-1 (O-H stretch), 1716 cm-1 (C=O stretch of cyclic dimer), 1691 cm-
1 (C=O amide stretch),1614 cm-1 (N-H stretch),1479 cm-1 (C-C stretch) 















Input 3474 cm-1 (O-H stretch), 3409 cm-1 (N-H stretch), 1616 cm-1 (C-N stretch), 
1507 cm-1 (C-N stretch), 1496 cm-1 (O-H bend), 1205 cm-1 (C-O phenolic 
stretch), 1112 cm-1 (C-O stretch), 1078 cm-1 (secondary alcoholic C–O 
stretch) 
_ 
24-MA1 Broad 3500 cm
-1 to 2200cm-1, 1614 cm-1 and 1510 cm-1 (C-N stretch), 1501 
cm-1 (O-H bend), 1201 cm-1 (C-O phenolic stretch), 1115 cm-1 (C-O stretch), 
Broad 1078 cm-1 (secondary alcoholic C–O stretch) 
broadening and shifts of a number 
of peaks in the FTIR spectrum 
bands in the region 3500 to 2200 
cm−1 and  1700 to 700 cm-1 
24-MA2 Broad 3500 cm
-1 to 2200cm-1, 1613 cm-1 and 1509 cm-1 (C-N stretch), 1500 
cm-1 (O-H bend), 1201 cm-1 (C-O phenolic stretch), 1115 cm-1 (C-O stretch), 
Broad 1078 cm-1 (secondary alcoholic C–O stretch) 
broadening and shifts of a number 
of peaks in the FTIR spectrum 
bands in the region 3500 to 2200 
cm−1 and  1700 to 700 cm-1 
24-MA3 Broad 3500 cm
-1 to 2200cm-1, 1614 cm-1 and 1507 cm-1 (C-N stretch), 1502 
cm-1 (O-H bend), 1202 cm-1 (C-O phenolic stretch), 1115 cm-1 (C-O stretch), 
Broad 1078 cm-1 (secondary alcoholic C–O stretch) 
broadening and shifts of a number 
of peaks in the FTIR spectrum 
bands in the region 3500 to 2200 
cm−1 and  1700 to 700 cm-1 
24-MB1 3473 cm
-1 (O-H stretch), 1616 cm-1 and 1507 cm-1 (C-N stretch), 1496 cm-1 (O-
H bend), 1206 cm-1 (C-O phenolic stretch), 1112 cm-1 (C-O stretch), 1079 cm-1 
(secondary alcoholic C–O stretch) 
No change, concordant with 
input/reference spectra 
24-MB2 3472 cm
-1 (O-H stretch), 1617 cm-1 and 1508 cm-1 (C-N stretch), 1498 cm-1 (O-
H bend), 1206 cm-1 (C-O phenolic stretch), 1112 cm-1 (C-O stretch), 1079 cm-1 
(secondary alcoholic C–O stretch) 
No change, concordant with 
input/reference spectra 
24-X1 3474 cm
-1 (O-H stretch), 1617 cm-1 and 1508 cm-1 (C-N stretch), 1497 cm-1 (O-
H bend), 1207 cm-1 (C-O phenolic stretch), 1113 cm-1 (C-O stretch), 1078 cm-1 
(secondary alcoholic C–O stretch) 
No change, concordant with 
input/reference spectra 
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  FTIR Response FTIR CRA 












-1 (C-H aromatic stretch),1623 cm-1 (C=O stretch tertiary amide),1484 
cm-1 (C-C aromatic stretch), 1448 cm-1 (C-O-H stretch) 
_ 
14-MA1 Broad 3500 cm-1 to 2200cm-1, 1628 cm
-1 (C=O stretch tertiary amide), broad 
1494cm-1, 1449 cm-1 (C-O-H stretch) 
Water present , peak broadening 
and peak shifts observed 
14-MB1 2959 cm
-1 (C-H aromatic stretch),1624 cm-1 (C=O stretch tertiary amide),1485 
cm-1 (C-C aromatic stretch), 1448 cm-1 (C-O-H stretch) 
Some slight broadening and shifts 
observed 
14-X1 2959 cm
-1 (C-H aromatic stretch),1624 cm-1 (C=O stretch tertiary amide),1485 
cm-1 (C-C aromatic stretch), 1449 cm-1 (C-O-H stretch) 















-1 (C=O acetyl stretch ester), 1680 cm-1 (C=O stretch carboxylic 
acid),1605 cm-1 (C=C aromatic), 1482 cm-1 (C=C aromatic) 
_ 
33-MA1 1751 cm
-1 (C=O acetyl stretch ester), 1682 cm-1 (C=O stretch carboxylic 
acid),1606 cm-1 (C=C aromatic), 1483 cm-1 (C=C aromatic) 
No change, concordant with 
input/reference spectra 
33-MB1 1751 cm
-1 (C=O acetyl stretch ester), 1682 cm-1 (C=O stretch carboxylic 
acid),1606 cm-1 (C=C aromatic), 1483 cm-1 (C=C aromatic) 
No change, concordant with 
input/reference spectra 
33-X1 1751 cm
-1 (C=O acetyl stretch ester), 1682 cm-1 (C=O stretch carboxylic 
acid),1606 cm-1 (C=C aromatic), 1483 cm-1 (C=C aromatic) 











-1 and 3482 cm-1 (NH2 stretch), 1641 cm
-1 and 1628 cm-1 (NH2 




-1  and 3482 cm-1 (NH2 stretch), 1641 cm
-1  and 1628 cm-1 (NH2 
scissoring), 1326 cm-1 and 1150 cm-1 (S=O stretch), 1304 cm-1 (Aromatic C-N 
stretch) 
Some new peaks for Form II and 
some peak shifts. Remainder,  
concordant with peaks for 
input/reference spectra 
54-MB1 3498 cm
-1  and 3485 cm-1 (NH2 stretch), 3458 cm-1 (NH2 stretch Form II), 
1644 cm-1  and 1630 cm-1 (NH2 scissoring), 1323 cm
-1 and 1149 cm-1 (S=O 
stretch), 1301 cm-1 (Aromatic C-N stretch) 
No change, concordant with 
input/reference spectra 
54-X1 3497 cm
-1  and 3483 cm-1 (NH2 stretch), 1641 cm
-1  and 1629 cm-1 (NH2 
scissoring), 1327 cm-1 and  1151 cm-1 (S=O stretch), 1304 cm-1 (Aromatic C-N 
stretch) 










-1 (N-H stretch), 3073 cm-1 (aromatic-H stretch), 2928 cm-1 (C-H 
stretch amide), 2885 cm-1 (C-H stretch), 1658 cm-1 (C=O stretch), 1645 cm-1 
(C-NH deformation), 1480 cm-1 (C-H bend), 1265 cm-1 (C-N stretch) 
_ 
69-MA1 3281 cm
-1 (N-H stretch), 3073 cm-1 (aromatic-H stretch), 2928 cm-1 (C-H 
stretch amide), 2884 cm-1 (C-H stretch), 1658 cm-1 (C=O stretch), 1645 cm-1 
(C-NH deformation), 1482 cm-1 (C-H bend), 1266 cm-1 (C-N stretch) 
No change, concordant with 
input/reference spectra 
69-MB1 3281 cm
-1 (N-H stretch), 3073 cm-1 (aromatic-H stretch), 2928 cm-1 (C-H 
stretch amide), 2885 cm-1 (C-H stretch), 1659 cm-1 (C=O stretch), 1645 cm-1 
(C-NH deformation), 1482 cm-1 (C-H bend), 1266 cm-1 (C-N stretch) 
No change, concordant with 
input/reference spectra 
69-X1 3282 cm
-1 (N-H stretch), 3073 cm-1 (aromatic-H stretch), 2928 cm-1 (C-H 
stretch amide), 2886 cm-1 (C-H stretch), 1659 cm-1 (C=O stretch), 1645 cm-1 
(C-NH deformation), 1482 cm-1 (C-H bend), 1266 cm-1 (C-N stretch) 











-1 (NH2 stretch), 3356 cm
-1 (NH2 stretch),1653 cm
-1 (NH2 scissoring), 
1580 cm-1 (NH2 scissoring), 1326 cm
-1 (S=O stretch), 1153 cm-1 (S=O stretch), 
_ 
87-MA1 3424 cm
-1 (NH2 stretch), 3355 cm
-1 (NH2 stretch),1653 cm
-1 (NH2 scissoring), 
1580 cm-1 (NH2 scissoring), 1326 cm
-1 (S=O stretch), 1152 cm-1 (S=O stretch), 
No change, concordant with 
input/reference spectra 
87-MB1 3424 cm
-1 (NH2 stretch), 3355 cm
-1 (NH2 stretch),1652 cm
-1 (NH2 scissoring), 
1580 cm-1 (NH2 scissoring), 1326 cm
-1 (S=O stretch), 1153 cm-1 (S=O stretch), 
No change, concordant with 
input/reference spectra 
87-X1 3424 cm
-1 (NH2 stretch), 3355 cm
-1 (NH2 stretch),1653 cm
-1 (NH2 scissoring), 
1579 cm-1 (NH2 scissoring), 1326 cm
-1 (S=O stretch), 1153 cm-1 (S=O stretch), 








-1 (C=O stretch), 1599 cm-1 (C-N stretch), 1547 cm-1 (C-N stretch), _ 
88-MA1 1696cm
-1 (C=O stretch), 1599 cm-1 (C-N stretch), 1548 cm-1 (C-N stretch), No change, concordant with 
input/reference spectra 
88-MB1 1697 cm
-1 (C=O stretch), 1599 cm-1 (C-N stretch), 1548 cm-1 (C-N stretch), No change, concordant with 
input/reference spectra 
88-X1 1697 cm
-1 (C=O stretch), 1599 cm-1 (C-N stretch), 1550cm-1 (C-N stretch), No change, concordant with 
input/reference spectra 
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  FTIR Response FTIR CRA 












-1 (O-H stretch) 1678 cm-1 (C=O stretch), 1513 cm-1 (Phenol C-O 
stretch), 1433 cm-1 (Enol C-O stretch) 
_ 
140-MA1 3287 cm
-1 (O-H stretch) 1678 cm-1 (C=O stretch), 1513 cm-1 (Phenol C-O 
stretch), 1433 cm-1 (Enol C-O stretch) 
No change, concordant with 
input/reference spectra 
140-MB1 3285 cm
-1 (O-H stretch) 1678 cm-1 (C=O stretch), 1513 cm-1 (Phenol C-O 
stretch), 1433 cm-1 (Enol C-O stretch) 
No change, concordant with 
input/reference spectra 
140-X1 3287 cm
-1 (O-H stretch) 1678 cm-1 (C=O stretch), 1513 cm-1 (Phenol C-O 
stretch), 1433 cm-1 (Enol C-O stretch) 
No change, concordant with 
input/reference spectra 
Red – changes in observed vibrations. #-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill 
method B. #-X#: jet micronisation method A.   
 
The FTIR spectra for the comminuted materials of acetylsalicylic acid, phenacetin, 
sulfadiazine, caffeine, γ-indomethacin, methyl paraben and acetaminophen were 
concordant with the FTIR spectra of the respective input material, as illustrated in 
Figure 6-33 for indomethacin. These observations indicate that there were no significant 
changes to the physical structure, conformation and/or chemical nature of the materials. 
 
 
Figure 6-33 Overlay of the normalised FTIR spectra for the comminuted materials of γ-indomethacin 
by high frequency ball-milling (Blue), low frequency ball-milling (Green) and 
micronisation (Black) compared to the Input/reference material (Red). 
 
FTIR can also be used to identify differences in the solid-state forms of the materials as 
a result of processing and shows great sensitivity to polar bonds such as O-H, C=O and 
N-H, hence, FTIR provides a good tool to investigate the presence of water and changes 
in any H-bonding
317,318
. This is illustrated by the FTIR spectra for the comminuted 
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materials for salbutamol sulphate (Figure 6-34) and loperamide HCl (Figure 6-35). High 
frequency ball-milling of salbutamol sulphate with and without liquid nitrogen resulted 
in peak broadening and shifts in a number of FTIR peaks s in the region 3500 to 2200 
cm
−1 
and  1700 to 700 cm
-1
 which were consistent with observations from the literature, 
suggesting the presence of disorder, and a small amount of adsorbed water
219,247,366
 
(Figure 6-34). The FTIR spectra for low frequency ball-milled and micronised 
salbutamol sulphate were generally consistent with that of the spectrum of the input 
material, therefore, these processes did not appear to alter the H-bonding pattern or 
change the chemical nature of the material. 
 
Figure 6-34 Overlay of the normalised FTIR spectra of the comminuted materials of salbutamol 
sulphate by high frequency ball-milling with liquid nitrogen (blue) at room temperature 
(purple), low frequency ball-milling Mill-B (green) and micronisation (black) compared 
to the input material (red). 
 
The FTIR spectra for the comminuted materials of loperamide HCl are shown Figure 
6-35. For the high frequency ball-milled material the presence of water and disorder can 
be inferred from the broad band between 3600 and 3100 cm
-1
 and the observed peak 
broadening and shifts. A small amount of peak broadening and peak shifts was observed 
for low frequency ball-milled loperamide HCl, suggesting that a small amount of 
disorder was possibly present. However, the FTIR spectra for the micronised material 
was concordant with that of the input material. 
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Figure 6-35 Overlay of the normalised FTIR spectra of the comminuted materials of loperamide HCl 
by high frequency ball-milling (blue), low frequency ball-milling (green) and 
micronisation (black) compared to the input material (red). 
 
Several polymorphs of sulfamerazine are known to exist and it has been shown that 
mechanical processing can induce solid-state transformations via the amorphous 
phase
349-351
. Additional vibrations were observed in the IR spectrum for high frequency 
ball-milled sulfamerazine consistent with those of Form II
157,184146,173
 and shifts in peaks 
suggesting changes in the intermolecular interactions (H-bonding) of the molecule
146,173
 
(Figure 6-36 and Table 6-21). Typically Form I sulfamerazine exhibits split vibrational 
stretches at 3498/3482 cm
-1
 for asymmetric stretching of NH2 and 1641/1628 cm
-1
 for 





for these stretches respectively. This confirms the observations made using other 
methods such as XRPD (Figure 6-8) and DSC (Figure 6-17) of the presence of a 






Figure 6-36 Overlay of the normalised FTIR spectra of the comminuted materials of sulfamerazine 
by high frequency ball-milling (blue), low frequency ball-milling (green) and 
micronisation (black) compared to the input material (red). 
 High pressure liquid chromatography (HPLC) 6.4.8
As discussed in Section 1.4, mechanical processes can be of high energy and can impart 
large amounts of stress to the material being processed. These stresses can result in the 
formation of impurities such as those generated by thermal degradation. This is 
especially important when investigating the generation of amorphous materials as these 
are often associated with temperature changes. In a number of historical studies 
involving the production of amorphous materials by melt-quenching or ball-milling, the 
assessment of final chemical purity has often not been investigated
160,205,208,221,257,367-369
. 
In the current study, the final chemical purity or the presence of impurities was assessed 
by HPLC to add a degree of confidence to the conclusion that the response changes 
observed as a consequence of different comminution processes are due to the presence 
of disorder rather than to changes in chemical purity. e.g. shifts in Tm and Td, etc.. To 
this end, the HPLC chromatograms and associated responses were obtained for the 
mechanically comminuted materials and compared to those of the input/reference 
materials (Table 6-22). 
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Table 6-22 Summary of HPLC responses and CRA of the comminuted materials 
  HPLC responses HPLC CRA 
Material Batch ID No. peaks 
Primary peak RT 
min (% area) 
Other Peaks RT 





Acetaminophen Input 1 1.56 (100) ND -- -- 
1-MA1 1 1.56 (100) ND 0 0 (0) 
1-MA2 1 1.55 (100) ND 0 0 (0) 
1-MB1 1 1.55 (100) ND 0 0 (0) 
1-MB2 1 1.55 (100) ND 0 0 (0) 
1-X1 1 1.55 (100) ND 0 0 (0) 
γ-Indomethacin Input 3 5.33 (99.7) 5.71 (<0.1), 6.35 (0.3) -- -- 
11-MA1 2 5.34 (99.7) 6.35 (0.3) -1 0 (0) 
11-MA2 2 5.34 (99.7) 6.35 (0.3) -1 0 (0) 
11-MB1 3 5.34 (99.6) 5.71 (<0.1), 6.35 (0.3),  0 0 (-0.1) 
11-MB2 2 5.34 (99.7) 6.36 (0.3) -1 0 (0) 
11-X1 2 5.34 (99.7) 6.35 (0.3) -1 0 (0) 
Salbutamol 
sulphate 
Input 2 1.88 (99.8) 2.61 (0.2) -- -- 
Post-DSC 22 1.89 (56.7) 2.60 (20.04), 2.30 (0.18), 2.41 (0.41), 2.53 (0.36) 20 0 (-43.1) 
24-MA1 5 1.88 (99.4) 2.61 (0.2), 2.29 (0.1), 2.41 (0.2), 2.53 (0.1) 3 0 (-0.4) 
24-MA2 5 1.88 (99.3) 2.61 (0.3), 2.29 (0.1), 2.41 (0.2), 2.53 (0.1) 3 0 (-0.5) 
24-MA3 5 1.87 (99.4) 2.61 (0.3), 2.29 (0.1), 2.41 (0.1), 2.53 (0.1) 3 0 (-0.4) 
24-MB1 2 1.88 (99.7) 2.60 (0.3) 0 0 (0) 
24-MB2 2 1.87 (99.7) 2.60 (0.3) 0 0 (0) 
24-X1 4 1.88 (99.5) 2.60 (0.3), 2.29 (0.1), 2.53 (0.1) 2 0 (-0.3) 
Loperamide HCl Input 3 4.53 (99.8) 2.57 (<0.1), 4.26 (0.1) -- -- 
14-MA1 3 4.53 (99.8) 2.56 (0.1), 4.26 (0.1) 0 0 (0) 
14-MB1 3 4.54 (99.8) 2.56 (<0.1) 4.27 (0.1) 0 0 (0) 
14-X1 3 4.52 (99.8) 2.56 (0.1), 4.26 (0.1) 0 0 (0) 
Acetylsalicylic 
acid 
Input 2 2.91 (99.4) 3.09 (0.6) -- -- 
33-MA1 2 2.91 (99.4) 3.09 (0.6) 0 0 (0) 
33-MB1 2 2.91 (99.4) 3.09 (0.6) 0 0 (0) 
33-X1 2 2.91 (99.4) 3.09 (0.6) 0 0 (0) 
Sulfamerazine Input 3 2.06 (99.8) 1.77 (<0.1), 3.10 (0.2) -- -- 
54-MA1 3 2.06 (99.8) 1.77 (<0.1), 3.10 (0.2) 0 0 (0) 
54-MB1 3 2.06 (99.8) 1.77 (<0.1), 3.10 (0.2) 0 0 (0) 
54-X1 3 2.06 (99.8) 1.77 (<0.1), 3.09 (0.2) 0 0 (0) 
Phenacetin Input 4 3.17 (99.5) 2.06 (<0.1), 3.48 (0.3), 3.57 (0.2) -- -- 
69-MA1 1 3.17 (100) ND -3 0 (0.5) 
69-MB1 2 3.17 (99.5) 3.48 (0.5), -2 0 (0) 
69-X1 2 3.17 (99.5) 3.48 (0.4) -2 0 (0) 
Sulfadiazine Input 1 1.67 (100) ND -- -- 
87-MA1 1 1.68 (100) ND 0 0 (0) 
87-MB1 1 1.68 (100) ND 0 0 (0) 
87-X1 1 1.68 (100) ND 0 0 (0) 
Caffeine Input 1 2.27 (100) ND -- -- 
88-MA1 1 2.27 (100) ND 0 0 (0) 
88-MB1 1 2.27 (100) ND 0 0 (0) 
88-X1 1 2.27 (100) ND 0 0 (0) 
Methyl paraben Input 1 3.04 (100) ND -- -- 
140-MA1 1 3.04 (100) ND 0 0 (0) 
140-MB1 1 3.04 (100) ND 0 0 (0) 
140-X1 1 3.04 (100) ND 0 0 (0) 
  :             m  (m  ), Δ    k : Change in number of observed peaks between sample and reference, ND: Not detected, 
∆   & ∆     :  h  g                 m              f    m  y    k. Red identifies identical peaks in comminuted material 
(Mill-A1 & JM-A) for salbutamol sulphate with those from the post-DSC sample 
#-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation method A 
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For the majority of the comminuted materials the estimated chemical purity, as 
indicated by the peak retention time and % area for the primary peak remained the same 
and no degradation (additional) peaks were observed. However, some additional peaks 
were observed for high frequency ball-milled and micronised salbutamol sulphate. 
It has been postulated that the process of ball-milling can cause “amorphisation” of a 
material due to collisions of the milling balls resulting in localised increases in 
temperature or the creation of “hot points”72. These local hot points may exceed the 
melting temperature of the compound and the sudden return to room temperature after 
the impact would then act as a quench mechanism, thereby generating amorphous 
material by a melt/quench process
72
. This phenomenon was investigated by ball-milling 
salbutamol sulphate with and without liquid nitrogen (temperature control). However, in 
both cases a predominately amorphous material was generated and HPLC analysis 
showed peaks indicative of the presence of a small amount of impurities similar to those 
obtained post-DSC. Nevertheless, the overall estimated purity remained relatively high, 
i.e. % area of the primary peak was only reduced by 0.5% and this could account for 
some of the decreases in the observed DSC responses (Table 6-17). However, it is most 
likely the presence of disorder that has the biggest impact on observed APRs. 
 General discussion 6.4.9
Compared to other pharmaceutical processes such as spray and freeze drying which can 
often result in “100%” amorphous content, detecting disorder as a result of milling and 
micronisation can be challenging, as the level of disorder present can vary depending on 
the energy applied. Therefore a combination of techniques should be employed to 
increase the probability of detection and to mitigate the potential for  misinterpreting the 
solid-state phase present by using only one or two techniques in isolation
16,17,119,185,186
. 
The selected study materials were subjected to ball milling at two different levels of 
impact and by micronisation using a fluid jet-mill (Chapter 5). The analytical responses 
of the comminuted materials have been reported here, using a number of different 
characterisation techniques, which have been referred to as the core test methods. The 
responses from these core test methods were then compared to those of the input 
material using a novel approach called CRA. The qualitative relevance of these changes 
was then defined with respect to the solid-state phase present for each of the 
comminuted materials. This CRA approach provided a more consistent and data driven 
classification process to define the solid-state phase present, rather than employing an 
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approach that relied solely on the knowledge, experience and interpretation of the 
investigator. Based on the CRA values, novel solid-state phase classifications or 
decision trees were applied to those core test methods which can detect the presence of 
disorder directly; these were designated the ‘primary’ disorder detection methods such 
as XRPD, DSC and GVS (Sections 6.3.1.3, 6.3.3.3 and 6.3.6.3 respectively). Other core 
test methods such as TGA, HPLC, FTIR and SEM, on the basis of the results obtained 
here, may be categorised as ‘secondary’ disorder detection methods, as it proved more 
difficult to discriminate between disordered and crystalline phases present in the 
materials. Solid-state phase decision trees were not created for these ‘secondary’ 
detection methods, instead, these methods were employed to provide supplementary or 
supportive evidence for the presence of disorder indirectly. For example, TGA was used 
to determine the change in sample mass as a function of temperature
288,289,370
. These 
mass change events primarily represented the loss of volatiles or material 
decomposition. Changes to surface disorder, particle size and levels of impurities could 
be inferred through changes to the mass loss profile and, or degradation temperatures
33-
36
. Understanding the causes of these changes especially the weight loss due to the 
presence of water that may have been sorbed as a consequence of processing or storage 
can be used to highlight any potential solid state stability issues. The sorption of water 
either during processing or storage can be used to accelerate the crystallisation of any 
disordered surfaces and could lead to agglomeration and in worst case, transformation 
to new solid states
288,290
. 
Using the combined information from the primary and secondary disorder detection 
methods, the solid-state phase present for each comminuted material was qualitatively 
defined and summarised in tabular form. An example is shown in Table 6-23 for 
comminuted loperamide HCl and in APPENDIX 7 for all of the study materials. 
For the ‘primary’ detection methods, XRPD, GVS and DSC, the solid-state phase 
identified was colour coded to represent the phase present, red for disordered, orange 
for microcrystalline or little to some degree of disorder present, while crystalline 
materials were colour coded green. With respect to moisture sorption information 
obtained by DSC, TGA and GVS the presence of moisture was commented on. For the 
GVS analysis data, “observed” refers to any large change in moisture uptake (ΔMADS1) 
greater than 0.5 % (w/w).  
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Table 6-23  Summary of the solid-state phase present in the comminuted materials of loperamide HCl 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 X-ray Amorphous  Disordered  Crystalline  
GVS 1 Disordered  Disordered  Disordered  
DSC 1 Disordered  
Mixed Phase B – maybe 
new crystalline form 
some disorder 
 
Mixed Phase A – same 






GVS 1 Observed (9.01%) Observed (2.88 %) Observed (0.83 %) 
DSC 1 Observed Observed Observed 
TGA 2 Observed (1.37 %) Observed (0.74 %) Not observed 
Chemical 
purity 
HPLC 2 Concordant with  Ref. Concordant with  Ref. Concordant with  Ref. 
FTIR 2 
Disorder - 
Broadening, water & shifts 
Some disorder - slight 
broadening and shifts 





D50 < 7 µm 
Broad multi-modal 
agglomeration 
D50 < 10 µm 
mono-modal 
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Disordered Some  disorder Crystalline –little disorder 
DM – detection method; 1:primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline or little/some disorder, Disordered  
 
 
Solid-state phase colour coding was not applied to ‘secondary’ disorder detection 
methods but the information from these techniques were summarised to help support the 
final phase classification. This final designation of the solid-state phase present for each 
comminuted material was qualitatively determined by considering the number of colour 
codes (Table 6-24) for the solid-state phase identified by the techniques, XRPD, GVS 
and DSC.  
Table 6-24 Colour coding for classifying the final solid-state phase present in comminute materials 
No. colours from 
primary detection 
methods 




   Disordered  
   Some disorder  
   Some disorder or microcrystalline   
   Some disorder or microcrystalline   
   Crystalline- little disorder or microcrystalline  
   Little disorder or microcrystalline  
   Crystalline- little disorder  
   Crystalline - little disorder or microcrystalline  
   Crystalline  
 
In the example given in Table 6-23 for the qualitative solid-state phase identification for 
the comminuted materials of loperamide HCl, it can be seen that for the high frequency 
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ball-milled material all three primary detection methods identified disorder being 
present (3 reds), hence this material was classified as being disordered. For low 
frequency ball-milling, both XRPD and GVS detected disorder (2 reds) but CRA for 
DSC only suggested that some disorder was present (orange). Therefore, the final 
material was designated as having “some disorder” (2 reds - 1 orange). CRA for the 
XRPD responses for micronised loperamide HCl suggests the material was crystalline 
(green) but disordered (red) by GVS and a mixture of phases from the DSC data 
(orange), hence the final solid-state phase designation for this material was crystalline 
with a little disorder present. 
Defining the presence of mainly crystalline or disordered materials can be easily 
performed. However, defining a mixture of phases or the presence of microcrystalline 
material can be more difficult. In this research, a consistent approach has been applied 
to assist with classifying microcrystalline material using XRPD data.  Microcrystalline 
refers to a material which is crystalline but the particle size has been significantly 
reduced, such that it may appear disordered by XRPD analysis, i.e. it may exhibit 
different MIP, broader peaks and the background heights may have increased.  
However, unlike disordered material there is no apparent peak shifting observed in the 
XRPD diffractogram. 
A summary of the final solid-state phases identified for all the comminuted materials is 
given in Table 6-25. It can be seen that the three comminution processes produced 
materials that encompassed the whole amorphous-crystalline continuum, and the 
designated solid-state phases were consistent with the observed PID assessment 
previously reported in the literature (Table 2-8), but the degree of disorder was 
dependent on the comminution process employed. Materials such as acetaminophen, 
acetylsalicylic acid, phenacetin and methyl paraben were resistant to PID regardless of 
the comminution process employed. For other materials such as sulfamerazine, 
sulfadiazine and caffeine some disorder was observed upon ball-milling but there was 
little or none induced when they were micronised. In the case of sulfamerazine, high 





Table 6-25 Summary of the identified solid-state phase present in the comminuted materials 
Material Process 
Literature PID  
(from Table 2-8) 







Crystalline    
Mill-B Crystalline    





Crystalline    
Mill-B Crystalline    





Crystalline    
Mill-B Crystalline    





Crystalline    
Mill-B Crystalline    




Some disorder – some new form    
Mill-B Microcrystalline - little disorder    





Crystalline – little disorder    
Mill-B Crystalline – little disorder    





Crystalline – little disorder    
Mill-B Crystalline – little disorder    




Disordered    
Mill-B Microcrystalline - little disorder    





Disordered    
Mill-B Microcrystalline - some disorder    





Disordered    
Mill-B Some disorder    
JM-A Crystalline – little disorder    
Crystalline, Microcrystalline – little disorder, Disordered   
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet micronisation 
method A. Summary of information from the primary and secondary disorder detection methods and the solid-state 
phase identified for each comminuted material can be found in APPENDIX 7. 
 
For the remainder of the materials: loperamide HCl, salbutamol sulphate and γ-
indomethacin different solid-state phases were observed depending on the comminution 
process employed. The level of disorder appeared to be proportional to the relative 
amount of energy imparted by the comminution process. Ball-milling in general had a 
greater tendency to induce disorder than micronisation, as it is a “closed system” 
(Section 1.4.3) as the material is constantly exposed to a number of high energetic 
forces (stresses). Micronisation on the other hand is an “open system” where material 
flows into the grinding chamber via a pressure gradient where it is size reduced and then 
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removed, once the desired particle size is attained. This final size is dependent on the 
operating parameters employed (Section 1.4.4). Based on the CRA responses and solid-
state phase classification of the comminuted materials, the comminution processes were 
ranked in order of their tendency to cause PID from lowest to highest: micronisation 
(JM-A) < low frequency ball-milling (Mill-B) < high frequency ball-milling (Mill-A). 
This order also reflects the efficiency of the comminution processes in reducing particle 
size without causing PID, with micronisation (JM-A) being the most efficient, followed 
by low frequency ball-milling (Mill-B)  and high frequency ball-milling (Mill-A) being 
the least efficient process. It is also important to note that, based on these observations 
the use of ball-milling to model the process of micronisation should be done with 
caution as the potential properties of the ball-milled material, such as levels of PID, 
particle size, agglomeration, etc. may not reflect that of the micronised material. 
In general the comminution processes did not appear to cause significant degradation 
within the materials, which suggests that any observed changes in the analytical 
responses were most likely due to physical changes, such as reductions in particle size 
or the generation of PID. However, in the case of salbutamol sulphate, a small level of 
degradation was detected by HPLC but the estimated overall purity was not 
significantly reduced. 
The novel qualitative CRA approach described here provides a more consistent and 
systematic approach to define the solid-state phase present in any given material 
subjected to a comminution process. However, the CRA values and qualitative colour 
coding of the solid-state phase present provides only a gross indication of the changes in 
the properties but is not definitive enough to be able to discriminate different levels of 
disorder. By redefining the CRA threshold levels for the technique responses specific to 
the presence of disorder, the amount of disorder may be able to be semi-quantified 
allowing better disorder identification and a better understanding of the impact a 
comminution process may have on a respective material to cause PID. This will be 
investigated in Chapter 7. 
 Conclusions 6.5
The characterisation of the mechanically comminuted study materials successfully 
demonstrated that the novel approach comprising of CRA and the use of solid-state 
phase decision trees, for the primary disorder detection methods of XRPD, DSC and 
GVS, could be used to effectively define changes in the individual technique responses, 
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as well as aid in appropriately classifying the solid-state phase of the resulting material. 
Using this approach it was demonstrated that the three comminution processes 
generated material that encompassed the whole amorphous-crystalline continuum and 
also showed that differences could be detected in the nature of the materials produced 
from the different comminution processes. Additionally, it was also shown that the 
comminution processes appeared to be HPLC pure, i.e. milling processes did not result 
in increased degradation apart from a very small amount for salbutamol sulphate.   
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7 Process disorder analysis (PDA) for mechanically 
comminuted materials  
 Introduction 7.1
Qualitatively assessing the presence of disorder can be somewhat subjective as such 
determination relies on the analyst’s experience and interpretation23,244,245,247. Typically 
the presence of amorphous material as a consequence of mechanical processing can be 
characterised qualitatively by defining one or a combination of the following: the 
presence of an amorphous halo by XRPD, a Tg and recrystallisation by DSC and/or an 
observed recrystallisation in GVS moisture sorption profiles
6,7,23,160,221,242-247,280
. Such an 
assessment gives no indication of the degree of induced disorder. However, the amount 
of disorder is typically determined using only a single response from a given technique 
and a number of ‘standards’ to construct a calibration curve137,199,369-371, despite these 
‘standards’ being specific to the individual material, thereby making it harder to make 
comparisons between materials. 
It has been successfully shown by the studies described in Chapter 6 that the novel CRA 
process based on the differences between analytical responses for the comminuted 
materials and those of the respective inputs could be used to classify qualitatively the 
presence of PID. However, this process has its limitations in that it may not be 
definitive enough to discriminate different levels of disorder. For example, high 
frequency ball-milling of indomethacin, loperamide HCl and salbutamol sulphate were 
all classified as being disordered using the CRA process but defining the relative 
amount of disordering and which of the three was the most affected by the ball-milling 
process could not be easily distinguished (Table 6-25). Comminution of salbutamol 
sulphate and loperamide HCl by low frequency ball-milling also exhibited “some 
disorder” but this also could not be quantified, nor could the materials be ranked 
according to the relative level of PID detected. However, an attempt to achieve this was 
made through the colour coding scheme based on the CRA results (Section 6.4.9), i.e. 
the greater the number red boxes, the more likely disorder is present (Table 6-25). This 
approach, even with its limitations provided a consistent and reproducible approach to 
defining the solid-state phase present which can be transferable between analysts and 
investigators working in different laboratories. 
To be able to fully discriminate inter-, intra-material and processing differences a semi-
quantitative approach is proposed, in which the amount of disorder may be first semi-
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quantified by redefining the CRA threshold levels for the individual technique 
responses specific to the presence of disorder. This new process will be referred to as 
response disorder analysis (RDA). The RDA values from a number of techniques can 
then be combined into a single normalised value by a process designated process 
disorder analysis (PDA) enabling more information regarding the nature of the disorder 
to be deduced, as the responses represent information from multiple properties of the 
material not just a single property. To date, there has been no quantitative approach that 
has incorporated the responses from multiple techniques into a singular value to define a 
certain property such as the presence of disorder or amorphous character.  
The objective for this chapter was to develop further the analytical approach introduced 
previously (Chapter 6) incorporating multiple responses from various techniques to 
determine the level of disorder present in a material as a consequence of mechanical 
comminution processes allowing semi-quantitative discrimination between materials 
and processing conditions.  
 Methods 7.2
 Overview of analytical approach to identify and quantify the 7.2.1
presence of disorder 
The novel analytical approach to determine and semi-quantify the amount of disorder 
present as a consequence of a comminution process is outlined in Figure 7.1. 
Once comminuted, the materials were characterised using the core test methods and 
individual responses, both qualitative and quantitative were obtained (RA) (Chapter 6). 
The responses for each technique were then compared to those of the initial input 
material by CRA (Section 6.3), and the relative amount of change in responses with 
respect to the presence of disorder could then assessed by RDA and a technique disorder 
score determined (DTechnique) (Sections 7.2.2 to 7.2.4). In this study only XRPD, DSC 
and GVS will be assessed by RDA, as these three techniques represent the ‘primary’ 
disorder detection methods and can also provide information for a number of other 
important properties, such as molecular structure, thermal behaviour, purity and 
moisture sorption. 
The technique disorder scores, DTechnique were then combined into a single normalised 
process disorder score (DPro), which represents the relative amount of disorder present 
as a result of a defined process (Section 7.2.5). This process disorder score combines the 
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information from changes in multiple analytical responses and techniques into a single 
value, enabling materials to be ranked according to the relative level of disorder present 
and may allow discrimination between the comminution processes with respect to the 
relative amount of disorder that they may induce. 
 
Figure 7-1 A novel analytical approach to define disorder as a consequence of a comminution 
process. 
Red dashed line shows the distinction between the processes to characterise the solid-state phase of 
the material (above the line) to those specific to determine relative disorder (below the line) 
 Response disorder analysis for X-ray powder diffraction 7.2.2
(XRPD) 
Using the XRPD CRA values for the different comminuted materials (Table 6-14), the 
amount of observed change in the responses over the whole XRPD diffractogram were 
assessed with respect to any perceived PID to give a response disorder score (RXRPD). 
RXRPD values were determined using Table 7.1. The magnitude of the RDS values reflect 
the changes in the peak characteristics over the whole XRPD diffractogram, such as 
shifts in peak positions (PP), changes in peak (PH) and background heights (BH), as well 
as changes in peak widths (PW) and were weighted to reflect the likelihood of PID being 
present.  
Changes in peak positions, the MIP and the presence of new peaks cannot be directly 
related to disorder; hence these responses have a lower maximum score of 2 or 3. While 


















Individual technique responses for comminuted material 
compared to those of input material and qualitative relevance 
determined with respect to solid-state phase present 
(Section 6.3) 
XRPD, DSC and GVS CRA values for comminuted materials 
converted into a response disorder score (RDS) which can be 
used to define the relative amount of disorder present as 
determined by a given technique (DTechnique), i.e. multiple 
responses converted to a single value for a given technique 
(Section 7.2.2 to 7.2.4) 
For a given process, disorder scores (RDS and DTechnique) 
values for different techniques can be converted into a 
process disorder score (DPro), i.e. multiple responses for 
multiple techniques converted to a single value for a given 
process (Section 7.2.5) 
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background heights as well as increased peak widths may be more indicative for the 
presence of disorder, hence they have higher maximum scores, 5, 7 or 9.  
Table 7-1  RDS score values (RXRPD) for key XRPD peak descriptors Pp, PH, BH, PW, MIP 
and changes in number of peaks 







Number of  peaks 
reduced? 
(missing or merged) 
No 0 
RXRPD1 
Yes  5 
All new peaks 5 
No peaks observed 7 
2 New peaks observed? 
No new peak or no peaks observed 0 
RXRPD2 
Yes   2 
3 
Average °2θ shift in 
peak positions across 
all peaks(AvPP) 
-0.03 to 0.03 (no change) 0 
RXRPD3 > ±0.03 (observed shift) 3 
No peaks observed or all new peaks 3 
4 Change in MIP? 
No 0 
RXRPD4 Yes 3 
No peaks observed or all new peaks 3 
5 
Average % change in 
peak heights across all 
peaks(AvPH) 
> -20 % (relatively unchanged or increased) 0 
RXRPD5 
-20 to -30 % (slight decrease) 2 
-30 to -40 % (small decrease) 5 
All new peaks observed 5 
-40 to -50 % (large decrease) 7 
Reduced more than -50 % (marked decrease) 9 
No peaks observed 9 
6 
Average % change in 
background heights  
across all peaks(AvBH) 
< 20 % (relatively unchanged or reduced) 0 
RXRPD6 
20 to 30 % (slight increase) 2 
30 to 40 % (small increase) 5 
All new peaks observed 5 
40 to 50 % (large increase) 7 
> 50 % (marked increase) 9 
No peaks observed 9 
7 
Average % change in 
peak widths across all 
peaks(AvPW) 
< 20 % (relatively unchanged or reduced) 0 
RXRPD7 
20 to 30 % (slight increase) 2 
30 to 50 % (small increase) 5 
All new peaks observed 5 
50 to 100 % (large increase) 7 
> 100% (marked increase) 9 
No peaks observed 9 
Proceed stepwise from step1 to 7, summing the RDS score (RXRPD1 to RXRPD7) for the comminuted material using the 
relevant CRA values  
Average changes in peak areas (PA) were not included in the calculation of RXRPD as 
changes in this response could be misinterpreted and skew RXRPD values. Increases in 
peak areas could arise due to peak merging or they could increase as a result of 
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increases crystallinity, i.e. increases in peak heights and peak widths, consequently the 
inclusion of peak areas could skew the RDS by over-emphasising the importance of the 
peak height and peak width information. 
The RDS values were then converted to a technique disorder score (DXRPD) using 
equation [7-1], which represents the total degree of observed disorder in the XRPD 
diffractogram as a consequence of a defined comminution process. 
 XRPD disorder score          (
 XRPD 
40
) x 10 [7-1]  
where RXRPD is the sum of RXRPD 1 to RXRPD 7 out of 40, the maximum score. 
DXRPD was therefore calculated as a value between 0 and 10 (Table 7-2); where, 0 
represents no perceived observation of PID and 10, represents a marked degree of 
inferred disorder based on the changes in the XRPD responses. The DXRPD values can 
also be represented by a colour code, green representing a low probability of disorder 
being present, orange a medium probability and red representing a high probability of 
disorder being present (Table 7-2). 
Table 7-2 XRPD Disorder classification using DXRPD values  
DXRPD value 
Likelihood that disorder is present. 




0.0 to 3.0 
Low probability of disorder being present 
– low levels of disorder 
 
3.1 to 7.0 
Medium probability of disorder being present 
– some disorder present 
 
7.1 to 10.0 
High probability of disorder being present 
– marked levels of disorder present 
 
A worked example of the method used to calculate DXRPD is shown using the CRA 
values for high frequency ball-milled γ-indomethacin, batch 11-MA1 (Table 7-3). 
Table 7-3 Calculated RXRPD score for γ-indomethacin (11-MA1) using determined CRA values 
 















Yes No -0.04 Yes -67 44 68 
RDS* 5 0 3 3 9 7 7 
RDS ID RXRPD1 RXRPD2 RXRPD3 RXRPD4 RXRPD5 RXRPD6 RXRPD7 
* RDS values determined using Table 7-1, CRA values from Table 6-14. Refer to appendix 8 for an overlay of the 
XRPD diffractogram of 11-MA1 and the input. 
The XRPD diffractogram of milled γ-indomethacin (Appendix 8), was found to have 
missing or merged peaks but no new peaks were observed, and hence a RXRPD1 value of 
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5 and a RXRPD2 of 0 were allotted respectively. There was also an observed average peak 
shift (AvΔPP) greater than ± 0.03, hence RXRPD3 was given a value of 3. An observed 
change in MIP, a marked reduction in peak height (AvΔPH) of -67 %, and a large 
increase in background height (AvΔBH) of 44% resulted in RDS values of 3, 9  and 7 
for RXRPD4, RXRPD5 and RXRPD6 respectively. A large increase in peak width (AvΔPW) of 
68% was also observed generating a RXRPD7 value of 7. Summing all the values for 
RXRPD1 to RXRPD7 gave a total RXRPD value of 34 and substituting this value into equation 
[7-1] produced a DXRPD score of 8.5 for high frequency ball-milled γ-indomethacin. 
 Response disorder analysis for differential scanning 7.2.3
calorimetry (DSC) 
Using the DSC CRA values for the different comminuted materials (Table 6-17) the 
amount of observed change in the responses over the whole DSC thermogram were 
assessed with respect towards PID, to give a response disorder score (RDSC). RDSC values 
were determined using Table 7.4 and reflect the average changes in the thermal 
responses with respect to the presence of disorder.  
Table 7-4  RDS score values (RDSC) for key DSC responses based on CRA values 




















Average shift in melting 
temperature ( Tm) °C 
> -3.0 °C 0 
RDSC4 -3 to -10 °C 3 
Decreased more than -10 °C 5 
5 
Average change in degradation 
temperature ( Td) 
> -3.0 °C 0 
RDSC5 -3 to -10 °C 5 
Decreased more than -10 °C 10 
Proceed stepwise from step1 to 5, summing the RDS score (RDSC 1 to RDSC5) for the comminuted material using the 
relevant CRA values. 
The maximum RDS values for the responses were weighted with respect to likelihood 
that they indicate the presence of disorder. The presence of a Tg, a new recrystallisation 
or transition event and decreases in Td values strongly suggests the presence of disorder, 
hence these responses have higher maximum RDS values (10). While, decreases in Tm 
and the presence of moisture (volatile) can indicate some disorder, it is not conclusive; 
hence these responses have lower maximum RDS values (5). Additionally, if disorder 
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was present and the material recrystallised to the same solid-sate form as the input, no 
change in Tm would be observed. By reducing the maximum RDS value for changes in 
Tm the RDS values are weighted (or skewed) more towards the responses more 
indicative of disorder. 
Previous researchers Rani et al. (2006)
23
 estimated the degree of crystallinity by DSC 
using the ratio of  Hf of sample and that of a 100% crystal sample. However this 
approach is not suitable for materials where  Hf cannot be calculated easily, i.e. melt-
degradation materials or those that sublime, such as salbutamol sulphate or caffeine. 
Therefore, changes in  Hf were not included in the RDS calculations as some of the 
study materials melt-degrade, hence changes in this response were not able to be 
determined. 
The RDS values were then converted to a technique disorder score (DDSC) using 
equation [7-2], which represents the total degree of observed disorder in the DSC 
thermogram as a consequence of a defined comminution process. 
DSC disorder score         (
RDSC 
40
) x 10 [7-2]  
where RDSC is the sum of RDSC1 to RDSC5 out of 40, the maximum score. 
DDSC was therefore calculated as a value between 0 and 10; where, 0 represents no 
perceived observation of PID and 10, represents a marked degree of inferred disorder 
based on the changes in the DSC responses (Table 7-5). 
Table 7-5 DSC Disorder classification using DDSC values  
DDSC value 
Likelihood that disorder is present. 




0.0 to 3.0 
Low probability of disorder being present 
– low levels of disorder 
 
3.1 to 7.0 
Medium probability of disorder being present 
– some disorder present 
 
7.1 to 10.0 
High probability of disorder being present 
– marked levels of disorder present 
 
A worked example of the method used to calculate DDSC is shown using the CRA values 
for high frequency ball-milled loperamide HCl (Table 7-6). 
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Table 7-6 Calculated RDSC score for loperamide HCl (14-MA1) using determined CRA values 
 









Average shift in 
melting 
temperature 





Yes Yes Yes -3.5 0 
RDS* 5 10 10 3 0 
RDS ID RDSC1 RDSC2 RDSC3 RDSC4 RDSC  
* RDS values determined using Table 7-4. RA and CRA values from Table 6-16 and 6-17 respectively. Refer to 
Figure 6-12 for an overlay of the DSC thermogram of 14-MA1 and the input 
A volatile (moisture) desolvation event was observed for loperamide HCl (Figure 6-12), 
hence RDSC1 was assigned a value of 5. This material also exhibited a glass transition 
and a recrystallisation event; therefore both RDSC1 and RDSC3 were assigned values of 10. 
Tm was reduced slightly hence the RDSC4 was allotted a value of 3 but there was no 
change in the degradation temperature as a consequence of ball-milling, i.e. RDSC5 was 
0. Summing all the values for RDSC1 to RDSC5 gave a total DRDS value of 28. Substituting 
this value into equation [7-2] gave a DDSC score of 7.0 for high frequency ball-milled 
loperamide HCl.  
 Response disorder analysis for Gravimetric vapour sorption 7.2.4
(GVS) 
Using the GVS CRA values for the different comminuted materials (Table 6-20), the 
amount of observed change in the moisture sorption responses were assessed with 
respect to any perceived PID to provide a response disorder score (RGVS). RGVS values 
were determined using Table 7.7 and reflect the changes in the moisture sorption 
responses with respect to the presence of disorder. Only two responses were selected to 
investigate the presence of disorder, the observation of a recrystallisation event and 
changes in the maximum moisture adsorption during the first adsorption cycle 
( MMAX1).  
Recrystallisation events are observed as a mass loss event as the %RH is maintained at 
an elevated level
312,313
, and were assigned a RGVS value of 10. Further evidence for the 
presence of disorder can be inferred to by the change in the maximum moisture 
adsorption during the first adsorption cycle ( MMAX1). The magnitude of  MMAX1 
provides a relative estimate to the magnitude of disorder and an estimate of moisture 
adsorption as a consequence of the comminution process. 
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Table 7-7 RDS score values (RGVS) for key GVS responses based on CRA values 










Maximum % change in mass 
during adsorption cycle 1 
( MMAX1) 
< 0.25 % 0 
RGVS2 
0.25 to 0.5 % 3 
0.5 to 2.0 % 5 
2.0 to 5.0 % 7 
> 5.0 % 10 
Proceed stepwise from step1 to 2, summing the RDS score (RGVS 1 to RGVS2) for the comminuted material using the 
relevant CRA values. 
The RDS values (RGVS1 and RGVS2) were then converted to a technique disorder score 
(DGVS) using equation [7-3], which represents the total degree of observed disorder in 
the GVS moisture sorption profile as a consequence of a defined comminution process. 
GVS disorder score         (
RG S 
20
) x 10 [7-3]  
where RGVS is the sum of RGVS1 and RGVS2 out of 20, the maximum score 
DGVS is therefore calculated as a value between 0 and 10; where, 0 represents no 
perceived observation of PID and 10, represents a marked degree of inferred disorder 
based on the changes in the GVS responses (Table 7-8). 
Table 7-8 GVS Disorder classification using DGVS values  
DGVS value 
Likelihood that disorder is present. 




0.0 to 3.0 
Low probability of disorder being present 
– low levels of disorder 
 
3.1 to 7.0 
Medium probability of disorder being present 
– some disorder present 
 
7.1 to 10.0 
High probability of disorder being present 
– marked levels of disorder present 
 
A worked example of the method used to calculate DGVS is shown using the CRA values 
for low frequency ball-milled salbutamol sulphate (Table 7-9). 
Table 7-9 Calculated RGVS score for salbutamol sulphate using determined CRA values 
 
CRA values for salbutamol sulphate 
Observed recrystallisation? 
Maximum % change in mass during adsorption 
cycle 1 ( MMAX1) 
Yes 1.14 
RDS* 10 5 
RDS ID RGVS1 RGVS2 
* RDS values determined using Table 7-7. RA and CRA values from Table 6-20. Refer to Figure 6-29 for the kinetic 
and isotherm plots. 
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A recrystallisation event was observed for low frequency ball-milled salbutamol 
sulphate (Figure 6-29), hence a RGVS1 value of 10 was assigned, whilst a change of 
1.14% was observed for  MMAX1 and therefore a RGVS2 value of 5 was allocated. 
Summing the values for RGVS 1 and RGVS2 gave a total RGVS value of 15. Substituting this 
value into equation [7-3] produced a DGVS score of 7.5 for low frequency ball-milled 
salbutamol sulphate. 
 Process disorder analysis (PDA) 7.2.5
In the previous sections (7.2.2 to 7.2.4), the relative amount of change in individual 
responses for the techniques XRPD, DSC and GVS were converted to response disorder 
scores. These response RDS values were then combined and converted into disorder 
scores DXRPD, DDSC and DGVS for the individual techniques. The magnitude of these 
technique disorder scores was thought to reflect the respective potential of each of these 
techniques to indicate the presence of disorder induced by any given process. 
By combining the individual RDS scores for the three techniques, XRPD, DSC and 
GVS an overall response disorder score (PRDS) can be determined for a given process 
(Equation [7-4]). 
Total process RDS  PRDS   RXRPD  RDSC  RG S [7-4]  
The individual technique contributions to PRDS were weighted based on their potential to 
detect the presence of disorder. Both the XRPD and DSC contributions have a 
maximum value of 40, whilst the GVS contribution is only 20. The decreased weighting 
for the GVS PRDS value reflects the number of individual responses involved in disorder 
scoring, i.e. only two responses are employed, the observation of recrystallisation and 
changes to  MMAX1 compared to 7 for XRPD and 5 for DSC. 
PRDS as calculated, produced a value between 0 and 100, the larger the value of PRDS, the 
more significant or likely that disorder is present (Table 7-10).  
Table 7-10 Disorder classification using PRDS values  
PRDS value 
Likelihood that disorder is present. 




0 to 30 
Low probability of disorder being present 
– low levels of disorder 
 
31 to 70 
Medium probability of disorder being present 
– some disorder present 
 
71 to 100 
High probability of disorder being present 




By dividing the PRDS value by 10, a value which represents the disorder for a given 
process can be calculated (DPro) (Equation [7-5]). 
Process disorder score           
RXRPD  RDSC  RG S
10
 [7-5]  
The larger the value of DPro1, the more significant or likely that disorder is present 
(Table 7-11). 
Table 7-11 Disorder classification using DPro values  
DPro value 
Likelihood that disorder is present. 




0.0 to 3.0 
Low probability of disorder being present 
– low levels of disorder 
 
3.1 to 7.0 
Medium probability of disorder being present 
– some disorder present 
 
7.1 to 10.0 
High probability of disorder being present 
– marked levels of disorder present 
 
Alternatively DPro can be determined by taking the average of the individual technique 
disorder scores DXRPD, DDSC and DGVS (Equation [7-6]). In this approach each technique 
disorder score has equal weighting. 
Process disorder score           
                 
3
 [7-6]  
The larger the value of DPro2, the more significant or likely that disorder is present 
(Table 7-11). 
By comparing the two approaches to calculate DPro the effect of technique contribution 
(weighting or no weighting) to the overall disorder score could be investigated.  
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 Results & discussion 7.3
 Response disorder analysis for X-ray powder diffraction 7.3.1
(XRPD) 
The total degree of observed disorder in the XRPD diffractogram as a consequence of a 
given comminution process can be described and semi-quantified using the technique 
disorder score, DXRPD. This value reflects the changes in the XRPD responses over the 
whole diffractogram with respect to any perceived PID that these changes may infer 
(Table 7-12 and Figure 7-2). The higher the score the more likely that disorder is 
present. 
The previously described novel XRPD phase classification (Table 6-3) successfully 
categorised the solid-state phases produced in comminuted materials but was limited 
when it came to discriminate differences in the amount of disorder present within a 
defined solid-state phase class. For example, a number of comminuted materials were 
identified as being crystalline (Table 6-14) but further separation of these materials 
could not be achieved. However, by modifying the tolerance ranges for changes in the 
XRPD responses with respect to PID, differences between the crystalline materials 
could now be discerned (Table 7-12). Furthermore, based on the DXRPD values, some 
materials which were initially classified as crystalline could now be reclassified as 
containing some degree of disorder based on their XRPD responses, e.g. micronised 
sulfamerazine and loperamide HCl, high frequency ball-milled caffeine, sulfadiazine 
and sulfamerazine, low frequency ball-milled sulfadiazine and caffeine and all of the 
comminuted materials for acetylsalicylic acid (Table 7-12). 
The data obtained using other comminuted materials, such as ball-milled γ-
indomethacin, loperamide HCl and salbutamol sulphate when processed resulted in high 
DXRPD values (> 7.0) and these powders were classified as containing high levels of 
disorder. Replicate comminution process results obtained for salbutamol sulphate, 
indomethacin and acetaminophen also produced DXRPD values, confirming the 















Chapter 6∆ RXRPD1 RXRPD2 RXRPD3 RXRPD4 RXRPD5 RXRPD6 RXRPD7 
Acetaminophen 
1-MA1 0 0 0 3 0 0 5 8 2.0 Crystalline 
1-MA2 0 0 0 3 0 0 5 8 2.0 Crystalline 
1-MB1 0 0 0 3 0 2 7 12 3.0 Crystalline 
1-MB2 0 0 0 3 0 2 7 12 3.0 Crystalline 
1-X1 0 0 0 3 0 0 0 3 0.8 Crystalline 
γ-Indomethacin 
11-MA1 5 0 3 3 9 7 7 34 8.5 Disordered 
11-MA2 5 0 0 3 9 5 9 31 7.8 Disordered 
11-MB1 5 0 0 3 5 2 7 22 5.5 Microcrystalline 
11-MB2 5 0 0 3 7 2 7 24 6.0 Microcrystalline 
11-X1 5 0 0 3 5 0 0 13 3.3 Crystalline 
Salbutamol 
sulphate 
24-MA1 7 0 3 3 9 9 9 40 10.0 X-ray Amorphous 
24-MA2 7 0 3 3 9 9 9 40 10.0 X-ray Amorphous 
24-MA3 7 0 3 3 9 9 9 40 10.0 X-ray Amorphous 
24-MB1 5 0 0 3 9 2 7 26 6.5 Microcrystalline 
24-MB2 5 0 0 3 9 2 7 26 6.5 Microcrystalline 
24-X1 0 0 0 3 9 0 0 12 3.0 Crystalline 
Loperamide 
HCl 
14-MA1 7 0 3 3 9 9 9 40 10.0 X-ray Amorphous 
14-MB1 5 0 3 3 9 7 9 36 9.0 Disordered 
14-X1 5 0 0 0 9 0 9 23 5.8 Crystalline 
Acetylsalicylic 
acid 
33-MA1 0 0 3 0 9 0 7 19 4.8 Crystalline 
33-MB1 0 0 3 0 9 0 7 19 4.8 Crystalline 
33-X1 0 0 3 0 9 0 5 17 4.3 Crystalline 
Sulfamerazine 
54-MA1 5 2 3 3 0 2 7 22 5.5 
Crystalline mixture of 
forms 
54-MB1 5 0 0 3 7 9 9 33 8.3 Microcrystalline 
54-X1 5 0 0 3 9 0 9 26 6.5 Crystalline 
Phenacetin 
69-MA1 0 0 0 3 0 2 5 10 2.5 Crystalline 
69-MB1 0 0 0 0 0 0 2 2 0.5 Crystalline 
69-X1 0 0 0 3 0 0 7 10 2.5 Crystalline 
Sulfadiazine 
87-MA1 5 0 0 3 0 0 9 17 4.3 Crystalline 
87-MB1 5 0 0 3 0 2 7 17 4.3 Crystalline 
87-X1 5 0 0 3 0 0 0 8 2.0 Crystalline 
Caffeine 
88-MA1 5 0 0 3 9 0 7 24 6.0 Crystalline 
88-MB1 5 0 0 0 7 0 5 17 4.3 Crystalline 
88-X1 5 0 0 0 9 0 0 14 3.5 Crystalline 
Methyl paraben 
140-MA1 0 0 0 0 0 0 0 0 0.0 Crystalline 
140-MB1 0 0 0 0 2 0 0 2 0.5 Crystalline 
140-X1 0 0 0 0 9 0 0 9 2.3 Crystalline 
* Determined using Table 7-1, RXRPD
 ǂ: combined total RDS value for XRPD responses, DXRPD
ϕ : XRPD disorder score calculated using 
equation [7-1]. ∆: XRPD classification reported in Table 6-14. Colours for DXRPD values are defined in Table 7-2 




Figure 7-2 Summary plot of DXRPD values for the comminuted materials 
Of the three comminution processes, high frequency ball-milling (ball-mill A) appeared 
to result in higher levels of disorder for a given material (Table 7-12 and Figure 7-2). 
This observation is more apparent in those materials that appear to be more susceptible 
to PID such as milled γ-indomethacin, loperamide HCl, salbutamol sulphate and 
caffeine. In the case of sulfamerazine, low frequency ball-milling (ball-mill B) appeared 
to cause higher levels of PID than high frequency ball-milling (Table 7-12 and Figure 7-
2). This can be misleading in some respects, as the level of disorder is not only 
dependent on the amount of disorder generated as a consequence of the comminution 
process but also on when the sample is analysed. For high frequency ball-milled 
sulfamerazine, disorder is generated within the material, but as the comminution 
progresses this disordered phase is transformed into a new solid-state form. When a 
sample of the comminuted material was analysed by XRPD only a moderate degree of 
disorder was apparent but peaks attributable to a new solid-state form were observed. 
However, low frequency ball-milled sulfamerazine (ball-mill B) appeared to have 
higher levels of disorder present (Table 7-12 and Figure 7-2). This is due to shorter 
milling time, therefore when a sample of this material was analysed by XRPD the 
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comminution process had been halted before the material had transformed into a new 
solid-state form, hence a relatively higher degree of disorder was observed.  
For materials which had previously been classified as microcrystalline using the 
approach outlined in Section 6.3.1.3, the DXRPD values by themselves were not sufficient 
to allow appropriate classification of microcrystalline material (Table 7-12). The 
materials appeared to have moderate levels of disorder (DXRPD values between 4 and 7). 
Microcrystalline material must be defined using a multi-technique approach and 
classification rules such as those defined in Table 6-4 and Figure 6-2. 
 Response disorder analysis for differential scanning 7.3.2
calorimetry (DSC) 
DSC analysis of a sample containing both crystalline and disordered phases can be 
directly identified if the acquisition parameters are chosen correctly. However, 
interpretation of DSC thermograms can be somewhat complex due to the potential 
number of thermal events that can occur simultaneously or sequentially due to the semi-
independent nature of each transformation. This means that interpretation of the 
thermogram to calculate and score the degree of perceived induced disorder may require 
a matrix analysis approach to provide a holistic view of what is occurring rather than 
depending on the analysis and interpretation of individual thermal responses. To this 
end, the total degree of observed disorder in the DSC thermogram as a consequence of a 
given comminution process can be described and quantified using the technique 
disorder score, DDSC. This value reflects the combined observed changes in a number of 
thermal responses between the comminuted material and those of the input material 
with respect to any perceived PID (Table 7-13 and Figure 7-3). The higher the score the 
more likely that disorder is present. 
In Chapter 6, the solid-state phases of the comminuted materials were successfully 
identified using the novel classification process based on changes in their respective 
DSC responses (Table 6-17). However, as in the case of the XRPD analysis, this 
approach was limited when it came to discriminate differences in the amount of disorder 
present within a defined solid-state phase class. By modifying the ranges applied to 
assess changes in a defined response specific to the inference of PID, the comminuted 
materials could be further discriminated and compared. 
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Chapter 6∆ RDSC1 RDSC2 RDSC3 RDSC4 RDSC5 
Acetaminophen 
1-MA1 0 0 0 0 0 0 0.0 Crystalline  
1-MA2 0 0 0 0 0 0 0.0 Crystalline 
1-MB1 0 0 0 0 0 0 0.0 Crystalline 
1-MB2 0 0 0 0 0 0 0.0 Crystalline 






















11-MB1 0 0 
10 
(XD 5.4) 
0 0 10 
2.5 
(XD 5.4) 
Mixed Phase A - 
crystalline some disorder 
11-MB2 0 0 XD 1.6) 0 0 10 
2.5 
(XD 1.6) 
Mixed Phase A - 
crystalline some disorder 
11-X1 0 0 0 0 0 0 0.0 Crystalline 
Salbutamol 
sulphate 
24-MA1 5 10 10 5 10 40 10.0 DSC amorphous 
24-MA2 5 10 10 5 10 40 10.0 DSC amorphous 
24-MA3 5 10 10 5 10 40 10.0 DSC amorphous 
24-MB1 5 0 10 5 5 25 6.3 
Mixed Phase A - 
crystalline some disorder X 
24-MB2 5 0 10 5 5 25 6.3 
Mixed Phase A - 
crystalline some disorder X 
24-X1 5 0 10 3 2 20 5.0 
Mixed Phase A - 












14-MB1 5 0 
10 
(XD 11.1) 
3 0 18 
4.5 
(XD 11.1) 
Mixed Phase A - 
crystalline some disorder X 
14-X1 5 0 
10 
(XD 8.0) 
0 0 15 
3.8 
(XD 8.0) 
Mixed Phase A - 
crystalline some disorder X 
Acetylsalicylic 
acid 
33-MA1 0 0 0 0 0 0 0.0 Crystalline 
33-MB1 0 0 0 0 0 0 0.0 Crystalline 
33-X1 0 0 0 0 0 0 0.0 Crystalline 
Sulfamerazine 
54-MA1 0 0 
10 
(T 9.6) 
0 0 10 
2.5 
(T 9.6) 
Mixture of crystalline 
forms- some disorder X 
54-MB1 0 0 0 0 0 0 0.0 Crystalline 
54-X1 0 0 0 0 0 0 0.0 Crystalline 
Phenacetin 
69-MA1 0 0 0 0 0 0 0.0 Crystalline 
69-MB1 0 0 0 0 0 0 0.0 Crystalline 
69-X1 0 0 0 0 0 0 0.0 Crystalline 
Sulfadiazine 
87-MA1 0 0 0 3 5 8 2.0 
Mixed Phase A - 
crystalline some disorder X 
87-MB1 0 0 0 3 5 8 2.0 
Mixed Phase A - 
crystalline some disorder X 
87-X1 0 0 0 0 5 5 1.3 
Mixed Phase A - 
crystalline some disorder X 
Caffeine 
88-MA1 5 0 0 0 0 5 1.3 
Mixed Phase A - 
crystalline some disorder 
88-MB1 0 0 0 0 0 0 0.0 
Mixed Phase A - 
crystalline some disorder 
88-X1 0 0 0 0 0 0 0.0 
Mixed Phase A - 
crystalline some disorder 
Methyl paraben 
140-MA1 0 0 0 0 0 0 0.0 Crystalline 
140-MB1 0 0 0 0 0 0 0.0 Crystalline 
140-X1 0 0 0 0 0 0 0.0 Crystalline 
* Determined using Table 7-4, Xsolid-state confirmed by XRPD. RDSC
 ǂ: combined total RDS value for DSC responses, DDSC
ϕ : DSC disorder 
score calculated using equation [7-2]. ∆: DSC classification reported in Table 6-17. (GD #): size of Tg in J/(g°C), (XD  ):  z   f ∆ c in J/g, (T 




Figure 7-3 Summary plot of DDSC values for the comminuted materials 
For a number of comminuted materials: acetaminophen, acetylsalicylic acid, phenacetin, 
methyl paraben, low frequency ball and jet-milled sulfamerazine and caffeine and jet- 
milled γ-indomethacin there were no changes in their DSC responses which could infer 
the presence of disorder, hence these materials were assigned DDSC values of 0 (Table 7-
13 and Figure 7-3).  
For other comminuted materials, such as sulfadiazine changes in Tm and Td suggests a 
low presence of disorder and this resulted in a DDSC value of less than 2 being obtained 
(Table 7-13 and Figure 7-3). The observation of a new desolvation event in some cases 
can also imply the presence of disorder. When this new desolvation event occurs below 
100 °C this is most likely to be due to the removal of adsorbed moisture, as a 
consequence of surface disorder. For example, high frequency ball-milled caffeine 
exhibits a desolvation event representing the removal of adsorbed moisture that was not 
observed in the input material (Table 6-16). However, no other events such as Tg or 
recrystallisation were observed that may suggest disorder, hence this material was only 
assigned a DDSC value of only1.3 (Table 7-13 and Figure 7-3). 
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It is important to note that the DDSC value is a normalised estimate of the likelihood of 
disorder being present and should not be considered an absolute value of the amount of 
disorder present. For example, the observance of a glass transition or recrystallisation 
event can provide evidence for the presence of disorder but the presence of these 
phenomena alone cannot fully quantify the amount of disorder present. This is because 
the size of the Tg or  Hc have not been included in the disorder analysis as they are 
generally new events, and as such are absent in the input. However, the size of these 
responses should be reported where they are available along with the DDSC value to 
assist in discriminating differences between different comminution processes and to 
investigate batch to batch variation for the same employed comminution process. For 
example the comminution of loperamide HCl by the three processes resulted in material 
with differing DDSC values (Table 7-13 and Figure 7-3). All three comminuted materials 
produced DSC thermograms exhibiting a new recrystallisation event and hence they 
were given RDSC3 values of 10. However, the actual values for ∆Hc showed that the 
material subjected to high frequency ball-milling (ball-mill A) had the largest 
recrystallisation event and was also the only material exhibiting a glass transition event. 
Accordingly, the material processed in this way is most likely to contain more disorder 
than the low frequency ball-milled and jet-milled material. As the DDSC values also 
follows this trend in the enthalpies, this demonstrates that the novel RDA process 
(Section 7.2.3) is effective in discriminating different levels of disorder. 
This trend in the effect of the comminution processes to induce disorder can also be 
seen in the comminuted samples of salbutamol sulphate and γ-indomethacin (Table 7-13 
and Figure 7-3). In the case of salbutamol sulphate, high frequency ball-milling resulted 
in DXRPD values of 10 and this material was classified as containing high levels of 
disorder. The magnitude of either Tg or  Hc for the comminuted materials of salbutamol 
sulphate were not reported as these events could not be resolved sufficiently. The ball-
milled γ-indomethacin exhibited different levels of disorder as shown by the relative 
changes in their DSC responses. New recrystallisation events were observed in both 
high and low frequency ball-milled materials but the  Hc values for these events 
differed between the processes,  Hc ~20J/g and ~ 4 J/g for high and low frequency ball-
milling respectively (Table 7-13). High frequency ball-milled samples also exhibited a 
Tg which was absent in the low frequency ball-milled materials. When a RDA was 
applied to these materials, DDSC values were obtained that reflected the relative levels of 
disorder present and confirmed the validity of the RDA approach in discriminating 
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differences between processes and relative levels of disorder, i.e. DDSC values of 5.0 and 
2.5 for high and low frequency ball-milled materials respectively.  
For some materials disorder can be inferred as a consequence of the appearance of a 
solid-state form. For these materials the comminution process mechanically activates 
the material disrupting the molecular structure in which disorder can occur, as 
comminution progresses molecular then re-ordering can result in the generation of a 
new solid-state form. Therefore, depending upon when comminution is halted different 
solid-state forms or phases may be observed. For example a solid-state transition of 
Form II to Form I was observed for high frequency ball-milled sulfamerazine which 
was not observed in the input material or in the low frequency or jet-milled sample. It is 
most likely that this solid-state transition is a result of induced disorder being generated 
during comminution
350,360-362
. Consequently, high frequency ball-milled sulfamerazine 
was assigned a RDSC3 score of 10. 
DDSC values for replicate samples subject to comminution for salbutamol sulphate, 
indomethacin and acetaminophen were also consistent. This confirmed the 
reproducibility of both the comminution processes and the novel disorder scoring 
methods (Table 7-13 and Figure 7-3). 
It can be seen from the results presented in Table 7-13 that the novel response disorder 
approach defined here is effective in defining both the presence of disorder based on 
changes in the DSC responses and also in discriminating between the different levels of 
disorder present for materials comminuted by different processes. 
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 Response disorder analysis for Gravimetric vapour sorption 7.3.3
(GVS) 
The total degree of observed disorder in the moisture sorption profile as a consequence 
of a given comminution process can be described and semi-quantified using the 
technique disorder score, DGVS. This value reflects the relative observed thermal 
response changes between the comminuted material and those of the input material with 
respect to any perceived PID changes (Table 7-14 and Figure 7-4). The higher the score 
the more likely that disorder is present.   
Although GVS RDA utilises changes in only two responses to detect and semi-quantify 
the presence of disorder, the resulting DGVS values were sufficient to discriminate 
differences between the materials and comminution processes (Table 7-14 and Figure 7-
4). These DGVS values were generally consistent with the GVS phase classification as 
determined previously (Table 6-20). However, like DSC, the observance of a new 
recrystallisation event in the moisture sorption profile cannot quantify the level of 
disorder and hence, the Mxtal (%) value should also be reported. Mxtal (%) is the value for 
% mass loss observed during recrystallisation.  
No disorder was induced by milling, as based upon the relative changes to the GVS 
responses that were observed for the comminuted materials of acetaminophen, 
acetylsalicylic acid, phenacetin and methyl paraben (Table 7-14 and Figure 7-4). 
Additionally, samples of jet-milled γ-indomethacin, sulfamerazine, sulfadiazine and 
caffeine did not exhibit any disorder when only the changes to their respective GVS 
responses are considered (Table 7-14 and Figure 7-4). However, low amounts of 
moisture sorption ( MMAX1) were observed when the ball-milled samples of γ-
indomethacin, sulfamerazine, sulfadiazine and low frequency ball-milled caffeine were 
analysed. This implied that there may have been a small amount of disorder generated 
as a consequence of the comminution processes and these materials were assigned RGVS 
values of 3 to 5. There was also observed a marked increase in moisture sorption when 
caffeine was subjected to high frequency ball-milling (Table 6.20) with the value of 
 MMAX1 being 7.17 % , which may suggest the presence of disorder. 
  
 219 
Table 7-14 RGVS and DGVS values for the comminuted materials 









1-MA1 0 0 0 0.0 Crystalline reversible moisture  sorption 
1-MA2 0 0 0 0.0 Crystalline reversible moisture  sorption 
1-MB1 0 0 0 0.0 Crystalline reversible moisture  sorption 
1-MB2 0 0 0 0.0 Crystalline reversible moisture  sorption 
1-X1 0 0 0 0.0 Crystalline reversible moisture  sorption 
γ-Indomethacin 
11-MA1 0 5 5 2.5 Disordered/increased surface area 
11-MA2 0 5 5 2.5 Disordered/increased surface area 
11-MB1 0 3 3 1.5 Crystalline reversible moisture  sorption 
11-MB2 0 3 3 1.5 Crystalline reversible moisture  sorption 









































































33-MA1 0 0 0 0.0 Crystalline reversible moisture  sorption 
33-MB1 0 0 0 0.0 Crystalline reversible moisture  sorption 
33-X1 0 0 0 0.0 Crystalline reversible moisture  sorption 
Sulfamerazine 
54-MA1 0 3 3 1.5 Disordered/increased surface area 
54-MB1 0 3 3 1.5 Crystalline reversible moisture  sorption 
54-X1 0 0 0 0.0 Crystalline reversible moisture  sorption 
Phenacetin 
69-MA1 0 0 0 0.0 Crystalline reversible moisture  sorption 
69-MB1 0 0 0 0.0 Crystalline reversible moisture  sorption 
69-X1 0 0 0 0.0 Crystalline reversible moisture  sorption 
Sulfadiazine 
87-MA1 0 5 5 2.5 Disordered/increased surface area 
87-MB1 0 5 5 2.5 Disordered/increased surface area 








Disordered/increased surface area 
88-MB1 0 5 5 2.5 Disordered/increased surface area 
88-X1 0 0 0 0.0 Crystalline reversible moisture  sorption 
Methyl paraben 
140-MA1 0 0 0 0.0 Crystalline reversible moisture  sorption 
140-MB1 0 0 0 0.0 Crystalline reversible moisture  sorption 
140-X1 0 0 0 0.0 Crystalline reversible moisture  sorption 
* Determined using Table 7-7 X solid-state confirmed by XRPD. RGVS
 ǂ: combined total RDS value for GVS responses, DGVS
ϕ : GVS disorder 
score calculated using equation [7-3]. ∆: GVS classification reported in Table 6-20. (XG #): size of Mxtal in %, (AG  ):   z   f ∆ MAX1. 
#-MA#: high frequency ball-mill method A, #-MB#: low frequency ball-mill method B. #-X#: jet micronisation method A. 
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For salbutamol sulphate, all the comminuted samples exhibited high values for DGVS due 
to the observation of a recrystallisation event and a large moisture adsorption during the 
first adsorption cycle. However, differences in the Mxtal values for the comminution 
processes do suggest that there may have been differences in the respective level of 
disorder present. High frequency ball-milling resulted in the largest Mxtal values 
followed by low frequency ball-milling and micronisation (Table 7-14). 
Comminution of loperamide HCl by high frequency ball-milling produced lower DGVS 
values than anticipated as no recrystallisation event was observed compared to that 
induced by other processes. Instead the material absorbed 9% (w/w) moisture reversibly 
during the first and second adsorption cycles, which can be indicative of the production 
of bulk disorder
255
. In the case of disorder generated by high frequency ball-milling, it 
has been demonstrated that moisture sorption by itself is not sufficient to facilitate a 
solid-state transformation of the bulk disordered material but rather the addition of heat 
is required for recrystallisation to occur. This was shown in the DSC thermogram for 
the high frequency ball-milled material (Figure 6-12). 
 
 
Figure 7-4 Summary plot of DGVS values for the comminuted materials 
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DGVS values that were obtained for replicate samples of comminuted salbutamol 
sulphate, indomethacin and acetaminophen were also consistent, confirming the 
reproducibility of both the comminution processes and the novel disorder scoring 
methods (Table 7-14 and Figure 7-4). 
 General discussion  7.3.4
To be able to fully discriminate between inter-, intra-material and processing differences 
in the degree of PID, a semi-quantitative approach was investigated. In this approach 
the amount of disorder in comminuted materials could be semi-quantified as a result of 
redefining the original CRA threshold levels from Chapter 6 for the individual 
technique responses specific to the presence of disorder. This enabled RDS values for 
the individual technique responses to be generated. These individual technique-specific 
RDS values were then combined to give PRDS scores which were then converted into a 
disorder score for the individual technique, i.e. DXRPD, DDSC and DGVS. The technique 
disorder scores were then combined to give a single normalised value, DPro, the 
magnitude of which represents the relative disorder present in the material as a result of 
a given pharmaceutical unit process. By using the relative combined changes between 
the individual technique responses of the comminuted material and those of the 
respective input the overall degree of PID can be defined multivariately instead of 
univariately and without the need for producing standard mixtures and calibration 
curves. 
 PRDS and DTechnique scores 7.3.4.1
In this study only RDS values for XRPD, DSC and GVS were used as these three 
techniques represent the ‘primary’ disorder detection methods in the core test set 
(Chapter 3). However, it is recommended that the full core test set is applied when 
characterising materials following comminution to provide a complete overview of the 
solid-state properties of the resulting material, such as monitoring changes in particle 
size, morphology and chemical purity.  
The individual technique RDA and disorder values for the comminuted materials are 
summarised in Table 7-15 and Figure 7-5 along with the overall process RDA (PRDS). 
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DXRPD DDSC DGVS PRDS 
Acetaminophen 
1-MA1 8 0 0 2.0 0.0 0.0 8 Crystalline 
No 
1-MA2 8 0 0 2.0 0.0 0.0 8 Crystalline 
1-MB1 12 0 0 3.0 0.0 0.0 12 Crystalline 
1-MB2 12 0 0 3.0 0.0 0.0 12 Crystalline 
1-X1 3 0 0 0.8 0.0 0.0 3 Crystalline 
Methyl paraben 
140-MA1 0 0 0 0.0 0.0 0.0 0 Crystalline 
No 140-MB1 2 0 0 0.5 0.0 0.0 2 Crystalline 
140-X1 9 0 0 2.3 0.0 0.0 9 Crystalline 
Phenacetin 
69-MA1 10 0 0 2.5 0.0 0.0 10 Crystalline 
No 69-MB1 2 0 0 0.5 0.0 0.0 2 Crystalline 
69-X1 10 0 0 2.5 0.0 0.0 10 Crystalline 
Acetylsalicylic 
acid 
33-MA1 19 0 0 4.8 0.0 0.0 19 Crystalline 
No 33-MB1 19 0 0 4.8 0.0 0.0 19 Crystalline 
33-X1 17 0 0 4.3 0.0 0.0 17 Crystalline 
Sulfadiazine 
87-MA1 17 8 5 4.3 2.0 2.5 30 Crystalline – little disorder 
Some 87-MB1 17 8 5 4.3 2.0 2.5 30 Crystalline – little disorder 
87-X1 8 5 0 2.0 1.3 0.0 13 Crystalline – little disorder 
Sulfamerazine 
54-MA1 22 10 3 5.5 2.5 1.5 35 Some disorder - some new form 
Some 54-MB1 33 0 3 8.3 0.0 1.5 36 Microcrystalline - little disorder 
54-X1 26 0 0 6.5 0.0 0.0 26 Crystalline 
Caffeine 
88-MA1 24 5 10 6.0 1.3 
5.0 
(AG 7.17) 
39 Crystalline – little disorder 
Some 88-MB1 17 0 5 4.3 0.0 2.5 22 Crystalline – little disorder 
88-X1 14 0 0 3.5 0.0 0.0 14 Crystalline – little disorder 
γ-Indomethacin 




2.5 59 Disordered 
Yes 




2.5 56 Disordered 
11-MB1 22 10 3 5.5 
2.5 
(XD 5.4) 
1.5 35 Microcrystalline - little disorder 
11-MB2 24 10 3 6.0 
2.5 
(XD 1.6) 
1.5 37 Microcrystalline - little disorder 
11-X1 13 0 0 3.3 0.0 0.0 13 Crystalline 
Loperamide  
HCl 














71 Some disorder 






53 Crystalline – little disorder  
Salbutamol 
sulphate 













24-MB1 26 25 15 6.5 6.3 
7.5 
(XG 1.33) 
66 Microcrystalline - some disorder 
24-MB2 26 25 15 6.5 6.3 
7.5 
(XG 1.25) 
66 Microcrystalline -  some disorder 
24-X1 12 20 15 3.0 5.0 
7.5 
(XG 0.68) 
47 Crystalline - little disorder 
RXRPD, RDSC and RGVS: combined total RDS value for XRPD, DSC and GVS responses respectively. DXRPD,
 DDSC and DGVS: XRPD, DSC and GVS disorder 
scores calculated using equations [7-1], [7-2] and [7-3] respectively. PRDS: Process response disorder score.. GD #): size of Tg in J/(g°C), (XD #):size of 
∆Hc in J/g (T  ):   z   f            ∆ t in J/g (XG #): size of Mxtal in %, (AG  ):   z   f ∆ MAX1. * from Table 6-25, ** from table 2-8. .#-MA#: high 






Figure 7-5 Plots of PRDS values for the comminuted materials  
Plots on the left show the PRDS values for the three comminuted processes, while the plot on the right shows a summary of the PRDS values across the comminuted materials 
MA: high frequency ball-mill method A, MB: low frequency ball-mill method B. X: jet micronisation method A. 
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PRDS values are a combination of the individual technique response disorder scores 
using the XRPD, DSC and GVS techniques, i.e. RXRPD, RDSC and RGVS respectively. The 
individual technique contributions to the overall PRDS score were weighted based on the 
number of responses used by each technique to infer the presence of disorder. RXRPD 
and RDSC values use a number of responses are employed, hence they provide a higher 
contribution or weight (with a maximum score of 40 allotted for each) to the overall 
PRDS score compared to GVS, which only utilises only two responses (with a maximum 
of score of 20). 
In general the overall response disorder scores (PRDS) for the comminuted materials 
were low, with acetaminophen, methyl paraben and phenacetin exhibiting the lowest 
values with PRDS values of less than 12 (Table 7-15). Only a few materials such as high 
frequency ball-milled γ-indomethacin, salbutamol sulphate and ball-milled loperamide 
HCl exhibited high PRDS values greater than 70, which indicated the presence of marked 
disorder (Table 7-15). Of all the comminution processes, high frequency ball-milling 
appeared to generate the greatest level disorder with respect to the magnitude of the 
PRDS values, followed by low frequency ball-milling and then jet-milling (Figure 7-5 
and Table 7-15).  In general, the calculated PRDS values (Table 7-15) agreed with the 
initial qualitative CRA solid-state phase classifications (Table 6-25). However, there 
were some exceptions to this observation and these were attributed to the increased 
resolution power of the RDA and PDA processes to discriminate the disorder within the 
comminuted materials. This will be discussed further in the proceeding pages. 
RXRPD values were obtained for most of the comminuted materials which implies that 
XRPD analysis could detect some degree of disorder in these materials (Figure 7-5 and 
Table 7-15). However, it is important to note that the RXRPD values represent not only 
changes in the XRPD responses for disordered material but also those associated with 
microcrystalline materials (Section 3.2). During a comminution process, material is 
mechanically broken down (ground) into smaller fragments with a consequential 
increase in surface area to produce particles within a specified particle size range 
(Section 1.4.2 and Figure 1-14). However, comminution can result in microcrystalline 
material, which may also contain some degree of disorder that can be difficult to define 
by XRPD analysis alone (Figure 7-6). With the addition of RDA scores by DSC and 
GVS analysis, the presence of disorder can be further discriminated and the solid-state 
phase present better defined (Figure 7-6). 
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Crystalline 
Crystalline 
(smaller particle size) 
Microcrystalline 






 Distinctive peaks  Distinctive peaks 
 Same peak positions 
 MIP may change 
 Peak heights maybe reduced 
 Peak heights reduced 
 Peak widths increased 
 Background increased 
 Some peaks merged 
 MIP may change 
 Same peak position 
 Peak heights reduced 
 Peak widths increased 
 Background increased 
 Some peaks merged 
 MIP may change 
 Some peak shifting maybe 
observed 
 Peak heights reduced 
 Peak widths increased 
 Background increased more 
 Increased peak merging 
 MIP may change 
 Some peak shifting maybe 
observed 
 No peaks observed 
 Amorphous “Halo” observed 
 Background increased 
 
RXRPD 0 to 12 
DXRPD  0 to 3.0 
RXRPD 13 to 28 
DXRPD  3.1 to 7.0 
RXRPD 29 to 40 
DXRPD  > 7.0 
GVS 
 No moisture sorption 
(<0.25 % w/w) 
 No moisture sorption    
(<0.25 % w/w) 
 No moisture sorption 
(<0.25 % w/w) 
 A new recrystallisation event 
maybe observed 
 An increase in absorption 
maybe observed 
 A new recrystallisation event 
maybe observed 
 large absorption maybe 
observed 
 A recrystallisation event 
maybe observed 
 Marked absorption 
RGVS 0 to 6 
DGVS 0 to 3.0 
RGVS 7 to 14 
DGVS  3.1 to 7.0 
RGVS 15 to 20 
DGVS > 7.0 
DSC 
 Distinct Tm observed 
 Degradation,  Td maybe 
observed 
 
 Maybe sharper Tm  
 ΔHf  unchanged 
 Td unchanged 
 Tmtrans maybe smaller 
 WHH larger 
 Maybe sharper Tm 
 ΔHf  unchanged 
 Td unchanged 
 A small desolvation event 
maybe observed 
 Tm  may decreased slightly 
 Td may decreased slightly 
 
 A small desolvation event 
maybe observed 
 A small Tg maybe observed 
 A new small recrystallisation 
or transition event maybe 
observed 
 Tm  maybe  decreased 
 Td maybe  decreased 
 A Tg maybe observed 
 A desolvation event maybe 
observed 
 A new recrystallisation or 
transition event maybe 
observed 
 Td maybe greatly reduced 
 Tm maybe greatly reduced 
RDSC 0 to 12 
DDSC  0 to 3.0 
RDSC 13 to 28 
DDSC 3.1 to 7.0 
RDSC 29 to 40 
DDSC > 7.0 
Figure 7-6 Technique response observations and RDA scores for different solid-state phase materials that could be generated during the comminution of an anhydrous 
crystalline input material 
MIP: Most intense peak,  RXRPD, RDSC and RGVS: combined total RDS value for XRPD, DSC and GVS responses respectively. DXRPD,
 DDSC and DGVS: XRPD, DSC and GVS disorder scores calculated using 
equations [7-1], [7-2] and [7-3] respectively. Td: Degradation temperature (°C), Tm: Onset of melting temperature (°C), Tm     :      g               g  (° ), Δ f: Heat of fusion (J/g), WHH: width at half 




For example, ball-milled materials of sulfadiazine have RXRPD values of 17 which 
implied the presence of some disorder (Table 7-15). However, XRPD analysis alone 
cannot discriminate whether the relative changes in the XRPD responses are a 
consequence of generated microcrystalline product, the presence of disordered material 
or a mixture of both. By including the RDA values and observations for the DSC and 
GVS data, the solid-state phase present can be better defined. The presence of a small 
amount of disorder in ball-milled sulfadiazine samples is indicated by the observed 
decreases in Tm and Td during DSC analysis (RDSC 8, DDSC 2.0) and change in moisture 
sorption ( MMAX1) observed during GVS analysis (RGVS 5, DGVS 2.5). However, the 
overall amount of disorder present as a consequence of ball-milling is low with a PRDS 
value of 30, hence this material is likely to be microcrystalline with a very small amount 
of disorder present. 
For the comminuted materials of acetylsalicylic acid (RXRPD 17 to 19) and jet-milled 
sulfamerazine (RXRPD 26), RXRPD values may have suggested the presence of some 
disorder (Table 7-15). However, relative changes in their DSC and GVS responses did 
not support the presence of disorder, i.e. RDSC and RGVS values were 0 (Table 7-15). 
Therefore, it is most likely that the relative changes observed in the XRPD responses for 
these two materials were due to the presence of microcrystalline material generated as a 
consequence of the comminution processes and not due to disorder.  PRDS scores for 
these materials were low, below 31, hence these materials were designated as being 
crystalline. 
Low frequency ball-milled γ-indomethacin was initially classified as being 
microcrystalline with a small amount of disorder using the CRA approach (Table 6-25). 
This was further confirmed using the new RDA and PDA approaches. A RXRPD value of 
23 (Average DXRPD ~5.8) was determined based on the relevant changes to the XRPD 
responses, i.e. the merging of peaks, change in MIP, small decrease in peak heights, 
slight increase in background profile and a large increase in peak widths (Table 7-12). 
This RXRPD value implies the presence of some disorder, microcrystalline material or a 
mixture of both, but using these data alone are insufficient to determine which of these 
is actually present. With the inclusion of the DSC and GVS data, a small level of 
recrystallisation and an increase in moisture sorption was observed giving rise to RDSC 
and RGVS scores of 10 and 3 respectively (Table 7-15). Hence, low frequency ball-
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milled γ-indomethacin was thought likely to consist of microcrystalline material with a 
small amount of disorder. 
It can be seen from examples given, relying on only one technique such as XRPD to 
define and discriminate the presence and degree of disorder present as a consequence of 
a comminution process may not be sufficient. By using multiple techniques and 
responses both the presence and relative amounts of disorder can be better determined 
and the probability of detecting disorder can be greatly enhanced. 
This can be further illustrated using RDA analysis for jet-milled salbutamol sulphate. 
RDA analysis of the XRPD data (RXRPD of 12, DXRPD of 3.0) did not identify high levels 
of disorder present in the sample. Instead changes in the XRPD responses were most 
likely caused by the decrease in particle size of the comminuted material and this 
resulted in a change in MIP and a marked decrease in peak heights (Table 7-12). 
However, when changes in the DSC and GVS responses are included in the disorder 
assessment, higher levels of disorder are identified, i.e. values of 20 and 15 were 
determined for RDSC and RGVS respectively (Table 7-15). The reason for this discrepancy 
could be due to the sensitivities of the individual techniques in detecting disorder for 
this particular material or level of disorder, i.e. both the GVS and DSC methods were 
more sensitive than that of XRPD in this case. 
It must be noted that the amount of recrystallisation observed in the DSC could not be 
calculated for salbutamol sulphate due to the presence of unresolved thermal events. 
However, visually, the recrystallisation observed in the DSC thermogram for the jet-
milled salbutamol sulphate sample was much lower than that observed for the ball-
milled materials (Figure 6-15). The combined PRDS value for jet-milled salbutamol 
sulphate was 47, suggesting that there was some degree of disorder present which would 
not have been identified if just XRPD analysis was used alone. 
The ball-milling of sulfamerazine resulted in material that exhibited changes in the 
XRPD diffractogram consistent with the presence of disorder. Interestingly, this was 
more so for the low frequency ball-milled material (RXRPD of 33) compared to high 
frequency ball-milled material (RXRPD of 22). As discussed earlier (Section 7.3.1), this 
observation was most likely due to the transformation kinetics of the disordered phase 
and not due to inaccuracies of the RDA method. Limited disorder was suggested with 
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the addition of DSC and GVS data as shown by their RDSC and RGVS values (Table 7-
15).  
In the case of high frequency ball-milled caffeine, RDA for the XRPD data suggested 
the presence of some disorder (RXRPD of 24). However, DSC analysis only showed a 
small loss of volatile solvent (RDSC of 5) but GVS analysis indicated that the moisture 
sorption properties of this material was greatly enhanced which may imply the presence 
of increased surface disorder (RGVS of 10). Overall, the PRDS for high frequency ball-
milled caffeine was 39, which suggested there was only a small amount of disorder 
present. 
 DPro scores 7.3.4.2
The total amount of disorder present (DPro) in a material as a consequence of a given 
pharmaceutical process was calculated by two different approaches to investigate the 
effect of scaling of the individual technique contributions to the overall disorder score. 
In the first approach, process PRDS values were converted into DPro1 values using 
equation [7-5], where the maximum individual RDS contributions of RXRPD, RDSC and 
RGVS were weighted towards the XRPD and DSC values. While in the second approach 
the process disorder score, DPro2 was calculated by averaging the technique disorder 
scores, DXRPD, DDSC and DGVS using equation [7-6]. In this approach the individual 
technique contributions were treated equally.  
The DPro values for the comminuted materials determined by both approaches are 
summarised in Table 7-16 and Figure 7-7. Using the DPro values, the comminuted 
materials can be separated and ranked into three classes of materials which reflect the 
solid-state phase present (Figure 7-11). 
Only three materials, high frequency ball-milled salbutamol sulphate and high and low 
frequency ball-milled loperamide HCl exhibited DPro scores above 7 and were 
categorised as being disordered (Table 7-16 and Figure 7-11). These results are in 
agreement with the CRA classification (Table 6-25) and the literature observations that 
demonstrated that these materials exhibit PID when comminuted (Table 2-8). 
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Table 7-16 Summary of process disorder scores for the comminuted materials 
Material Process 
Process scores PDA solid-state 
phase 
classification 
Overview CRA solid-state 
phase classification *  
Lit 
PID** PRDS DPro1 DPro2 
Methyl 
paraben 
MA 0 0.0 0.0 Crystalline Crystalline 
No MB 2 0.2 0.2 Crystalline Crystalline 
X 9 0.9 0.8 Crystalline Crystalline 
Acetaminophen 
MA 8 0.8 0.7 Crystalline Crystalline 
No MB 12 1.2 1.0 Crystalline Crystalline 
X 3 0.3 0.3 Crystalline Crystalline 
Phenacetin 
MA 10 1.0 0.8 Crystalline Crystalline 
No MB 2 0.2 0.2 Crystalline Crystalline 
X 10 1.0 0.8 Crystalline Crystalline 
Acetylsalicylic 
acid 
MA 19 1.9 1.6 Crystalline Crystalline 
No MB 19 1.9 1.6 Crystalline Crystalline 
X 17 1.7 1.4 Crystalline Crystalline 
Sulfadiazine 
MA 30 3.0 2.9 
Microcrystalline – 
little disorder 
Crystalline – little disorder 
Some MB 30 3.0 2.9 
Microcrystalline – 
little disorder 
Crystalline – little disorder 





3.9 4.1 Little disorder Crystalline – little disorder 
Some MB 22 2.2 2.3 Crystalline Crystalline – little disorder 





3.5 3.2 Little disorder Some disorder - some new form 
Some MB 36 3.6 3.3 Little disorder Microcrystalline - little disorder 




(GD 0.315,XD 20.3)ǂ 







Microcrystalline - little disorder 





(GD 0.265, XD 60.7, 
AG 9.10) 




(XD 11.1, XG 3.46, 
AG 2.88) 
7.1 7.3 Disordered Some disorder 
X 
53 
(XG 1.08, AG 0.72) 





(XG 9.69) ǂ 
10.0 10.0 Disordered Disordered 
Yes MB 
66 
(XG 1.29) ǂ 
6.6 6.8 Some disorder Microcrystalline - some disorder 
X 
47 




Crystalline - little disorder 
ǂ Average value from replicate processes. DXRPD,
 DDSC and DGVS: XRPD, DSC and GVS disorder scores calculated using equations [7-
1], [7-2] and [7-3] respectively. PRDS: Process response disorder score. DPro1 and DPro2 : process disorder score calculated using 
equation s [7-5]and [7-6] respectively.* from Table 6-25, ** from table 2-8. (GD #): size of Tg in J/(g°C), (XD  ):  z   f ∆ c in J/g, (T 
 ):   z   f            ∆ t in J/g. (XG #): size of Mxtal in %, (AG  ):   z   f ∆ MAX1. 
M: high frequency ball-mill method A, MB: low frequency ball-mill method B. X: jet micronisation method A.  
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Figure 7-7 Calculated DPro scores using weighted and average approaches for the comminuted materials  
MA: high frequency ball-mill method A, MB: low frequency ball-mill method B. X: jet micronisation method A. 
DPro1(weighted): process disorder score calculated using equation [7-5], DPro2(average): process disorder score calculated 
using equation [7-6],  
 
When comparing the DPro values calculated by the two different approaches for the 
same material, it can be seen that the weighted approach appears to be better at 
discriminating between the comminution processes for materials containing higher 
degrees of disorder (Figure 7-11). For example, DPro1 values of 7.8 and 7.1 were 
calculated using the weighted approach for high and low frequency ball-milled 
loperamide respectively, but the DPro2 values were identical (DPro2 of 7.3) when 
calculated using the average approach (Table 7-16 and Figure 7-11). However, the 
reported  Hc values for recrystallisation from the DSC thermograms (Table 7-13), 
suggests high frequency ball-milled loperamide HCl ( Hc of 60.7 J/g) is more 
disordered than the low frequency ball-milled sample ( Hc of 11.1 J/g). Therefore, the 
weighted approach appears to be better at discriminating between the comminution 
processes and quantify the relative levels of disorder present. 
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A number of materials appear to have some level of disorder with DPro values between 3 
and 7 such as: ball-milled sulfamerazine, γ-indomethacin, high frequency ball-milled 
caffeine, jet-milled loperamide HCl and salbutamol sulphate and low frequency ball-
milled salbutamol sulphate (Table 7-16). For these materials, the method by which the 
DPro values were calculated had minimal impact to the overall PID ranking or to 
amounts of relative disorder estimated to be present. The relative levels of disorder 
present in the comminuted materials were in agreement with the CRA classification 
(Table 6-25) and those from literature observations that demonstrated that these 
materials exhibit some degree of PID when comminuted (Table 2-8). 
Literature observations
221,270 
for sulfadiazine suggested that this material may exhibit 
some degree of disorder when comminuted. This was confirmed using the CRA 
approach (Table 6-25) in chapter 6. However, these approaches only provide a 
qualitative assessment of disorder. When the new RDA and PDA approaches were 
applied to assess the degree of disorder present as a consequence of the three 
comminution processes a relatively low DPro value of less than 3.0 was obtained (Table 
7-16). This illustrates the effectiveness of the new processes in quantifying the relative 
levels of disorder present, as it can remove some of the ambiguity concerning the degree 
of disorder by providing a numerical value, allowing better comparisons to be made 
between both different material types and processes. 
 Conclusions 7.4
The development of a novel analytical approach to determine the level of disorder 
present in a material as a consequence of a comminution process has been described.  
To date, there has been no quantitative approach reported that has incorporated the 
responses from multiple techniques into a single value to define a certain property such 
as the presence of disorder or amorphous character.  
The validity and verification of the novel analytical approach to determine disorder has 
been further demonstrated through its application in characterising the resulting 
comminuted materials. It has been successfully shown that this approach will allow 
materials of differing chemical and crystallographic properties to be ranked according to 
the relative level of disorder being present, and that the approach can differentiate the 
effectiveness of different comminution processes in generating PID. 
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8 General discussion and conclusions  
 General discussion 8.1
Pharmaceutical medicines are most frequently manifested as solid dosage forms which 
are manufactured using a number of different pharmaceutical unit operations or 
processes. Such processes often impose a number of thermal and mechanical stresses 
upon the formulation, comprising of an API and associated excipients (Figure 1-11). 
The forces associated with mechanical processing may inadvertently cause process-
induced phase transformations
11,12
 (such as the generation of lattice disorder or PID
17-28
) 
to any crystalline components within the formulation, which is a significant concern to 
the pharmaceutical industry
17-28,65
 as it may ultimately change the intended 
pharmaceutical product’s physiochemical stability and therapeutic performance13-17. The 
extent of this disorder will depend on the type and conditions of the pharmaceutical unit 
process employed and upon the intrinsic properties of the materials involved.  Typically 
Particle size reduction or comminution by milling or micronisation is often required to 
enhance the bioavailability of pharmaceutical solids as a consequence of it conferring 
increased dissolution rate or solubility
1-4
 upon the API. For an inhaled pharmaceutical 
powder, the overall size is also a major determinant of its site of deposition in the 
airways after aerosolised delivery
372-376
. However, such size reduction unit operations 
have the highest risk of generating PID due to their intense mechanical nature and the 
associated high processing input energies that are required
5-10
. It is therefore important 
to develop strategies to control, characterise and optimise the particle properties to 
ensure the safety and quality of the final product.  
Knowledge of the molecular structure and mechanical properties of the input material 
and the potential pre-existing structural flaws could enable the development of more 
robust pharmaceutical comminution processes and lead to a better understanding of the 
potential for certain materials to undergo PID.  However, currently the propensity of 
crystalline materials to become disordered or the extent to which this might proceed as a 
function of imposed processing conditions is poorly understood
137,160,192,221,264
. Recent 
studies have made attempts to correlate the presence of disorder with known material 
properties, in order to predict their disordering potential or propensity
160,221,264
. 
However, the materials employed in these studies have potentially been over-processed 
in an attempt to force the generation of “pure” amorphous phases using different 
processes and/or conditions. Additionally, differences in milling times were not taken 
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into account when interpreting and modelling any property-phase relationships
160,221
. 
Continuingly milling for excessive periods effectively forces the material to become 
“amorphous” and treats all those materials that exhibit amorphous behaviour identically, 
regardless of the time it may have taken to induce this disorder. It can be argued that it 
is more appropriate to mill all the materials for the same period of time using the same 
operational conditions or include a weighting/scale factor that takes into account the 
time required to generate disorder. This time period could be classed as a measure of the 
materials PID resistance or susceptibility under standardized conditions. The shorter the 
time period, the lower the PID resistance, and the greater the susceptibility of the 
material to PID. 
In recent years methods to define “pure” crystalline and “pure” amorphous materials has 
vastly improved
11,12,14,15,17,31
. Nevertheless, the detection and quantification of the 
relative amounts of solid-state phases across the amorphous-crystalline continuum 
within a given material is still not readily achieved 
Typically the qualitative detection of PID is performed using individual techniques such 
as XRPD, DSC and GVS
21,28,88,175,190-193
, which can produce somewhat subjective 
results since such determinations rely on the analyst’s experience and 
interpretation
23,244,245,247
. Conversely, quantifying the amount of disorder present within 
a solid material depends greatly on the sensitivity of the technique. It is also typically 
only achieved with the use of single analytical responses and employing calibration 
curves constructed using mixtures of “pure” amorphous and crystalline standards that 
can be both problematic and complex to generate
23,24,65,87,194-198
. For example, in a 
number of earlier studies, investigators  made the assumptions that the analytical 
responses from a potential disordered material being investigated were the same as 
those of an amorphous standard
18,24,190,191,252,307,308
. However, this may not always be the 
case, as the “pure” amorphous standards were typically generated using a different 
process from than that being applied to the material being investigated, e.g. amorphous 
standards generated by spray drying (bulk disorder) will exhibit different moisture 
sorption properties/responses when analysed by GVS than disordered ball-milled 
samples (surface disorder). The use of such standards can therefore result in errors in 
the estimation of the amount of amorphous material present
309
. Additionally a number 
of previous studies generated amorphous standards by the process of “melt-quenching”, 
which is the process of melting the materials followed by a rapid cooling so as to “trap” 
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or isolate the amorphous form
56,63,271
. This is in effect, the formation of a kinetamorph, 
where different cooling and process parameters may give rise to a different 
polyamorphic form (Section 1.1.2). However, amorphous standards prepared in this 
manner will also be bulk disordered and as such may exhibit different analytical 
responses compared to mechanically comminuted materials where disorder is mainly 
located upon the surface
56,63,279
. Furthermore, it is important to check the chemical 
purity post-processing to ensure no impurities have been introduced that could interfere 
with the analytical response measurements. However, historically this has not always 
the case
158,205,208,221,257,367-369
. This is especially important for materials that exhibit a 
melt-degradation events such as salbutamol sulphate
1,19,297
 as the amorphous materials 
prepared by melt-quenching are more likely to contain thermal degradants. 
To address the need for an effective method to both detect and quantify levels of 
induced disorder in a material as a consequence of a given mechanical process, a novel 
analytical approach was investigated that negated the need for standard mixtures or 
calibration curves. This provided the main research focus for this thesis (Section 1.5). 
To develop this new analytical approach a model set of ten pharmaceutical materials 
that encompassed the whole of the amorphous-crystalline continuum were selected 
using a defined set of criteria (Table 2-4). This systematic selection process, which does 
not appear to have been utilized previously, ensured materials were chosen not only 
based on the literature assessments of their propensity for PID by mechanical 
comminution, but also ensured that the materials selected had sufficient diversity in 
their structural and molecular properties. For example, diversities in their H-bond donor 
and acceptor capabilities, molecular weights, melting onset temperatures, LogP, 
solubilities, molecular space group numbers and the number of rotatable bonds etc 
(Table 2-9). Mechanical properties were not included in the selection criteria, due to the 
difficulty in obtaining this information for all materials either from the literature or from 
databases. Additionally, there are no mechanical property prediction software programs 
available, unlike those for solubility and H-bond properties. 
Of the materials selected, four were selected from the literature that appeared to be 









. Three materials were selected from the literature that 







finally three materials were selected from the literature that appeared mainly disordered 
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 and loperamide hydrochloride
278
. 
Prior to subjecting the compounds to mechanical comminution, the materials were 
classified into different particle size fractions by mechanical sieving and the sieving 
efficiency investigated using a combination of techniques (PSA, SEM and PLM) 
(Section 4.3.2). Sieving the materials can reduce the inherent variation in the bulk as 
unsieved materials can exhibit a wide range of particle properties, such as size or 
morphology (habit) and these may give rise to a wide range of analytical responses 
when characterised. 
It was noted that many investigators use materials as received from the supplier without 
performing any pre-processing steps, such as particle size fractionation. Alternatively, if 
the materials are sieved, then assumptions are often made that the particle size fractions 
obtained will always match the mesh sizes employed
247,248
. However, data obtained in 
the current study have shown that despite the sieving process being effective in 
separating the materials into different particle size fractions, the final particle sizes did 
not necessarily correlate precisely with the sieve size used (Table 4-5). Such differences 
were most likely attributable to the presence or breaking of agglomerates, other material 
properties such as crystal morphology, or electrostatic charges generated during the 
sieving process that caused particle retention. Such behaviour is typified by loperamide 
HCl, caffeine and methyl paraben whereby, fairly strong agglomerates remained (Table 
4-6). 
For each study material only one sieved fraction was selected for further investigation 
thereby reducing the potential range of analytical response variability as a consequence 
of particle size (Table 4-8). The selected sieved fractions for the materials were then 
successfully characterised using a set of core analytical test methods comprising of 
XRPD, GVS, DSC, TGA, SEM, PLM, PSA, HPLC, and FTIR (Chapter 4). The 
analytical responses from these core techniques demonstrated that all the sieved 
powders were highly crystalline and anhydrous. Furthermore, the analytical responses 
from these core tests became the reference values that were then used to compare to the 
responses of the corresponding mechanically comminuted materials. 
Unlike previous studies
160,221
 where different comminution conditions were applied to 
different materials, all the materials in this thesis were comminuted the same way and 
for the same length of time. This regimen allowed the relative amounts of any observed 
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disorder to be compared between materials and also between processes and or 
conditions for the same material.   
Three mechanical comminution methods involving cryogenic vibrating ball-milling and 
air jet-milling (fluid energy mill or micronisation) were employed to generate different 
levels of PID for the selected study materials using varying but standardised parameters 
(Chapter 5). Any variation in PID within the material might then be reasonably 
attributable to the different processing conditions. Such changes could, in turn be 
investigated using the core analytical test methods. Of the comminution processes 
employed, two comprised cryogenic ball-milling methods, which involved low and high 
frequency impaction using different ball sizes and milling periods, performed whilst 
cooling at the temperature of liquid nitrogen (Table 5-1). These methods were referred 
to as the high frequency (Mill-A) and low frequency (Mill-B) milling methods. Method 
Mill-A, was a high energy comminution process that vibrated a larger milling ball at a 
higher frequency and for a longer period then method Mill-B, hence, method mill-A 
was the more likely of the two techniques to generate the most PID. 
Cryogenic ball-milling using liquid nitrogen was used to ensure that milling occurred 
below room temperature as it has been noted in the literature that low temperature 
milling can be more efficient in generating amorphous material compared to room 
temperature
146,345
. This may be attributed in part to the materials being rendered more 
brittle (less elastic) at low temperatures and therefore more amenable to size reduction 
processes and hence induced disorder
137,146,160,191,192,221,247,345
. Additionally, precautions 
were taken to reduce the influence of local %RH to cause recrystallisation
311
 of any 
transient meta-stable phases or solid-state forms during and after ball-milling by using a 
dry nitrogen atmosphere to charge and discharge the milling jars. Similarly, jet-milling 
or micronisation of the materials was performed under a dry nitrogen atmosphere, to 
reduce the effects of environmental %RH. However, an increase in the temperature of 
10 °C in the collection vessel was observed during the micronisation process, which 
partially contradicts previous assumptions that jet-milling using air as a component of 
the grinding media can help to cool or dissipate any generated heat
180
. 
The degree of comminution obtained by micronisation depends on the critical milling 
parameters: feed rate, feed pressure and grind pressure
21,344
. Micronisation feed and 
grind pressures of 8 and 6 bar respectively were selected
11,344
 so as to prevent clogging 
and to ensure a maximum jet speed (sonic velocity) could be obtained
21
. The feed rates 
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were similar for all materials, ranging from 0.23 to 0.29 gmin
-1
 (Table 5-3), allowing 
the materials to be readily be accelerated upon entry into the grinding chamber. If the 
material concentration inside the grinding chamber was too large then a decrease in 
inter-particulate acceleration distance would result, giving rise to coarser particles
21
. 
Following comminution, most materials were electrostatically charged especially those 
processed by high frequency ball-milling or micronisation. However, by applying an 
ionizing airflow to these materials the electrostatic charges tended to dissipate. For 
some materials a colour change was observed upon comminution, the most notable of 
these was for γ-indomethacin377, which upon high frequency ball-milling changed 
colour from white to bright yellow and formed lumps and a hard layer that encased the 
milling ball (Figure 5-1). Similar, although less-intense colour changes, were also 
observed for the low frequency ball-milled and micronised materials. 
Once comminuted, the materials were characterised using the core analytical test 
methods and the technique responses compared to those obtained for the input materials 
by a new approach called comparative response analysis (CRA) (Chapter 6). This 
approach allowed a systematic and consistent process, in which the amount of change in 
the individual technique responses could be determined and the qualitative relevance of 
these changes with respect to the solid-state phase present for each of the comminuted 
materials to be defined. This is advocated to be an improvement on previous methods to 
define the solid-state phase in materials which solely relied on the analyst’s experience 
and interpretation using single techniques and/or responses
23,244,245,247
. 
Based on the CRA values, novel solid-state phase classifications or decision trees were 
developed and applied to those core test methods which could detect the presence of 
disorder directly; these were referred to as the ‘primary’ disorder detection methods 
XRPD, DSC and GVS. The other test methods were classed as ‘secondary’ disorder 
detection methods as it was concluded that the results generated by the latter methods 
could not be employed solely to infer the presence of disorder. However, such 
‘secondary’ methods can be used to provide supplementary or supportive evidence for 
the presence of disorder indirectly. 
By using the combined information from the primary and secondary disorder detection 
methods, the solid-state phase present for each comminuted material could be 
qualitatively defined (Table 6-25).  
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Four materials, acetaminophen, acetylsalicylic acid, phenacetin and methyl paraben 
appeared resistant to PID regardless of the comminution process employed which was 
consistent with the initial literature PID classifications (Table 6-25).  
Three other materials, sulfamerazine, sulfadiazine and caffeine exhibited some degree 
of disorder when ball-milled but not when micronised which is in general agreement 
with the initial literature PID classifications (Table 6-25). However, in the case of 
sulfamerazine, high frequency ball-milling resulted in the generation of a small amount 
of Form II material via the amorphous phase which was consistent with previous 
studies
336,349-351,361,362
. This new solid-state form is thought to arise as a consequence of 
ball-milling, whereby the material is transformed through a series of transitions from 
Form I to amorphous to Form II. If the comminution process were to continue then the 
material would then revert back to Form I. The comminution of sulfamerazine 
highlights an important observation in that the identification of the presence of disorder 
typically relies on disorder being present at the time of analysis. This means, therefore, 
that disorder may have already have been generated but such changes may then have 
been transformed to another solid-state as the comminution process progresses. By 
using the CRA methods and combining the results from multiple techniques, the 
probability of identifying either the presence or remnants (effects) of disorder would 
likely to be greatly enhanced. 
For loperamide HCl, salbutamol sulphate and γ-indomethacin different solid-state 
phases were observed depending on the comminution process employed. The level of 
disorder present appeared to be proportional to the relative amount of energy imparted 
by the comminution process. Ball-milling in general had a greater tendency to induce 
disorder than micronisation, hence the comminution processes could be ranked in order 
of their tendency to cause PID from lowest to highest: micronisation (JM-A) < low 
frequency ball-milling (Mill-B) < high frequency ball-milling (Mill-A). This order also 
reflects the efficiency of the comminution processes in reducing particle size without 
causing PID, with micronisation (JM-A) being the most efficient and ball-milling (Mill-
B and Mill-A) being least efficient of the processes investigated. 
It has been postulated that the process of ball-milling can cause “amorphisation” of a 
material via melt-quenching at localised “hot spots” where there is no temperature 
control during the comminution process
72
. This phenomenon was investigated by ball-
milling salbutamol sulphate at high frequency with and without temperature control 
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using liquid nitrogen. Salbutamol sulphate was chosen for this investigation as it has a 
Tg that has been shown to be affected by the presence of water, around 65 °C when 
“wet” 19,247,358 or 120 °C if “dry” 
359
, and has been shown to exhibit a melt-degradation 
event
1,19,297
, hence, any increase in internal milling temperature could affect PID 
generation as well as chemical purity. High frequency ball-milling salbutamol sulphate 
with and without temperature control resulted in a predominately amorphous material 
but the overall estimated chemical purity remained relatively high with only a 0.5 % 
observed drop  in the primary peak area by HPLC analysis. This implied that the 
observed “amorphisation” of salbutamol sulphate was most likely due to the mechanical 
disordering of the molecules and not because of melt-quenching at localised “hot spots”. 




Using the novel CRA procedure (Chapter 6) the solid-state phases present in the 
comminuted materials were identified and defined and were in general, in agreement 
with the initial literature PID classifications (Table 6-25). For example, acetaminophen 
appeared not to generate PID when subjected to mechanical comminution processes as 
observed by Wildfong et al. (2006)
160
. However, for other materials such as γ-
indomethacin which had been initially classified as being sucepitble to PID when 
mechanically comminuted
148,160,178,212,221,268,271
, the solid-state phase classification using 
the CRA approach depended on the comminution process employed. However, it must 
be noted that the initial literature PID classification was based on observations from a 
number of studies that used different comminution conditions and milling periods from 
those employed in this current study to ensure complete amorphisation of γ-
indomethacin. For example, Wildfong et al. (2006)
160
 and Lin et al. (2009)
221
 used a 
cryogenic impact mill to generate amorphous γ-indomethacin afer 3 h milling, while 
Otsuka et al. (1994)
148
 ball-milled at 4 °C for 10h generate the amorphous form. In all 
these examples, complete disorder was assumed by the demonstration of a diffuse halo 
in XRPD patterns without detectable diffraction peaks and also verified by the presence 





Using the CRA approach, the high frequency ball-milling of γ-indomethacin resulted in 
material classified as being disordered which was consistent with the literature PID 
classification. While low frequency ball-milling generated microcrystalline material 
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with a small level of disorder present and micronisation did not alter the solid-state 
phase, i.e. micronised γ-indomethacin appeared to be remain crystalline. 
The comminution of γ-indomethacin successfully demonstrates that the different 
comminuted materials can be classified into different solid-state phase classes based on 
relative changes to their technique responses. However, there are some limitations in 
using the CRA approach, in that the process cannot discriminate the degree of disorder 
within a certain class, i.e. which materials were more disordered than others with a 
solid-state phase class. However, some attempt to achieve a degree of disorder scaling 
was made by developing a colour-coding scheme. This procedure employed the 
qualitative CRA results obtained from the XRPD, DSC and GVS experiments (Section 
6.4.9) and assigning a colour (red, orange or green) corresponding to the degree of 
change. The greater the number red boxes, the more likely disorder is present (Table 6-
25). 
The CRA results further demonstrated that the three comminution processes 
successfully produced materials that encompassed the whole amorphous-crystalline 
continuum and that the defined solid-state phases were consistent with those reported 
from the literature (Table 6-25). 
In order to improve the discrimination of the resultant degree of induced disorder the 
data were further processed to develop a procedure, termed response disorder analysis 
(RDA) (Chapter 7). This was achieved by redefining the CRA threshold levels for the 
individual technique responses so that they were specific to the presence of disorder. 
This allowed the relative amount of disorder present in the comminuted materials to be 
semi-quantified and generated response disorder scores (RDS) for the individual 
technique responses. These individual RDS values were then combined to give an 
overall RDS score for the technique, (RTechnique). In this study only RDS values for 
XRPD (RXRPD), DSC (RDSC) and GVS (RGVS) were used as these three techniques 
represent the ‘primary’ disorder detection methods in the core analytical methods test 
set.  
The maximum sum of the individual RDS for each technique was weighted depending 
on the number of inherent specific responses associated with each technique that can be 
used to identify disorder. For example, both XRPD and DSC have a number of 
responses that are specific to identifying disorder in a compound, so that the maximum 
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sum of their individual RDS values was 40, while for GVS the maximum sum was 20, 
as it only allowed two different responses specific to disorder to be determined. 
To enable comparisons between the relative amounts of disorder detected by each 
technique to be made, the weighted RTechnique values were converted to technique 
disorder scores (DTechnique). It is important to note that the DTechnique values are 
normalised estimates of the likelihood of disorder being present as determined by 
observed response changes using the given technique and should not be considered as 
absolute values for the amount of disorder present. DTechnique values were allocated a 
maximum value of 10, the higher the value the greater the relative amount of disorder 
detected by the given technique. 
When comparing DTechnique values between different comminution processes, it may be 
advantageous to also quote the observed magnitude of certain responses, i.e. the size of 
the Tg and  Hc responses from the DSC response analysis, or the size of Mxtal (%) and 
 MMAX1 responses from the GVS analyses. For example, the comminution of 
loperamide HCl by the three different comminution processes (Mill-A, Mill-B and JM-
A) resulted in material with differing DDSC values, 7.0, 4.5 and 3.8 and values for  Hc of 
60.7, 11.1 and 8.0 J/g respectively. Therefore, the high frequency ball-milled sample 
contained more disorder than the low frequency ball-milled or jet-milled materials as 
indicated by the DDSC values and verified by the magnitudes of the recrystallisation 
enthalpies.  
Though disorder could be detected to some degree in most of the comminuted materials 
by XRPD analysis alone, it is important to note that observed changes in the XRPD 
responses may not necessarily be completely due to the presence of disorder. The 
presence of microcrystalline material may also result in similar changes and lead to 
DXRPD values between 3 and 7 being obtained. Therefore, relying on only one technique 
such as XRPD to define and discriminate the presence of disorder as a consequence of a 
comminution process may not be sufficient, but with the addition of the RDSC and RGVS 
values the presence of disorder could be further verified and the solid-state phase 
present confirmed (Figure 7.6). 
The process of determining the relative amount of disorder as a consequence of a 
defined comminution process, was referred to as process disorder analysis (PDA), and 
involved combining either the individual technique RDS values of the three techniques, 
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RXRPD, RDSC and RGVS to give an overall process response disorder score (PRDS) or the 
use of DTechnique scores to give an overall process disorder score (DPro). 
The PRDS values were scored out of 100, the higher the value the greater the relative 
degree of disorder present. These calculated PRDS values for the comminuted materials 
(Table 7-15) generally correlated well with the initial qualitative CRA solid-state phase 
and the literature PID classifications (Table 6-25). However, there were some 
exceptions that could be attributed to the increased resolution power of the RDA and 
PDA processes to discriminate the disorder within the comminuted materials. For 
example, high frequency ball-milled γ-indomethacin had initially been classified as 
being disordered by the CRA process and the PID literature review but the combined 
XRPD, DSC and GVS RDS values obtained using the PDA process produced a PRDS 
value of only 58. This suggested that although there was some disorder present in the 
sample, the material was not completely disordered.  Though γ-indomethacin does form 
an amorphous material when subjected to a mechanical process, the degree of disorder 
induced is dependent upon the comminution process and the relative operating 
conditions employed. For example, Wildfong et al. (2006)
160
 cryogenically milled 
indomethacin for 3 h to generate amorphous γ-indomethacin, while Chieng et al. 
(2009)
212 
ball-milled for only 60 min in a 25 mL volume stainless-steel milling jar 
containing two 12 mm diameter stainless-steel balls and at a milling frequency of 30 Hz 
to generate material that appeared predominately disordered. In both cases the degree of 
disorder present was assessed based on qualitative analysis of the XRPD and DSC data, 






For other materials such as ball-milled caffeine the increased resolution power of the 
RDA process enabled the degree of disorder present to be better defined. In addition the 
better discrimination power associated with this factor allowed the effects of the 
different comminution processes to generate PID to be determined. The CRA values 
suggested the material derived from both the ball-milling processes for caffeine was 
predominately crystalline with only a small amount of disorder induced in the samples 
(Table 6-25), which was in agreement with observations from the literature
217,269
. 
However, the degree of PID as a result of these two processes could not be 
distinguished, but by using the RDA and PDA approaches the calculated PRDS values for 
these comminuted materials indicated that different levels of disorder were present but 
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the overall the amount of disorder present was low. The high frequency ball-milled 
sample generated material having a PRDS value of 39, confirming the presence of some 
disorder. The low frequency ball-milled sample had less disorder present with a 
calculated PRDS value of only 22, hence this material was classified as being crystalline 
(Table 7-15). 
The total amount of disorder present (DPro) in a material as a consequence of a given 
pharmaceutical process was calculated by two different approaches to investigate the 
effect of scaling of the individual technique contributions to the overall process disorder 
score. 
In the first approach the DPro values were calculated using process PRDS values that were 
weighted with respect to the number of response contributions of the individual 
techniques. In the second approach the DPro values were calculated by averaging the 
individual technique disorder scores, DXRPD, DDSC and DGVS. In this approach the 
individual technique contributions were treated equally. 
When comparing the calculated DPro values by the two different approaches for the 
same material, it was observed that the weighted approach appeared to provide a better 
discrimination between the comminution processes for materials containing higher 
degrees of disorder (Table 7-16 and Figure 7-7). 
As with the CRA approach, the PDA process also differentiated between the 
comminuted materials on the basis of the solid-state phase present. However, the PDA 
process has the additional advantage in that the materials could also be ranked in 
accordance to their DPro or PRDS values, which appeared to reflect the relative degree of 
disorder present (Table 7-16 and Figure 7-7). Based on the DPro or PRDS values, the 
materials were ranked from highest to lowest with respect to the general degree of 
disorder determined across all the comminution processes: salbutamol sulphate > 
loperamide HCl > γ-indomethacin > sulfamerazine > caffeine > sulfadiazine > 
acetylsalicylic acid > phenacetin > acetaminophen > methyl paraben. This order also 
reflected the general susceptibility of the materials to PID by mechanical comminution 
processes. 
Of all the comminution processes, high frequency ball-milling appeared to generate the 
greatest level disorder based on the magnitude of the PRDS and DPro values, followed by 
low frequency ball-milling and then jet-milling.  
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The validity and verification of the novel analytical approach to determine the relative 
degree of disorder present in materials as a consequence of a mechanical comminution 
process has been successfully demonstrated here through its application in 
characterising the resulting comminuted materials from the three different milling and 
micronisation processes. It has also been successfully shown that this approach will 
allow materials of differing chemical and crystallographic properties to be ranked 
according to the relative level of disorder being present, and that the approach can 
differentiate the effectiveness of different comminution processes in generating PID. 
 Recommendations for future work 8.2
It is important to note that this study should be viewed as developing the first iteration 
of the CRA, RDA and PDA processes and it is anticipated that as the understanding of 
the relationship of technique responses with observed disorder develops, so a better 
knowledge of the CRA and RDA limits for the individual technique responses will 
evolve. In order to provide a starting point for future work, an analytical protocol has 
been developed (Appendix 9) that outlines the general process for defining disorder in a 
material as a consequence of a pharmaceutical process or unit operation. It is envisaged 
that this protocol will assist future researchers when investigating and expanding the 
novel approaches described in this thesis.  
Currently the described RDA and PDA approaches employed data derived from the 
primary disorder detection techniques of XRPD, DSC and GVS but in future studies 
data from other analytical techniques could also be incorporated such as those from 
Raman spectroscopy, solid state NMR, dynamic mechanical analysis, inverse gas 
chromatography and solution calorimetry. However it should be noted that further 
improvements could also be made to the current RDA and PDA methods by 
investigating the potential enhancement in detecting disorder using the current primary 
disorder detection techniques of XRPD, DSC and GVS. For example, the use of 
transmission or capillary XRPD may reduce some preferred orientation effects. 
Nevertheless, some care will always be required in data interpretation since a grinding 
of the material is typically required as part of the sample preparation for these methods. 
The use of high speed DSC could also be applied to increase the sensitivity for disorder 
detection. However such use could be at the expense of thermal resolution and such 
events as the loss of volatiles may be lost. Additionally modulated DSC (MDSC) could 
possibly be used but this type of analysis typically requires long run times and very 
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small heating rates. Accordingly, any transient solid-state forms or phases could be lost 
during the period of analysis and the stability of the material should be investigated 
prior to performing MDSC analysis. Improvements to the GVS analysis method could 
also be made by investigating the potential use of %RH ramps instead of %RH steps 
etc. Should any technique be modified however, it is important to note that the 
sensitivities and instrumental variances could change, hence modification to the CRA 
and RDA response criteria maybe warranted. 
To further validate the analytical CRA, RDA and PDA approaches using the same 
standardised ball-milling and micronisation comminution processes as described in this 
thesis, other study materials should also be investigated such as: (i) materials that 
encompass the amorphous-crystalline continuum, (ii) different polymorphic forms of a 
given material, (iii) different crystal morphologies and particle sizes of a given material,  
(iv)  materials that exhibit melt-degradation and (v) different salts of a given material. 
The latter would enable the investigation of the influence of a counter-ion on the 
stability of the crystal lattice to restrict the susceptibility for PID during mechanical 
processing
253
. Additionally, verification of the benefits of the RDA/PDA processes 
could be investigated for a given material by comparing the calculated relative disorder 
values using the RDA/PDA processes with those obtained using a more traditional 
approach that employs standard mixtures and calibration curves.  
It is also envisaged that the current set of materials might be used as a standard model 
set to investigate different pharmaceutical unit operations or changes in operating 
parameters. Alternatively a subset of materials that encompasses the amorphous-
crystalline continuum could be used. For example acetaminophen (crystalline), 
sulfadiazine and caffeine (some disorder) and loperamide HCl (disordered). Some 
examples of the different ball milling conditions that could be investigated are: size of 
the milling balls, the number of balls, different charge ratios, different vibration 
frequencies and mill duration. While different micronisation conditions may include 
different feed rates and pressure differentials between the feed and grind pressures. 
The CRA, RDA and PDA processes could also be applied to investigating and 
monitoring stability samples post-comminution. Samples at different stability time-
points could be compared to either the responses of the input material or to the 
responses of the comminuted material at time zero (i.e. directly after milling). This 
would result in a single value being obtained at each time point and set of conditions 
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that represent all the results from the stability tests not just the result from a single 
technique. Changes in this value at different time points could then be used to measure 
the change in stability of the solid-state phase.  
By using the RDA and PDA processes the relative amount of disorder present in a 
material as a consequence of mechanical comminution can be estimated. However, it is 
also important to be able to relate the amount of disorder to any effect on product 
performance. For example, a future study may involve using an API with different 
levels of calculated disorder to formulate a tablet and then determine whether any 
changes with respect to performance parameters occur (e.g. disintegration, dissolution, 
and bioavailability). 
The CRA, RDA and PDA processes should be applied to a much larger number of 
materials that encompass the whole range of the amorphous-crystalline continuum with 
a view to establishing any correlations between the level of observed PID and the 
inherent and derived crystalline properties. It might then be possible ultimately predict 
the propensity for PID that might be induced by a given pharmaceutical process. Such 
predictive capacity might not only lead to a better understanding of the crystalline state 
but also that of the disordered state. This could help to minimise and mitigate the risk of 
process induced phase transformations during pharmaceutical manufacturing, and assist 
in candidate drug selection. 
 Concluding remarks 8.3
A relative estimate of the degree of PID inadvertently generated as a consequence of a 
defined comminution process could be obtained by application of the novel analytical 
approaches as developed in the current study. These approaches utilised the combined 
differences between the individual technique responses for the comminuted materials to 
those of the respective inputs allowing changes from multiple techniques to be 
incorporated into a singular value to define a certain property such as the presence of 
disorder or amorphous character. 
This approach provides the developmental pharmaceutical scientist with a more 
consistent and efficient means to define and quantify the presence of PID without the 
need of standard mixtures and calibration curves and can lead to better understanding of 
the generation of PID and the comminution process, allowing appropriate mitigation 
strategies to be implemented.  
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APPENDIX 1. Risk statement codes 
Risk Statement codes234- Risk statement codes for materials to be excluded from selection coloured red 
R1 Explosive when dry. 
R2 Risk of explosion by shock, friction, fire or other 
source of ignition. 
R3 Extreme risk of explosion by shock, friction, fire or 
other sources of ignition. 
R4 Forms very sensitive explosive metallic compounds. 
R5 Heating may cause an explosion. 
R6 Explosive with or without contact with air. 
R7 May cause fire. 
R8 Contact with combustible material may cause fire. 
R9 Explosive when mixed with combustible material. 
R10 Flammable. 
R11 Highly flammable. 
R12 Extremely flammable. 
R13 Extremely flammable liquefied gas 
R14 Reacts violently with water. 
R15 Contact with water liberates extremely flammable 
gases. 
R16 Explosive when mixed with oxidizing substances. 
R17 Spontaneously flammable in air. 
R18 In use, may form inflammable/explosive vapour-air 
mixture. 
R19 May form explosive peroxides. 
R20 Harmful by inhalation. 
R21 Harmful in contact with skin. 
R22 Harmful if swallowed. 
R23 Toxic by inhalation. 
R24 Toxic in contact with skin. 
R25 Toxic if swallowed. 
R26 Very toxic by inhalation. 
R27 Very toxic in contact with skin. 
R28 Very toxic if swallowed. 
R29 Contact with water liberates toxic gas. 
R30 Can become highly flammable in use. 
R31 Contact with acids liberates toxic gas. 
R32 Contact with acid liberates very toxic gas. 
R33 Danger of cumulative effects. 
R34 Causes burns. 
R35 Causes severe burns. 
R36 Irritating to eyes. 
R37 Irritating to respiratory system. 
R38 Irritating to skin. 
R39 Danger of very serious irreversible effects. 
R40 Limited evidence of a carcinogenic effect. 
R41 Risk of serious damage to the eyes. 
R42 May cause sensitization by inhalation. 
R43 May cause sensitization by skin contact. 
R44 Risk of explosion if heated under confinement. 
R45 May cause cancer. 
R46 May cause heritable genetic damage. 
R47 May cause birth defects 
R48 Danger of serious damage to health by 
prolonged exposure. 
R49 May cause cancer by inhalation. 
R50 Very toxic to aquatic organisms. 
R51 Toxic to aquatic organisms. 
R52 Harmful to aquatic organisms. 
R53 May cause long-term adverse effects in the 
aquatic environment. 
R54 Toxic to flora. 
R55 Toxic to fauna. 
R56 Toxic to soil organisms. 
R57 Toxic to bees. 
R58 May cause long-term adverse effects in the 
environment. 
R59 Dangerous to the ozone layer. 
R60 May impair fertility. 
R61 May cause harm to the unborn child. 
R62 Risk of impaired fertility. 
R63 Possible risk of harm to the unborn child. 
R64 May cause harm to breastfed babies. 
R65 Harmful: may cause lung damage if swallowed. 
R66 Repeated exposure may cause skin dryness or 
cracking. 
R67 Vapours may cause drowsiness and dizziness. 
R68 Possible risk of irreversible effects. 
R20/21: Harmful by inhalation and in contact with skin. 
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed. 
R20/22: Harmful by inhalation and if swallowed. 
R21/22: Harmful in contact with skin and if swallowed. 
R23/24/25: Toxic by inhalation, in contact with skin and if swallowed. 
R23/25: Toxic by inhalation and if swallowed. 
R26/27/28: Very toxic by inhalation, in contact with skin and if swallowed. 
R26/28: Very toxic by inhalation and if swallowed. 
R36/37: Irritating to eyes and respiratory system. 
R36/37/38: Irritating to eyes, respiratory system and skin. 
R36/38: Irritating to eyes and skin. 
R37/38: Irritating to respiratory system and skin. 
R42/43: May cause sensitization by inhalation and skin contact. 
R48/22: Harmful: danger of serious damage to health by prolonged exposure if swallowed. 
R50/53: Very toxic to aquatic organisms may cause long-term adverse effects in the aquatic environment. 
R51/53: Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. 
R52/53: Harmful to aquatic organisms may cause long-term adverse effects in the aquatic environment. 
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APPENDIX 2. PCA model data for final material selection  
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APPENDIX 3. Supplier, therapeutic classification and use 
for the final 10 selected materials 
Bulk material Supplier 
Batch No. & 
Purity (% w/w) 








inflammatory agent (NSAID) 
with analgesic, antipyretic, and 
platelet-inhibitory actions. Used 
in the treatment of chronic 




GSK  (Ware) 
R355888 
(99.0%) 
A short-acting beta-2 adrenergic 
agonist that is used as a 











Bulk material Supplier 
Batch No. & 
Purity (% w/w) 







A central nervous system (CNS) 





















Pharmaceutical excipient used as 
a preservative 
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Bulk material Supplier 
Batch No. & 
Purity (% w/w) 







Analgesic antipyretic derivative 
of acetanilide. It has weak anti-
inflammatory properties and is 












A NSAID analgesic used in the 
treatment of mild to moderate 
pain. It has anti-inflammatory 
and antipyretic properties and 
acts as an inhibitor of 





APPENDIX 4. Experimental Equipment 
Technique/Process Instrument Supplier Serial Number 
XRPD CubiX PRO Fast diffractometer 
(PW3800/00 with a Cu LFF X-
ray tube (PW3373/00) 
PANalytical, Almelo, Netherlands DY753 
TGA Q500 TGA  TA Instruments (Crawley, UK) 0500-0057 
DSC Q2000 DSC TA Instruments (Crawley, UK) Q2000-060 
PLM Axioplan2 microscope  Zeiss 35091-65 
SEM FEI Quanta 200 FEI XTE 13/D7513 
SEM coater Au/Pd sputter coater model 108A Agar A2096 
GVS DVS-1 vapour sorption 
instrument 
Surface Measurement Systems 
(SMS), Alperton, UK 
010726 
PSA HELOS (system H0933) Sympatec 56 
HPLC 1100 series HPLC Aligent  
FTIR Spectrum One FT-IR 
Spectrometer 
Perkin Elmer 58880 
Sieving Retsch sieve shaker Retsch GmbH, Rheinische 
Straße, Haan, Germany 
9 0503 019 
Ball-mill MM301, Retsch 125041013M 
Microniser McOne microniser JetPharma 19000C0418/08 
Mixer REAX Vortex Top  Mixer Heidolph  N/A 
Mixer Spiramix 5 Denley N/A 
Balance MC5 microbalance (6 place) Sartorius 13110100 
Balance ME 215S balance 5 place Sartorius 13507552 
RH meter Portable relative humidity meter, 
ms1 
Novasina 0105013/2 
Antistatic Sentry ionizing air blower SIMCO Industrial static control N/A 







APPENDIX 5. Appropriate settings for the 
determination of the background (baseline) in the XRPD 
Data treatment process.  
A typical XRPD pattern for a crystalline material will consist of two principal 
components; the crystalline peaks and the background component (Figure A4-1). 
However, it is important to note that the size of the background component will depend 
on the amount of amorphous or disorder and microcrystalline material present as well as 
any background scattering due to the instrument and sample preparation etc. 
 
Figure A4-1 Two components (crystalline and background) of an XRPD diffractogram depicting 
bending and granulation factors 
To determine appropriately the crystalline attributes such as peak position, relative 
intensity and area a background or baseline determination need to be performed. This 
background search can be performed using proprietary software such as PANalytical’s 
X’Pert HighScore Plus (version 3.0) software. But before the background can be 
determined appropriate data analysis settings typically have to be selected. For the 
X’Pert HighScore Plus software used in this research, arbitrary settings for granularity 
and bending factor are first selected before performing the background determination 
for a given XRPD diffractogram
287
. 
Granularity refers to the size of the intervals used during the background determination 
and should be of a sufficient size such that the baseline follows that expected for the 
crystalline component (red dashed line Figure A4-1). The larger the granularity value 
(1-100), the wider the size of the interval and the broader the baseline
287
. The bending 
factor adjusts the curvature of the background (black curve in Figure A4-1). The higher 
the bending factor value, the greater the curvature.  
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Choosing a too low a granularity value may cause an under estimation of the crystalline 
peak responses and could lead to an over estimation of the background contribution
287
. 
This effect is illustrated by the size of the red arrow line in Figure A4-2. As the amount 
of disorder or amorphous content increases, the potential over estimation of the 





Figure A4-2 XRPD diffractograms depicting the effect of the granularity value in determining the 
background for [A] crystalline, [B] a disordered mixture and [C] an amorphous material 
The most important factor when selecting the appropriate settings is consistency. The 
same settings need to be applied when comparing results for different materials as well 
as different processing conditions. This will ensure that the integrated areas and 
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observed responses are reported consistently allowing them to be utilized for 
comparative analysis purposes.  
For the purposes of this research a granularity value of 25 with a bending factor of 0 
have been selected as appropriate settings to determine the background (baseline) for 
the acquired XRPD diffractograms. 
Once the background has been determined the sum of net intensity values for the 
crystalline peaks, the background (disorder, microcrystalline and instrument 
components) and the total observed signals can be obtained from the object inspector 
panel and reported (Table A4-1). 
Table A4-1 Sum of net intensity values and calculated XRPD components based on different 
granularity value settings. 
 Crystalline Crystalline/amorphous Mostly amorphous 















Peaks (X) 5005652 5130720 1459524 1791419 402622 986836 
Background (B) 4368972 4243903 5532350 5200455 5891151 5306937 
Observed (T) 9374623 9374623 6991874 6991874 6293774 6293774 
Ratio X/T (Crystalline) 0.53 0.55 0.21 0.26 0.06 0.16 
Ratio B/T (Background) 0.47 0.45 0.79 0.74 0.94 0.84 
Ratio X/B 1.15 1.21 0.26 0.34 0.07 0.19 
Ratio B/X 0.87 0.83 3.79 2.90 14.63 5.38 
 
Differences in the net intensity ratios can be used to provide an estimate of the reduction 
of crystallinity in a material as a result of a process. For example in Table A4-1, as the 
amount of amorphous material increases, so do the ratios for B/T and B/X, while the 
ratios for X/T and X/B decrease (Table A4-1). It is important to note that the calculated 
values for the components of the XRPD diffractograms should be treated as gross 
estimates and not absolute values. As the amount of background scattering due to the 
instrument and other sample affects have not been accounted for or subtracted from the 
signals. Hence, the individual contributions of the different components maybe over or 
under exaggerated which could result in erroneously over or under integrating of the 
total sample diffraction signal. 
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APPENDIX 6. XRPD response variation investigation 
The amount of apparent variation between replicates observed in the XRPD peak 
responses as a result of sample preparation, acquisition and instrument parameters was 
investigated using the procedure outlined below and the XRPD data obtained for three 
replicates for sulfamerazine as a worked example.  
The overlay of the three XRPD replicates for sulfamerazine in Figure A6-1 shows that 
there is very little differences between them, with only some minor variation in peak 
height intensity. On closer inspection of the reported data and using the process outlined 
below, the amount of variation in the XRPD responses can be quantified. It can be seen 
that there is only a small amount of variation in the XRPD responses as indicated by the 
low RSD’s (< 15%) and the small average range for the peak position values (0.01 
°2Th) . 
 
Figure A6-1.  XRPD diffractograms for the three replicates of the input sulfamerazine material.  
The Insert shows the determined background profiles for the three replicates in blue and that for 
the calculated average XRPD pattern in red 
 
 
1. For each replicate and calculated average XRPD pattern, the XRPD responses 
were tabulated using the methods described in Section 3.2.1 and 3.2.2 (Table A6-
1 to A6-4). The MIP is highlighted in yellow.  
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Table A6- 1  Reported XRPD responses for sulfamerazine input material replicate 1 
 
Table A6- 2 Reported XRPD responses for sulfamerazine input material replicate 2 
 
  
Pos. [°2Th.] Rel. Int. [%] Height [cts] Backgr.[cts] d-spacing [Å] FWHM Left [°2Th.] Area [cts*°2Th.]
11.55 4.4 1611.22 704.05 7.66255 0.026705 28.6851
12.42 28.7 10586.58 744.64 7.12668 0.0984 1027.604
12.91 11.8 4371.555 766.7 6.85568 0.164542 479.5366
13.06 17.0 6268.22 773.25 6.77777 0.07872 486.7482
14.67 100.0 36914.24 839.06 6.03805 0.07872 2866.514
16.15 14.9 5504.965 891.57 5.48806 0.0984 534.3486
17.23 45.6 16824.93 924.63 5.14623 0.07872 1306.512
20.29 41.2 15198.74 992.42 4.37681 0.11808 1770.35
21.39 3.6 1312.238 1006.93 4.16403 0.0984 127.3746
21.66 11.6 4279.237 1010.59 4.10364 0.15744 664.594
22.52 8.3 3058.607 1018.33 3.94778 0.0984 296.8888
22.87 13.8 5096.922 1020.75 3.88893 0.17712 890.5343
23.67 8.3 3068.6 1024.84 3.75855 0.11808 357.4305
23.94 8.5 3145.375 1025.83 3.71681 0.0984 305.3111
24.29 31.6 11681.03 1026.76 3.66369 0.11808 1360.607
24.59 16.6 6111.35 1027.3 3.61994 0.11808 711.8501
24.91 5.8 2133.998 1027.72 3.57408 0.251166 273.2116
25.28 5.1 1872.744 1027.83 3.52327 0.140249 175.1009
25.64 3.8 1403.071 1027.78 3.47457 0.1263 118.1387
25.89 4.5 1651.842 1027.57 3.44181 0.11808 192.4066
26.87 3.2 1167.077 1026.03 3.31797 0.11808 135.9411
27.44 6.8 2522.536 1024.66 3.25004 0.11808 293.825
27.78 5.4 1978.266 1023.78 3.21199 0.13776 268.8331
29.40 2.1 776.1166 1018.54 3.03804 0.15744 120.5361
31.02 12.0 4441.464 1012.66 2.88318 0.13776 603.5654
32.56 12.2 4490.159 1006.82 2.75036 0.13776 610.1827
35.10 1.3 482.5252 996.98 2.55672 0.47232 224.8181
36.73 3.5 1279.426 997.39 2.44697 0.23616 298.0551
37.44 2.8 1046.458 998.72 2.40192 0.15744 162.5218
38.10 8.1 2991.712 999.75 2.36172 0.11808 348.4746
38.90 4.0 1469.809 1000.68 2.31552 0.125553 123.0258
39.79 2.9 1063.974 1001.2 2.26554 0.048895 34.682
41.19 2.1 791.7665 1000.75 2.19166 0.23616 184.4499
43.03 2.0 751.8278 997.2 2.10226 0.55104 408.6736
45.93 1.7 617.2333 983.98 1.97578 0.47232 287.5814
49.88 1.2 443.5289 951.33 1.82843 0.62976 275.532
Pos. [°2Th.] Rel. Int. [%] Height [cts] Backgr.[cts] d-spacing [Å] FWHM Left [°2Th.] Area [cts*°2Th.]
11.50 2.0 659.4543 594.68 7.6949 0.09 39.5673
12.42 33.6 11381.92 635.14 7.12426 0.0984 1104.805
13.07 19.7 6660.609 662.14 6.77608 0.07872 517.2185
14.67 100.0 33849.89 725.28 6.03781 0.0984 3285.696
16.15 15.7 5306.775 777.22 5.48944 0.13776 721.1554
17.23 46.3 15668.75 811.36 5.14647 0.0984 1520.913
18.86 0.9 304.0215 855.8 4.70567 0.7872 236.0829
20.29 44.6 15092.89 887.8 4.37626 0.11808 1758.02
21.39 5.8 1961.637 907.92 4.15351 0.124368 162.643
21.68 15.0 5078.192 912.58 4.0995 0.15744 788.6771
22.53 9.9 3334.388 924.74 3.94678 0.13776 453.1211
22.87 16.5 5592.64 929.13 3.88783 0.17712 977.146
23.68 8.9 3016.535 938.05 3.75665 0.11808 351.366
23.95 9.8 3326.373 940.59 3.71633 0.0984 322.8799
24.29 34.4 11639.44 943.64 3.66411 0.13776 1581.723
24.59 17.8 6027.955 946.06 3.61968 0.11808 702.1362
24.92 6.3 2117.869 948.49 3.57317 0.251166 354.6239
25.29 3.8 1276.458 950.84 3.52203 0.15744 198.2424
25.89 4.8 1636.297 954.2 3.44122 0.11808 190.5958
27.01 3.9 1322.605 958.63 3.30123 0.310271 273.5772
27.45 7.2 2431.852 959.82 3.24874 0.13776 330.4724
27.78 6.4 2175.41 960.55 3.2116 0.13776 295.6237
29.41 2.5 845.9543 961.97 3.03742 0.15744 131.3823
30.48 4.0 1346.809 961.35 2.93286 0.043224 38.8097
31.02 14.0 4753.514 960.64 2.88322 0.15744 738.2524
32.56 13.3 4486.966 957.32 2.7505 0.13776 609.7487
34.97 1.8 606.8247 948.48 2.56606 0.47232 282.7318
36.71 4.0 1349.48 939.37 2.44845 0.1968 261.9791
37.45 3.1 1042.888 934.73 2.40152 0.15744 161.9674
38.10 8.8 2971.108 930.28 2.3617 0.0984 288.3956
38.90 4.7 1575.848 924.44 2.31528 0.179073 188.1279
39.27 3.5 1167.17 921.54 2.29451 0.043121 33.5528
39.71 1.1 376.7007 917.9 2.26986 0.09 22.602
41.20 2.1 704.2089 904.44 2.19092 0.1968 136.7104
43.01 2.9 973.2185 885.55 2.10319 0.47232 453.442
45.91 1.8 615.6275 849.02 1.97666 0.3936 239.0276
49.85 1.2 403.0612 787.87 1.82923 0.62976 250.3923
55.78 1.2 413.67 677.66 1.64798 0.31488 128.4914
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Table A6- 3 Reported XRPD responses for sulfamerazine input material replicate 3 
 
Table A6- 4 Reported XRPD responses for the calculated average XRPD pattern for sulfamerazine  
 
Pos. [°2Th.] Rel. Int. [%] Height [cts] Backgr.[cts] d-spacing [Å] FWHM Left [°2Th.] Area [cts*°2Th.]
8.09 1.3 413.1377 402.41 10.92409 0.15744 64.163
10.54 0.4 139.7935 509.63 8.39351 0.09 8.3876
11.54 3.5 1110.646 551.79 7.66657 0.0984 107.8068
12.42 41.3 13110.75 587.5 7.12555 0.11808 1527.14
13.07 23.5 7473.25 612.84 6.77626 0.0984 725.4035
14.67 100.0 31778.25 672.5 6.03936 0.11808 3701.53
16.15 17.3 5486.641 722.5 5.48954 0.13776 745.5979
17.23 48.0 15252.43 755.52 5.14761 0.0984 1480.502
18.26 1.4 438.2874 784.06 4.85859 0.09 26.2972
18.82 0.9 286.1457 798.17 4.71526 0.09 17.1687
20.29 44.0 13994.57 830.39 4.37735 0.15744 2173.45
21.39 5.8 1850.721 850.17 4.15424 0.124368 43.3319
21.66 16.1 5112.313 854.47 4.10357 0.15744 793.9763
22.53 12.1 3845.608 866.68 3.94647 0.13776 522.5924
22.88 19.7 6251.825 870.97 3.88723 0.15744 970.9501
23.67 9.4 2996.792 879.44 3.75866 0.11808 349.0664
23.95 11.1 3520.581 882.03 3.71584 0.11808 410.0772
24.29 37.6 11954.42 884.95 3.66398 0.13776 1624.525
24.60 19.6 6214.698 887.29 3.61906 0.11808 723.888
24.93 6.8 2156.039 889.64 3.57212 0.205191 294.933
25.28 4.8 1527.005 891.79 3.52302 0.0984 148.2213
25.88 4.4 1403.039 894.96 3.44332 0.11808 163.4259
26.86 3.6 1130.408 898.8 3.31976 0.13776 153.6149
27.44 8.1 2575.802 900.37 3.25076 0.11808 300.0294
27.78 7.6 2416.496 901.14 3.21095 0.13776 328.3857
29.41 2.6 812.7604 902.66 3.03702 0.15744 126.2271
30.48 4.2 1333.836 902.28 2.93321 0.041027 36.4824
31.01 14.2 4498.134 901.73 2.88379 0.15744 698.5902
32.55 14.4 4563.358 898.91 2.75107 0.13776 620.13
35.00 3.5 1109.377 890.49 2.56402 0.058902 43.5629
35.29 2.1 673.8705 889.11 2.54353 0.15744 104.6566
36.70 4.3 1350.828 881.37 2.44874 0.15744 209.7925
37.44 3.2 1020.138 876.47 2.40209 0.15744 158.4343
38.10 9.3 2938.037 871.6 2.36199 0.11808 342.2226
38.90 4.9 1540.9 865.11 2.31536 0.158206 162.5194
39.24 3.6 1148.232 862.06 2.2959 0.049159 37.6305
39.79 3.5 1109.714 856.95 2.26548 0.040468 29.9385
41.22 2.4 754.9661 842.1 2.19021 0.1968 146.5641
43.02 2.2 709.0392 820.15 2.10277 0.47232 330.3556
45.93 1.9 612.5115 777.84 1.97602 0.3936 237.8178
55.79 1.3 426.4833 602.12 1.64792 0.31488 132.4714
Pos. [°2Th.] Rel. Int. [%] Height [cts] Backgr.[cts] d-spacing [Å] FWHM Left [°2Th.] Area [cts*°2Th.]
8.10 1.2 405.1344 459.23 10.91562 0.09 24.3081
11.54 3.3 1120.206 620.49 7.66792 0.0984 108.7346
12.42 34.2 11688.55 658.53 7.12545 0.0984 1134.569
13.06 19.9 6790.498 685.22 6.77671 0.07872 527.3048
14.67 100.0 34175.29 747.45 6.03834 0.0984 3317.282
16.15 15.9 5437.88 798.47 5.48886 0.11808 633.4043
17.23 46.5 15903.38 831.57 5.14672 0.07872 1234.951
18.21 1.1 380.7452 858.29 4.87181 0.09 22.8447
18.86 0.9 304.9836 874.08 4.70643 0.7872 236.83
20.29 43.2 14764.93 903.93 4.37675 0.13776 2006.455
21.38 5.5 1892.509 921.94 4.1556 0.257816 325.2791
21.66 14.0 4790.505 925.98 4.10277 0.15744 743.9974
22.53 10.0 3412.075 936.61 3.94705 0.13776 463.6783
22.87 16.5 5629.656 940.27 3.88807 0.17712 983.6135
23.44 4.8 1627.458 945.49 3.79501 0.289979 314.6195
23.67 8.8 3002.981 947.36 3.75822 0.11808 349.7872
23.95 9.8 3336.417 949.4 3.71639 0.0984 323.8549
24.29 34.4 11756.52 951.7 3.66389 0.11808 1369.399
24.59 17.9 6102.972 953.46 3.61964 0.11808 710.8742
24.92 6.3 2153.381 955.19 3.57301 0.170874 245.3048
25.28 3.8 1305.947 956.75 3.52292 0.15744 202.8222
25.64 4.5 1539.023 958.12 3.47462 0.140838 144.5019
25.89 4.7 1595.155 958.9 3.44181 0.11808 185.8036
26.87 3.3 1133.139 961.12 3.31775 0.11808 131.988
27.44 7.4 2518.414 961.81 3.24998 0.13776 342.2356
27.78 6.4 2190.936 962.08 3.21149 0.13776 297.7336
29.41 2.4 811.759 961.8 3.03745 0.15744 126.0716
30.48 3.8 1289.838 960.68 2.93309 0.135736 116.7182
31.02 13.4 4576.854 959.91 2.88336 0.15744 710.8159
32.55 13.2 4507.283 957.08 2.7506 0.13776 612.5097
35.11 1.5 521.0271 950.35 2.55602 0.47232 242.7569
36.73 3.7 1263.529 944.47 2.44689 0.23616 294.3517
37.44 3.0 1032.032 941.36 2.40184 0.15744 160.2814
38.10 8.7 2985.395 938.2 2.3618 0.0984 289.7823
38.89 6.2 2101.917 934.02 2.31581 0.115523 161.8799
39.25 3.4 1145.406 931.95 2.2955 1.019054 778.1535
39.79 3.2 1077.258 928.65 2.2657 0.036529 26.2341
40.73 1.2 402.6698 922.29 2.21534 0.09 36.2403
41.20 2.1 729.3008 918.82 2.19102 0.1968 141.5816
43.02 2.3 799.256 903.49 2.1027 0.47232 372.3894
45.94 1.7 584.3146 872.25 1.97549 0.47232 272.2438
55.79 1.3 457.0247 723.88 1.64788 0.31488 141.958
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2. For each replicate, the peak positions were aligned and compared to the calculated 
average XRPD pattern. Red indicates peaks that are absent with respect to the 
other replicates and the calculated average XRPD pattern. (Table A6-5)  
Table A6-5 Alignment of peaks for 3 replicate XRPD samples of sulfamerazine and the calculated 
average XRPD pattern. 
  
Pos. [°2Th.] Rel. Int. [%] Pos. [°2Th.] Rel. Int. [%] Pos. [°2Th.] Rel. Int. [%] Pos. [°2Th.] Rel. Int. [%]
8.09 1.3 8.10 1.2
10.54 0.4
11.55 4.4 11.50 2.0 11.54 3.5 11.54 3.3
12.42 28.7 12.42 33.6 12.42 41.3 12.42 34.2
12.91 11.8
13.06 17.0 13.07 19.7 13.07 23.5 13.06 19.9
14.67 100.0 14.67 100.0 14.67 100.0 14.67 100.0
16.15 14.9 16.15 15.7 16.15 17.3 16.15 15.9
17.23 45.6 17.23 46.3 17.23 48.0 17.23 46.5
18.26 1.4 18.21 1.1
18.86 0.9 18.82 0.9 18.86 0.9
20.29 41.2 20.29 44.6 20.29 44.0 20.29 43.2
21.34 3.6 21.39 5.8 21.39 5.8 21.38 5.5
21.66 11.6 21.68 15.0 21.66 16.1 21.66 14.0
22.52 8.3 22.53 9.9 22.53 12.1 22.53 10.0
22.87 13.8 22.87 16.5 22.88 19.7 22.87 16.5
23.44 4.8
23.67 8.3 23.68 8.9 23.67 9.4 23.67 8.8
23.94 8.5 23.95 9.8 23.95 11.1 23.95 9.8
24.29 31.6 24.29 34.4 24.29 37.6 24.29 34.4
24.59 16.6 24.59 17.8 24.60 19.6 24.59 17.9
24.91 5.8 24.92 6.3 24.93 6.8 24.92 6.3
25.28 5.1 25.29 3.8 25.28 4.8 25.28 3.8
25.64 3.8 25.64 4.5
25.89 4.5 25.89 4.8 25.88 4.4 25.89 4.7
26.87 3.2 26.86 3.6 26.87 3.3
27.01 3.9
27.44 6.8 27.45 7.2 27.44 8.1 27.44 7.4
27.78 5.4 27.78 6.4 27.78 7.6 27.78 6.4
29.40 2.1 29.41 2.5 29.41 2.6 29.41 2.4
30.48 4.0 30.48 4.2 30.48 3.8
31.02 12.0 31.02 14.0 31.01 14.2 31.02 13.4
32.56 12.2 32.56 13.3 32.55 14.4 32.55 13.2
34.97 1.8 35.00 3.5
35.10 1.3 35.11 1.5
35.29 2.1
36.73 3.5 36.71 4.0 36.70 4.3 36.73 3.7
37.44 2.8 37.45 3.1 37.44 3.2 37.44 3.0
38.10 8.1 38.10 8.8 38.10 9.3 38.10 8.7
38.90 4.0 38.90 4.7 38.90 4.9 38.89 6.2
39.79 2.9 39.27 3.5 39.24 3.6 39.25 3.4
39.71 1.1 39.79 3.5 39.79 3.2
40.73 1.2
41.19 2.1 41.20 2.1 41.22 2.4 41.20 2.1
43.03 2.0 43.01 2.9 43.02 2.2 43.02 2.3
45.93 1.7 45.91 1.8 45.93 1.9 45.94 1.7
49.88 1.2 49.85 1.2
55.78 1.2 55.79 1.3 55.79 1.3
Average XRPDReplicate 3Replicate 2Replicate 1
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3. The most significant peaks were selected based on a minimum relative intensity 
value of the average XRPD pattern; 
a. If the most intense peak (MIP) height was less than 100k cts then peaks 
with a relative intensity > 5% were selected 
b. If MIP height is greater than 100k cts in size then peaks with a relative 
intensity value of greater than  0.5,1.0 or 2.0 % were selected 
For sulfamerazine the MIP is at 14.67 °2Theta with a peak height less than 100K 
cts. Therefore a relative intensity limit value of 5.0 % was used to select 21 
significant peaks for the calculated average XRPD pattern (Table A6- 6). 
Table A6- 6 Selected significant peaks for sulfamerazine using a 5.0% RI limit 
 
  
Peak Pos. [°2Th.] Rel. Int. [%] Pos. [°2Th.] Rel. Int. [%] Pos. [°2Th.] Rel. Int. [%] Pos. [°2Th.] Rel. Int. [%]
1 12.42 28.7 12.42 33.6 12.42 41.3 12.42 34.2
2 13.06 17.0 13.07 19.7 13.07 23.5 13.06 19.9
3 14.67 100.0 14.67 100.0 14.67 100.0 14.67 100.0
4 16.15 14.9 16.15 15.7 16.15 17.3 16.15 15.9
5 17.23 45.6 17.23 46.3 17.23 48.0 17.23 46.5
6 20.29 41.2 20.29 44.6 20.29 44.0 20.29 43.2
7 21.34 3.6 21.39 5.8 21.39 5.8 21.38 5.5
8 21.66 11.6 21.68 15.0 21.66 16.1 21.66 14.0
9 22.52 8.3 22.53 9.9 22.53 12.1 22.53 10.0
10 22.87 13.8 22.87 16.5 22.88 19.7 22.87 16.5
11 23.67 8.3 23.68 8.9 23.67 9.4 23.67 8.8
12 23.94 8.5 23.95 9.8 23.95 11.1 23.95 9.8
13 24.29 31.6 24.29 34.4 24.29 37.6 24.29 34.4
14 24.59 16.6 24.59 17.8 24.60 19.6 24.59 17.9
15 24.91 5.8 24.92 6.3 24.93 6.8 24.92 6.3
16 27.44 6.8 27.45 7.2 27.44 8.1 27.44 7.4
17 27.78 5.4 27.78 6.4 27.78 7.6 27.78 6.4
18 31.02 12.0 31.02 14.0 31.01 14.2 31.02 13.4
19 32.56 12.2 32.56 13.3 32.55 14.4 32.55 13.2
20 38.10 8.1 38.10 8.8 38.10 9.3 38.10 8.7
21 38.90 4.0 38.90 4.7 38.90 4.9 38.89 6.2
Replicate 1 Replicate 2 Replicate 3 Average XRPD
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4. The amount of variation in peak position was estimated using the average range 
value at each  identified peak position and then reporting the average overall value 
Table A6- 7 Variation in peak positions for the 3 replicates of sulfamerazine  
 
 
5. An estimate of the variation in the peak XRPD responses for the three replicates at 
each peak position was obtained using the relative standard deviation (RSD) 
values for the peak responses; peak height (cts), background  height  (cts), peak 
width - FWHM (°2theta) and peak area (cts.2°Theta). The total observed variation 
in the peak responses over the whole XRPD profile was then estimated by taking 
the average of the individual RSD values calculated at each peak position. 
  
Replicate 1 Replicate 2 Replicate 3
Peak Pos. [°2Th.] Pos. [°2Th.] Pos. [°2Th.] Range  [°2Th.]
1 12.42 12.42 12.42 0.00
2 13.06 13.07 13.07 0.00
3 14.67 14.67 14.67 0.00
4 16.15 16.15 16.15 0.00
5 17.23 17.23 17.23 0.00
6 20.29 20.29 20.29 0.01
7 21.39 21.39 21.39 0.00
8 21.66 21.68 21.66 0.02
9 22.52 22.53 22.53 0.01
10 22.87 22.87 22.88 0.01
11 23.67 23.68 23.67 0.01
12 23.94 23.95 23.95 0.01
13 24.29 24.29 24.29 0.00
14 24.59 24.59 24.60 0.01
15 24.91 24.92 24.93 0.01
16 27.44 27.45 27.44 0.02
17 27.78 27.78 27.78 0.01
18 31.02 31.02 31.01 0.01
19 32.56 32.56 32.55 0.01
20 38.10 38.10 38.10 0.00
21 38.90 38.90 38.90 0.00
Overall Average 0.01
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Therefore estimates of the variation in XRPD responses for sulfamerazine would be  on 
average 0.01°2Th for changes in peak position, 6 % in peak heights, 8 % in the 
background heights, 10 % in peak widths (FWHM) and 14 % in peak areas over the 
whole XRPD pattern, 
  
Replicate 1 Replicate 2 Replicate 3 Replicate 1 Replicate 2 Replicate 3
Peak Height [cts] Height [cts] Height [cts] RSD Backgr.[cts] Backgr.[cts] Backgr.[cts] RSD
1 10586.58 11381.92 13110.75 11 744.64 635.14 587.5 12
2 6268.22 6660.609 7473.25 9 773.25 662.14 612.84 12
3 36914.24 33849.89 31778.25 8 839.06 725.28 672.5 11
4 5504.965 5306.775 5486.641 2 891.57 777.22 722.5 11
5 16824.93 15668.75 15252.43 5 924.63 811.36 755.52 10
6 15198.74 15092.89 13994.57 5 992.42 887.8 830.39 9
7 1312.238 1961.637 1850.721 20 1006.93 907.92 850.17 9
8 4279.237 5078.192 5112.313 10 1010.59 912.58 854.47 9
9 3058.607 3334.388 3845.608 12 1018.33 924.74 866.68 8
10 5096.922 5592.64 6251.825 10 1020.75 929.13 870.97 8
11 3068.6 3016.535 2996.792 1 1024.84 938.05 879.44 8
12 3145.375 3326.373 3520.581 6 1025.83 940.59 882.03 8
13 11681.03 11639.44 11954.42 1 1026.76 943.64 884.95 7
14 6111.35 6027.955 6214.698 2 1027.3 946.06 887.29 7
15 2133.998 2117.869 2156.039 1 1027.72 948.49 889.64 7
16 2522.536 2431.852 2575.802 3 1024.66 959.82 900.37 6
17 1978.266 2175.41 2416.496 10 1023.78 960.55 901.14 6
18 4441.464 4753.514 4498.134 4 1012.66 960.64 901.73 6
19 4490.159 4486.966 4563.358 1 1006.82 957.32 898.91 6
20 2991.712 2971.108 2938.037 1 999.75 930.28 871.6 7
21 1469.809 1575.848 1540.9 4 1000.68 924.44 865.11 7
Overall Average 6 Overall Average 8
Peak Replicate 1 Replicate 2 Replicate 3 Replicate 1 Replicate 2 Replicate 3
1 FWHM Left [°2Th.] FWHM Left [°2Th.] FWHM Left [°2Th.] RSD Area [cts*°2Th.] Area [cts*°2Th.] Area [cts*°2Th.] RSD
2 0.0984 0.0984 0.11808 11 1027.604 1104.805 1527.14 22
3 0.07872 0.07872 0.0984 13 486.7482 517.2185 725.4035 23
4 0.07872 0.0984 0.11808 20 2866.514 3285.696 3701.53 13
5 0.0984 0.13776 0.13776 18 534.3486 721.1554 745.5979 17
6 0.07872 0.0984 0.0984 12 1306.512 1520.913 1480.502 8
7 0.11808 0.11808 0.15744 17 1770.35 1758.02 2173.45 12
8 0.0984 0.124368 0.124368 13 127.3746 162.643 43.3319 55
9 0.15744 0.15744 0.15744 0 664.594 788.6771 793.9763 10
10 0.0984 0.13776 0.13776 18 296.8888 453.1211 522.5924 27
11 0.17712 0.17712 0.15744 7 890.5343 977.146 970.9501 5
12 0.11808 0.11808 0.11808 0 357.4305 351.366 349.0664 1
13 0.0984 0.0984 0.11808 11 305.3111 322.8799 410.0772 16
14 0.11808 0.13776 0.13776 9 1360.607 1581.723 1624.525 9
15 0.11808 0.11808 0.11808 0 711.8501 702.1362 723.888 2
16 0.251166 0.251166 0.205191 11 273.2116 354.6239 294.933 14
17 0.11808 0.13776 0.11808 9 293.825 330.4724 300.0294 6
18 0.13776 0.13776 0.13776 0 268.8331 295.6237 328.3857 10
19 0.13776 0.15744 0.15744 8 603.5654 738.2524 698.5902 10
20 0.13776 0.13776 0.13776 0 610.1827 609.7487 620.13 1
21 0.11808 0.0984 0.11808 10 348.4746 288.3956 342.2226 10
0.125553 0.179073 0.158206 17 123.0258 188.1279 162.5194 21
Overall Average 10 Overall Average 14
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APPENDIX 7. Summary of solid-state phase present in 
comminuted materials.  
Table A7- 1 Summary of the solid-state phase present in the comminuted materials of acetaminophen 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 
Crystalline  Form 1 – 
preferred orientation 
 
Crystalline  Form 1 – 
preferred orientation 
 
Crystalline  Form 1 – 
preferred orientation 
 
GVS 1 Crystalline  Crystalline  Crystalline  





Reversible moisture sorption 
(0.06 %) 
Reversible moisture sorption 
(0.03 %) 
Reversible moisture  sorption 
(0.01 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 
Not observed - concordant 
with  Ref. 
Not observed - concordant 
with  reference 
Not observed - concordant 
with  reference 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 




D50 < 35 µm 
Agglomerated 
D50 < 12 µm 
Mono-modal 
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
acicular, rounded smooth, 
agglomerated 
Solid-state phase present Crystalline Crystalline Crystalline 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
*Summary from 2 replicate process runs, i.e. two batches 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered  
 
Table A7- 2 Summary of the solid-state phase present in the comminuted materials of γ-indomethacin 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 Disordered  Microcrystalline  
Crystalline  γ Form– 
preferred orientation 
 
GVS 1 Disordered  Crystalline  Crystalline  
DSC 1 Disordered  
Mixed Phase A – same 
crystalline form with 
some disorder 
 
Crystalline - concordant 





GVS 1 Observed (1.32 %) 
Reversible moisture sorption 
(0.29 %) 
Reversible moisture sorption 
(0.09 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 
Not observed - concordant 
with  reference 
Not observed - concordant 
with  reference 
Not observed - concordant 
with  reference 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 




D50 < 20 µm 
Broad multi-modal 
D50 < 15 µm 
Mono-modal 
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Disordered 
Microcrystalline – little 
disorder 
Crystalline 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
*Summary from 2 replicate process runs, i.e. two batches 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered  
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Table A7- 3 Summary of the solid-state phase present in the comminuted materials of salbutamol 
sulphate 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 X-ray Amorphous  Microcrystalline  
Crystalline – preferred 
orientation 
 
GVS 1 Disordered  Disordered  Crystalline -electrostatic  
DSC 1 DSC amorphous  
Mixed Phase C – maybe 
mixture of crystalline 
forms with some 
disorder 
 
Mixed Phase C – maybe 
mixture of crystalline 





GVS 1 Observed (7.60 %) Observed (1.06 %) Observed (0.61 %) 
DSC 1 Observed  Observed Observed 
TGA 2 Observed (1.85 %) Observed (0.72 %) Observed <0.5% 
Chemical 
purity 
HPLC 2 Small degradation Concordant with  reference Small degradation 
FTIR 2 
Disorder - 
Broadening & shifts 




D50 < 12 µm 
Broad multi-modal 
D50 < 7 µm 
Mono-modal 
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Disordered 
Microcrystalline -some 
disorder  
Crystalline –little disorder 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
*Summary from 2 replicate process runs, i.e. two batches 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered  
 
Table A7- 4 Summary of the solid-state phase present in the comminuted materials of loperamide HCl 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 X-ray Amorphous  Disordered  Crystalline  
GVS 1 Disordered  Disordered  Disordered  
DSC 1 Disordered  
Mixed Phase B – maybe 
new crystalline form 
some disorder 
 
Mixed Phase A – same 






GVS 1 Observed (9.01%) Observed (2.88 %) Observed (0.83 %) 
DSC 1 Observed Observed Observed 
TGA 2 Observed (1.37 %) Observed (0.74%) Not observed 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 
FTIR 2 
Disorder - 
Broadening, water & shifts 
Some disorder - slight 
broadening and shifts 





D50 < 7 µm 
Broad multi-modal 
agglomeration 
D50 < 10 µm 
mono-modal  
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Disordered Some Disorder  Crystalline –little disorder 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 




Table A7- 5 Summary of the solid-state phase present in the comminuted materials of acetylsalicylic 
acid 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 Crystalline  Crystalline  Crystalline  
GVS 1 Crystalline   Crystalline   Crystalline   
DSC 1 
Crystalline - concordant 
with  reference 
 
Crystalline - concordant 
with  reference 
 
Crystalline - concordant 






Reversible moisture sorption 
(0.12 %) 
Reversible moisture sorption 
(0.07 %) 
Reversible moisture sorption 
(0.03 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 Not observed Not observed Not observed 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 
FTIR 2 Concordant with  reference Concordant with  reference Concordant with  reference 
Particle size 
PSA 2 
Broad multi-modal  
D50 < 15 µm 
Broad multi-modal  
D50 < 6 µm 
Mono-modal  
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Crystalline Crystalline Crystalline 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered  
 
Table A7- 6 Summary of the solid-state phase present in the comminuted materials of sulfamerazine 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 
Crystalline mixture of 
Forms I & II 
 Microcrystalline  
Crystalline – preferred 
orientation 
 
GVS 1 Disordered  Crystalline   Crystalline   
DSC 1 
Mixed Phase C – maybe 
mixture of crystalline 
forms with some 
disorder 
 
Crystalline - concordant 
with  reference 
 
Crystalline - concordant 





GVS 1 Observed (0.63 %) 
Reversible moisture sorption 
(0.45 %) 
Reversible moisture sorption 
(0.23 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 Not observed Not observed Not observed 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 
FTIR 2 
Some peaks for Form II and 
some peak shifts.  





D50 < 10 µm 
Broad multi-modal 
agglomeration 
D50 < 30 µm 
Mono-modal  
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present 
Some disorder – some new 
form 
Microcrystalline Crystalline 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 




Table A7- 7 Summary of the solid-state phase present in the comminuted materials of phenacetin 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 
Crystalline – preferred 
orientation 
 
Crystalline – concordant 
with  reference 
 
Crystalline – preferred 
orientation 
 
GVS 1 Crystalline   Crystalline   Crystalline   
DSC 1 
Crystalline - concordant 
with  reference 
 
Crystalline - concordant 
with  reference 
 
Crystalline  - concordant 






Reversible moisture sorption 
(0.12 %) 
Reversible moisture sorption 
(0 %) 
Reversible moisture sorption 
(0.01 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 Not observed Not observed Not observed 
Chemical 
purity 
HPLC 2 Concordant with reference Concordant with reference Concordant with  reference 
FTIR 2 Concordant with reference. Concordant with reference Concordant with  reference 
Particle size 
PSA 2 
Broad multi-modal  
D50 < 12 µm 
Broad multi-modal  
D50 < 16 µm 
Mono-modal  
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Crystalline Crystalline Crystalline 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered  
 
Table A7- 8 Summary of the solid-state phase present in the comminuted materials of sulfadiazine 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 Crystalline  Crystalline  
Crystalline – preferred 
orientation 
 
GVS 1 Disordered   Disordered  Crystalline   
DSC 1 
Mixed Phase C – maybe 
mixture of crystalline 
forms with some 
disorder 
 
Mixed Phase C – maybe 
mixture of crystalline 
forms with some 
disorder 
 
Mixed Phase C – maybe 
mixture of crystalline 





GVS 1 Observed (1.13 %) Observed (0.91 %) 
Reversible moisture sorption 
(0.20 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 Not observed Not observed Not observed 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 





D50 < 22 µm 
Broad multi-modal 
agglomeration 
D50 < 28 µm 
Mono-modal  
D50 < 2 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Crystalline –little disorder Crystalline –little disorder Crystalline  
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered   
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Table A7- 9 Summary of the solid-state phase present in the comminuted materials of caffeine 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 
Crystalline – preferred 
orientation 
 Crystalline  
Crystalline – concordant 
with  reference 
 
GVS 1 Disordered   Disordered  Crystalline   
DSC 1 
Mixed Phase A – same 
crystalline form with 
some disorder 
 
Mixed Phase A – same 
crystalline form with 
some disorder 
 
Mixed Phase A – same 






GVS 1 Observed (0.63 %) Observed (0.12 %) 
Reversible moisture sorption 
(0 %) 
DSC 1 Observed Not observed Not observed 
TGA 2 Observed (1.09 %) Not observed Not observed 
Chemical 
purity 
HPLC 2 Concordant with reference Concordant with reference. Concordant with  reference 





D50 < 35 µm 
Broad multi-modal 
agglomeration 
D50 < 45 µm 
Mono-modal  
D50 < 2 µm 
SEM 2 
Acicular, sharp, smooth, 
agglomerated  
Acicular, sharp, smooth, 
agglomerated 
Acicular, rounded, smooth, 
agglomerated 
Solid-state phase present Crystalline –little disorder Crystalline –little disorder Crystalline  
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 
Phase indicated by colour Crystalline, Microcrystalline – little/some disorder, Disordered  
 
Table A7- 10 Summary of the solid-state phase present in the comminuted materials of methyl paraben 
   Solid-state phase classifications and analytical response observations 
Material 
Property 
Technique DM Mill-A*** Mill-B*** JM-A 
Phase 
detection &  
identification 
XRPD 1 
Crystalline – concordant 
with  reference 
 
Crystalline – concordant 
with  reference 
 
Crystalline – concordant 
with  reference 
 
GVS 1 Crystalline   Crystalline   Crystalline   
DSC 1 
Crystalline – concordant 
with  reference 
 
Crystalline – concordant 
with  reference 
 
Crystalline – concordant 






Reversible moisture sorption 
(0.06 %) 
Reversible moisture sorption 
(0.07 %) 
Reversible moisture sorption 
(0.02 %) 
DSC 1 Not observed Not observed Not observed 
TGA 2 Not observed Not observed Not observed 
Chemical 
purity 
HPLC 2 Concordant with  reference Concordant with  reference Concordant with  reference 
FTIR 2 Concordant with  reference Concordant with  reference Concordant with  reference 
Particle size 
PSA 2 
Broad multi-modal  
D50 < 30 µm 
Broad multi-modal  
D50 < 30 µm 
Mono-modal  
D50 < 8 µm 
SEM 2 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Irregular, fractured, rough, 
agglomerated & drusy 
Solid-state phase present Crystalline Crystalline Crystalline 
DM – detection method; 1: primary disorder detection technique. 2: secondary disorder detection technique 
Mill-A: high frequency ball-mill method A, Mill-B: low frequency ball-mill method B. JM-A: jet-mill method A. 




APPENDIX 8. Overlay of the XRPD diffractograms for 
high frequency ball-milled indomethacin (11-MA1) and 
its input.  
 
 
Blue – high frequency ball-m      γ-indomethacin, batch 11-MA1. Red –    u  γ-indomethacin. Insert 
depicts overlay of background profiles for the two materials 
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APPENDIX 9. General analytical protocol to identify 
and quantify relative disorder in pharmaceutical 
materials 
 
Step 1: Define the study intent and or objective. 
 Define the purpose of the investigation and what it is hoped to achieve, e.g. 
investigate the degree of PID that may be generated as a consequence of jet-
milling using different micronisation parameters to achieve a particle size of 
X90 of 5 µm. 
Step 2: Define the appropriate core test methods. 
 Define the primary and secondary disorder detection methods that will be used, 
e.g. the table below lists some recommended techniques that should be 
employed to ensure the adequate characterisation of a material properties. 









 Define the acquisition parameters for each technique and the responses that will 
be reported. 
 Determine the instrumental variances and operational tolerances, e.g. signal to 
noise values, background heights of blanks etc. 
Step 3: Perform any appropriate pre-processing on the bulk. 
 e.g. sieving, or recrystallisation. 
Step 4: Characterise the input material (RA). 
 Using the core test methods determine the responses for the input material. 
 Determine the sample and material variance in the responses. 
 Determine the criteria limits for the individual technique responses to allow 
appropriate identification of the solid-state phase, i.e. define the CRA limits. 
 Determine appropriate RDA limits for the responses of the primary disorder 
detection methods. 
Step 5: Process the input material. 
 Process the material using the appropriate parameters under defined conditions.   
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Step 6: Characterise the processed material (RA). 
 Using the core test methods determine the responses for the processed material. 
Step 7: Perform CRA on processed material. 
 For each of the core test methods compare the responses of the processed 
material (from Step 6) with those of the input material (from step 4). 
 Using the CRA response limits identify the solid-state phase present. 
Step 8: Determine relative levels of disorder using RDA and PDA approaches. 
 Perform a RDA for each of the identified primary disorder detection methods, 
determining the RTechnique and DTechnique scores. 
 Perform PDA for each process being investigated, determining the overall PRDS 
and DPro values. 
 Define and classify the relative amount of PID generated along with the solid-
state phase present in the material based on the overall PRDS and DPro values for 
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